<html lang="en" class="pb-page fonts-loaded fonts-loaded" data-request-id="fb12cd7c-1458-49da-bc22-c9e231dea5ae" style="--article-sticky-top: 82.00019999999999px; --scroll-padding: 163.594px auto auto;"><head data-pb-dropzone="head"><meta name="pbContext" content=";product:product:elsevier\:product\:cell;website:website:cell-site;ctype:string:Journal Content;journal:journal:cell;pageGroup:string:Article View;page:string:Show Full Text;requestedJournal:journal:cell;issue:issue:pii\:S0092867420X00262;wgroup:string:Default Website Group;subPage:string:Full Text;article:article:pii\:S0092867421013222">




<!-- if there is any customization for Responsive Project widget  -->


























    
    







    
            
        



        
                <meta name="robots" content="noarchive,nocache">
            
    






    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=1, user-scalable=1">











        <meta property="og:title" content="Neoantigen-driven B cell and CD4&nbsp;T follicular helper cell collaboration promotes anti-tumor CD8 T&nbsp;cell responses">
    


        <meta property="og:type" content="Article">
    


        <meta property="og:url" content="https://www.cell.com/cell/abstract/S0092-8674(21)01322-2">
    



        <meta property="og:site_name" content="Cell">
    


        <meta property="og:image" content="https://www.cell.com/cms/asset/26f89396-4c7a-4ea7-8c0f-cd635f260eb5/fx1.jpg">
    


        <meta property="og:description" content="B cells promote the differentiation of tumor-specific CD4&nbsp;T follicular helper cells
in a neoantigen-dependent manner, which in turn enhance CD8 T&nbsp;cell effector functions
by producing IL-21 and drive anti-tumor immunity in a murine model of lung adenocarcinoma.">
    











        <meta name="twitter:title" content="Neoantigen-driven B cell and CD4&nbsp;T follicular helper cell collaboration promotes anti-tumor CD8 T&nbsp;cell responses">
    




        <meta name="twitter:image" content="https://www.cell.com/cms/asset/26f89396-4c7a-4ea7-8c0f-cd635f260eb5/fx1.jpg">
    


        <meta name="twitter:description" content="B cells promote the differentiation of tumor-specific CD4&nbsp;T follicular helper cells
in a neoantigen-dependent manner, which in turn enhance CD8 T&nbsp;cell effector functions
by producing IL-21 and drive anti-tumor immunity in a murine model of lung adenocarcinoma.">
    

        <meta name="twitter:card" content="summary_large_image">
    











    
    
            
            
        <link rel="canonical" href="https://www.cell.com/cell/fulltext/S0092-8674(21)01322-2">
    


<meta name="tdm-reservation" content="1">
<meta name="tdm-policy" content="https://www.elsevier.com/tdm/tdmrep-policy.json">

<title>Neoantigen-driven B cell and CD4&nbsp;T follicular helper cell collaboration promotes anti-tumor CD8 T&nbsp;cell responses: Cell</title><meta name="citation_journal_title" content="Cell"> <meta name="citation_journal_abbrev" content="Cell"> <meta name="citation_publisher" content="Elsevier"> <meta name="citation_title" content="Neoantigen-driven B cell and CD4&nbsp;T follicular helper cell collaboration promotes anti-tumor CD8 T&nbsp;cell responses"> <meta name="citation_date" content="2021/12/09"> <meta name="citation_online_date" content="2021/11/30"> <meta name="citation_volume" content="184"> <meta name="citation_issue" content="25"> <meta name="citation_firstpage" content="6101"> <meta name="citation_lastpage" content="6118.e13"> <meta name="citation_pmid" content="34852236"> <meta name="citation_abstract_html_url" content="https://www.cell.com/action/showAbstract?pii=S0092867421013222"> <meta name="citation_fulltext_html_url" content="https://www.cell.com/action/showFullText?pii=S0092867421013222"> <meta name="citation_pdf_url" content="https://www.cell.com/action/showPdf?pii=S0092867421013222"> <meta name="citation_issn" content="0092-8674"> <meta name="citation_issn" content="1097-4172"> <meta name="citation_language" content="English"> <meta name="citation_doi" content="10.1016/j.cell.2021.11.007"> <meta name="citation_pmid" content="34852236"> <meta name="citation_author" content="Can Cui"><meta name="citation_author_orcid" content="0000-0003-4736-4330"><meta name="citation_author_institution" content="Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA"><meta name="citation_author" content="Jiawei Wang"><meta name="citation_author_institution" content="Program of Computational Biology and Bioinformatics, Yale University, New Haven, CT 06510, USA"><meta name="citation_author" content="Eric Fagerberg"><meta name="citation_author_orcid" content="0000-0003-0313-3717"><meta name="citation_author_institution" content="Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA"><meta name="citation_author" content="Ping-Min Chen"><meta name="citation_author_orcid" content="0000-0001-6532-4549"><meta name="citation_author_institution" content="Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA"><meta name="citation_author" content="Kelli A. Connolly"><meta name="citation_author_institution" content="Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA"><meta name="citation_author" content="Martina Damo"><meta name="citation_author_institution" content="Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA"><meta name="citation_author" content="Julie F. Cheung"><meta name="citation_author_orcid" content="0000-0003-1346-0930"><meta name="citation_author_institution" content="Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA"><meta name="citation_author" content="Tianyang Mao"><meta name="citation_author_orcid" content="0000-0001-9251-8592"><meta name="citation_author_institution" content="Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA"><meta name="citation_author" content="Adnan S. Askari"><meta name="citation_author_orcid" content="0000-0001-9511-4702"><meta name="citation_author_institution" content="Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA"><meta name="citation_author" content="Shuting Chen"><meta name="citation_author_institution" content="Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA"><meta name="citation_author" content="Brittany Fitzgerald"><meta name="citation_author_institution" content="Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA"><meta name="citation_author" content="Gena G. Foster"><meta name="citation_author_orcid" content="0000-0003-3482-0579"><meta name="citation_author_institution" content="Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA"><meta name="citation_author" content="Stephanie C. Eisenbarth"><meta name="citation_author_institution" content="Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA"><meta name="citation_author_institution" content="Department of Internal Medicine (Rheumatology, Allergy and Immunology), Yale University School of Medicine, New Haven, CT 06520, USA"><meta name="citation_author_institution" content="Department of Lab Medicine, Yale University School of Medicine, New Haven, CT 06519, USA"><meta name="citation_author" content="Hongyu Zhao"><meta name="citation_author_orcid" content="0000-0003-1195-9607"><meta name="citation_author_institution" content="Department of Biostatistics, Yale School of Public Health, New Haven, CT 06510, USA"><meta name="citation_author" content="Joseph Craft"><meta name="citation_author_email" content="joseph.craft@yale.edu"><meta name="citation_author_institution" content="Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA"><meta name="citation_author_institution" content="Department of Internal Medicine (Rheumatology, Allergy and Immunology), Yale University School of Medicine, New Haven, CT 06520, USA"><meta name="citation_author" content="Nikhil S. Joshi"><meta name="citation_author_email" content="nikhil.joshi@yale.edu"><meta name="citation_author_orcid" content="0000-0002-7045-7837"><meta name="citation_author_institution" content="Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA"><meta name="citation_keywords" content="lung cancer; neoantigen; T follicular helper cell; B cell; IL-21; CD8 T cell"><meta name="citation_reference" content="citation_title=A Modular Assembly Platform for Rapid Generation of DNA Constructs; citation_author=E.H. Akama-Garren; citation_author=N.S. Joshi; citation_author=T. Tammela; citation_author=G.P. Chang; citation_author=B.L. Wagner; citation_author=D.Y. Lee; citation_author=W.M. Rideout; citation_author=T. Papagiannakopoulos; citation_author=W. Xue; citation_author=T. Jacks; citation_journal_title=Sci. Rep.; citation_volume=6; citation_firstpage=16836; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=MHC-II neoantigens shape tumour immunity and response to immunotherapy; citation_author=E. Alspach; citation_author=D.M. Lussier; citation_author=A.P. Miceli; citation_author=I. Kizhvatov; citation_author=M. DuPage; citation_author=A.M. Luoma; citation_author=W. Meng; citation_author=C.F. Lichti; citation_author=E. Esaulova; citation_author=A.N. Vomund; citation_author=et al.; citation_journal_title=Nature; citation_volume=574; citation_firstpage=696; citation_lastpage=701; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Disruption of CD8+ Treg activity results in expansion of T follicular helper cells and enhanced antitumor immunity; citation_author=D.A. Alvarez Arias; citation_author=H.J. Kim; citation_author=P. Zhou; citation_author=T.A. Holderried; citation_author=X. Wang; citation_author=G. Dranoff; citation_author=H. Cantor; citation_journal_title=Cancer Immunol. Res.; citation_volume=2; citation_firstpage=207; citation_lastpage=216; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Gapped sequence alignment using artificial neural networks: application to the MHC class I system; citation_author=M. Andreatta; citation_author=M. Nielsen; citation_journal_title=Bioinformatics; citation_volume=32; citation_doi=10.1093/bioinformatics/btv639; citation_firstpage=511; citation_lastpage=517; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice; citation_author=M. Battegay; citation_author=D. Moskophidis; citation_author=A. Rahemtulla; citation_author=H. Hengartner; citation_author=T.W. Mak; citation_author=R.M. Zinkernagel; citation_journal_title=J.&nbsp;Virol.; citation_volume=68; citation_firstpage=4700; citation_lastpage=4704; citation_publication_date=1994; "><meta name="citation_reference" content="citation_title=Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer; citation_author=G. Bindea; citation_author=B. Mlecnik; citation_author=M. Tosolini; citation_author=A. Kirilovsky; citation_author=M. Waldner; citation_author=A.C. Obenauf; citation_author=H. Angell; citation_author=T. Fredriksen; citation_author=L. Lafontaine; citation_author=A. Berger; citation_author=et al.; citation_journal_title=Immunity; citation_volume=39; citation_firstpage=782; citation_lastpage=795; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21; citation_author=A.V. Bocharnikov; citation_author=J. Keegan; citation_author=V.S. Wacleche; citation_author=Y. Cao; citation_author=C.Y. Fonseka; citation_author=G. Wang; citation_author=E.S. Muise; citation_author=K.X. Zhang; citation_author=A. Arazi; citation_author=G. Keras; citation_author=Accelerating Medicines Partnership (AMP) RA/SLE Network; citation_author=et al.; citation_journal_title=JCI Insight; citation_volume=4; citation_firstpage=130062; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=CD4+ T&nbsp;cell help in cancer immunology and immunotherapy; citation_author=J. Borst; citation_author=T. Ahrends; citation_author=N. Bąbała; citation_author=C.J.M. Melief; citation_author=W. Kastenmüller; citation_journal_title=Nat. Rev. Immunol.; citation_volume=18; citation_firstpage=635; citation_lastpage=647; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries; citation_author=F. Bray; citation_author=J. Ferlay; citation_author=I. Soerjomataram; citation_author=R.L. Siegel; citation_author=L.A. Torre; citation_author=A. Jemal; citation_journal_title=CA Cancer J. Clin.; citation_volume=68; citation_firstpage=394; citation_lastpage=424; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=High-dimensional single cell analysis identifies stem-like cytotoxic CD8+ T&nbsp;cells infiltrating human tumors; citation_author=J. Brummelman; citation_author=E.M.C. Mazza; citation_author=G. Alvisi; citation_author=F.S. Colombo; citation_author=A. Grilli; citation_author=J. Mikulak; citation_author=D. Mavilio; citation_author=M. Alloisio; citation_author=F. Ferrari; citation_author=E. Lopci; citation_author=et al.; citation_journal_title=J.&nbsp;Exp. Med.; citation_volume=215; citation_firstpage=2520; citation_lastpage=2535; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Antigen-Presenting Intratumoral B Cells Affect CD4+ TIL Phenotypes in Non-Small Cell Lung Cancer Patients; citation_author=T.C. Bruno; citation_author=P.J. Ebner; citation_author=B.L. Moore; citation_author=O.G. Squalls; citation_author=K.A. Waugh; citation_author=E.B. Eruslanov; citation_author=S. Singhal; citation_author=J.D. Mitchell; citation_author=W.A. Franklin; citation_author=D.T. Merrick; citation_author=et al.; citation_journal_title=Cancer Immunol. Res.; citation_volume=5; citation_firstpage=898; citation_lastpage=907; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Germinal center antibody mutation trajectories are determined by rapid self/foreign discrimination; citation_author=D.L. Burnett; citation_author=D.B. Langley; citation_author=P. Schofield; citation_author=J.R. Hermes; citation_author=T.D. Chan; citation_author=J. Jackson; citation_author=K. Bourne; citation_author=J.H. Reed; citation_author=K. Patterson; citation_author=B.T. Porebski; citation_author=et al.; citation_journal_title=Science; citation_volume=360; citation_firstpage=223; citation_lastpage=226; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Tertiary lymphoid structures improve immunotherapy and survival in melanoma; citation_author=R. Cabrita; citation_author=M. Lauss; citation_author=A. Sanna; citation_author=M. Donia; citation_author=M. Skaarup Larsen; citation_author=S. Mitra; citation_author=I. Johansson; citation_author=B. Phung; citation_author=K. Harbst; citation_author=J. Vallon-Christersson; citation_author=et al.; citation_journal_title=Nature; citation_volume=577; citation_firstpage=561; citation_lastpage=565; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=BATF regulates progenitor to cytolytic effector CD8+ T&nbsp;cell transition during chronic viral infection; citation_author=Y. Chen; citation_author=R.A. Zander; citation_author=X. Wu; citation_author=D.M. Schauder; citation_author=M.Y. Kasmani; citation_author=J. Shen; citation_author=S. Zheng; citation_author=R. Burns; citation_author=E.J. Taparowsky; citation_author=W. Cui; citation_journal_title=Nat. Immunol.; citation_volume=22; citation_firstpage=996; citation_lastpage=1007; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6; citation_author=Y.S. Choi; citation_author=R. Kageyama; citation_author=D. Eto; citation_author=T.C. Escobar; citation_author=R.J. Johnston; citation_author=L. Monticelli; citation_author=C. Lao; citation_author=S. Crotty; citation_journal_title=Immunity; citation_volume=34; citation_firstpage=932; citation_lastpage=946; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Dynamic regulation of Bcl6 in follicular helper CD4&nbsp;T (Tfh) cells; citation_author=Y.S. Choi; citation_author=J.A. Yang; citation_author=S. Crotty; citation_journal_title=Curr. Opin. Immunol.; citation_volume=25; citation_firstpage=366; citation_lastpage=372; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells; citation_author=T. Chtanova; citation_author=S.G. Tangye; citation_author=R. Newton; citation_author=N. Frank; citation_author=M.R. Hodge; citation_author=M.S. Rolph; citation_author=C.R. Mackay; citation_journal_title=J.&nbsp;Immunol.; citation_volume=173; citation_firstpage=68; citation_lastpage=78; citation_publication_date=2004; "><meta name="citation_reference" content="citation_title=Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer; citation_author=A.R. Cillo; citation_author=C.H.L. Kürten; citation_author=T. Tabib; citation_author=Z. Qi; citation_author=S. Onkar; citation_author=T. Wang; citation_author=A. Liu; citation_author=U. Duvvuri; citation_author=S. Kim; citation_author=R.J. Soose; citation_author=et al.; citation_journal_title=Immunity; citation_volume=52; citation_firstpage=183; citation_lastpage=199.e9; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=A reservoir of stem-like CD8+ T&nbsp;cells in the tumor-draining lymph node preserves the ongoing antitumor immune response; citation_author=K.A. Connolly; citation_author=M. Kuchroo; citation_author=A. Venkat; citation_author=A. Khatun; citation_author=J. Wang; citation_author=I. William; citation_author=N.I. Hornick; citation_author=B.L. Fitzgerald; citation_author=M. Damo; citation_author=M.Y. Kasmani; citation_author=et al.; citation_journal_title=Sci. Immunol.; citation_volume=6; citation_firstpage=eabg7836; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production; citation_author=J.M. Coquet; citation_author=K. Kyparissoudis; citation_author=D.G. Pellicci; citation_author=G. Besra; citation_author=S.P. Berzins; citation_author=M.J. Smyth; citation_author=D.I. Godfrey; citation_journal_title=J.&nbsp;Immunol.; citation_volume=178; citation_firstpage=2827; citation_lastpage=2834; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=Follicular helper CD4 T&nbsp;cells (TFH); citation_author=S. Crotty; citation_journal_title=Annu. Rev. Immunol.; citation_volume=29; citation_firstpage=621; citation_lastpage=663; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=T Follicular Helper Cell Biology: A Decade of Discovery and Diseases; citation_author=S. Crotty; citation_journal_title=Immunity; citation_volume=50; citation_firstpage=1132; citation_lastpage=1148; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=B Cell Responses: Cell Interaction Dynamics and Decisions; citation_author=J.G. Cyster; citation_author=C.D.C. Allen; citation_journal_title=Cell; citation_volume=177; citation_firstpage=524; citation_lastpage=540; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Inducible de novo expression of neoantigens in tumor cells and mice; citation_author=M. Damo; citation_author=B. Fitzgerald; citation_author=Y. Lu; citation_author=M. Nader; citation_author=I. William; citation_author=J.F. Cheung; citation_author=K.A. Connolly; citation_author=G.G. Foster; citation_author=E. Akama-Garren; citation_author=D.Y. Lee; citation_author=et al.; citation_journal_title=Nat. Biotechnol.; citation_volume=39; citation_firstpage=64; citation_lastpage=73; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=Targeting tumors with IL-21 reshapes the tumor microenvironment by proliferating PD-1intTim-3-CD8+ T&nbsp;cells; citation_author=S. Deng; citation_author=Z. Sun; citation_author=J. Qiao; citation_author=Y. Liang; citation_author=L. Liu; citation_author=C. Dong; citation_author=A. Shen; citation_author=Y. Wang; citation_author=H. Tang; citation_author=Y.X. Fu; citation_author=H. Peng; citation_journal_title=JCI Insight; citation_volume=5; citation_firstpage=132000; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures; citation_author=M.C. Dieu-Nosjean; citation_author=M. Antoine; citation_author=C. Danel; citation_author=D. Heudes; citation_author=M. Wislez; citation_author=V. Poulot; citation_author=N. Rabbe; citation_author=L. Laurans; citation_author=E. Tartour; citation_author=L. de Chaisemartin; citation_author=et al.; citation_journal_title=J.&nbsp;Clin. Oncol.; citation_volume=26; citation_firstpage=4410; citation_lastpage=4417; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase; citation_author=M. DuPage; citation_author=A.L. Dooley; citation_author=T. Jacks; citation_journal_title=Nat. Protoc.; citation_volume=4; citation_firstpage=1064; citation_lastpage=1072; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Endogenous T&nbsp;cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression; citation_author=M. DuPage; citation_author=A.F. Cheung; citation_author=C. Mazumdar; citation_author=M.M. Winslow; citation_author=R. Bronson; citation_author=L.M. Schmidt; citation_author=D. Crowley; citation_author=J. Chen; citation_author=T. Jacks; citation_journal_title=Cancer Cell; citation_volume=19; citation_firstpage=72; citation_lastpage=85; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Molecular mechanism and function of CD40/CD40L engagement in the immune system; citation_author=R. Elgueta; citation_author=M.J. Benson; citation_author=V.C. de Vries; citation_author=A. Wasiuk; citation_author=Y. Guo; citation_author=R.J. Noelle; citation_journal_title=Immunol. Rev.; citation_volume=229; citation_firstpage=152; citation_lastpage=172; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=IL-21 is required to control chronic viral infection; citation_author=H. Elsaesser; citation_author=K. Sauer; citation_author=D.G. Brooks; citation_journal_title=Science; citation_volume=324; citation_firstpage=1569; citation_lastpage=1572; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity; citation_author=V.H. Engelhard; citation_author=A.B. Rodriguez; citation_author=I.S. Mauldin; citation_author=A.N. Woods; citation_author=J.D. Peske; citation_author=C.L. Slingluff; citation_journal_title=J.&nbsp;Immunol.; citation_volume=200; citation_firstpage=432; citation_lastpage=442; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020; citation_author=D.S. Ettinger; citation_author=D.E. Wood; citation_author=C. Aggarwal; citation_author=D.L. Aisner; citation_author=W. Akerley; citation_author=J.R. Bauman; citation_author=A. Bharat; citation_author=D.S. Bruno; citation_author=J.Y. Chang; citation_author=L.R. Chirieac; citation_author=OCN; citation_author=et al.; citation_journal_title=J.&nbsp;Natl. Compr. Canc. Netw.; citation_volume=17; citation_firstpage=1464; citation_lastpage=1472; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=cDC1 prime and are licensed by CD4+ T&nbsp;cells to induce anti-tumour immunity; citation_author=S.T. Ferris; citation_author=V. Durai; citation_author=R. Wu; citation_author=D.J. Theisen; citation_author=J.P. Ward; citation_author=M.D. Bern; citation_author=J.T. Davidson; citation_author=P. Bagadia; citation_author=T. Liu; citation_author=C.G. Briseño; citation_author=et al.; citation_journal_title=Nature; citation_volume=584; citation_firstpage=624; citation_lastpage=629; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=A mouse model for the study of anti-tumor T&nbsp;cell responses in Kras-driven lung adenocarcinoma; citation_author=B. Fitzgerald; citation_author=K.A. Connolly; citation_author=C. Cui; citation_author=E. Fagerberg; citation_author=D.L. Mariuzza; citation_author=N.I. Hornick; citation_author=G.G. Foster; citation_author=I. William; citation_author=J.F. Cheung; citation_author=N.S. Joshi; citation_journal_title=Cell Rep Methods; citation_volume=1; citation_firstpage=100080; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=Neoadjuvant PD-1 Blockade in Resectable Lung Cancer; citation_author=P.M. Forde; citation_author=J.E. Chaft; citation_author=K.N. Smith; citation_author=V. Anagnostou; citation_author=T.R. Cottrell; citation_author=M.D. Hellmann; citation_author=M. Zahurak; citation_author=S.C. Yang; citation_author=D.R. Jones; citation_author=S. Broderick; citation_author=et al.; citation_journal_title=N.&nbsp;Engl. J. Med.; citation_volume=378; citation_firstpage=1976; citation_lastpage=1986; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=The immune contexture in cancer prognosis and treatment; citation_author=W.H. Fridman; citation_author=L. Zitvogel; citation_author=C. Sautès-Fridman; citation_author=G. Kroemer; citation_journal_title=Nat. Rev. Clin. Oncol.; citation_volume=14; citation_firstpage=717; citation_lastpage=734; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=IL-21R on T&nbsp;cells is critical for sustained functionality and control of chronic viral infection; citation_author=A. Fröhlich; citation_author=J. Kisielow; citation_author=I. Schmitz; citation_author=S. Freigang; citation_author=A.T. Shamshiev; citation_author=J. Weber; citation_author=B.J. Marsland; citation_author=A. Oxenius; citation_author=M. Kopf; citation_journal_title=Science; citation_volume=324; citation_firstpage=1576; citation_lastpage=1580; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures; citation_author=J. Galon; citation_author=H.K. Angell; citation_author=D. Bedognetti; citation_author=F.M. Marincola; citation_journal_title=Immunity; citation_volume=39; citation_firstpage=11; citation_lastpage=26; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer; citation_author=L. Gandhi; citation_author=D. Rodríguez-Abreu; citation_author=S. Gadgeel; citation_author=E. Esteban; citation_author=E. Felip; citation_author=F. De Angelis; citation_author=M. Domine; citation_author=P. Clingan; citation_author=M.J. Hochmair; citation_author=S.F. Powell; citation_author=KEYNOTE-189 Investigators; citation_author=et al.; citation_journal_title=N.&nbsp;Engl. J. Med.; citation_volume=378; citation_firstpage=2078; citation_lastpage=2092; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer; citation_author=S. Garaud; citation_author=L. Buisseret; citation_author=C. Solinas; citation_author=C. Gu-Trantien; citation_author=A. de Wind; citation_author=G. Van den Eynden; citation_author=C. Naveaux; citation_author=J.N. Lodewyckx; citation_author=A. Boisson; citation_author=H. Duvillier; citation_author=et al.; citation_journal_title=JCI Insight; citation_volume=5; citation_firstpage=129641; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer; citation_author=C. Germain; citation_author=S. Gnjatic; citation_author=F. Tamzalit; citation_author=S. Knockaert; citation_author=R. Remark; citation_author=J. Goc; citation_author=A. Lepelley; citation_author=E. Becht; citation_author=S. Katsahian; citation_author=G. Bizouard; citation_author=et al.; citation_journal_title=Am. J. Respir. Crit. Care Med.; citation_volume=189; citation_firstpage=832; citation_lastpage=844; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers; citation_author=S.N. Gettinger; citation_author=J. Choi; citation_author=N. Mani; citation_author=M.F. Sanmamed; citation_author=I. Datar; citation_author=R. Sowell; citation_author=V.Y. Du; citation_author=E. Kaftan; citation_author=S. Goldberg; citation_author=W. Dong; citation_author=et al.; citation_journal_title=Nat. Commun.; citation_volume=9; citation_firstpage=3196; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T&nbsp;cells; citation_author=J. Goc; citation_author=C. Germain; citation_author=T.K. Vo-Bourgais; citation_author=A. Lupo; citation_author=C. Klein; citation_author=S. Knockaert; citation_author=L. de Chaisemartin; citation_author=H. Ouakrim; citation_author=E. Becht; citation_author=M. Alifano; citation_author=et al.; citation_journal_title=Cancer Res.; citation_volume=74; citation_firstpage=705; citation_lastpage=715; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice; citation_author=C.C. Goodnow; citation_author=J. Crosbie; citation_author=S. Adelstein; citation_author=T.B. Lavoie; citation_author=S.J. Smith-Gill; citation_author=R.A. Brink; citation_author=H. Pritchard-Briscoe; citation_author=J.S. Wotherspoon; citation_author=R.H. Loblay; citation_author=K. Raphael; citation_author=et al.; citation_journal_title=Nature; citation_volume=334; citation_firstpage=676; citation_lastpage=682; citation_publication_date=1988; "><meta name="citation_reference" content="citation_title=B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma; citation_author=J. Griss; citation_author=W. Bauer; citation_author=C. Wagner; citation_author=M. Simon; citation_author=M. Chen; citation_author=K. Grabmeier-Pfistershammer; citation_author=M. Maurer-Granofszky; citation_author=F. Roka; citation_author=T. Penz; citation_author=C. Bock; citation_author=et al.; citation_journal_title=Nat. Commun.; citation_volume=10; citation_firstpage=4186; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=CD4+ follicular helper T&nbsp;cell infiltration predicts breast cancer survival; citation_author=C. Gu-Trantien; citation_author=S. Loi; citation_author=S. Garaud; citation_author=C. Equeter; citation_author=M. Libin; citation_author=A. de Wind; citation_author=M. Ravoet; citation_author=H. Le Buanec; citation_author=C. Sibille; citation_author=G. Manfouo-Foutsop; citation_author=et al.; citation_journal_title=J.&nbsp;Clin. Invest.; citation_volume=123; citation_firstpage=2873; citation_lastpage=2892; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer; citation_author=C. Gu-Trantien; citation_author=E. Migliori; citation_author=L. Buisseret; citation_author=A. de Wind; citation_author=S. Brohée; citation_author=S. Garaud; citation_author=G. Noël; citation_author=V.L. Dang Chi; citation_author=J.N. Lodewyckx; citation_author=C. Naveaux; citation_author=et al.; citation_journal_title=JCI Insight; citation_volume=2; citation_firstpage=91487; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Global characterization of T&nbsp;cells in non-small-cell lung cancer by single-cell sequencing; citation_author=X. Guo; citation_author=Y. Zhang; citation_author=L. Zheng; citation_author=C. Zheng; citation_author=J. Song; citation_author=Q. Zhang; citation_author=B. Kang; citation_author=Z. Liu; citation_author=L. Jin; citation_author=R. Xing; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=24; citation_firstpage=978; citation_lastpage=985; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Distinct memory CD4+ T&nbsp;cells with commitment to T follicular helper- and T helper 1-cell lineages are generated after acute viral infection; citation_author=J.S. Hale; citation_author=B. Youngblood; citation_author=D.R. Latner; citation_author=A.U. Mohammed; citation_author=L. Ye; citation_author=R.S. Akondy; citation_author=T. Wu; citation_author=S.S. Iyer; citation_author=R. Ahmed; citation_journal_title=Immunity; citation_volume=38; citation_firstpage=805; citation_lastpage=817; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update; citation_author=N.H. Hanna; citation_author=B.J. Schneider; citation_author=S. Temin; citation_author=S. Baker; citation_author=J. Brahmer; citation_author=P.M. Ellis; citation_author=L.E. Gaspar; citation_author=R.Y. Haddad; citation_author=P.J. Hesketh; citation_author=D. Jain; citation_author=et al.; citation_journal_title=J.&nbsp;Clin. Oncol.; citation_volume=38; citation_firstpage=1608; citation_lastpage=1632; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Follicular CXCR5- expressing CD8(+) T&nbsp;cells curtail chronic viral infection; citation_author=R. He; citation_author=S. Hou; citation_author=C. Liu; citation_author=A. Zhang; citation_author=Q. Bai; citation_author=M. Han; citation_author=Y. Yang; citation_author=G. Wei; citation_author=T. Shen; citation_author=X. Yang; citation_author=et al.; citation_journal_title=Nature; citation_volume=537; citation_firstpage=412; citation_lastpage=428; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=B cells and tertiary lymphoid structures promote immunotherapy response; citation_author=B.A. Helmink; citation_author=S.M. Reddy; citation_author=J. Gao; citation_author=S. Zhang; citation_author=R. Basar; citation_author=R. Thakur; citation_author=K. Yizhak; citation_author=M. Sade-Feldman; citation_author=J. Blando; citation_author=G. Han; citation_author=et al.; citation_journal_title=Nature; citation_volume=577; citation_firstpage=549; citation_lastpage=555; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Tumor infiltration by Tbet+ effector T&nbsp;cells and CD20+ B cells is associated with survival in gastric cancer patients; citation_author=A. Hennequin; citation_author=V. Derangère; citation_author=R. Boidot; citation_author=L. Apetoh; citation_author=J. Vincent; citation_author=D. Orry; citation_author=J. Fraisse; citation_author=S. Causeret; citation_author=F. Martin; citation_author=L. Arnould; citation_author=et al.; citation_journal_title=OncoImmunology; citation_volume=5; citation_firstpage=e1054598; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC; citation_author=R.S. Herbst; citation_author=G. Giaccone; citation_author=F. de Marinis; citation_author=N. Reinmuth; citation_author=A. Vergnenegre; citation_author=C.H. Barrios; citation_author=M. Morise; citation_author=E. Felip; citation_author=Z. Andric; citation_author=S. Geater; citation_author=et al.; citation_journal_title=N.&nbsp;Engl. J. Med.; citation_volume=383; citation_firstpage=1328; citation_lastpage=1339; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer; citation_author=D.P. Hollern; citation_author=N. Xu; citation_author=A. Thennavan; citation_author=C. Glodowski; citation_author=S. Garcia-Recio; citation_author=K.R. Mott; citation_author=X. He; citation_author=J.P. Garay; citation_author=K. Carey-Ewend; citation_author=D. Marron; citation_author=et al.; citation_journal_title=Cell; citation_volume=179; citation_firstpage=1191; citation_lastpage=1206.e21; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Insights into the role of Bcl6 in follicular Th cells using a new conditional mutant mouse model; citation_author=K. Hollister; citation_author=S. Kusam; citation_author=H. Wu; citation_author=N. Clegg; citation_author=A. Mondal; citation_author=D.V. Sawant; citation_author=A.L. Dent; citation_journal_title=J.&nbsp;Immunol.; citation_volume=191; citation_firstpage=3705; citation_lastpage=3711; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=T-cell invigoration to tumour burden ratio associated with anti-PD-1 response; citation_author=A.C. Huang; citation_author=M.A. Postow; citation_author=R.J. Orlowski; citation_author=R. Mick; citation_author=B. Bengsch; citation_author=S. Manne; citation_author=W. Xu; citation_author=S. Harmon; citation_author=J.R. Giles; citation_author=B. Wenz; citation_author=et al.; citation_journal_title=Nature; citation_volume=545; citation_firstpage=60; citation_lastpage=65; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Defining CD8+ T&nbsp;cells that provide the proliferative burst after PD-1 therapy; citation_author=S.J. Im; citation_author=M. Hashimoto; citation_author=M.Y. Gerner; citation_author=J. Lee; citation_author=H.T. Kissick; citation_author=M.C. Burger; citation_author=Q. Shan; citation_author=J.S. Hale; citation_author=J. Lee; citation_author=T.H. Nasti; citation_author=et al.; citation_journal_title=Nature; citation_volume=537; citation_firstpage=417; citation_lastpage=421; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=PD-1+ stemlike CD8 T&nbsp;cells are resident in lymphoid tissues during persistent LCMV infection; citation_author=S.J. Im; citation_author=B.T. Konieczny; citation_author=W.H. Hudson; citation_author=D. Masopust; citation_author=R. Ahmed; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=117; citation_firstpage=4292; citation_lastpage=4299; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=T Follicular Helper Cell-Germinal Center B Cell Interaction Strength Regulates Entry into Plasma Cell or Recycling Germinal Center Cell Fate; citation_author=W. Ise; citation_author=K. Fujii; citation_author=K. Shiroguchi; citation_author=A. Ito; citation_author=K. Kometani; citation_author=K. Takeda; citation_author=E. Kawakami; citation_author=K. Yamashita; citation_author=K. Suzuki; citation_author=T. Okada; citation_author=T. Kurosaki; citation_journal_title=Immunity; citation_volume=48; citation_firstpage=702; citation_lastpage=715.e4; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Intratumoral delivery of RIG-I agonist SLR14 induces robust antitumor responses; citation_author=X. Jiang; citation_author=V. Muthusamy; citation_author=O. Fedorova; citation_author=Y. Kong; citation_author=D.J. Kim; citation_author=M. Bosenberg; citation_author=A.M. Pyle; citation_author=A. Iwasaki; citation_journal_title=J.&nbsp;Exp. Med.; citation_volume=216; citation_firstpage=2854; citation_lastpage=2868; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation; citation_author=R.J. Johnston; citation_author=A.C. Poholek; citation_author=D. DiToro; citation_author=I. Yusuf; citation_author=D. Eto; citation_author=B. Barnett; citation_author=A.L. Dent; citation_author=J. Craft; citation_author=S. Crotty; citation_journal_title=Science; citation_volume=325; citation_firstpage=1006; citation_lastpage=1010; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses; citation_author=N.S. Joshi; citation_author=E.H. Akama-Garren; citation_author=Y. Lu; citation_author=D.Y. Lee; citation_author=G.P. Chang; citation_author=A. Li; citation_author=M. DuPage; citation_author=T. Tammela; citation_author=N.R. Kerper; citation_author=A.F. Farago; citation_author=et al.; citation_journal_title=Immunity; citation_volume=43; citation_firstpage=579; citation_lastpage=590; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Germinal center B cell and T follicular helper cell development initiates in the interfollicular zone; citation_author=S.M. Kerfoot; citation_author=G. Yaari; citation_author=J.R. Patel; citation_author=K.L. Johnson; citation_author=D.G. Gonzalez; citation_author=S.H. Kleinstein; citation_author=A.M. Haberman; citation_journal_title=Immunity; citation_volume=34; citation_firstpage=947; citation_lastpage=960; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Neoantigen vaccine generates intratumoral T&nbsp;cell responses in phase Ib glioblastoma trial; citation_author=D.B. Keskin; citation_author=A.J. Anandappa; citation_author=J. Sun; citation_author=I. Tirosh; citation_author=N.D. Mathewson; citation_author=S. Li; citation_author=G. Oliveira; citation_author=A. Giobbie-Hurder; citation_author=K. Felt; citation_author=E. Gjini; citation_author=et al.; citation_journal_title=Nature; citation_volume=565; citation_firstpage=234; citation_lastpage=239; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma; citation_author=N. Kim; citation_author=H.K. Kim; citation_author=K. Lee; citation_author=Y. Hong; citation_author=J.H. Cho; citation_author=J.W. Choi; citation_author=J.I. Lee; citation_author=Y.L. Suh; citation_author=B.M. Ku; citation_author=H.H. Eum; citation_author=et al.; citation_journal_title=Nat. Commun.; citation_volume=11; citation_firstpage=2285; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Generation of T follicular helper cells in&nbsp;vitro: requirement for B-cell receptor cross-linking and cognate B- and T-cell interaction; citation_author=A. Kolenbrander; citation_author=B. Grewe; citation_author=D. Nemazee; citation_author=K. Überla; citation_author=V. Temchura; citation_journal_title=Immunology; citation_volume=153; citation_firstpage=214; citation_lastpage=224; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells; citation_author=T. Korn; citation_author=E. Bettelli; citation_author=W. Gao; citation_author=A. Awasthi; citation_author=A. Jäger; citation_author=T.B. Strom; citation_author=M. Oukka; citation_author=V.K. Kuchroo; citation_journal_title=Nature; citation_volume=448; citation_firstpage=484; citation_lastpage=487; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=Mutant MHC class II epitopes drive therapeutic immune responses to cancer; citation_author=S. Kreiter; citation_author=M. Vormehr; citation_author=N. van de Roemer; citation_author=M. Diken; citation_author=M. Löwer; citation_author=J. Diekmann; citation_author=S. Boegel; citation_author=B. Schrörs; citation_author=F. Vascotto; citation_author=J.C. Castle; citation_author=et al.; citation_journal_title=Nature; citation_volume=520; citation_firstpage=692; citation_lastpage=696; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer; citation_author=D.R. Kroeger; citation_author=K. Milne; citation_author=B.H. Nelson; citation_journal_title=Clin. Cancer Res.; citation_volume=22; citation_firstpage=3005; citation_lastpage=3015; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T&nbsp;cells; citation_author=R. Lapointe; citation_author=A. Bellemare-Pelletier; citation_author=F. Housseau; citation_author=J. Thibodeau; citation_author=P. Hwu; citation_journal_title=Cancer Res.; citation_volume=63; citation_firstpage=2836; citation_lastpage=2843; citation_publication_date=2003; "><meta name="citation_reference" content="citation_title=Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma; citation_author=C. Lee-Chang; citation_author=J. Miska; citation_author=D. Hou; citation_author=A. Rashidi; citation_author=P. Zhang; citation_author=R.A. Burga; citation_author=I. Jusué-Torres; citation_author=T. Xiao; citation_author=V.A. Arrieta; citation_author=D.Y. Zhang; citation_author=et al.; citation_journal_title=J.&nbsp;Exp. Med.; citation_volume=218; citation_firstpage=e20200913; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=CXCR5(+) follicular cytotoxic T&nbsp;cells control viral infection in B cell follicles; citation_author=Y.A. Leong; citation_author=Y. Chen; citation_author=H.S. Ong; citation_author=D. Wu; citation_author=K. Man; citation_author=C. Deleage; citation_author=M. Minnich; citation_author=B.J. Meckiff; citation_author=Y. Wei; citation_author=Z. Hou; citation_author=et al.; citation_journal_title=Nat. Immunol.; citation_volume=17; citation_firstpage=1187; citation_lastpage=1196; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Association of circulating follicular helper T&nbsp;cells with disease course of NMO spectrum disorders; citation_author=Y.J. Li; citation_author=F. Zhang; citation_author=Y. Qi; citation_author=G.Q. Chang; citation_author=Y. Fu; citation_author=L. Su; citation_author=Y. Shen; citation_author=N. Sun; citation_author=A. Borazanci; citation_author=C. Yang; citation_author=et al.; citation_journal_title=J.&nbsp;Neuroimmunol.; citation_volume=278; citation_firstpage=239; citation_lastpage=246; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Dysfunctional CD8&nbsp;T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma; citation_author=H. Li; citation_author=A.M. van der Leun; citation_author=I. Yofe; citation_author=Y. Lubling; citation_author=D. Gelbard-Solodkin; citation_author=A.C.J. van Akkooi; citation_author=M. van den Braber; citation_author=E.A. Rozeman; citation_author=J.B.A.G. Haanen; citation_author=C.U. Blank; citation_author=et al.; citation_journal_title=Cell; citation_volume=176; citation_firstpage=775; citation_lastpage=789.e18; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Targeting IL-21 to tumor-reactive T&nbsp;cells enhances memory T&nbsp;cell responses and anti-PD-1 antibody therapy; citation_author=Y. Li; citation_author=Y. Cong; citation_author=M. Jia; citation_author=Q. He; citation_author=H. Zhong; citation_author=Y. Zhao; citation_author=H. Li; citation_author=M. Yan; citation_author=J. You; citation_author=J. Liu; citation_author=et al.; citation_journal_title=Nat. Commun.; citation_volume=12; citation_firstpage=951; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T&nbsp;cells in human melanoma; citation_author=C. Linnemann; citation_author=M.M. van Buuren; citation_author=L. Bies; citation_author=E.M. Verdegaal; citation_author=R. Schotte; citation_author=J.J. Calis; citation_author=S. Behjati; citation_author=A. Velds; citation_author=H. Hilkmann; citation_author=D.E. Atmioui; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=21; citation_firstpage=81; citation_lastpage=85; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses; citation_author=M.A. Linterman; citation_author=L. Beaton; citation_author=D. Yu; citation_author=R.R. Ramiscal; citation_author=M. Srivastava; citation_author=J.J. Hogan; citation_author=N.K. Verma; citation_author=M.J. Smyth; citation_author=R.J. Rigby; citation_author=C.G. Vinuesa; citation_journal_title=J.&nbsp;Exp. Med.; citation_volume=207; citation_firstpage=353; citation_lastpage=363; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=T-B-cell entanglement and ICOSL-driven feed-forward regulation of germinal centre reaction; citation_author=D. Liu; citation_author=H. Xu; citation_author=C. Shih; citation_author=Z. Wan; citation_author=X. Ma; citation_author=W. Ma; citation_author=D. Luo; citation_author=H. Qi; citation_journal_title=Nature; citation_volume=517; citation_firstpage=214; citation_lastpage=218; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=TGF-β suppresses type 2 immunity to cancer; citation_author=M. Liu; citation_author=F. Kuo; citation_author=K.J. Capistrano; citation_author=D. Kang; citation_author=B.G. Nixon; citation_author=W. Shi; citation_author=C. Chou; citation_author=M.H. Do; citation_author=E.G. Stamatiades; citation_author=S. Gao; citation_author=et al.; citation_journal_title=Nature; citation_volume=587; citation_firstpage=115; citation_lastpage=120; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Multiparametric profiling of non-small-cell lung cancers reveals distinct immunophenotypes; citation_author=P.H. Lizotte; citation_author=E.V. Ivanova; citation_author=M.M. Awad; citation_author=R.E. Jones; citation_author=L. Keogh; citation_author=H. Liu; citation_author=R. Dries; citation_author=C. Almonte; citation_author=G.S. Herter-Sprie; citation_author=A. Santos; citation_author=et al.; citation_journal_title=JCI Insight; citation_volume=1; citation_firstpage=e89014; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Complement Signals Determine Opposite Effects of B Cells in Chemotherapy-Induced Immunity; citation_author=Y. Lu; citation_author=Q. Zhao; citation_author=J.Y. Liao; citation_author=E. Song; citation_author=Q. Xia; citation_author=J. Pan; citation_author=Y. Li; citation_author=J. Li; citation_author=B. Zhou; citation_author=Y. Ye; citation_author=et al.; citation_journal_title=Cell; citation_volume=180; citation_firstpage=1081; citation_lastpage=1097.e24; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Single-Cell Profiling Defines Transcriptomic Signatures Specific to Tumor-Reactive versus Virus-Responsive CD4+ T Cells; citation_author=A. Magen; citation_author=J. Nie; citation_author=T. Ciucci; citation_author=S. Tamoutounour; citation_author=Y. Zhao; citation_author=M. Mehta; citation_author=B. Tran; citation_author=D.B. McGavern; citation_author=S. Hannenhalli; citation_author=R. Bosselut; citation_journal_title=Cell Rep.; citation_volume=29; citation_firstpage=3019; citation_lastpage=3032.e6; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint; citation_author=A. Manzo; citation_author=B. Vitolo; citation_author=F. Humby; citation_author=R. Caporali; citation_author=D. Jarrossay; citation_author=F. Dell’accio; citation_author=L. Ciardelli; citation_author=M. Uguccioni; citation_author=C. Montecucco; citation_author=C. Pitzalis; citation_journal_title=Arthritis Rheum.; citation_volume=58; citation_firstpage=3377; citation_lastpage=3387; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=Differential expression of Ly6C and T-bet distinguish effector and memory Th1 CD4(+) cell properties during viral infection; citation_author=H.D. Marshall; citation_author=A. Chandele; citation_author=Y.W. Jung; citation_author=H. Meng; citation_author=A.C. Poholek; citation_author=I.A. Parish; citation_author=R. Rutishauser; citation_author=W. Cui; citation_author=S.H. Kleinstein; citation_author=J. Craft; citation_author=S.M. Kaech; citation_journal_title=Immunity; citation_volume=35; citation_firstpage=633; citation_lastpage=646; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=T helper 17 cells promote cytotoxic T&nbsp;cell activation in tumor immunity; citation_author=N. Martin-Orozco; citation_author=P. Muranski; citation_author=Y. Chung; citation_author=X.O. Yang; citation_author=T. Yamazaki; citation_author=S. Lu; citation_author=P. Hwu; citation_author=N.P. Restifo; citation_author=W.W. Overwijk; citation_author=C. Dong; citation_journal_title=Immunity; citation_volume=31; citation_firstpage=787; citation_lastpage=798; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=CD4+ T&nbsp;cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection; citation_author=M. Matloubian; citation_author=R.J. Concepcion; citation_author=R. Ahmed; citation_journal_title=J.&nbsp;Virol.; citation_volume=68; citation_firstpage=8056; citation_lastpage=8063; citation_publication_date=1994; "><meta name="citation_reference" content="citation_title=Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinoma; citation_author=D.G. McFadden; citation_author=K. Politi; citation_author=A. Bhutkar; citation_author=F.K. Chen; citation_author=X. Song; citation_author=M. Pirun; citation_author=P.M. Santiago; citation_author=C. Kim-Kiselak; citation_author=J.T. Platt; citation_author=E. Lee; citation_author=et al.; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=113; citation_firstpage=E6409; citation_lastpage=E6417; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Germinal Center B Cell Dynamics; citation_author=L. Mesin; citation_author=J. Ersching; citation_author=G.D. Victora; citation_journal_title=Immunity; citation_volume=45; citation_firstpage=471; citation_lastpage=482; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T&nbsp;cell site; citation_author=D.R. Milich; citation_author=A. McLachlan; citation_author=G.B. Thornton; citation_author=J.L. Hughes; citation_journal_title=Nature; citation_volume=329; citation_firstpage=547; citation_lastpage=549; citation_publication_date=1987; "><meta name="citation_reference" content="citation_title=Human germinal center transcriptional programs are de-synchronized in B cell lymphoma; citation_author=P. Milpied; citation_author=I. Cervera-Marzal; citation_author=M.L. Mollichella; citation_author=B. Tesson; citation_author=G. Brisou; citation_author=A. Traverse-Glehen; citation_author=G. Salles; citation_author=L. Spinelli; citation_author=B. Nadel; citation_journal_title=Nat. Immunol.; citation_volume=19; citation_firstpage=1013; citation_lastpage=1024; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=The carrier effect in the secondary response to hapten-protein conjugates. I. Measurement of the effect with transferred cells and objections to the local environment hypothesis; citation_author=N.A. Mitchison; citation_journal_title=Eur. J. Immunol.; citation_volume=1; citation_firstpage=10; citation_lastpage=17; citation_publication_date=1971; "><meta name="citation_reference" content="citation_title=The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation; citation_author=N.A. Mitchison; citation_journal_title=Eur. J. Immunol.; citation_volume=1; citation_firstpage=18; citation_lastpage=27; citation_publication_date=1971; "><meta name="citation_reference" content="citation_title=Human blood CXCR5(+)CD4(+) T&nbsp;cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion; citation_author=R. Morita; citation_author=N. Schmitt; citation_author=S.E. Bentebibel; citation_author=R. Ranganathan; citation_author=L. Bourdery; citation_author=G. Zurawski; citation_author=E. Foucat; citation_author=M. Dullaers; citation_author=S. Oh; citation_author=N. Sabzghabaei; citation_author=et al.; citation_journal_title=Immunity; citation_volume=34; citation_firstpage=108; citation_lastpage=121; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Early Th1 cell differentiation is marked by a Tfh cell-like transition; citation_author=S. Nakayamada; citation_author=Y. Kanno; citation_author=H. Takahashi; citation_author=D. Jankovic; citation_author=K.T. Lu; citation_author=T.A. Johnson; citation_author=H.W. Sun; citation_author=G. Vahedi; citation_author=O. Hakim; citation_author=R. Handon; citation_author=et al.; citation_journal_title=Immunity; citation_volume=35; citation_firstpage=919; citation_lastpage=931; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Robust enumeration of cell subsets from tissue expression profiles; citation_author=A.M. Newman; citation_author=C.L. Liu; citation_author=M.R. Green; citation_author=A.J. Gentles; citation_author=W. Feng; citation_author=Y. Xu; citation_author=C.D. Hoang; citation_author=M. Diehn; citation_author=A.A. Alizadeh; citation_journal_title=Nat. Methods; citation_volume=12; citation_firstpage=453; citation_lastpage=457; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity; citation_author=G. Noël; citation_author=M.L. Fontsa; citation_author=S. Garaud; citation_author=P. De Silva; citation_author=A. de Wind; citation_author=G.G. Van den Eynden; citation_author=R. Salgado; citation_author=A. Boisson; citation_author=H. Locy; citation_author=N. Thomas; citation_author=et al.; citation_journal_title=J.&nbsp;Clin. Invest.; citation_volume=131; citation_firstpage=e139905; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=Essential autocrine regulation by IL-21 in the generation of inflammatory T&nbsp;cells; citation_author=R. Nurieva; citation_author=X.O. Yang; citation_author=G. Martinez; citation_author=Y. Zhang; citation_author=A.D. Panopoulos; citation_author=L. Ma; citation_author=K. Schluns; citation_author=Q. Tian; citation_author=S.S. Watowich; citation_author=A.M. Jetten; citation_author=C. Dong; citation_journal_title=Nature; citation_volume=448; citation_firstpage=480; citation_lastpage=483; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages; citation_author=R.I. Nurieva; citation_author=Y. Chung; citation_author=D. Hwang; citation_author=X.O. Yang; citation_author=H.S. Kang; citation_author=L. Ma; citation_author=Y.H. Wang; citation_author=S.S. Watowich; citation_author=A.M. Jetten; citation_author=Q. Tian; citation_author=C. Dong; citation_journal_title=Immunity; citation_volume=29; citation_firstpage=138; citation_lastpage=149; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=Bcl6 mediates the development of T follicular helper cells; citation_author=R.I. Nurieva; citation_author=Y. Chung; citation_author=G.J. Martinez; citation_author=X.O. Yang; citation_author=S. Tanaka; citation_author=T.D. Matskevitch; citation_author=Y.H. Wang; citation_author=C. Dong; citation_journal_title=Science; citation_volume=325; citation_firstpage=1001; citation_lastpage=1005; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Mechanisms underlying lineage commitment and plasticity of helper CD4+ T&nbsp;cells; citation_author=J.J. O’Shea; citation_author=W.E. Paul; citation_journal_title=Science; citation_volume=327; citation_firstpage=1098; citation_lastpage=1102; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Intratumoral CD4(+) T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer; citation_author=D.Y. Oh; citation_author=S.S. Kwek; citation_author=S.S. Raju; citation_author=T. Li; citation_author=E. McCarthy; citation_author=E. Chow; citation_author=D. Aran; citation_author=A. Ilano; citation_author=C.S. Pai; citation_author=C. Rancan; citation_author=et al.; citation_journal_title=Cell; citation_volume=181; citation_firstpage=1612; citation_lastpage=1625; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=An immunogenic personal neoantigen vaccine for patients with melanoma; citation_author=P.A. Ott; citation_author=Z. Hu; citation_author=D.B. Keskin; citation_author=S.A. Shukla; citation_author=J. Sun; citation_author=D.J. Bozym; citation_author=W. Zhang; citation_author=A. Luoma; citation_author=A. Giobbie-Hurder; citation_author=L. Peter; citation_author=et al.; citation_journal_title=Nature; citation_volume=547; citation_firstpage=217; citation_lastpage=221; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer; citation_author=P.A. Ott; citation_author=S. Hu-Lieskovan; citation_author=B. Chmielowski; citation_author=R. Govindan; citation_author=A. Naing; citation_author=N. Bhardwaj; citation_author=K. Margolin; citation_author=M.M. Awad; citation_author=M.D. Hellmann; citation_author=J.J. Lin; citation_author=et al.; citation_journal_title=Cell; citation_volume=183; citation_firstpage=347; citation_lastpage=362.e24; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation; citation_author=D. Paus; citation_author=T.G. Phan; citation_author=T.D. Chan; citation_author=S. Gardam; citation_author=A. Basten; citation_author=R. Brink; citation_journal_title=J.&nbsp;Exp. Med.; citation_volume=203; citation_firstpage=1081; citation_lastpage=1091; citation_publication_date=2006; "><meta name="citation_reference" content="citation_title=B cells are associated with survival and immunotherapy response in sarcoma; citation_author=F. Petitprez; citation_author=A. de Reyniès; citation_author=E.Z. Keung; citation_author=T.W. Chen; citation_author=C.M. Sun; citation_author=J. Calderaro; citation_author=Y.M. Jeng; citation_author=L.P. Hsiao; citation_author=L. Lacroix; citation_author=A. Bougoüin; citation_author=et al.; citation_journal_title=Nature; citation_volume=577; citation_firstpage=556; citation_lastpage=560; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy; citation_author=C. Pfirschke; citation_author=C. Engblom; citation_author=S. Rickelt; citation_author=V. Cortez-Retamozo; citation_author=C. Garris; citation_author=F. Pucci; citation_author=T. Yamazaki; citation_author=V. Poirier-Colame; citation_author=A. Newton; citation_author=Y. Redouane; citation_author=et al.; citation_journal_title=Immunity; citation_volume=44; citation_firstpage=343; citation_lastpage=354; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells; citation_author=T.G. Phan; citation_author=M. Amesbury; citation_author=S. Gardam; citation_author=J. Crosbie; citation_author=J. Hasbold; citation_author=P.D. Hodgkin; citation_author=A. Basten; citation_author=R. Brink; citation_journal_title=J.&nbsp;Exp. Med.; citation_volume=197; citation_firstpage=845; citation_lastpage=860; citation_publication_date=2003; "><meta name="citation_reference" content="citation_title=Ectopic lymphoid-like structures in infection, cancer and autoimmunity; citation_author=C. Pitzalis; citation_author=G.W. Jones; citation_author=M. Bombardieri; citation_author=S.A. Jones; citation_journal_title=Nat. Rev. Immunol.; citation_volume=14; citation_firstpage=447; citation_lastpage=462; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=In&nbsp;vivo regulation of Bcl6 and T follicular helper cell development; citation_author=A.C. Poholek; citation_author=K. Hansen; citation_author=S.G. Hernandez; citation_author=D. Eto; citation_author=A. Chandele; citation_author=J.S. Weinstein; citation_author=X. Dong; citation_author=J.M. Odegard; citation_author=S.M. Kaech; citation_author=A.L. Dent; citation_author=et al.; citation_journal_title=J.&nbsp;Immunol.; citation_volume=185; citation_firstpage=313; citation_lastpage=326; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer; citation_author=M. Rakaee; citation_author=T.K. Kilvaer; citation_author=S. Jamaly; citation_author=T. Berg; citation_author=E.E. Paulsen; citation_author=M. Berglund; citation_author=E. Richardsen; citation_author=S. Andersen; citation_author=S. Al-Saad; citation_author=M. Poehl; citation_author=et al.; citation_journal_title=Br. J. Cancer; citation_volume=124; citation_firstpage=1680; citation_lastpage=1689; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis; citation_author=D.A. Rao; citation_author=M.F. Gurish; citation_author=J.L. Marshall; citation_author=K. Slowikowski; citation_author=C.Y. Fonseka; citation_author=Y. Liu; citation_author=L.T. Donlin; citation_author=L.A. Henderson; citation_author=K. Wei; citation_author=F. Mizoguchi; citation_author=et al.; citation_journal_title=Nature; citation_volume=542; citation_firstpage=110; citation_lastpage=114; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer; citation_author=M. Reck; citation_author=D. Rodríguez-Abreu; citation_author=A.G. Robinson; citation_author=R. Hui; citation_author=T. Csőszi; citation_author=A. Fülöp; citation_author=M. Gottfried; citation_author=N. Peled; citation_author=A. Tafreshi; citation_author=S. Cuffe; citation_author=KEYNOTE-024 Investigators; citation_author=et al.; citation_journal_title=N.&nbsp;Engl. J. Med.; citation_volume=375; citation_firstpage=1823; citation_lastpage=1833; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=IL-21 from high-affinity CD4 T&nbsp;cells drives differentiation of brain-resident CD8 T&nbsp;cells during persistent viral infection; citation_author=H.M. Ren; citation_author=E.M. Kolawole; citation_author=M. Ren; citation_author=G. Jin; citation_author=C.S. Netherby-Winslow; citation_author=Q. Wade; citation_author=Shwetank; citation_author=Z.S.M. Rahman; citation_author=B.D. Evavold; citation_author=A.E. Lukacher; citation_journal_title=Sci. Immunol.; citation_volume=5; citation_firstpage=eabb5590; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Humoral immune responses in CD40 ligand-deficient mice; citation_author=B.R. Renshaw; citation_author=W.C. Fanslow; citation_author=R.J. Armitage; citation_author=K.A. Campbell; citation_author=D. Liggitt; citation_author=B. Wright; citation_author=B.L. Davison; citation_author=C.R. Maliszewski; citation_journal_title=J.&nbsp;Exp. Med.; citation_volume=180; citation_firstpage=1889; citation_lastpage=1900; citation_publication_date=1994; "><meta name="citation_reference" content="citation_title=Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer; citation_author=M.P. Roberti; citation_author=S. Yonekura; citation_author=C.P.M. Duong; citation_author=M. Picard; citation_author=G. Ferrere; citation_author=M. Tidjani Alou; citation_author=C. Rauber; citation_author=V. Iebba; citation_author=C.H.K. Lehmann; citation_author=L. Amon; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=26; citation_firstpage=919; citation_lastpage=931; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Lymphatic vessels and tertiary lymphoid organs; citation_author=N.H. Ruddle; citation_journal_title=J.&nbsp;Clin. Invest.; citation_volume=124; citation_firstpage=953; citation_lastpage=959; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma; citation_author=A.T. Ruffin; citation_author=A.R. Cillo; citation_author=T. Tabib; citation_author=A. Liu; citation_author=S. Onkar; citation_author=S.R. Kunning; citation_author=C. Lampenfeld; citation_author=H.I. Atiya; citation_author=I. Abecassis; citation_author=C.H.L. Kürten; citation_author=et al.; citation_journal_title=Nat. Commun.; citation_volume=12; citation_firstpage=3349; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=T cells primed by influenza virion internal components can cooperate in the antibody response to haemagglutinin; citation_author=S.M. Russell; citation_author=F.Y. Liew; citation_journal_title=Nature; citation_volume=280; citation_firstpage=147; citation_lastpage=148; citation_publication_date=1979; "><meta name="citation_reference" content="citation_title=Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral T&nbsp;cell exhaustion; citation_author=A.T. Satpathy; citation_author=J.M. Granja; citation_author=K.E. Yost; citation_author=Y. Qi; citation_author=F. Meschi; citation_author=G.P. McDermott; citation_author=B.N. Olsen; citation_author=M.R. Mumbach; citation_author=S.E. Pierce; citation_author=M.R. Corces; citation_author=et al.; citation_journal_title=Nat. Biotechnol.; citation_volume=37; citation_firstpage=925; citation_lastpage=936; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention; citation_author=C. Sautès-Fridman; citation_author=M. Lawand; citation_author=N.A. Giraldo; citation_author=H. Kaplon; citation_author=C. Germain; citation_author=W.H. Fridman; citation_author=M.C. Dieu-Nosjean; citation_journal_title=Front. Immunol.; citation_volume=7; citation_firstpage=407; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Tertiary lymphoid structures in the era of cancer immunotherapy; citation_author=C. Sautès-Fridman; citation_author=F. Petitprez; citation_author=J. Calderaro; citation_author=W.H. Fridman; citation_journal_title=Nat. Rev. Cancer; citation_volume=19; citation_firstpage=307; citation_lastpage=325; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Cancer Progress and Priorities: Lung Cancer; citation_author=M.B. Schabath; citation_author=M.L. Cote; citation_journal_title=Cancer Epidemiol. Biomarkers Prev.; citation_volume=28; citation_firstpage=1563; citation_lastpage=1579; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1+ CD8+ T&nbsp;cells in tumor-draining lymph nodes; citation_author=J.M. Schenkel; citation_author=R.H. Herbst; citation_author=D. Canner; citation_author=A. Li; citation_author=M. Hillman; citation_author=S.L. Shanahan; citation_author=G. Gibbons; citation_author=O.C. Smith; citation_author=J.Y. Kim; citation_author=P. Westcott; citation_author=et al.; citation_journal_title=Immunity; citation_volume=54; citation_firstpage=2338; citation_lastpage=2353.e6; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=Neoantigens encoded in the cancer genome; citation_author=T.N. Schumacher; citation_author=N. Hacohen; citation_journal_title=Curr. Opin. Immunol.; citation_volume=41; citation_firstpage=98; citation_lastpage=103; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Cancer Neoantigens; citation_author=T.N. Schumacher; citation_author=W. Scheper; citation_author=P. Kvistborg; citation_journal_title=Annu. Rev. Immunol.; citation_volume=37; citation_firstpage=173; citation_lastpage=200; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Selective CD4+ T&nbsp;cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities; citation_author=A. Sette; citation_author=M. Moutaftsi; citation_author=J. Moyron-Quiroz; citation_author=M.M. McCausland; citation_author=D.H. Davies; citation_author=R.J. Johnston; citation_author=B. Peters; citation_author=M. Rafii-El-Idrissi Benhnia; citation_author=J. Hoffmann; citation_author=H.P. Su; citation_author=et al.; citation_journal_title=Immunity; citation_volume=28; citation_firstpage=847; citation_lastpage=858; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=B cells, plasma cells and antibody repertoires in the tumour microenvironment; citation_author=G.V. Sharonov; citation_author=E.O. Serebrovskaya; citation_author=D.V. Yuzhakova; citation_author=O.V. Britanova; citation_author=D.M. Chudakov; citation_journal_title=Nat. Rev. Immunol.; citation_volume=20; citation_firstpage=294; citation_lastpage=307; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Dynamic signaling by T follicular helper cells during germinal center B cell selection; citation_author=Z. Shulman; citation_author=A.D. Gitlin; citation_author=J.S. Weinstein; citation_author=B. Lainez; citation_author=E. Esplugues; citation_author=R.A. Flavell; citation_author=J.E. Craft; citation_author=M.C. Nussenzweig; citation_journal_title=Science; citation_volume=345; citation_firstpage=1058; citation_lastpage=1062; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma; citation_author=K. Siliņa; citation_author=A. Soltermann; citation_author=F.M. Attar; citation_author=R. Casanova; citation_author=Z.M. Uckeley; citation_author=H. Thut; citation_author=M. Wandres; citation_author=S. Isajevs; citation_author=P. Cheng; citation_author=A. Curioni-Fontecedro; citation_author=et al.; citation_journal_title=Cancer Res.; citation_volume=78; citation_firstpage=1308; citation_lastpage=1320; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Reprogramming CD19-specific T&nbsp;cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies; citation_author=H. Singh; citation_author=M.J. Figliola; citation_author=M.J. Dawson; citation_author=H. Huls; citation_author=S. Olivares; citation_author=K. Switzer; citation_author=T. Mi; citation_author=S. Maiti; citation_author=P. Kebriaei; citation_author=D.A. Lee; citation_author=et al.; citation_journal_title=Cancer Res.; citation_volume=71; citation_firstpage=3516; citation_lastpage=3527; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=CD8+ T Cell Priming in Established Chronic Viral Infection Preferentially Directs Differentiation of Memory-like Cells for Sustained Immunity; citation_author=L.M. Snell; citation_author=B.L. MacLeod; citation_author=J.C. Law; citation_author=I. Osokine; citation_author=H.J. Elsaesser; citation_author=K. Hezaveh; citation_author=R.J. Dickson; citation_author=M.A. Gavin; citation_author=C.J. Guidos; citation_author=T.L. McGaha; citation_author=D.G. Brooks; citation_journal_title=Immunity; citation_volume=49; citation_firstpage=678; citation_lastpage=694.e5; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=IL-21: roles in immunopathology and cancer therapy; citation_author=H. Søndergaard; citation_author=K. Skak; citation_journal_title=Tissue Antigens; citation_volume=74; citation_firstpage=467; citation_lastpage=479; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Interleukin 21 Enhances Survival and Expansion of CAR T Cells Via Inhibition of Their Terminal Differentiation during Interaction with Tumor Target Cells; citation_author=M. Štach; citation_author=J. Musil; citation_author=P. Cetkovsky; citation_author=P. Otahal; citation_journal_title=Blood; citation_volume=132; citation_firstpage=4545; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Development and characterization of IL-21-producing CD4+ T&nbsp;cells; citation_author=A. Suto; citation_author=D. Kashiwakuma; citation_author=S. Kagami; citation_author=K. Hirose; citation_author=N. Watanabe; citation_author=K. Yokote; citation_author=Y. Saito; citation_author=T. Nakayama; citation_author=M.J. Grusby; citation_author=I. Iwamoto; citation_author=H. Nakajima; citation_journal_title=J.&nbsp;Exp. Med.; citation_volume=205; citation_firstpage=1369; citation_lastpage=1379; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis; citation_author=Z. Tang; citation_author=B. Kang; citation_author=C. Li; citation_author=T. Chen; citation_author=Z. Zhang; citation_journal_title=Nucleic Acids Res.; citation_volume=47; citation_number=W1; citation_firstpage=W556; citation_lastpage=W560; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=A transcriptionally and functionally distinct PD-1+ CD8+ T&nbsp;cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade; citation_author=D.S. Thommen; citation_author=V.H. Koelzer; citation_author=P. Herzig; citation_author=A. Roller; citation_author=M. Trefny; citation_author=S. Dimeloe; citation_author=A. Kiialainen; citation_author=J. Hanhart; citation_author=C. Schill; citation_author=C. Hess; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=24; citation_firstpage=994; citation_lastpage=1004; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Safety, activity, and immune correlates of anti-PD-1 antibody in cancer; citation_author=S.L. Topalian; citation_author=F.S. Hodi; citation_author=J.R. Brahmer; citation_author=S.N. Gettinger; citation_author=D.C. Smith; citation_author=D.F. McDermott; citation_author=J.D. Powderly; citation_author=R.D. Carvajal; citation_author=J.A. Sosman; citation_author=M.B. Atkins; citation_author=et al.; citation_journal_title=N.&nbsp;Engl. J. Med.; citation_volume=366; citation_firstpage=2443; citation_lastpage=2454; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Cancer immunotherapy based on mutation-specific CD4+ T&nbsp;cells in a patient with epithelial cancer; citation_author=E. Tran; citation_author=S. Turcotte; citation_author=A. Gros; citation_author=P.F. Robbins; citation_author=Y.C. Lu; citation_author=M.E. Dudley; citation_author=J.R. Wunderlich; citation_author=R.P. Somerville; citation_author=K. Hogan; citation_author=C.S. Hinrichs; citation_author=et al.; citation_journal_title=Science; citation_volume=344; citation_firstpage=641; citation_lastpage=645; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients; citation_author=I. Truxova; citation_author=L. Kasikova; citation_author=M. Hensler; citation_author=P. Skapa; citation_author=J. Laco; citation_author=L. Pecen; citation_author=L. Belicova; citation_author=I. Praznovec; citation_author=M.J. Halaska; citation_author=T. Brtnicky; citation_author=et al.; citation_journal_title=J.&nbsp;Immunother. Cancer; citation_volume=6; citation_firstpage=139; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=New insights into the development of lymphoid tissues; citation_author=S.A. van de Pavert; citation_author=R.E. Mebius; citation_journal_title=Nat. Rev. Immunol.; citation_volume=10; citation_firstpage=664; citation_lastpage=674; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=CD8+ T&nbsp;cell states in human cancer: insights from single-cell analysis; citation_author=A.M. van der Leun; citation_author=D.S. Thommen; citation_author=T.N. Schumacher; citation_journal_title=Nat. Rev. Cancer; citation_volume=20; citation_firstpage=218; citation_lastpage=232; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression; citation_author=L. Vanhersecke; citation_author=M. Brunet; citation_author=J.-P. Guégan; citation_author=C. Rey; citation_author=A. Bougouin; citation_author=S. Cousin; citation_author=S. Le Moulec; citation_author=B. Besse; citation_author=Y. Loriot; citation_author=M. Larroquette; citation_author=et al.; citation_journal_title=Nat. Cancer; citation_volume=2; citation_firstpage=794; citation_lastpage=802; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=T follicular helper cells in human efferent lymph retain lymphoid characteristics; citation_author=L.A. Vella; citation_author=M. Buggert; citation_author=S. Manne; citation_author=R.S. Herati; citation_author=I. Sayin; citation_author=L. Kuri-Cervantes; citation_author=I. Bukh Brody; citation_author=K.C. O’Boyle; citation_author=H. Kaprielian; citation_author=J.R. Giles; citation_author=et al.; citation_journal_title=J.&nbsp;Clin. Invest.; citation_volume=129; citation_firstpage=3185; citation_lastpage=3200; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=An ex&nbsp;vivo tumor fragment platform to dissect response to PD-1 blockade in cancer; citation_author=P. Voabil; citation_author=M. de Bruijn; citation_author=L.M. Roelofsen; citation_author=S.H. Hendriks; citation_author=S. Brokamp; citation_author=M. van den Braber; citation_author=A. Broeks; citation_author=J. Sanders; citation_author=P. Herzig; citation_author=A. Zippelius; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=27; citation_firstpage=1250; citation_lastpage=1261; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=An IL-4/21 Inverted Cytokine Receptor Improving CAR-T Cell Potency in Immunosuppressive Solid-Tumor Microenvironment; citation_author=Y. Wang; citation_author=H. Jiang; citation_author=H. Luo; citation_author=Y. Sun; citation_author=B. Shi; citation_author=R. Sun; citation_author=Z. Li; citation_journal_title=Front. Immunol.; citation_volume=10; citation_firstpage=1691; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner; citation_author=L. Wei; citation_author=A. Laurence; citation_author=K.M. Elias; citation_author=J.J. O’Shea; citation_journal_title=J.&nbsp;Biol. Chem.; citation_volume=282; citation_firstpage=34605; citation_lastpage=34610; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=TFH cells progressively differentiate to regulate the germinal center response; citation_author=J.S. Weinstein; citation_author=E.I. Herman; citation_author=B. Lainez; citation_author=P. Licona-Limón; citation_author=E. Esplugues; citation_author=R. Flavell; citation_author=J. Craft; citation_journal_title=Nat. Immunol.; citation_volume=17; citation_firstpage=1197; citation_lastpage=1205; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=STAT4 and T-bet control follicular helper T&nbsp;cell development in viral infections; citation_author=J.S. Weinstein; citation_author=B.J. Laidlaw; citation_author=Y. Lu; citation_author=J.K. Wang; citation_author=V.P. Schulz; citation_author=N. Li; citation_author=E.I. Herman; citation_author=S.M. Kaech; citation_author=P.G. Gallagher; citation_author=J. Craft; citation_journal_title=J.&nbsp;Exp. Med.; citation_volume=215; citation_firstpage=337; citation_lastpage=355; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction; citation_author=D.K. Wells; citation_author=M.M. van Buuren; citation_author=K.K. Dang; citation_author=V.M. Hubbard-Lucey; citation_author=K.C.F. Sheehan; citation_author=K.M. Campbell; citation_author=A. Lamb; citation_author=J.P. Ward; citation_author=J. Sidney; citation_author=A.B. Blazquez; citation_author=Tumor Neoantigen Selection Alliance; citation_author=et al.; citation_journal_title=Cell; citation_volume=183; citation_firstpage=818; citation_lastpage=834.e13; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Defining HPV-specific B cell responses in patients with head and neck cancer; citation_author=A. Wieland; citation_author=M.R. Patel; citation_author=M.A. Cardenas; citation_author=C.S. Eberhardt; citation_author=W.H. Hudson; citation_author=R.C. Obeng; citation_author=C.C. Griffith; citation_author=X. Wang; citation_author=Z.G. Chen; citation_author=H.T. Kissick; citation_author=et al.; citation_journal_title=Nature; citation_volume=597; citation_firstpage=274; citation_lastpage=278; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=A Critical Role of IL-21-Induced BATF in Sustaining CD8-T-Cell-Mediated Chronic Viral Control; citation_author=G. Xin; citation_author=D.M. Schauder; citation_author=B. Lainez; citation_author=J.S. Weinstein; citation_author=Z. Dai; citation_author=Y. Chen; citation_author=E. Esplugues; citation_author=R. Wen; citation_author=D. Wang; citation_author=I.A. Parish; citation_author=et al.; citation_journal_title=Cell Rep.; citation_volume=13; citation_firstpage=1118; citation_lastpage=1124; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing; citation_author=M. Yadav; citation_author=S. Jhunjhunwala; citation_author=Q.T. Phung; citation_author=P. Lupardus; citation_author=J. Tanguay; citation_author=S. Bumbaca; citation_author=C. Franci; citation_author=T.K. Cheung; citation_author=J. Fritsche; citation_author=T. Weinschenk; citation_author=et al.; citation_journal_title=Nature; citation_volume=515; citation_firstpage=572; citation_lastpage=576; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=A T&nbsp;cell activation antigen, Ly6C, induced on CD4+ Th1 cells mediates an inhibitory signal for secretion of IL-2 and proliferation in peripheral immune responses; citation_author=S. Yamanouchi; citation_author=K. Kuwahara; citation_author=A. Sakata; citation_author=T. Ezaki; citation_author=S. Matsuoka; citation_author=J. Miyazaki; citation_author=S. Hirose; citation_author=T. Tamura; citation_author=H. Nariuchi; citation_author=N. Sakaguchi; citation_journal_title=Eur. J. Immunol.; citation_volume=28; citation_firstpage=696; citation_lastpage=707; citation_publication_date=1998; "><meta name="citation_reference" content="citation_title=A vital role for interleukin-21 in the control of a chronic viral infection; citation_author=J.S. Yi; citation_author=M. Du; citation_author=A.J. Zajac; citation_journal_title=Science; citation_volume=324; citation_firstpage=1572; citation_lastpage=1576; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment; citation_author=D. Yu; citation_author=S. Rao; citation_author=L.M. Tsai; citation_author=S.K. Lee; citation_author=Y. He; citation_author=E.L. Sutcliffe; citation_author=M. Srivastava; citation_author=M. Linterman; citation_author=L. Zheng; citation_author=N. Simpson; citation_author=et al.; citation_journal_title=Immunity; citation_volume=31; citation_firstpage=457; citation_lastpage=468; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Viral immune evasion due to persistence of activated T&nbsp;cells without effector function; citation_author=A.J. Zajac; citation_author=J.N. Blattman; citation_author=K. Murali-Krishna; citation_author=D.J. Sourdive; citation_author=M. Suresh; citation_author=J.D. Altman; citation_author=R. Ahmed; citation_journal_title=J.&nbsp;Exp. Med.; citation_volume=188; citation_firstpage=2205; citation_lastpage=2213; citation_publication_date=1998; "><meta name="citation_reference" content="citation_title=Th1-like Plasmodium-Specific Memory CD4+ T Cells Support Humoral Immunity; citation_author=R.A. Zander; citation_author=R. Vijay; citation_author=A.D. Pack; citation_author=J.J. Guthmiller; citation_author=A.C. Graham; citation_author=S.E. Lindner; citation_author=A.M. Vaughan; citation_author=S.H.I. Kappe; citation_author=N.S. Butler; citation_journal_title=Cell Rep.; citation_volume=23; citation_firstpage=1230; citation_lastpage=1237; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=CD4+ T Cell Help Is Required for the Formation of a Cytolytic CD8+ T Cell Subset that Protects against Chronic Infection and Cancer; citation_author=R. Zander; citation_author=D. Schauder; citation_author=G. Xin; citation_author=C. Nguyen; citation_author=X. Wu; citation_author=A. Zajac; citation_author=W. Cui; citation_journal_title=Immunity; citation_volume=51; citation_firstpage=1028; citation_lastpage=1042.e4; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Divergent T follicular helper cell requirement for IgA and IgE production to peanut during allergic sensitization; citation_author=B. Zhang; citation_author=E. Liu; citation_author=J.A. Gertie; citation_author=J. Joseph; citation_author=L. Xu; citation_author=E.Y. Pinker; citation_author=D.A. Waizman; citation_author=J. Catanzaro; citation_author=K.H. Hamza; citation_author=K. Lahl; citation_author=et al.; citation_journal_title=Sci. Immunol.; citation_volume=5; citation_firstpage=eaay2754; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer; citation_author=Y. Zhang; citation_author=H. Chen; citation_author=H. Mo; citation_author=X. Hu; citation_author=R. Gao; citation_author=Y. Zhao; citation_author=B. Liu; citation_author=L. Niu; citation_author=X. Sun; citation_author=X. Yu; citation_author=et al.; citation_journal_title=Cancer Cell; citation_doi=10.1016/j.ccell.2021.09.010; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy; citation_author=T. Zhou; citation_author=W. Damsky; citation_author=O.E. Weizman; citation_author=M.K. McGeary; citation_author=K.P. Hartmann; citation_author=C.E. Rosen; citation_author=S. Fischer; citation_author=R. Jackson; citation_author=R.A. Flavell; citation_author=J. Wang; citation_author=et al.; citation_journal_title=Nature; citation_volume=583; citation_firstpage=609; citation_lastpage=614; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism; citation_author=D. Zotos; citation_author=J.M. Coquet; citation_author=Y. Zhang; citation_author=A. Light; citation_author=K. D’Costa; citation_author=A. Kallies; citation_author=L.M. Corcoran; citation_author=D.I. Godfrey; citation_author=K.M. Toellner; citation_author=M.J. Smyth; citation_author=et al.; citation_journal_title=J.&nbsp;Exp. Med.; citation_volume=207; citation_firstpage=365; citation_lastpage=378; citation_publication_date=2010; "><meta name="citation_abstract" content="<h2>Summary</h2><p>CD4&nbsp;T follicular helper (TFH) cells support B cells, which are critical for germinal center (GC) formation, but the importance of TFH-B cell interactions in cancer is unclear. We found enrichment of TFH cell transcriptional signature correlates with GC B cell signature and with prolonged survival in individuals with lung adenocarcinoma (LUAD). We further developed a murine LUAD model in which tumor cells express B cell- and T&nbsp;cell-recognized neoantigens. Interactions between tumor-specific TFH and GC B cells, as well as interleukin (IL)-21 primarily produced by TFH cells, are necessary for tumor control and effector CD8 T&nbsp;cell function. Development of TFH cells requires B cells and B cell-recognized neoantigens. Thus, tumor neoantigens can regulate the fate of tumor-specific CD4 T&nbsp;cells by facilitating their interactions with tumor-specific B cells, which in turn promote anti-tumor immunity by enhancing CD8 T&nbsp;cell effector functions.</p>"><meta charset="UTF-8"><!--

    Pagebuild admin UI
-->



<script type="text/javascript" src="https://bam.nr-data.net/1/16e2192192?a=916957862&amp;sa=1&amp;v=1177.96a4d39&amp;t=Unnamed%20Transaction&amp;rst=6931&amp;ck=1&amp;ref=https://www.cell.com/cell/fulltext/S0092-8674(21)01322-2&amp;be=3054&amp;fe=6890&amp;dc=6499&amp;af=err,xhr,stn,ins,spa&amp;perf=%7B%22timing%22:%7B%22of%22:1749592075149,%22n%22:0,%22f%22:2423,%22dn%22:2424,%22dne%22:2424,%22c%22:2424,%22s%22:2424,%22ce%22:2424,%22rq%22:2424,%22rp%22:3038,%22rpe%22:3864,%22dl%22:3043,%22di%22:4097,%22ds%22:6499,%22de%22:6510,%22dc%22:6890,%22l%22:6890,%22le%22:6923%7D,%22navigation%22:%7B%7D%7D&amp;jsonp=NREUM.setToken"></script><script src="https://js-agent.newrelic.com/nr-spa-1177.min.js"></script><script type="text/javascript">
    ;window.NREUM||(NREUM={});NREUM.init={privacy:{cookies_enabled:true}};
    window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{c.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(26),c={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(c.console=!0,o.indexOf("dev")!==-1&&(c.dev=!0),o.indexOf("nr_dev")!==-1&&(c.nrDev=!0))}catch(s){}c.nrDev&&i.on("internal-error",function(t){r(t.stack)}),c.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),c.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(c,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,c){try{l?l-=1:o(c||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,s.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:s.now();i("err",[t,n])}var i=t("handle"),a=t(27),c=t("ee"),s=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError",l=0;s.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(13),t(12),"addEventListener"in window&&t(6),s.xhrWrappable&&t(14),d=!0)}c.on("fn-start",function(t,e,n){d&&(l+=1)}),c.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),c.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),c.on("internal-error",function(t){i("ierr",[t,s.now(),!0])})},{}],3:[function(t,e,n){t("loader").features.ins=!0},{}],4:[function(t,e,n){function r(){_++,T=g.hash,this[u]=y.now()}function o(){_--,g.hash!==T&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var c="-start",s="-end",f="-body",u="fn"+c,d="fn"+s,p="cb"+c,l="cb"+s,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable){var x=t(10),b=t(11),E=t(8),R=t(6),O=t(13),N=t(7),M=t(14),P=t(9),S=t("ee"),C=S.get("tracer");t(16),y.features.spa=!0;var T,_=0;S.on(u,r),S.on(p,r),S.on(d,o),S.on(l,o),S.buffer([u,d,"xhr-done","xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+s,"clearTimeout"+c,u]),M.buffer([u,"new-xhr","send-xhr"+c]),N.buffer([m+c,m+"-done",m+f+c,m+f+s]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+c]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(M,"send-xhr"+c),a(S,"xhr-resolved"),a(S,"xhr-done"),a(N,m+c),a(N,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,!0),w[v]("load",i,!0),w[v]("popstate",function(){i(0,_>1)},!0)}},{}],5:[function(t,e,n){function r(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var o=t("ee"),i=t("handle"),a=t(13),c=t(12),s="learResourceTimings",f="addEventListener",u="resourcetimingbufferfull",d="bstResource",p="resource",l="-start",h="-end",m="fn"+l,v="fn"+h,w="bstTimer",g="pushState",y=t("loader");y.features.stn=!0,t(8),"addEventListener"in window&&t(6);var x=NREUM.o.EV;o.on(m,function(t,e){var n=t[0];n instanceof x&&(this.bstStart=y.now())}),o.on(v,function(t,e){var n=t[0];n instanceof x&&i("bst",[n,e,this.bstStart,y.now()])}),a.on(m,function(t,e,n){this.bstStart=y.now(),this.bstType=n}),a.on(v,function(t,e){i(w,[e,this.bstStart,y.now(),this.bstType])}),c.on(m,function(){this.bstStart=y.now()}),c.on(v,function(t,e){i(w,[e,this.bstStart,y.now(),"requestAnimationFrame"])}),o.on(g+l,function(t){this.time=y.now(),this.startPath=location.pathname+location.hash}),o.on(g+h,function(t){i("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),f in window.performance&&(window.performance["c"+s]?window.performance[f](u,function(t){i(d,[window.performance.getEntriesByType(p)]),window.performance["c"+s]()},!1):window.performance[f]("webkit"+u,function(t){i(d,[window.performance.getEntriesByType(p)]),window.performance["webkitC"+s]()},!1)),document[f]("scroll",r,{passive:!0}),document[f]("keypress",r,!1),document[f]("click",r,!1)}},{}],6:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){c.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),c=t("wrap-function")(a,!0),s=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1],r=s(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?c(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],7:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var c=r.apply(this,t);return o.emit(n+"start",[t,a],c),c.then(function(t){return o.emit(n+"end",[null,t],c),t},function(t){throw o.emit(n+"end",[t],c),t})})}var o=t("ee").get("fetch"),i=t(27),a=t(26);e.exports=o;var c=window,s="fetch-",f=s+"body-",u=["arrayBuffer","blob","json","text","formData"],d=c.Request,p=c.Response,l=c.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(c,"fetch",s),o.on(s+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(s+"done",[null,e],n)}else o.emit(s+"done",[t],n)}))},{}],8:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],9:[function(t,e,n){function r(t){function e(){s.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}function n(){s.emit("jsonp-error",[],p),s.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var u=c(a),d="function"==typeof u.parent[u.key];if(d){var p={};f.inPlace(u.parent,[u.key],"cb-",p),t.addEventListener("load",e,!1),t.addEventListener("error",n,!1),s.emit("new-jsonp",[t.src],p)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(u);return e?e[1]:null}function a(t,e){var n=t.match(p),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function c(t){var e=t.match(d);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var s=t("ee").get("jsonp"),f=t("wrap-function")(s);if(e.exports=s,o()){var u=/[?&](?:callback|cb)=([^&#]+)/,d=/(.*)\.([^.]+)/,p=/^(\w+)(\.|$)(.*)$/,l=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?f.inPlace(Node.prototype,l,"dom-"):(f.inPlace(HTMLElement.prototype,l,"dom-"),f.inPlace(HTMLHeadElement.prototype,l,"dom-"),f.inPlace(HTMLBodyElement.prototype,l,"dom-")),s.on("dom-start",function(t){r(t[0])})}},{}],10:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],11:[function(t,e,n){function r(t){var e=a.context(),n=c(t,"executor-",e),r=new f(n);return a.context(r).getCtx=function(){return e},a.emit("new-promise",[r,e],e),r}function o(t,e){return e}var i=t("wrap-function"),a=t("ee").get("promise"),c=i(a),s=t(26),f=NREUM.o.PR;e.exports=a,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){a.emit("propagate",[null,!o],i),o=o||!t}}var o=!1;s(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var i=e.apply(f,arguments),c=f.resolve(i);return c}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&a.emit("propagate",[t,!0],n),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),s(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),a.on("executor-start",function(t){t[0]=c(t[0],"resolve-",this),t[1]=c(t[1],"resolve-",this)}),a.on("executor-err",function(t,e,n){t[1](n)}),c.inPlace(f.prototype,["then"],"then-",o),a.on("then-start",function(t,e){this.promise=e,t[0]=c(t[0],"cb-",this),t[1]=c(t[1],"cb-",this)}),a.on("then-end",function(t,e,n){this.nextPromise=n;var r=this.promise;a.emit("propagate",[r,!0],n)}),a.on("cb-end",function(t,e,n){a.emit("propagate",[n,!0],this.nextPromise)}),a.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=a.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],12:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],13:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),c="setTimeout",s="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[c,"setImmediate"],c+d),a.inPlace(window,[s],s+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(s+u,r),i.on(c+u,o)},{}],14:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",c)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,g,"fn-",c)}function i(t){y.push(t),h&&(b?b.then(a):v?v(a):(E=-E,R.data=E))}function a(){for(var t=0;t<y.length;t++)r([],y[t]);y.length&&(y=[])}function c(t,e){return e}function s(t,e){for(var n in t)e[n]=t[n];return e}t(6);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=NREUM.o,l=p.XHR,h=p.MO,m=p.PR,v=p.SI,w="readystatechange",g=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],y=[];e.exports=u;var x=window.XMLHttpRequest=function(t){var e=new l(t);try{u.emit("new-xhr",[e],e),e.addEventListener(w,o,!1)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(s(l,x),x.prototype=l.prototype,d.inPlace(x.prototype,["open","send"],"-xhr-",c),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),h){var b=m&&m.resolve();if(!v&&!m){var E=1,R=document.createTextNode(E);new h(a).observe(R,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===w||a()})},{}],15:[function(t,e,n){function r(t){if(!c(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||s(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&s(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",c=1,s="",f="";return o+"@nr="+i+"-"+c+"-"+n+"-"+r+"-"+t+"-"+a+"-"+s+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var c={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(c.d.tk=i),btoa(JSON.stringify(c))}function c(t){return f()&&s(t)}function s(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(23),h=t(17);e.exports={generateTracePayload:r,shouldGenerateTrace:c}},{}],16:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,u.emit("xhr-done",[t],t),c("xhr",[e,n,this.startTime]))}}function o(t,e){var n=s(e),r=t.params;r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=s(e),t.sameOrigin=t.parsedOrigin.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable){var c=t("handle"),s=t(17),f=t(15).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(21),m=t(20),v=t(18),w=window.XMLHttpRequest;a.features.xhr=!0,t(14),t(7),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,t.addEventListener("load",function(n){i(e,t)},!1),h&&(h>34||h<10)||window.opera||t.addEventListener("progress",function(t){e.lastSize=t.loaded},!1)}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var c=0;c<p;c++)e.addEventListener(d[c],this.listener,!1)}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("addEventListener-end",function(t,e){e instanceof w&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof w&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof w&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url&&(n=t[0].url),n&&(this.parsedOrigin=s(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)})}},{}],17:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,c=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||c),"/"===o.pathname&&(r[t]=o),o}},{}],18:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(20);e.exports=r},{}],19:[function(t,e,n){function r(){}function o(t,e,n){return function(){return i(t,[f.now()].concat(c(arguments)),e?null:this,n),e?void 0:this}}var i=t("handle"),a=t(26),c=t(27),s=t("ee").get("tracer"),f=t("loader"),u=NREUM;"undefined"==typeof window.newrelic&&(newrelic=u);var d=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],p="api-",l=p+"ixn-";a(d,function(t,e){u[e]=o(p+e,!0,"api")}),u.addPageAction=o(p+"addPageAction",!0),u.setCurrentRouteName=o(p+"routeName",!0),e.exports=newrelic,u.interaction=function(){return(new r).get()};var h=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(l+"tracer",[f.now(),t,n],r),function(){if(s.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw s.emit("fn-err",[arguments,this,t],n),t}finally{s.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){h[e]=o(l+e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),i("err",[t,f.now(),!1,e])}},{}],20:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],21:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],22:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?d("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&d("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();n.length>0&&d("lcp",[n[n.length-1]])}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||d("cls",[t])})}function a(t){if(t instanceof h&&!v){var e=Math.round(t.timeStamp),n={type:t.type};e<=p.now()?n.fid=p.now()-e:e>p.offset&&e<=Date.now()?(e-=p.offset,n.fid=p.now()-e):e=p.now(),v=!0,d("timing",["fi",e,n])}}function c(t){d("pageHide",[p.now(),t])}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var s,f,u,d=t("handle"),p=t("loader"),l=t(25),h=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){s=new PerformanceObserver(r);try{s.observe({entryTypes:["paint"]})}catch(m){}f=new PerformanceObserver(o);try{f.observe({entryTypes:["largest-contentful-paint"]})}catch(m){}u=new PerformanceObserver(i);try{u.observe({type:"layout-shift",buffered:!0})}catch(m){}}if("addEventListener"in document){var v=!1,w=["click","keydown","mousedown","pointerdown","touchstart"];w.forEach(function(t){document.addEventListener(t,a,!1)})}l(c)}},{}],23:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",c=0;c<i.length;c++)o=i[c],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(31)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],24:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var c=navigator.userAgent,s=c.match(a);s&&c.indexOf("Chrome")===-1&&c.indexOf("Chromium")===-1&&(o="Safari",i=s[1])}e.exports={agent:o,version:i,match:r}},{}],25:[function(t,e,n){function r(t){function e(){t(a&&document[a]?document[a]:document[o]?"hidden":"visible")}"addEventListener"in document&&i&&document.addEventListener(i,e,!1)}e.exports=r;var o,i,a;"undefined"!=typeof document.hidden?(o="hidden",i="visibilitychange",a="visibilityState"):"undefined"!=typeof document.msHidden?(o="msHidden",i="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(o="webkitHidden",i="webkitvisibilitychange",a="webkitVisibilityState")},{}],26:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],27:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],28:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?s(t,c,i):i()}function n(n,r,o,i){if(!p.aborted||i){t&&t(n,r,o);for(var a=e(o),c=m(n),s=c.length,f=0;f<s;f++)c[f].apply(a,r);var d=u[y[n]];return d&&d.push([x,n,r,a]),a}}function l(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return d[t]=d[t]||o(n)}function w(t,e){f(t,function(t,n){e=e||"feature",y[n]=e,e in u||(u[e]=[])})}var g={},y={},x={on:l,addEventListener:l,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:a,aborted:!1};return x}function i(){return new r}function a(){(u.api||u.feature)&&(p.aborted=!0,u=p.backlog={})}var c="nr@context",s=t("gos"),f=t(26),u={},d={},p=e.exports=o();p.backlog=u},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!E++){var t=b.info=NREUM.info,e=l.getElementsByTagName("script")[0];if(setTimeout(u.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return u.abort();f(y,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+b.offset],null,"api"),s("timing",["load",n]);var r=l.createElement("script");r.src="https://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===l.readyState&&i()}function i(){s("mark",["domContent",a()+b.offset],null,"api")}function a(){return R.exists&&performance.now?Math.round(performance.now()):(c=Math.max((new Date).getTime(),c))-b.offset}var c=(new Date).getTime(),s=t("handle"),f=t(26),u=t("ee"),d=t(24),p=window,l=p.document,h="addEventListener",m="attachEvent",v=p.XMLHttpRequest,w=v&&v.prototype;NREUM.o={ST:setTimeout,SI:p.setImmediate,CT:clearTimeout,XHR:v,REQ:p.Request,EV:p.Event,PR:p.Promise,MO:p.MutationObserver};var g=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1177.min.js"},x=v&&w&&w[h]&&!/CriOS/.test(navigator.userAgent),b=e.exports={offset:c,now:a,origin:g,features:{},xhrWrappable:x,userAgent:d};t(19),t(22),l[h]?(l[h]("DOMContentLoaded",i,!1),p[h]("load",r,!1)):(l[m]("onreadystatechange",o),p[m]("onload",r)),s("mark",["firstbyte",c],null,"api");var E=0,R=t(28)},{}],"wrap-function":[function(t,e,n){function r(t){return!(t&&t instanceof Function&&t.apply&&!t[a])}var o=t("ee"),i=t(27),a="nr@original",c=Object.prototype.hasOwnProperty,s=!1;e.exports=function(t,e){function n(t,e,n,o){function nrWrapper(){var r,a,c,s;try{a=this,r=i(arguments),c="function"==typeof n?n(r,a):n||{}}catch(f){p([f,"",[r,a,o],c])}u(e+"start",[r,a,o],c);try{return s=t.apply(a,r)}catch(d){throw u(e+"err",[r,a,d],c),d}finally{u(e+"end",[r,a,s],c)}}return r(t)?t:(e||(e=""),nrWrapper[a]=t,d(t,nrWrapper),nrWrapper)}function f(t,e,o,i){o||(o="");var a,c,s,f="-"===o.charAt(0);for(s=0;s<e.length;s++)c=e[s],a=t[c],r(a)||(t[c]=n(a,f?c+o:o,i,c))}function u(n,r,o){if(!s||e){var i=s;s=!0;try{t.emit(n,r,o,e)}catch(a){p([a,n,r,o])}s=i}}function d(t,e){if(Object.defineProperty&&Object.keys)try{var n=Object.keys(t);return n.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(r){p([r])}for(var o in t)c.call(t,o)&&(e[o]=t[o]);return e}function p(e){try{t.emit("internal-error",e)}catch(n){}}return t||(t=o),n.inPlace=f,n.flag=a,n}},{}]},{},["loader",2,16,5,3,4]);
    ;NREUM.loader_config={accountID:"2095297",trustKey:"2038175",agentID:"916957862",licenseKey:"16e2192192",applicationID:"916957862"}
    ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"16e2192192",applicationID:"916957862",sa:1}
</script>
    <script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="dada9834-04e2-4bcd-b5ba-cae44d498dfa"></script>
    <script type="text/javascript">
        function getCookie(name) {
            var value = "; " + document.cookie;
            var parts = value.split("; " + name + "=");
            if (parts.length == 2) {
                return true;
            }
        }
            function OptanonWrapper() {
                var optCookie = getCookie("OptanonAlertBoxClosed");
                var isActiveCategory = "false";
                var isFoundCookieBox = "false";
                if(isActiveCategory == 'false' && isFoundCookieBox == 'false' && optCookie) {
                    OneTrust.InsertScript('/pb-assets/adobe/prod/adobedtm-1616606406233.js', 'head', null, null, '2');
                }
            }
    </script>


<noscript>
    <style>.requiresJS {
        display: none
    }

    .dartAd {
        display: block !important
    }</style>
</noscript>
        <script type="text/javascript" src="/wro/o4ny~selected-legacy.js"></script><script src="https://cdn.cookielaw.org/scripttemplates/202411.2.0/otBannerSdk.js" async="" type="text/javascript"></script>
        <link rel="stylesheet" type="text/css" href="/wro/o4ny~selected-legacy.css">
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans">
        <script>window.MSInputMethodContext && document.documentMode && document.write('<script src="https://cdn.jsdelivr.net/gh/nuxodin/ie11CustomProperties@4.1.0/ie11CustomProperties.min.js"><\x2fscript>');</script><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/build-b26f3342b722959c7931.css"><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/print-b26f3342b722959c7931.css" media="print"><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/themes/theme-cell.css">







        
        
        <script class="optanon-category-4" type="text/plain" async="" src="https://www.youtube.com/iframe_api"></script>
        
    





<!---->
<meta http-equiv="X-UA-Compatible" content="IE=edge">












<style id="onetrust-style">#onetrust-banner-sdk .onetrust-vendors-list-handler{cursor:pointer;color:#1f96db;font-size:inherit;font-weight:bold;text-decoration:none;margin-left:5px}#onetrust-banner-sdk .onetrust-vendors-list-handler:hover{color:#1f96db}#onetrust-banner-sdk:focus{outline:2px solid #000;outline-offset:-2px}#onetrust-banner-sdk a:focus{outline:2px solid #000}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{outline-offset:1px}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{height:64px;width:64px}#onetrust-banner-sdk .ot-tcf2-vendor-count.ot-text-bold{font-weight:bold}#onetrust-banner-sdk .ot-close-icon,#onetrust-pc-sdk .ot-close-icon,#ot-sync-ntfy .ot-close-icon{background-size:contain;background-repeat:no-repeat;background-position:center;height:12px;width:12px}#onetrust-banner-sdk .powered-by-logo,#onetrust-banner-sdk .ot-pc-footer-logo a,#onetrust-pc-sdk .powered-by-logo,#onetrust-pc-sdk .ot-pc-footer-logo a,#ot-sync-ntfy .powered-by-logo,#ot-sync-ntfy .ot-pc-footer-logo a{background-size:contain;background-repeat:no-repeat;background-position:center;height:25px;width:152px;display:block;text-decoration:none;font-size:.75em}#onetrust-banner-sdk .powered-by-logo:hover,#onetrust-banner-sdk .ot-pc-footer-logo a:hover,#onetrust-pc-sdk .powered-by-logo:hover,#onetrust-pc-sdk .ot-pc-footer-logo a:hover,#ot-sync-ntfy .powered-by-logo:hover,#ot-sync-ntfy .ot-pc-footer-logo a:hover{color:#565656}#onetrust-banner-sdk h3 *,#onetrust-banner-sdk h4 *,#onetrust-banner-sdk h6 *,#onetrust-banner-sdk button *,#onetrust-banner-sdk a[data-parent-id] *,#onetrust-pc-sdk h3 *,#onetrust-pc-sdk h4 *,#onetrust-pc-sdk h6 *,#onetrust-pc-sdk button *,#onetrust-pc-sdk a[data-parent-id] *,#ot-sync-ntfy h3 *,#ot-sync-ntfy h4 *,#ot-sync-ntfy h6 *,#ot-sync-ntfy button *,#ot-sync-ntfy a[data-parent-id] *{font-size:inherit;font-weight:inherit;color:inherit}#onetrust-banner-sdk .ot-hide,#onetrust-pc-sdk .ot-hide,#ot-sync-ntfy .ot-hide{display:none !important}#onetrust-banner-sdk button.ot-link-btn:hover,#onetrust-pc-sdk button.ot-link-btn:hover,#ot-sync-ntfy button.ot-link-btn:hover{text-decoration:underline;opacity:1}#onetrust-pc-sdk .ot-sdk-row .ot-sdk-column{padding:0}#onetrust-pc-sdk .ot-sdk-container{padding-right:0}#onetrust-pc-sdk .ot-sdk-row{flex-direction:initial;width:100%}#onetrust-pc-sdk [type=checkbox]:checked,#onetrust-pc-sdk [type=checkbox]:not(:checked){pointer-events:initial}#onetrust-pc-sdk [type=checkbox]:disabled+label::before,#onetrust-pc-sdk [type=checkbox]:disabled+label:after,#onetrust-pc-sdk [type=checkbox]:disabled+label{pointer-events:none;opacity:.8}#onetrust-pc-sdk #vendor-list-content{transform:translate3d(0, 0, 0)}#onetrust-pc-sdk li input[type=checkbox]{z-index:1}#onetrust-pc-sdk li .ot-checkbox label{z-index:2}#onetrust-pc-sdk li .ot-checkbox input[type=checkbox]{height:auto;width:auto}#onetrust-pc-sdk li .host-title a,#onetrust-pc-sdk li .ot-host-name a,#onetrust-pc-sdk li .accordion-text,#onetrust-pc-sdk li .ot-acc-txt{z-index:2;position:relative}#onetrust-pc-sdk input{margin:3px .1ex}#onetrust-pc-sdk .pc-logo,#onetrust-pc-sdk .ot-pc-logo{height:60px;width:180px;background-position:center;background-size:contain;background-repeat:no-repeat;display:inline-flex;justify-content:center;align-items:center}#onetrust-pc-sdk .pc-logo img,#onetrust-pc-sdk .ot-pc-logo img{max-height:100%;max-width:100%}#onetrust-pc-sdk .screen-reader-only,#onetrust-pc-sdk .ot-scrn-rdr,.ot-sdk-cookie-policy .screen-reader-only,.ot-sdk-cookie-policy .ot-scrn-rdr{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}#onetrust-pc-sdk.ot-fade-in,.onetrust-pc-dark-filter.ot-fade-in,#onetrust-banner-sdk.ot-fade-in{animation-name:onetrust-fade-in;animation-duration:400ms;animation-timing-function:ease-in-out}#onetrust-pc-sdk.ot-hide{display:none !important}.onetrust-pc-dark-filter.ot-hide{display:none !important}#ot-sdk-btn.ot-sdk-show-settings,#ot-sdk-btn.optanon-show-settings{color:#fff;background-color:#468254;height:auto;white-space:normal;word-wrap:break-word;padding:.8em 2em;font-size:.8em;line-height:1.2;cursor:pointer;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease}#ot-sdk-btn.ot-sdk-show-settings:hover,#ot-sdk-btn.optanon-show-settings:hover{color:#fff;background-color:#2c6415}#ot-sdk-btn.ot-sdk-show-settings:active,#ot-sdk-btn.optanon-show-settings:active{color:#fff;background-color:#2c6415;border:1px solid rgba(162,192,169,.5)}.onetrust-pc-dark-filter{background:rgba(0,0,0,.5);z-index:2147483646;width:100%;height:100%;overflow:hidden;position:fixed;top:0;bottom:0;left:0}@keyframes onetrust-fade-in{0%{opacity:0}100%{opacity:1}}.ot-cookie-label{text-decoration:underline}@media only screen and (min-width: 426px)and (max-width: 896px)and (orientation: landscape){#onetrust-pc-sdk p{font-size:.75em}}#onetrust-banner-sdk .banner-option-input:focus+label{outline:1px solid #000;outline-style:auto}.category-vendors-list-handler+a:focus,.category-vendors-list-handler+a:focus-visible{outline:2px solid #000}#onetrust-pc-sdk .ot-userid-title{margin-top:10px}#onetrust-pc-sdk .ot-userid-title>span,#onetrust-pc-sdk .ot-userid-timestamp>span{font-weight:700}#onetrust-pc-sdk .ot-userid-desc{font-style:italic}#onetrust-pc-sdk .ot-host-desc a{pointer-events:initial}#onetrust-pc-sdk .ot-ven-hdr>p a{position:relative;z-index:2;pointer-events:initial}#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info a{margin-right:auto}#onetrust-pc-sdk .ot-pc-footer-logo img{width:136px;height:16px}#onetrust-pc-sdk .ot-pur-vdr-count{font-weight:400;font-size:.7rem;padding-top:3px;display:block}#onetrust-banner-sdk .ot-optout-signal,#onetrust-pc-sdk .ot-optout-signal{border:1px solid #32ae88;border-radius:3px;padding:5px;margin-bottom:10px;background-color:#f9fffa;font-size:.85rem;line-height:2}#onetrust-banner-sdk .ot-optout-signal .ot-optout-icon,#onetrust-pc-sdk .ot-optout-signal .ot-optout-icon{display:inline;margin-right:5px}#onetrust-banner-sdk .ot-optout-signal svg,#onetrust-pc-sdk .ot-optout-signal svg{height:20px;width:30px;transform:scale(0.5)}#onetrust-banner-sdk .ot-optout-signal svg path,#onetrust-pc-sdk .ot-optout-signal svg path{fill:#32ae88}#onetrust-consent-sdk .ot-general-modal{overflow:hidden;position:fixed;margin:0 auto;top:50%;left:50%;width:40%;padding:1.5rem;max-width:575px;min-width:575px;z-index:2147483647;border-radius:2.5px;transform:translate(-50%, -50%)}#onetrust-consent-sdk .ot-signature-health-group{margin-top:1rem;padding-left:1.25rem;padding-right:1.25rem;margin-bottom:.625rem;width:calc(100% - 2.5rem)}#onetrust-consent-sdk .ot-signature-health-group .ot-signature-health-form{gap:.5rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:70%;gap:.35rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-input{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-consent-sdk .ot-signature-health .ot-signature-subtitle{font-size:1.125rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-group-title{font-size:1.25rem;font-weight:bold}#onetrust-consent-sdk .ot-signature-health,#onetrust-consent-sdk .ot-signature-health-group{display:flex;flex-direction:column;gap:1rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-cont{display:flex;flex-direction:column;gap:.25rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-paragraph,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-paragraph{margin:0;line-height:20px;font-size:max(14px,.875rem)}#onetrust-consent-sdk .ot-signature-health .ot-health-signature-error,#onetrust-consent-sdk .ot-signature-health-group .ot-health-signature-error{color:#4d4d4d;font-size:min(12px,.75rem)}#onetrust-consent-sdk .ot-signature-health .ot-signature-buttons-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-buttons-cont{margin-top:max(.75rem,2%);gap:1rem;display:flex;justify-content:flex-end}#onetrust-consent-sdk .ot-signature-health .ot-signature-button,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button{flex:1;height:auto;color:#fff;cursor:pointer;line-height:1.2;min-width:125px;font-weight:600;font-size:.813em;border-radius:2px;padding:12px 10px;white-space:normal;word-wrap:break-word;word-break:break-word;background-color:#68b631;border:2px solid #68b631}#onetrust-consent-sdk .ot-signature-health .ot-signature-button.reject,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button.reject{background-color:#fff}#onetrust-consent-sdk .ot-input-field-cont{display:flex;flex-direction:column;gap:.5rem}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:65%}#onetrust-consent-sdk .ot-signature-health-form{display:flex;flex-direction:column}#onetrust-consent-sdk .ot-signature-health-form .ot-signature-label{margin-bottom:0;line-height:20px;font-size:max(14px,.875rem)}@media only screen and (max-width: 600px){#onetrust-consent-sdk .ot-general-modal{min-width:100%}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:100%}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:100%}}#onetrust-banner-sdk,#onetrust-pc-sdk,#ot-sdk-cookie-policy,#ot-sync-ntfy{font-size:16px}#onetrust-banner-sdk *,#onetrust-banner-sdk ::after,#onetrust-banner-sdk ::before,#onetrust-pc-sdk *,#onetrust-pc-sdk ::after,#onetrust-pc-sdk ::before,#ot-sdk-cookie-policy *,#ot-sdk-cookie-policy ::after,#ot-sdk-cookie-policy ::before,#ot-sync-ntfy *,#ot-sync-ntfy ::after,#ot-sync-ntfy ::before{-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box}#onetrust-banner-sdk div,#onetrust-banner-sdk span,#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-banner-sdk p,#onetrust-banner-sdk img,#onetrust-banner-sdk svg,#onetrust-banner-sdk button,#onetrust-banner-sdk section,#onetrust-banner-sdk a,#onetrust-banner-sdk label,#onetrust-banner-sdk input,#onetrust-banner-sdk ul,#onetrust-banner-sdk li,#onetrust-banner-sdk nav,#onetrust-banner-sdk table,#onetrust-banner-sdk thead,#onetrust-banner-sdk tr,#onetrust-banner-sdk td,#onetrust-banner-sdk tbody,#onetrust-banner-sdk .ot-main-content,#onetrust-banner-sdk .ot-toggle,#onetrust-banner-sdk #ot-content,#onetrust-banner-sdk #ot-pc-content,#onetrust-banner-sdk .checkbox,#onetrust-pc-sdk div,#onetrust-pc-sdk span,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#onetrust-pc-sdk p,#onetrust-pc-sdk img,#onetrust-pc-sdk svg,#onetrust-pc-sdk button,#onetrust-pc-sdk section,#onetrust-pc-sdk a,#onetrust-pc-sdk label,#onetrust-pc-sdk input,#onetrust-pc-sdk ul,#onetrust-pc-sdk li,#onetrust-pc-sdk nav,#onetrust-pc-sdk table,#onetrust-pc-sdk thead,#onetrust-pc-sdk tr,#onetrust-pc-sdk td,#onetrust-pc-sdk tbody,#onetrust-pc-sdk .ot-main-content,#onetrust-pc-sdk .ot-toggle,#onetrust-pc-sdk #ot-content,#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk .checkbox,#ot-sdk-cookie-policy div,#ot-sdk-cookie-policy span,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy p,#ot-sdk-cookie-policy img,#ot-sdk-cookie-policy svg,#ot-sdk-cookie-policy button,#ot-sdk-cookie-policy section,#ot-sdk-cookie-policy a,#ot-sdk-cookie-policy label,#ot-sdk-cookie-policy input,#ot-sdk-cookie-policy ul,#ot-sdk-cookie-policy li,#ot-sdk-cookie-policy nav,#ot-sdk-cookie-policy table,#ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy tr,#ot-sdk-cookie-policy td,#ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy .ot-main-content,#ot-sdk-cookie-policy .ot-toggle,#ot-sdk-cookie-policy #ot-content,#ot-sdk-cookie-policy #ot-pc-content,#ot-sdk-cookie-policy .checkbox,#ot-sync-ntfy div,#ot-sync-ntfy span,#ot-sync-ntfy h1,#ot-sync-ntfy h2,#ot-sync-ntfy h3,#ot-sync-ntfy h4,#ot-sync-ntfy h5,#ot-sync-ntfy h6,#ot-sync-ntfy p,#ot-sync-ntfy img,#ot-sync-ntfy svg,#ot-sync-ntfy button,#ot-sync-ntfy section,#ot-sync-ntfy a,#ot-sync-ntfy label,#ot-sync-ntfy input,#ot-sync-ntfy ul,#ot-sync-ntfy li,#ot-sync-ntfy nav,#ot-sync-ntfy table,#ot-sync-ntfy thead,#ot-sync-ntfy tr,#ot-sync-ntfy td,#ot-sync-ntfy tbody,#ot-sync-ntfy .ot-main-content,#ot-sync-ntfy .ot-toggle,#ot-sync-ntfy #ot-content,#ot-sync-ntfy #ot-pc-content,#ot-sync-ntfy .checkbox{font-family:inherit;font-weight:normal;-webkit-font-smoothing:auto;letter-spacing:normal;line-height:normal;padding:0;margin:0;height:auto;min-height:0;max-height:none;width:auto;min-width:0;max-width:none;border-radius:0;border:none;clear:none;float:none;position:static;bottom:auto;left:auto;right:auto;top:auto;text-align:left;text-decoration:none;text-indent:0;text-shadow:none;text-transform:none;white-space:normal;background:none;overflow:visible;vertical-align:baseline;visibility:visible;z-index:auto;box-shadow:none}#onetrust-banner-sdk label:before,#onetrust-banner-sdk label:after,#onetrust-banner-sdk .checkbox:after,#onetrust-banner-sdk .checkbox:before,#onetrust-pc-sdk label:before,#onetrust-pc-sdk label:after,#onetrust-pc-sdk .checkbox:after,#onetrust-pc-sdk .checkbox:before,#ot-sdk-cookie-policy label:before,#ot-sdk-cookie-policy label:after,#ot-sdk-cookie-policy .checkbox:after,#ot-sdk-cookie-policy .checkbox:before,#ot-sync-ntfy label:before,#ot-sync-ntfy label:after,#ot-sync-ntfy .checkbox:after,#ot-sync-ntfy .checkbox:before{content:"";content:none}#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{position:relative;width:100%;max-width:100%;margin:0 auto;padding:0 20px;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{width:100%;float:left;box-sizing:border-box;padding:0;display:initial}@media(min-width: 400px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:90%;padding:0}}@media(min-width: 550px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:100%}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{margin-left:4%}#onetrust-banner-sdk .ot-sdk-column:first-child,#onetrust-banner-sdk .ot-sdk-columns:first-child,#onetrust-pc-sdk .ot-sdk-column:first-child,#onetrust-pc-sdk .ot-sdk-columns:first-child,#ot-sdk-cookie-policy .ot-sdk-column:first-child,#ot-sdk-cookie-policy .ot-sdk-columns:first-child{margin-left:0}#onetrust-banner-sdk .ot-sdk-two.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-two.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-two.ot-sdk-columns{width:13.3333333333%}#onetrust-banner-sdk .ot-sdk-three.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-three.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-three.ot-sdk-columns{width:22%}#onetrust-banner-sdk .ot-sdk-four.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-four.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-four.ot-sdk-columns{width:30.6666666667%}#onetrust-banner-sdk .ot-sdk-eight.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eight.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eight.ot-sdk-columns{width:65.3333333333%}#onetrust-banner-sdk .ot-sdk-nine.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-nine.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-nine.ot-sdk-columns{width:74%}#onetrust-banner-sdk .ot-sdk-ten.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-ten.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-ten.ot-sdk-columns{width:82.6666666667%}#onetrust-banner-sdk .ot-sdk-eleven.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eleven.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eleven.ot-sdk-columns{width:91.3333333333%}#onetrust-banner-sdk .ot-sdk-twelve.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-twelve.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-twelve.ot-sdk-columns{width:100%;margin-left:0}}#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6{margin-top:0;font-weight:600;font-family:inherit}#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem;line-height:1.2}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem;line-height:1.25}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem;line-height:1.3}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem;line-height:1.35}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem;line-height:1.5}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem;line-height:1.6}@media(min-width: 550px){#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem}}#onetrust-banner-sdk p,#onetrust-pc-sdk p,#ot-sdk-cookie-policy p{margin:0 0 1em 0;font-family:inherit;line-height:normal}#onetrust-banner-sdk a,#onetrust-pc-sdk a,#ot-sdk-cookie-policy a{color:#565656;text-decoration:underline}#onetrust-banner-sdk a:hover,#onetrust-pc-sdk a:hover,#ot-sdk-cookie-policy a:hover{color:#565656;text-decoration:none}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{display:inline-block;height:38px;padding:0 30px;color:#555;text-align:center;font-size:.9em;font-weight:400;line-height:38px;letter-spacing:.01em;text-decoration:none;white-space:nowrap;background-color:rgba(0,0,0,0);border-radius:2px;border:1px solid #bbb;cursor:pointer;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-button:hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#onetrust-pc-sdk .ot-sdk-button:hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#ot-sdk-cookie-policy .ot-sdk-button:hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus{color:#333;border-color:#888;opacity:.9}#onetrust-banner-sdk .ot-sdk-button:focus,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:focus,#onetrust-pc-sdk .ot-sdk-button:focus,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:focus,#ot-sdk-cookie-policy .ot-sdk-button:focus,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:focus{outline:2px solid #000}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-banner-sdk button.ot-sdk-button-primary,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-pc-sdk button.ot-sdk-button-primary,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary,#ot-sdk-cookie-policy button.ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary{color:#fff;background-color:#33c3f0;border-color:#33c3f0}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-banner-sdk button.ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-banner-sdk button.ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:focus,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-pc-sdk button.ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-pc-sdk button.ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:focus{color:#fff;background-color:#1eaedb;border-color:#1eaedb}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{-webkit-appearance:none;-moz-appearance:none;appearance:none}#onetrust-banner-sdk input[type=text]:focus,#onetrust-pc-sdk input[type=text]:focus,#ot-sdk-cookie-policy input[type=text]:focus{border:1px solid #000;outline:0}#onetrust-banner-sdk label,#onetrust-pc-sdk label,#ot-sdk-cookie-policy label{display:block;margin-bottom:.5rem;font-weight:600}#onetrust-banner-sdk input[type=checkbox],#onetrust-pc-sdk input[type=checkbox],#ot-sdk-cookie-policy input[type=checkbox]{display:inline}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{list-style:circle inside}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{padding-left:0;margin-top:0}#onetrust-banner-sdk ul ul,#onetrust-pc-sdk ul ul,#ot-sdk-cookie-policy ul ul{margin:1.5rem 0 1.5rem 3rem;font-size:90%}#onetrust-banner-sdk li,#onetrust-pc-sdk li,#ot-sdk-cookie-policy li{margin-bottom:1rem}#onetrust-banner-sdk th,#onetrust-banner-sdk td,#onetrust-pc-sdk th,#onetrust-pc-sdk td,#ot-sdk-cookie-policy th,#ot-sdk-cookie-policy td{padding:12px 15px;text-align:left;border-bottom:1px solid #e1e1e1}#onetrust-banner-sdk button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-container:after,#onetrust-banner-sdk .ot-sdk-row:after,#onetrust-pc-sdk .ot-sdk-container:after,#onetrust-pc-sdk .ot-sdk-row:after,#ot-sdk-cookie-policy .ot-sdk-container:after,#ot-sdk-cookie-policy .ot-sdk-row:after{content:"";display:table;clear:both}#onetrust-banner-sdk .ot-sdk-row,#onetrust-pc-sdk .ot-sdk-row,#ot-sdk-cookie-policy .ot-sdk-row{margin:0;max-width:none;display:block}#onetrust-banner-sdk{box-shadow:0 0 18px rgba(0,0,0,.2)}#onetrust-banner-sdk.otFlat{position:fixed;z-index:2147483645;bottom:0;right:0;left:0;background-color:#fff;max-height:90%;overflow-x:hidden;overflow-y:auto}#onetrust-banner-sdk.otFlat.top{top:0px;bottom:auto}#onetrust-banner-sdk.otRelFont{font-size:1rem}#onetrust-banner-sdk>.ot-sdk-container{overflow:hidden}#onetrust-banner-sdk::-webkit-scrollbar{width:11px}#onetrust-banner-sdk::-webkit-scrollbar-thumb{border-radius:10px;background:#c1c1c1}#onetrust-banner-sdk{scrollbar-arrow-color:#c1c1c1;scrollbar-darkshadow-color:#c1c1c1;scrollbar-face-color:#c1c1c1;scrollbar-shadow-color:#c1c1c1}#onetrust-banner-sdk #onetrust-policy{margin:1.25em 0 .625em 2em;overflow:hidden}#onetrust-banner-sdk #onetrust-policy .ot-gv-list-handler{float:left;font-size:.82em;padding:0;margin-bottom:0;border:0;line-height:normal;height:auto;width:auto}#onetrust-banner-sdk #onetrust-policy-title{font-size:1.2em;line-height:1.3;margin-bottom:10px}#onetrust-banner-sdk #onetrust-policy-text{clear:both;text-align:left;font-size:.88em;line-height:1.4}#onetrust-banner-sdk #onetrust-policy-text *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk #onetrust-policy-text a{font-weight:bold;margin-left:5px}#onetrust-banner-sdk #onetrust-policy-title,#onetrust-banner-sdk #onetrust-policy-text{color:dimgray;float:left}#onetrust-banner-sdk #onetrust-button-group-parent{min-height:1px;text-align:center}#onetrust-banner-sdk #onetrust-button-group{display:inline-block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{background-color:#68b631;color:#fff;border-color:#68b631;margin-right:1em;min-width:125px;height:auto;white-space:normal;word-break:break-word;word-wrap:break-word;padding:12px 10px;line-height:1.2;font-size:.813em;font-weight:600}#onetrust-banner-sdk #onetrust-pc-btn-handler.cookie-setting-link{background-color:#fff;border:none;color:#68b631;text-decoration:underline;padding-left:0;padding-right:0}#onetrust-banner-sdk .onetrust-close-btn-ui{width:44px;height:44px;background-size:12px;border:none;position:relative;margin:auto;padding:0}#onetrust-banner-sdk .banner_logo{display:none}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{position:absolute;top:50%;transform:translateY(-50%);left:0px}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-policy{margin-left:65px}#onetrust-banner-sdk .ot-b-addl-desc{clear:both;float:left;display:block}#onetrust-banner-sdk #banner-options{float:left;display:table;margin-right:0;margin-left:1em;width:calc(100% - 1em)}#onetrust-banner-sdk .banner-option-input{cursor:pointer;width:auto;height:auto;border:none;padding:0;padding-right:3px;margin:0 0 10px;font-size:.82em;line-height:1.4}#onetrust-banner-sdk .banner-option-input *{pointer-events:none;font-size:inherit;line-height:inherit}#onetrust-banner-sdk .banner-option-input[aria-expanded=true]~.banner-option-details{display:block;height:auto}#onetrust-banner-sdk .banner-option-input[aria-expanded=true] .ot-arrow-container{transform:rotate(90deg)}#onetrust-banner-sdk .banner-option{margin-bottom:12px;margin-left:0;border:none;float:left;padding:0}#onetrust-banner-sdk .banner-option:first-child{padding-left:2px}#onetrust-banner-sdk .banner-option:not(:first-child){padding:0;border:none}#onetrust-banner-sdk .banner-option-header{cursor:pointer;display:inline-block}#onetrust-banner-sdk .banner-option-header :first-child{color:dimgray;font-weight:bold;float:left}#onetrust-banner-sdk .banner-option-header .ot-arrow-container{display:inline-block;border-top:6px solid rgba(0,0,0,0);border-bottom:6px solid rgba(0,0,0,0);border-left:6px solid dimgray;margin-left:10px;vertical-align:middle}#onetrust-banner-sdk .banner-option-details{display:none;font-size:.83em;line-height:1.5;padding:10px 0px 5px 10px;margin-right:10px;height:0px}#onetrust-banner-sdk .banner-option-details *{font-size:inherit;line-height:inherit;color:dimgray}#onetrust-banner-sdk .ot-arrow-container,#onetrust-banner-sdk .banner-option-details{transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-banner-sdk .ot-dpd-container{float:left}#onetrust-banner-sdk .ot-dpd-title{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-title,#onetrust-banner-sdk .ot-dpd-desc{font-size:.88em;line-height:1.4;color:dimgray}#onetrust-banner-sdk .ot-dpd-title *,#onetrust-banner-sdk .ot-dpd-desc *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text *{margin-bottom:0}#onetrust-banner-sdk.ot-iab-2 .onetrust-vendors-list-handler{display:block;margin-left:0;margin-top:5px;clear:both;margin-bottom:0;padding:0;border:0;height:auto;width:auto}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk.ot-close-btn-link{padding-top:25px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container{top:15px;transform:none;right:15px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container button{padding:0;white-space:pre-wrap;border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em}#onetrust-banner-sdk #onetrust-policy-text,#onetrust-banner-sdk .ot-dpd-desc,#onetrust-banner-sdk .ot-b-addl-desc{font-size:.813em;line-height:1.5}#onetrust-banner-sdk .ot-dpd-desc{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-desc>.ot-b-addl-desc{margin-top:10px;margin-bottom:10px;font-size:1em}@media only screen and (max-width: 425px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:6px;right:2px}#onetrust-banner-sdk #onetrust-policy{margin-left:0;margin-top:3em}#onetrust-banner-sdk #onetrust-button-group{display:block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk .onetrust-close-btn-ui{top:auto;transform:none}#onetrust-banner-sdk #onetrust-policy-title{display:inline;float:none}#onetrust-banner-sdk #banner-options{margin:0;padding:0;width:100%}}@media only screen and (min-width: 426px)and (max-width: 896px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:0;right:0}#onetrust-banner-sdk #onetrust-policy{margin-left:1em;margin-right:1em}#onetrust-banner-sdk .onetrust-close-btn-ui{top:10px;right:10px}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:95%}#onetrust-banner-sdk.ot-iab-2 #onetrust-group-container{width:100%}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-button-group-parent{padding-left:50px}#onetrust-banner-sdk #onetrust-button-group-parent{width:100%;position:relative;margin-left:0}#onetrust-banner-sdk #onetrust-button-group button{display:inline-block}#onetrust-banner-sdk #onetrust-button-group{margin-right:0;text-align:center}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler{float:left}#onetrust-banner-sdk .has-reject-all-button #onetrust-reject-all-handler,#onetrust-banner-sdk .has-reject-all-button #onetrust-accept-btn-handler{float:right}#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group{width:calc(100% - 2em);margin-right:0}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler.cookie-setting-link{padding-left:0px;text-align:left}#onetrust-banner-sdk.ot-buttons-fw .ot-sdk-three button{width:100%;text-align:center}#onetrust-banner-sdk.ot-buttons-fw #onetrust-button-group-parent button{float:none}#onetrust-banner-sdk.ot-buttons-fw #onetrust-pc-btn-handler.cookie-setting-link{text-align:center}}@media only screen and (min-width: 550px){#onetrust-banner-sdk .banner-option:not(:first-child){border-left:1px solid #d8d8d8;padding-left:25px}}@media only screen and (min-width: 425px)and (max-width: 550px){#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group,#onetrust-banner-sdk.ot-iab-2 #onetrust-policy,#onetrust-banner-sdk.ot-iab-2 .banner-option{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler{float:left}}@media only screen and (min-width: 769px){#onetrust-banner-sdk #onetrust-button-group{margin-right:30%}#onetrust-banner-sdk #banner-options{margin-left:2em;margin-right:5em;margin-bottom:1.25em;width:calc(100% - 7em)}}@media only screen and (min-width: 897px)and (max-width: 1023px){#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:75%;transform:translateY(-50%)}#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;padding:0;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{position:relative;margin:0;right:-22px;top:2px}}@media only screen and (min-width: 1024px){#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{right:-12px}#onetrust-banner-sdk #onetrust-policy{margin-left:2em}#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:60%;transform:translateY(-50%)}#onetrust-banner-sdk .ot-optout-signal{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-title{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text,#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:1em;width:50%;border-right:1px solid #d8d8d8;padding-right:1rem}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-container{width:45%;padding-left:1rem;display:inline-block;float:none}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-title{line-height:1.7}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group-parent{left:auto;right:4%;margin-left:0}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:auto;width:30%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:60%}#onetrust-banner-sdk #onetrust-button-group{margin-right:auto}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{margin-top:1em}}@media only screen and (min-width: 890px){#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group-parent{padding-left:3%;padding-right:4%;margin-left:0}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{margin-right:0;margin-top:1.25em;width:100%}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button{width:100%;margin-bottom:5px;margin-top:5px}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type{margin-bottom:20px}}@media only screen and (min-width: 1280px){#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:55%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{width:44%;padding-left:2%;padding-right:2%}#onetrust-banner-sdk:not(.ot-iab-2).vertical-align-content #onetrust-button-group-parent{position:absolute;left:55%}}
        #onetrust-consent-sdk #onetrust-banner-sdk {background-color: #FFF;}
            #onetrust-consent-sdk #onetrust-policy-title,
                    #onetrust-consent-sdk #onetrust-policy-text,
                    #onetrust-consent-sdk .ot-b-addl-desc,
                    #onetrust-consent-sdk .ot-dpd-desc,
                    #onetrust-consent-sdk .ot-dpd-title,
                    #onetrust-consent-sdk #onetrust-policy-text *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk .ot-dpd-desc *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk #onetrust-banner-sdk #banner-options *,
                    #onetrust-banner-sdk .ot-cat-header,
                    #onetrust-banner-sdk .ot-optout-signal
                    {
                        color: #2E2E2E;
                    }
            #onetrust-consent-sdk #onetrust-banner-sdk .banner-option-details {
                    background-color: #E9E9E9;}
             #onetrust-consent-sdk #onetrust-banner-sdk a[href],
                    #onetrust-consent-sdk #onetrust-banner-sdk a[href] font,
                    #onetrust-consent-sdk #onetrust-banner-sdk .ot-link-btn
                        {
                            color: #007398;
                        }#onetrust-consent-sdk #onetrust-accept-btn-handler,
                         #onetrust-banner-sdk #onetrust-reject-all-handler {
                            background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-banner-sdk *:focus,
            #onetrust-consent-sdk #onetrust-banner-sdk:focus {
               outline-color: #000000;
               outline-width: 1px;
            }
            #onetrust-consent-sdk #onetrust-pc-btn-handler,
            #onetrust-consent-sdk #onetrust-pc-btn-handler.cookie-setting-link {
                color: #6CC04A; border-color: #6CC04A;
                background-color:
                #FFF;
            }/*! v6.10.0 2021-01-18 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #d0d3d4!important;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007dbc!important;border:2px solid #007dbc!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#949494!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007dbc!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007dbc!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #949494!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:inherit!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #007dbc;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:inherit;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#007dbc;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#007dbc;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #007dbc!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}
#onetrust-pc-sdk.otPcCenter{overflow:hidden;position:fixed;margin:0 auto;top:5%;right:0;left:0;width:40%;max-width:575px;min-width:575px;border-radius:2.5px;z-index:2147483647;background-color:#fff;-webkit-box-shadow:0px 2px 10px -3px #999;-moz-box-shadow:0px 2px 10px -3px #999;box-shadow:0px 2px 10px -3px #999}#onetrust-pc-sdk.otPcCenter[dir=rtl]{right:0;left:0}#onetrust-pc-sdk.otRelFont{font-size:1rem}#onetrust-pc-sdk .ot-optout-signal{margin-top:.625rem}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus,#onetrust-pc-sdk .ot-hide-tgl{visibility:hidden}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr *,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus *,#onetrust-pc-sdk .ot-hide-tgl *{visibility:hidden}#onetrust-pc-sdk #ot-gn-venlst .ot-ven-item .ot-acc-hdr{min-height:40px}#onetrust-pc-sdk .ot-pc-header{height:39px;padding:10px 0 10px 30px;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk #ot-pc-title,#onetrust-pc-sdk #ot-category-title,#onetrust-pc-sdk .ot-cat-header,#onetrust-pc-sdk #ot-lst-title,#onetrust-pc-sdk .ot-ven-hdr .ot-ven-name,#onetrust-pc-sdk .ot-always-active{font-weight:bold;color:dimgray}#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:55%;font-weight:700}#onetrust-pc-sdk .ot-cat-item p{clear:both;float:left;margin-top:10px;margin-bottom:5px;line-height:1.5;font-size:.812em;color:dimgray}#onetrust-pc-sdk .ot-close-icon{height:44px;width:44px;background-size:10px}#onetrust-pc-sdk #ot-pc-title{float:left;font-size:1em;line-height:1.5;margin-bottom:10px;margin-top:10px;width:100%}#onetrust-pc-sdk #accept-recommended-btn-handler{margin-right:10px;margin-bottom:25px;outline-offset:-1px}#onetrust-pc-sdk #ot-pc-desc{clear:both;width:100%;font-size:.812em;line-height:1.5;margin-bottom:25px}#onetrust-pc-sdk #ot-pc-desc *{font-size:inherit;line-height:inherit}#onetrust-pc-sdk #ot-pc-desc ul li{padding:10px 0px}#onetrust-pc-sdk a{color:#656565;cursor:pointer}#onetrust-pc-sdk a:hover{color:#3860be}#onetrust-pc-sdk label{margin-bottom:0}#onetrust-pc-sdk #vdr-lst-dsc{font-size:.812em;line-height:1.5;padding:10px 15px 5px 15px}#onetrust-pc-sdk button{max-width:394px;padding:12px 30px;line-height:1;word-break:break-word;word-wrap:break-word;white-space:normal;font-weight:bold;height:auto}#onetrust-pc-sdk .ot-link-btn{padding:0;margin-bottom:0;border:0;font-weight:normal;line-height:normal;width:auto;height:auto}#onetrust-pc-sdk #ot-pc-content{position:absolute;overflow-y:scroll;padding-left:2px;padding-right:30px;top:60px;bottom:110px;margin:1px 3px 0 30px;width:calc(100% - 63px)}#onetrust-pc-sdk .ot-vs-list .ot-always-active,#onetrust-pc-sdk .ot-cat-grp .ot-always-active{float:right;clear:none;color:#3860be;margin:0;font-size:.813em;line-height:1.3}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-track{margin-right:20px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar{width:11px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-thumb{border-radius:10px;background:#d8d8d8}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-pc-scrollbar{scrollbar-arrow-color:#d8d8d8;scrollbar-darkshadow-color:#d8d8d8;scrollbar-face-color:#d8d8d8;scrollbar-shadow-color:#d8d8d8}#onetrust-pc-sdk .save-preference-btn-handler{margin-right:20px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-right:10px}#onetrust-pc-sdk #ot-pc-desc .privacy-notice-link{margin-left:0;margin-right:8px}#onetrust-pc-sdk #ot-pc-desc .ot-imprint-handler{margin-left:0;margin-right:8px}#onetrust-pc-sdk .ot-subgrp-cntr{display:inline-block;clear:both;width:100%;padding-top:15px}#onetrust-pc-sdk .ot-switch+.ot-subgrp-cntr{padding-top:10px}#onetrust-pc-sdk ul.ot-subgrps{margin:0;font-size:initial}#onetrust-pc-sdk ul.ot-subgrps li p,#onetrust-pc-sdk ul.ot-subgrps li h5{font-size:.813em;line-height:1.4;color:dimgray}#onetrust-pc-sdk ul.ot-subgrps .ot-switch{min-height:auto}#onetrust-pc-sdk ul.ot-subgrps .ot-switch-nob{top:0}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr{display:inline-block;width:100%}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-txt{margin:0}#onetrust-pc-sdk ul.ot-subgrps li{padding:0;border:none}#onetrust-pc-sdk ul.ot-subgrps li h5{position:relative;top:5px;font-weight:bold;margin-bottom:0;float:left}#onetrust-pc-sdk li.ot-subgrp{margin-left:20px;overflow:auto}#onetrust-pc-sdk li.ot-subgrp>h5{width:calc(100% - 100px)}#onetrust-pc-sdk .ot-cat-item p>ul,#onetrust-pc-sdk li.ot-subgrp p>ul{margin:0px;list-style:disc;margin-left:15px;font-size:inherit}#onetrust-pc-sdk .ot-cat-item p>ul li,#onetrust-pc-sdk li.ot-subgrp p>ul li{font-size:inherit;padding-top:10px;padding-left:0px;padding-right:0px;border:none}#onetrust-pc-sdk .ot-cat-item p>ul li:last-child,#onetrust-pc-sdk li.ot-subgrp p>ul li:last-child{padding-bottom:10px}#onetrust-pc-sdk .ot-pc-logo{height:40px;width:120px}#onetrust-pc-sdk .ot-pc-footer{position:absolute;bottom:0px;width:100%;max-height:160px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-refuse-all-handler{margin-bottom:0px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:160px}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-footer button{width:100%;max-width:none}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:0 30px;width:calc(100% - 60px);padding-right:0}#onetrust-pc-sdk .ot-pc-footer-logo{height:30px;width:100%;text-align:right;background:#f4f4f4}#onetrust-pc-sdk .ot-pc-footer-logo a{display:inline-block;margin-top:5px;margin-right:10px}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo{direction:rtl}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo a{margin-right:25px}#onetrust-pc-sdk .ot-tgl{float:right;position:relative;z-index:1}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background-color:#468254;border:1px solid #fff}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{-webkit-transform:translateX(20px);-ms-transform:translateX(20px);transform:translateX(20px);background-color:#fff;border-color:#fff}#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch{outline:#000 solid 1px}#onetrust-pc-sdk .ot-switch{position:relative;display:inline-block;width:45px;height:25px}#onetrust-pc-sdk .ot-switch-nob{position:absolute;cursor:pointer;top:0;left:0;right:0;bottom:0;background-color:#767676;border:1px solid #ddd;transition:all .2s ease-in 0s;-moz-transition:all .2s ease-in 0s;-o-transition:all .2s ease-in 0s;-webkit-transition:all .2s ease-in 0s;border-radius:20px}#onetrust-pc-sdk .ot-switch-nob:before{position:absolute;content:"";height:18px;width:18px;bottom:3px;left:3px;background-color:#fff;-webkit-transition:.4s;transition:.4s;border-radius:20px}#onetrust-pc-sdk .ot-chkbox input:checked~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox label{position:relative;display:inline-block;padding-left:30px;cursor:pointer;font-weight:500}#onetrust-pc-sdk .ot-chkbox label::before,#onetrust-pc-sdk .ot-chkbox label::after{position:absolute;content:"";display:inline-block;border-radius:3px}#onetrust-pc-sdk .ot-chkbox label::before{height:18px;width:18px;border:1px solid #3860be;left:0px;top:auto}#onetrust-pc-sdk .ot-chkbox label::after{height:5px;width:9px;border-left:3px solid;border-bottom:3px solid;transform:rotate(-45deg);-o-transform:rotate(-45deg);-ms-transform:rotate(-45deg);-webkit-transform:rotate(-45deg);left:4px;top:5px}#onetrust-pc-sdk .ot-label-txt{display:none}#onetrust-pc-sdk .ot-chkbox input,#onetrust-pc-sdk .ot-tgl input{position:absolute;opacity:0;width:0;height:0}#onetrust-pc-sdk .ot-arw-cntr{float:right;position:relative;pointer-events:none}#onetrust-pc-sdk .ot-arw-cntr .ot-arw{width:16px;height:16px;margin-left:5px;color:dimgray;display:inline-block;vertical-align:middle;-webkit-transition:all 150ms ease-in 0s;-moz-transition:all 150ms ease-in 0s;-o-transition:all 150ms ease-in 0s;transition:all 150ms ease-in 0s}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw-cntr svg{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-tgl-cntr,#onetrust-pc-sdk .ot-arw-cntr{display:inline-block}#onetrust-pc-sdk .ot-tgl-cntr{width:45px;float:right;margin-top:2px}#onetrust-pc-sdk #ot-lst-cnt .ot-tgl-cntr{margin-top:10px}#onetrust-pc-sdk .ot-always-active-subgroup{width:auto;padding-left:0px !important;top:3px;position:relative}#onetrust-pc-sdk .ot-label-status{font-size:.75em;display:none;font-size:.75em;position:relative;top:2px;padding-right:5px;float:left}#onetrust-pc-sdk .ot-arw-cntr{margin-top:-1px}#onetrust-pc-sdk .ot-arw-cntr svg{-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s;transition:all 300ms ease-in 0s;height:10px;width:10px}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk .ot-arw{width:10px;margin-left:15px;transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0}#onetrust-pc-sdk .ot-hlst-cntr{margin-top:5px;display:inline-block;width:100%}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{clear:both;color:#3860be;margin-left:0;font-size:.813em;text-decoration:none;float:left;overflow:hidden}#onetrust-pc-sdk .category-vendors-list-handler:hover,#onetrust-pc-sdk .category-vendors-list-handler+a:hover,#onetrust-pc-sdk .category-host-list-handler:hover{text-decoration-line:underline}#onetrust-pc-sdk .category-vendors-list-handler+a{clear:none}#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{display:inline-block;height:13px;width:13px;background-repeat:no-repeat;margin-left:1px;margin-top:6px;cursor:pointer}#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{margin-bottom:-1px}#onetrust-pc-sdk .back-btn-handler{font-size:1em;text-decoration:none}#onetrust-pc-sdk .back-btn-handler:hover{opacity:.6}#onetrust-pc-sdk #ot-lst-title h3{display:inline-block;word-break:break-word;word-wrap:break-word;margin-bottom:0;color:#656565;font-size:1em;font-weight:bold;margin-left:15px}#onetrust-pc-sdk #ot-lst-title{margin:10px 0 10px 0px;font-size:1em;text-align:left}#onetrust-pc-sdk #ot-pc-hdr{margin:0 0 0 30px;height:auto;width:auto}#onetrust-pc-sdk #ot-pc-hdr input::placeholder{color:#707070;font-style:italic}#onetrust-pc-sdk #vendor-search-handler{height:31px;width:100%;border-radius:50px;font-size:.8em;padding-right:35px;padding-left:15px;float:left;margin-left:15px}#onetrust-pc-sdk .ot-ven-name{display:block;width:auto;padding-right:5px}#onetrust-pc-sdk #ot-lst-cnt{overflow-y:auto;margin-left:20px;margin-right:7px;width:calc(100% - 27px);max-height:calc(100% - 80px);height:100%;transform:translate3d(0, 0, 0)}#onetrust-pc-sdk #ot-pc-lst{width:100%;bottom:100px;position:absolute;top:60px}#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr *{visibility:hidden}#onetrust-pc-sdk #ot-pc-lst .ot-tgl-cntr{right:12px;position:absolute}#onetrust-pc-sdk #ot-pc-lst .ot-arw-cntr{float:right;position:relative}#onetrust-pc-sdk #ot-pc-lst .ot-arw{margin-left:10px}#onetrust-pc-sdk #ot-pc-lst .ot-acc-hdr{overflow:hidden;cursor:pointer}#onetrust-pc-sdk .ot-vlst-cntr{overflow:hidden}#onetrust-pc-sdk #ot-sel-blk{overflow:hidden;width:100%;position:sticky;position:-webkit-sticky;top:0;z-index:3}#onetrust-pc-sdk #ot-back-arw{height:12px;width:12px}#onetrust-pc-sdk .ot-lst-subhdr{width:100%;display:inline-block}#onetrust-pc-sdk .ot-search-cntr{float:left;width:78%;position:relative}#onetrust-pc-sdk .ot-search-cntr>svg{width:30px;height:30px;position:absolute;float:left;right:-15px}#onetrust-pc-sdk .ot-fltr-cntr{float:right;right:50px;position:relative}#onetrust-pc-sdk #filter-btn-handler{background-color:#3860be;border-radius:17px;display:inline-block;position:relative;width:32px;height:32px;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease;padding:0;margin:0}#onetrust-pc-sdk #filter-btn-handler:hover{background-color:#3860be}#onetrust-pc-sdk #filter-btn-handler svg{width:12px;height:12px;margin:3px 10px 0 10px;display:block;position:static;right:auto;top:auto}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{color:#3860be;text-decoration:none;font-weight:100;display:inline-block;padding-top:10px;transform:translate(0, 1%);-o-transform:translate(0, 1%);-ms-transform:translate(0, 1%);-webkit-transform:translate(0, 1%);position:relative;z-index:2}#onetrust-pc-sdk .ot-ven-link *,#onetrust-pc-sdk .ot-ven-legclaim-link *{font-size:inherit}#onetrust-pc-sdk .ot-ven-link:hover,#onetrust-pc-sdk .ot-ven-legclaim-link:hover{text-decoration:underline}#onetrust-pc-sdk .ot-ven-hdr{width:calc(100% - 160px);height:auto;float:left;word-break:break-word;word-wrap:break-word;vertical-align:middle;padding-bottom:3px}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{letter-spacing:.03em;font-size:.75em;font-weight:400}#onetrust-pc-sdk .ot-ven-dets{border-radius:2px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-ven-dets li:first-child p:first-child{border-top:none}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:not(:first-child){border-top:1px solid #ddd !important}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(odd){width:30%}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(even){width:50%;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p,#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{padding-top:5px;padding-bottom:5px;display:block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-last-child(-n+1){padding-bottom:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-child(-n+2):not(.disc-pur){padding-top:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur-cont{display:inline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur{position:relative;width:50% !important;word-break:break-word;word-wrap:break-word;left:calc(30% + 17px)}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur:nth-child(-n+1){position:static}#onetrust-pc-sdk .ot-ven-dets p,#onetrust-pc-sdk .ot-ven-dets h5,#onetrust-pc-sdk .ot-ven-dets span{font-size:.69em;text-align:left;vertical-align:middle;word-break:break-word;word-wrap:break-word;margin:0;padding-bottom:10px;padding-left:15px;color:#2e3644}#onetrust-pc-sdk .ot-ven-dets h5{padding-top:5px}#onetrust-pc-sdk .ot-ven-dets span{color:dimgray;padding:0;vertical-align:baseline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-pur h5{border-top:1px solid #e9e9e9;border-bottom:1px solid #e9e9e9;padding-bottom:5px;margin-bottom:5px;font-weight:bold}#onetrust-pc-sdk #ot-host-lst .ot-sel-all{float:right;position:relative;margin-right:42px;top:10px}#onetrust-pc-sdk #ot-host-lst .ot-sel-all input[type=checkbox]{width:auto;height:auto}#onetrust-pc-sdk #ot-host-lst .ot-sel-all label{height:20px;width:20px;padding-left:0px}#onetrust-pc-sdk #ot-host-lst .ot-acc-txt{overflow:hidden;width:95%}#onetrust-pc-sdk .ot-host-hdr{position:relative;z-index:1;pointer-events:none;width:calc(100% - 125px);float:left}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-desc{display:inline-block;width:90%}#onetrust-pc-sdk .ot-host-name{pointer-events:none}#onetrust-pc-sdk .ot-host-hdr>a{text-decoration:underline;font-size:.82em;position:relative;z-index:2;float:left;margin-bottom:5px;pointer-events:initial}#onetrust-pc-sdk .ot-host-name+a{margin-top:5px}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a,#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{color:dimgray;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a{font-weight:bold;font-size:.82em;line-height:1.3}#onetrust-pc-sdk .ot-host-name a{font-size:1em}#onetrust-pc-sdk .ot-host-expand{margin-top:3px;margin-bottom:3px;clear:both;display:block;color:#3860be;font-size:.72em;font-weight:normal}#onetrust-pc-sdk .ot-host-expand *{font-size:inherit}#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{font-size:.688em;line-height:1.4;font-weight:normal}#onetrust-pc-sdk .ot-host-desc{margin-top:10px}#onetrust-pc-sdk .ot-host-opt{margin:0;font-size:inherit;display:inline-block;width:100%}#onetrust-pc-sdk .ot-host-opt li>div div{font-size:.8em;padding:5px 0}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(1){width:30%;float:left}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(2){width:70%;float:left;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-info{border:none;display:inline-block;width:calc(100% - 10px);padding:10px;margin-bottom:10px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-host-info>div{overflow:auto}#onetrust-pc-sdk #no-results{text-align:center;margin-top:30px}#onetrust-pc-sdk #no-results p{font-size:1em;color:#2e3644;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk #no-results p span{font-weight:bold}#onetrust-pc-sdk #ot-fltr-modal{width:100%;height:auto;display:none;-moz-transition:.2s ease;-o-transition:.2s ease;-webkit-transition:2s ease;transition:.2s ease;overflow:hidden;opacity:1;right:0}#onetrust-pc-sdk #ot-fltr-modal .ot-label-txt{display:inline-block;font-size:.85em;color:dimgray}#onetrust-pc-sdk #ot-fltr-cnt{z-index:2147483646;background-color:#fff;position:absolute;height:90%;max-height:300px;width:325px;left:210px;margin-top:10px;margin-bottom:20px;padding-right:10px;border-radius:3px;-webkit-box-shadow:0px 0px 12px 2px #c7c5c7;-moz-box-shadow:0px 0px 12px 2px #c7c5c7;box-shadow:0px 0px 12px 2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-scrlcnt{overflow-y:auto;overflow-x:hidden;clear:both;max-height:calc(100% - 60px)}#onetrust-pc-sdk #ot-anchor{border:12px solid rgba(0,0,0,0);display:none;position:absolute;z-index:2147483647;right:55px;top:75px;transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);-webkit-transform:rotate(45deg);background-color:#fff;-webkit-box-shadow:-3px -3px 5px -2px #c7c5c7;-moz-box-shadow:-3px -3px 5px -2px #c7c5c7;box-shadow:-3px -3px 5px -2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-btns{margin-left:15px}#onetrust-pc-sdk #filter-apply-handler{margin-right:15px}#onetrust-pc-sdk .ot-fltr-opt{margin-bottom:5px;margin-left:15px;min-height:20px;width:75%;position:relative}#onetrust-pc-sdk .ot-fltr-opt p{display:inline-block;margin:0;font-size:.9em;color:#2e3644}#onetrust-pc-sdk .ot-chkbox label span{font-size:.85em;color:dimgray}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox][aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk #ot-selall-vencntr,#onetrust-pc-sdk #ot-selall-adtlvencntr,#onetrust-pc-sdk #ot-selall-hostcntr,#onetrust-pc-sdk #ot-selall-licntr,#onetrust-pc-sdk #ot-selall-gnvencntr{right:15px;position:relative;width:20px;height:20px;float:right}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label,#onetrust-pc-sdk #ot-selall-gnvencntr label{float:left;padding-left:0}#onetrust-pc-sdk #ot-ven-lst:first-child{border-top:1px solid #e2e2e2}#onetrust-pc-sdk ul{list-style:none;padding:0}#onetrust-pc-sdk ul li{position:relative;margin:0;padding:15px 15px 15px 10px;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk ul li h3,#onetrust-pc-sdk ul li h4{font-size:.75em;color:#656565;margin:0;display:inline-block;width:70%;height:auto;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk ul li p{margin:0;font-size:.7em}#onetrust-pc-sdk ul li input[type=checkbox]{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0}#onetrust-pc-sdk .ot-cat-item>button:focus,#onetrust-pc-sdk .ot-acc-cntr>button:focus,#onetrust-pc-sdk li>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-cat-item>button,#onetrust-pc-sdk .ot-acc-cntr>button,#onetrust-pc-sdk li>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-host-item>button:focus,#onetrust-pc-sdk .ot-ven-item>button:focus{outline:0;border:2px solid #000}#onetrust-pc-sdk .ot-hide-acc>button{pointer-events:none}#onetrust-pc-sdk .ot-hide-acc .ot-plus-minus>*,#onetrust-pc-sdk .ot-hide-acc .ot-arw-cntr>*{visibility:hidden}#onetrust-pc-sdk .ot-hide-acc .ot-acc-hdr{min-height:30px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt){padding-right:10px;width:calc(100% - 37px);margin-top:10px;max-height:calc(100% - 90px)}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk{background-color:#f9f9fc;border:1px solid #e2e2e2;width:calc(100% - 2px);padding-bottom:5px;padding-top:5px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt{border:unset;background-color:unset}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all-hdr{display:none}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all{padding-right:.5rem}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all .ot-chkbox{right:0}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all{padding-right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all-chkbox{width:auto}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) ul li{border:1px solid #e2e2e2;margin-bottom:10px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-acc-cntr>.ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk.ot-addtl-vendors .ot-sel-all-chkbox{float:right}#onetrust-pc-sdk.ot-addtl-vendors .ot-plus-minus~.ot-sel-all-chkbox{right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-ven-lst:first-child{border-top:none}#onetrust-pc-sdk .ot-acc-cntr{position:relative;border-left:1px solid #e2e2e2;border-right:1px solid #e2e2e2;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr input{z-index:1}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr{background-color:#f9f9fc;padding:5px 0 5px 15px;width:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-plus-minus{vertical-align:middle;top:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-arw-cntr{right:10px}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr input{z-index:2}#onetrust-pc-sdk .ot-acc-cntr.ot-add-tech .ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk .ot-acc-cntr>input[type=checkbox]:checked~.ot-acc-hdr{border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-txt{padding-left:10px;padding-right:10px}#onetrust-pc-sdk .ot-acc-cntr button[aria-expanded=true]~.ot-acc-txt{width:auto}#onetrust-pc-sdk .ot-acc-cntr .ot-addtl-venbox{display:none}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0;width:100%}#onetrust-pc-sdk .ot-vensec-title{font-size:.813em;vertical-align:middle;display:inline-block}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a{margin-left:0;margin-top:10px}#onetrust-pc-sdk #ot-selall-vencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-adtlvencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-licntr.line-through label::after,#onetrust-pc-sdk #ot-selall-hostcntr.line-through label::after,#onetrust-pc-sdk #ot-selall-gnvencntr.line-through label::after{height:auto;border-left:0;transform:none;-o-transform:none;-ms-transform:none;-webkit-transform:none;left:5px;top:9px}#onetrust-pc-sdk #ot-category-title{float:left;padding-bottom:10px;font-size:1em;width:100%}#onetrust-pc-sdk .ot-cat-grp{margin-top:10px}#onetrust-pc-sdk .ot-cat-item{line-height:1.1;margin-top:10px;display:inline-block;width:100%}#onetrust-pc-sdk .ot-btn-container{text-align:right}#onetrust-pc-sdk .ot-btn-container button{display:inline-block;font-size:.75em;letter-spacing:.08em;margin-top:19px}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon{position:absolute;top:10px;right:0;z-index:1;padding:0;background-color:rgba(0,0,0,0);border:none}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon svg{display:block;height:10px;width:10px}#onetrust-pc-sdk #clear-filters-handler{margin-top:20px;margin-bottom:10px;float:right;max-width:200px;text-decoration:none;color:#3860be;font-size:.9em;font-weight:bold;background-color:rgba(0,0,0,0);border-color:rgba(0,0,0,0);padding:1px}#onetrust-pc-sdk #clear-filters-handler:hover{color:#2285f7}#onetrust-pc-sdk #clear-filters-handler:focus{outline:#000 solid 1px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl,#onetrust-pc-sdk .ot-enbl-chr h4~.ot-always-active{right:45px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl+.ot-tgl{right:120px}#onetrust-pc-sdk .ot-enbl-chr .ot-pli-hdr.ot-leg-border-color span:first-child{width:90px}#onetrust-pc-sdk .ot-enbl-chr li.ot-subgrp>h5+.ot-tgl-cntr{padding-right:25px}#onetrust-pc-sdk .ot-plus-minus{width:20px;height:20px;font-size:1.5em;position:relative;display:inline-block;margin-right:5px;top:3px}#onetrust-pc-sdk .ot-plus-minus span{position:absolute;background:#27455c;border-radius:1px}#onetrust-pc-sdk .ot-plus-minus span:first-of-type{top:25%;bottom:25%;width:10%;left:45%}#onetrust-pc-sdk .ot-plus-minus span:last-of-type{left:25%;right:25%;height:10%;top:45%}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:first-of-type,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{transform:rotate(90deg)}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{left:50%;right:50%}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk .ot-host-item .ot-plus-minus,#onetrust-pc-sdk .ot-ven-item .ot-plus-minus{float:left;margin-right:8px;top:10px}#onetrust-pc-sdk .ot-ven-item ul{list-style:none inside;font-size:100%;margin:0}#onetrust-pc-sdk .ot-ven-item ul li{margin:0 !important;padding:0;border:none !important}#onetrust-pc-sdk .ot-pli-hdr{color:#77808e;overflow:hidden;padding-top:7.5px;padding-bottom:7.5px;width:calc(100% - 2px);border-top-left-radius:3px;border-top-right-radius:3px}#onetrust-pc-sdk .ot-pli-hdr span:first-child{top:50%;transform:translateY(50%);max-width:90px}#onetrust-pc-sdk .ot-pli-hdr span:last-child{padding-right:10px;max-width:95px;text-align:center}#onetrust-pc-sdk .ot-li-title{float:right;font-size:.813em}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color{background-color:#f4f4f4;border:1px solid #d8d8d8}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color span:first-child{text-align:left;width:70px}#onetrust-pc-sdk li.ot-subgrp>h5,#onetrust-pc-sdk .ot-cat-header{width:calc(100% - 130px)}#onetrust-pc-sdk li.ot-subgrp>h5+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-acc-grpdesc{margin-bottom:5px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-acc-grpcntr .ot-vlst-cntr+.ot-subgrp-cntr{border-top:none}#onetrust-pc-sdk .ot-acc-hdr .ot-arw-cntr+.ot-tgl-cntr,#onetrust-pc-sdk .ot-acc-txt h4+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-subgrp>h5,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header{width:calc(100% - 145px)}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item h5+.ot-tgl-cntr,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header+.ot-tgl{padding-left:28px}#onetrust-pc-sdk .ot-sel-all-hdr,#onetrust-pc-sdk .ot-sel-all-chkbox{display:inline-block;width:100%;position:relative}#onetrust-pc-sdk .ot-sel-all-chkbox{z-index:1}#onetrust-pc-sdk .ot-sel-all{margin:0;position:relative;padding-right:23px;float:right}#onetrust-pc-sdk .ot-consent-hdr,#onetrust-pc-sdk .ot-li-hdr{float:right;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-li-hdr{max-width:100px;padding-right:10px}#onetrust-pc-sdk .ot-consent-hdr{max-width:55px}#onetrust-pc-sdk #ot-selall-licntr{display:block;width:21px;height:auto;float:right;position:relative;right:80px}#onetrust-pc-sdk #ot-selall-licntr label{position:absolute}#onetrust-pc-sdk .ot-ven-ctgl{margin-left:66px}#onetrust-pc-sdk .ot-ven-litgl+.ot-arw-cntr{margin-left:81px}#onetrust-pc-sdk .ot-enbl-chr .ot-host-cnt .ot-tgl-cntr{width:auto}#onetrust-pc-sdk #ot-lst-cnt:not(.ot-host-cnt) .ot-tgl-cntr{width:auto;top:auto;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox label{position:absolute;padding:0;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-acc-grpdesc+.ot-leg-btn-container{padding-left:20px;padding-right:20px;width:calc(100% - 40px);margin-bottom:5px}#onetrust-pc-sdk .ot-subgrp .ot-leg-btn-container{margin-bottom:5px}#onetrust-pc-sdk #ot-ven-lst .ot-leg-btn-container{margin-top:10px}#onetrust-pc-sdk .ot-leg-btn-container{display:inline-block;width:100%;margin-bottom:10px}#onetrust-pc-sdk .ot-leg-btn-container button{height:auto;padding:6.5px 8px;margin-bottom:0;letter-spacing:0;font-size:.75em;line-height:normal}#onetrust-pc-sdk .ot-leg-btn-container svg{display:none;height:14px;width:14px;padding-right:5px;vertical-align:sub}#onetrust-pc-sdk .ot-active-leg-btn{cursor:default;pointer-events:none}#onetrust-pc-sdk .ot-active-leg-btn svg{display:inline-block}#onetrust-pc-sdk .ot-remove-objection-handler{text-decoration:underline;padding:0;font-size:.75em;font-weight:600;line-height:1;padding-left:10px}#onetrust-pc-sdk .ot-obj-leg-btn-handler span{font-weight:bold;text-align:center;font-size:inherit;line-height:1.5}#onetrust-pc-sdk.ot-close-btn-link #close-pc-btn-handler{border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em;background:none;right:15px;top:15px;width:auto;font-weight:normal}#onetrust-pc-sdk .ot-pgph-link{font-size:.813em !important;margin-top:5px;position:relative}#onetrust-pc-sdk .ot-pgph-link.ot-pgph-link-subgroup{margin-bottom:1rem}#onetrust-pc-sdk .ot-pgph-contr{margin:0 2.5rem}#onetrust-pc-sdk .ot-pgph-title{font-size:1.18rem;margin-bottom:2rem}#onetrust-pc-sdk .ot-pgph-desc{font-size:1rem;font-weight:400;margin-bottom:2rem;line-height:1.5rem}#onetrust-pc-sdk .ot-pgph-desc:not(:last-child):after{content:"";width:96%;display:block;margin:0 auto;padding-bottom:2rem;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk .ot-cat-header{float:left;font-weight:600;font-size:.875em;line-height:1.5;max-width:90%;vertical-align:middle}#onetrust-pc-sdk .ot-vnd-item>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-vnd-item>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{position:relative;border-radius:2px;margin:0;padding:0;border:1px solid #d8d8d8;border-top:none;width:calc(100% - 2px);float:left}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{margin-top:10px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc{padding-left:20px;padding-right:20px;width:calc(100% - 40px);font-size:.812em;margin-bottom:10px;margin-top:15px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul{padding-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul li{padding-top:0;line-height:1.5;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout div+.ot-acc-grpdesc{margin-top:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:first-child{margin-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:last-child,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr:last-child{margin-bottom:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding-top:11.5px;padding-bottom:11.5px;padding-left:20px;padding-right:20px;width:calc(100% - 40px);display:inline-block}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-txt{width:100%;padding:0}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp-cntr{padding-left:20px;padding-right:15px;padding-bottom:0;width:calc(100% - 35px)}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp{padding-right:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpcntr{z-index:1;position:relative}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr{position:absolute;top:50%;transform:translateY(-50%);right:20px;margin-top:-2px}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr .ot-arw{width:15px;height:20px;margin-left:5px;color:dimgray}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{float:none;color:#2e3644;margin:0;display:inline-block;height:auto;word-wrap:break-word;min-height:inherit}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding-left:20px;width:calc(100% - 20px);display:inline-block;margin-top:0;padding-bottom:2px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{position:relative;min-height:25px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl,#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{position:absolute;top:50%;transform:translateY(-50%);right:20px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl+.ot-tgl{right:95px}#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler,#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler+a{margin-top:5px}#onetrust-pc-sdk #ot-lst-cnt{margin-top:1rem;max-height:calc(100% - 96px)}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list,#onetrust-pc-sdk .ot-vnd-serv{width:auto;padding:1rem 1.25rem;padding-bottom:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:600;font-size:.95em;line-height:2;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item{border:none;margin:0;padding:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button{outline:none;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button[aria-expanded=true],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button[aria-expanded=true]{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:first-child{margin-top:.25rem;border-top:unset}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child{margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child button{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 1.75rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-lbl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-cnt,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt{padding-left:40px}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-size:.8em}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-cat-header{font-size:.8em}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv{margin-bottom:1rem;padding:1rem .95rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:700;font-size:.8em;line-height:20px;margin-left:.82rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-cat-header{font-weight:700;font-size:.8em;line-height:20px}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-vnd-serv .ot-vnd-lst-cont .ot-accordion-layout .ot-acc-hdr div.ot-chkbox{margin-left:.82rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr{padding:.7rem 0;margin:0;display:flex;width:100%;align-items:center;justify-content:space-between}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:first-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:first-child{margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:last-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:last-child{margin-right:.5rem;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-always-active{position:relative;right:unset;top:unset;transform:unset}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-plus-minus{top:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-arw-cntr{float:none;top:unset;right:unset;transform:unset;margin-top:-2px;position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-cat-header{flex:1;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-tgl{position:relative;transform:none;right:0;top:0;float:none}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox{position:relative;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label{padding:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label::before{position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox input{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0;z-index:1}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h5.ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h4.ot-cat-header{margin:0}#onetrust-pc-sdk .ot-vs-config .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp h5{top:0;line-height:20px}#onetrust-pc-sdk .ot-vs-list{display:flex;flex-direction:column;padding:0;margin:.5rem 4px}#onetrust-pc-sdk .ot-vs-selc-all{display:flex;padding:0;float:unset;align-items:center;justify-content:flex-start}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf{justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf.ot-caret-conf .ot-sel-all-chkbox{margin-right:48px}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf .ot-sel-all-chkbox{margin:0;padding:0;margin-right:14px;justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-chkbox,#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-tgl{display:inline-block;right:unset;width:auto;height:auto;float:none}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr label{width:45px;height:25px}#onetrust-pc-sdk .ot-vs-selc-all .ot-sel-all-chkbox{margin-right:11px;margin-left:.75rem;display:flex;align-items:center}#onetrust-pc-sdk .ot-vs-selc-all .sel-all-hdr{margin:0 1.25rem;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-vnd-list-cnt #ot-selall-vencntr.ot-chkbox{float:unset;right:0}#onetrust-pc-sdk[dir=rtl] #ot-back-arw,#onetrust-pc-sdk[dir=rtl] input~.ot-acc-hdr .ot-arw{transform:rotate(180deg);-o-transform:rotate(180deg);-ms-transform:rotate(180deg);-webkit-transform:rotate(180deg)}#onetrust-pc-sdk[dir=rtl] input:checked~.ot-acc-hdr .ot-arw{transform:rotate(270deg);-o-transform:rotate(270deg);-ms-transform:rotate(270deg);-webkit-transform:rotate(270deg)}#onetrust-pc-sdk[dir=rtl] .ot-chkbox label::after{transform:rotate(45deg);-webkit-transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);border-left:0;border-right:3px solid}#onetrust-pc-sdk[dir=rtl] .ot-search-cntr>svg{right:0}@media only screen and (max-width: 600px){#onetrust-pc-sdk.otPcCenter{left:0;min-width:100%;height:100%;top:0;border-radius:0}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:1px 3px 0 10px;padding-right:10px;width:calc(100% - 23px)}#onetrust-pc-sdk .ot-btn-container button{max-width:none;letter-spacing:.01em}#onetrust-pc-sdk #close-pc-btn-handler{top:10px;right:17px}#onetrust-pc-sdk p{font-size:.7em}#onetrust-pc-sdk #ot-pc-hdr{margin:10px 10px 0 5px;width:calc(100% - 15px)}#onetrust-pc-sdk .vendor-search-handler{font-size:1em}#onetrust-pc-sdk #ot-back-arw{margin-left:12px}#onetrust-pc-sdk #ot-lst-cnt{margin:0;padding:0 5px 0 10px;min-width:95%}#onetrust-pc-sdk .switch+p{max-width:80%}#onetrust-pc-sdk .ot-ftr-stacked button{width:100%}#onetrust-pc-sdk #ot-fltr-cnt{max-width:320px;width:90%;border-top-right-radius:0;border-bottom-right-radius:0;margin:0;margin-left:15px;left:auto;right:40px;top:85px}#onetrust-pc-sdk .ot-fltr-opt{margin-left:25px;margin-bottom:10px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-bottom:0}#onetrust-pc-sdk #ot-fltr-cnt{right:40px}}@media only screen and (max-width: 476px){#onetrust-pc-sdk .ot-fltr-cntr,#onetrust-pc-sdk #ot-fltr-cnt{right:10px}#onetrust-pc-sdk #ot-anchor{right:25px}#onetrust-pc-sdk button{width:100%}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-sel-all{padding-right:9px}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr{right:0}}@media(min-width: 768px){#onetrust-pc-sdk.ot-tgl-with-label .ot-label-status{display:inline}#onetrust-pc-sdk.ot-tgl-with-label #ot-pc-lst .ot-label-status{display:none}}@media only screen and (max-width: 896px)and (max-height: 425px)and (orientation: landscape){#onetrust-pc-sdk.otPcCenter{left:0;top:0;min-width:100%;height:100%;border-radius:0}#onetrust-pc-sdk .ot-pc-header{height:auto;min-height:20px}#onetrust-pc-sdk .ot-pc-header .ot-pc-logo{max-height:30px}#onetrust-pc-sdk .ot-pc-footer{max-height:60px;overflow-y:auto}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk #ot-pc-lst{bottom:70px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:70px}#onetrust-pc-sdk #ot-anchor{left:initial;right:50px}#onetrust-pc-sdk #ot-lst-title{margin-top:12px}#onetrust-pc-sdk #ot-lst-title *{font-size:inherit}#onetrust-pc-sdk #ot-pc-hdr input{margin-right:0;padding-right:45px}#onetrust-pc-sdk .switch+p{max-width:85%}#onetrust-pc-sdk #ot-sel-blk{position:static}#onetrust-pc-sdk #ot-pc-lst{overflow:auto}#onetrust-pc-sdk #ot-lst-cnt{max-height:none;overflow:initial}#onetrust-pc-sdk #ot-lst-cnt.no-results{height:auto}#onetrust-pc-sdk input{font-size:1em !important}#onetrust-pc-sdk p{font-size:.6em}#onetrust-pc-sdk #ot-fltr-modal{width:100%;top:0}#onetrust-pc-sdk ul li p,#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{font-size:.6em}#onetrust-pc-sdk.ot-shw-fltr #ot-anchor{display:none !important}#onetrust-pc-sdk.ot-shw-fltr #ot-pc-lst{height:100% !important;overflow:hidden;top:0px}#onetrust-pc-sdk.ot-shw-fltr #ot-fltr-cnt{margin:0;height:100%;max-height:none;padding:10px;top:0;width:calc(100% - 20px);position:absolute;right:0;left:0;max-width:none}#onetrust-pc-sdk.ot-shw-fltr .ot-fltr-scrlcnt{max-height:calc(100% - 65px)}}
            #onetrust-consent-sdk #onetrust-pc-sdk,
                #onetrust-consent-sdk #ot-search-cntr,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-switch.ot-toggle,
                #onetrust-consent-sdk #onetrust-pc-sdk ot-grp-hdr1 .checkbox,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title:after
                ,#onetrust-consent-sdk #onetrust-pc-sdk #ot-sel-blk,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-cnt,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-anchor {
                    background-color: #FFF;
                }
               
            #onetrust-consent-sdk #onetrust-pc-sdk h3,
                #onetrust-consent-sdk #onetrust-pc-sdk h4,
                #onetrust-consent-sdk #onetrust-pc-sdk h5,
                #onetrust-consent-sdk #onetrust-pc-sdk h6,
                #onetrust-consent-sdk #onetrust-pc-sdk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-ven-lst .ot-ven-opts p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-desc,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-li-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-sel-all-hdr span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-modal #modal-header,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-checkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-sel-blk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-lst-title h3,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .back-btn-handler p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .ot-ven-name,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-ven-lst .consent-category,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-label-status,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-chkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #clear-filters-handler,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-optout-signal
                {
                    color: #2E2E2E;
                }
             #onetrust-consent-sdk #onetrust-pc-sdk .privacy-notice-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-pgph-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler + a,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-host-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-legclaim-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-name a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-acc-hdr .ot-host-expand,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-content #ot-pc-desc .ot-link-btn,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info a
                    {
                        color: #007398;
                    }
            #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler:hover { text-decoration: underline;}
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-subgrp-tgl .ot-switch.ot-toggle
             {
                background-color: #F8F8F8;
            }
             #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-ven-dets
                            {
                                background-color: #F8F8F8;
                            }
        #onetrust-consent-sdk #onetrust-pc-sdk
            button:not(#clear-filters-handler):not(.ot-close-icon):not(#filter-btn-handler):not(.ot-remove-objection-handler):not(.ot-obj-leg-btn-handler):not([aria-expanded]):not(.ot-link-btn),
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-active-leg-btn {
                background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-active-menu {
                border-color: #007398;
            }
            
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-remove-objection-handler{
                background-color: transparent;
                border: 1px solid transparent;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn {
                background-color: #FFFFFF;
                color: #4D4D4D; border-color: #4D4D4D;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-tgl input:focus + .ot-switch, .ot-switch .ot-switch-nob, .ot-switch .ot-switch-nob:before,
            #onetrust-pc-sdk .ot-checkbox input[type="checkbox"]:focus + label::before,
            #onetrust-pc-sdk .ot-chkbox input[type="checkbox"]:focus + label::before {
                outline-color: #000000;
                outline-width: 1px;
                outline-offset: 1px;
            }
            #onetrust-pc-sdk .ot-host-item > button:focus, #onetrust-pc-sdk .ot-ven-item > button:focus {
                border: 1px solid #000000;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk *:focus,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-vlst-cntr > a:focus {
               outline: 1px solid #000000;
               outline-offset: 1px;
            }#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,  #onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{
                    background-image: url('https://cdn.cookielaw.org/logos/static/ot_external_link.svg');
                }
            /*! v6.10.0 2021-01-18 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #d0d3d4!important;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007dbc!important;border:2px solid #007dbc!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#949494!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007dbc!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007dbc!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #949494!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:inherit!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #007dbc;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:inherit;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#007dbc;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#007dbc;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #007dbc!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}
.ot-sdk-cookie-policy{font-family:inherit;font-size:16px}.ot-sdk-cookie-policy.otRelFont{font-size:1rem}.ot-sdk-cookie-policy h3,.ot-sdk-cookie-policy h4,.ot-sdk-cookie-policy h6,.ot-sdk-cookie-policy p,.ot-sdk-cookie-policy li,.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy th,.ot-sdk-cookie-policy #cookie-policy-description,.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}.ot-sdk-cookie-policy h4{font-size:1.2em}.ot-sdk-cookie-policy h6{font-size:1em;margin-top:2em}.ot-sdk-cookie-policy th{min-width:75px}.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy a:hover{background:#fff}.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}.ot-sdk-cookie-policy .ot-mobile-border{display:none}.ot-sdk-cookie-policy section{margin-bottom:2em}.ot-sdk-cookie-policy table{border-collapse:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy{font-family:inherit;font-size:1rem}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup{margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group-desc,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-table-header,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td{font-size:.9em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td a{font-size:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group{font-size:1em;margin-bottom:.6em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-title{margin-bottom:1.2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy>section{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th{min-width:75px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a:hover{background:#fff}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-mobile-border{display:none}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy section{margin-bottom:2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li{list-style:disc;margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li h4{display:inline-block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{border-collapse:inherit;margin:auto;border:1px solid #d7d7d7;border-radius:5px;border-spacing:initial;width:100%;overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border-bottom:1px solid #d7d7d7;border-right:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr th:last-child,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr td:last-child{border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:25%}.ot-sdk-cookie-policy[dir=rtl]{text-align:left}#ot-sdk-cookie-policy h3{font-size:1.5em}@media only screen and (max-width: 530px){.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) table,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tbody,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) th,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{display:block}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead tr{position:absolute;top:-9999px;left:-9999px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{margin:0 0 1em 0}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd),.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd) a{background:#f6f6f4}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td{border:none;border-bottom:1px solid #eee;position:relative;padding-left:50%}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{position:absolute;height:100%;left:6px;width:40%;padding-right:10px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) .ot-mobile-border{display:inline-block;background-color:#e4e4e4;position:absolute;height:100%;top:0;left:45%;width:2px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{content:attr(data-label);font-weight:bold}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border:none;border-bottom:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{display:block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:auto}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{margin:0 0 1em 0}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{height:100%;width:40%;padding-right:10px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{content:attr(data-label);font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead tr{position:absolute;top:-9999px;left:-9999px;z-index:-9999}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:1px solid #d7d7d7;border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td:last-child{border-bottom:0px}}
                
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h5,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group {
                        color: #696969;
                    }
                    
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title {
                            color: #696969;
                        }
                    
            
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th {
                            background-color: #F8F8F8;
                        }
                    
            .ot-floating-button__front{background-image:url('https://cdn.cookielaw.org/logos/static/ot_persistent_cookie_icon.png')}</style><script src="https://static.addtoany.com/menu/modules/core.pt5ow5lr.js" type="module"></script><style type="text/css">.a2a_hide{display:none}.a2a_logo_color{background-color:#0166ff}.a2a_menu,.a2a_menu *{-moz-box-sizing:content-box;-webkit-box-sizing:content-box;box-sizing:content-box;float:none;margin:0;padding:0;position:static;height:auto;width:auto}.a2a_menu{border-radius:6px;display:none;direction:ltr;background:#FFF;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;color:#000;line-height:12px;border:1px solid #CCC;vertical-align:baseline;overflow:hidden}.a2a_mini{min-width:200px;position:absolute;width:300px;z-index:9999997}.a2a_overlay{display:none;background:#616c7deb;backdrop-filter:blur(4px);-webkit-backdrop-filter:blur(4px);position:fixed;top:0;right:0;left:0;bottom:0;z-index:9999998;-webkit-tap-highlight-color:transparent;transition:opacity .14s,backdrop-filter .14s}.a2a_full{background:#FFF;border:1px solid #FFF;box-shadow:#2a2a2a1a 0 0 20px 10px;height:auto;height:calc(320px);top:15%;left:50%;margin-left:-320px;position:fixed;text-align:center;width:640px;z-index:9999999;transition:transform .14s,opacity .14s}.a2a_full_footer,.a2a_full_header,.a2a_full_services{border:0;margin:0;padding:12px;box-sizing:border-box}.a2a_full_header{padding-bottom:8px}.a2a_full_services{height:280px;overflow-y:scroll;padding:0 12px;-webkit-overflow-scrolling:touch}.a2a_full_services .a2a_i{display:inline-block;float:none;width:181px;width:calc(33.334% - 18px)}div.a2a_full_footer{font-size:12px;text-align:center;padding:8px 14px}div.a2a_full_footer a,div.a2a_full_footer a:visited{display:inline;font-size:12px;line-height:14px;padding:8px 14px}div.a2a_full_footer a:focus,div.a2a_full_footer a:hover{background:0 0;border:0;color:#0166FF}div.a2a_full_footer a span.a2a_s_a2a,div.a2a_full_footer a span.a2a_w_a2a{background-size:14px;border-radius:3px;display:inline-block;height:14px;line-height:14px;margin:0 3px 0 0;vertical-align:top;width:14px}.a2a_modal{height:0;left:50%;margin-left:-320px;position:fixed;text-align:center;top:15%;width:640px;z-index:9999999;transition:transform .14s,opacity .14s;-webkit-tap-highlight-color:transparent}.a2a_modal_body{background:0 0;border:0;font:24px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;position:relative;height:auto;width:auto}.a2a_thanks{color:#fff;height:auto;margin-top:20px;width:auto}.a2a_thanks>div:first-child{margin:0 0 40px 0}.a2a_thanks div *{height:inherit}#a2a_copy_link{background:#FFF;border:1px solid #FFF;cursor:pointer;margin-top:15%}label.a2a_s_link#a2a_copy_link_icon,label.a2a_w_link#a2a_copy_link_icon{background-size:48px;border-radius:0;display:inline-block;height:48px;left:0;line-height:48px;margin:0 3px 0 0;position:absolute;vertical-align:top;width:48px}#a2a_modal input#a2a_copy_link_text{background-color:transparent;border:0;color:#2A2A2A;cursor:pointer;font:inherit;height:48px;left:62px;max-width:initial;min-height:auto;padding:0;position:relative;width:564px;width:calc(100% - 76px)}#a2a_copy_link_copied{background-color:#0166ff;color:#fff;display:none;font:inherit;font-size:16px;margin-top:1px;padding:3px 8px}@media (forced-colors:active){.a2a_color_buttons a,.a2a_svg{forced-color-adjust:none}}@media (prefers-color-scheme:dark){.a2a_menu a,.a2a_menu a.a2a_i,.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more,i.a2a_i{border-color:#2a2a2a!important;color:#fff!important}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover,.a2a_menu_find_container{border-color:#444!important;background-color:#444!important}.a2a_menu:not(.a2a_thanks){background-color:#2a2a2a;border-color:#2a2a2a}.a2a_menu_find{color:#fff!important}.a2a_menu label.a2a_s_find svg{background-color:transparent!important}.a2a_menu label.a2a_s_find svg path{fill:#fff!important}.a2a_full{box-shadow:#00000066 0 0 20px 10px}.a2a_overlay{background-color:#373737eb}}@media print{.a2a_floating_style,.a2a_menu,.a2a_overlay{visibility:hidden}}@keyframes a2aFadeIn{from{opacity:0}to{opacity:1}}.a2a_starting{opacity:0}.a2a_starting.a2a_full,.a2a_starting.a2a_modal{transform:scale(.8)}@media (max-width:639px){.a2a_full{border-radius:0;top:15%;left:0;margin-left:auto;width:100%}.a2a_modal{left:0;margin-left:10px;width:calc(100% - 20px)}}@media (min-width:318px) and (max-width:437px){.a2a_full .a2a_full_services .a2a_i{width:calc(50% - 18px)}}@media (max-width:317px){.a2a_full .a2a_full_services .a2a_i{width:calc(100% - 18px)}}@media (max-height:436px){.a2a_full{bottom:40px;height:auto;top:40px}}@media (max-height:550px){.a2a_modal{top:30px}}@media (max-height:360px){.a2a_modal{top:20px}.a2a_thanks>div:first-child{margin-bottom:20px}}.a2a_menu a{color:#0166FF;text-decoration:none;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;line-height:14px;height:auto;width:auto;outline:0}.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more{color:#0166FF}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover{color:#2A2A2A;border-color:#EEE;border-style:solid;background-color:#EEE;text-decoration:none}.a2a_menu label.a2a_s_find{background-size:24px;height:24px;left:8px;pointer-events:auto;position:absolute;top:7px;width:24px}.a2a_menu label.a2a_s_find svg{background-color:#FFF}.a2a_menu label.a2a_s_find svg path{fill:#CCC}#a2a_menu_container{display:inline-block}.a2a_menu_find_container{border:1px solid #CCC;border-radius:6px;padding:2px 24px 2px 0;position:relative;text-align:left}.a2a_cols_container .a2a_col1{overflow-x:hidden;overflow-y:auto;-webkit-overflow-scrolling:touch}#a2a_modal input,#a2a_modal input[type=text],.a2a_menu input,.a2a_menu input[type=text]{display:block;background-image:none;box-shadow:none;line-height:100%;margin:0;outline:0;overflow:hidden;padding:0;-moz-box-shadow:none;-webkit-box-shadow:none;-webkit-appearance:none}#a2afeed_find_container input,#a2afeed_find_container input[type=text],#a2apage_find_container input,#a2apage_find_container input[type=text]{background-color:transparent;border:0;box-sizing:content-box;color:#2A2A2A;float:none;font:inherit;font-size:16px;height:28px;line-height:20px;left:38px;outline:0;margin:0;max-width:initial;min-height:initial;padding:2px 0;position:relative;width:99%}.a2a_clear{clear:both}.a2a_svg{background-repeat:no-repeat;display:block;overflow:hidden;height:32px;line-height:32px;padding:0;pointer-events:none;width:32px}.a2a_svg svg{background-repeat:no-repeat;background-position:50% 50%;border:none;display:block;left:0;margin:0 auto;overflow:hidden;padding:0;position:relative;top:0;width:auto;height:auto}a.a2a_i,i.a2a_i{display:block;float:left;border:1px solid #FFF;line-height:24px;padding:6px 8px;text-align:left;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;width:132px}a.a2a_i span,a.a2a_more span{display:inline-block;overflow:hidden;vertical-align:top}a.a2a_i .a2a_svg{margin:0 6px 0 0}a.a2a_i .a2a_svg,a.a2a_more .a2a_svg{background-size:24px;height:24px;line-height:24px;width:24px}a.a2a_sss:hover{border-left:1px solid #CCC}a.a2a_more{border-bottom:1px solid #FFF;border-left:0;border-right:0;line-height:24px;margin:6px 0 0;padding:6px;-webkit-touch-callout:none}a.a2a_more span{height:24px;margin:0 6px 0 0}.a2a_kit .a2a_svg{background-repeat:repeat}.a2a_default_style a:empty,.a2a_flex_style a:empty,.a2a_floating_style a:empty,.a2a_overlay_style a:empty{display:none}.a2a_color_buttons a,.a2a_floating_style a{text-decoration:none}.a2a_default_style:not(.a2a_flex_style) a{float:left;line-height:16px;padding:0 2px}.a2a_default_style a:hover .a2a_svg,.a2a_floating_style a:hover .a2a_svg,.a2a_overlay_style a:hover .a2a_svg svg{opacity:.7}.a2a_overlay_style.a2a_default_style a:hover .a2a_svg{opacity:1}.a2a_default_style .a2a_count,.a2a_default_style .a2a_svg,.a2a_floating_style .a2a_svg,.a2a_menu .a2a_svg,.a2a_vertical_style .a2a_count,.a2a_vertical_style .a2a_svg{border-radius:4px}.a2a_default_style .a2a_counter img,.a2a_default_style .a2a_dd,.a2a_default_style .a2a_svg{float:left}.a2a_default_style .a2a_img_text{margin-right:4px}.a2a_default_style .a2a_divider{border-left:1px solid #000;display:inline;float:left;height:16px;line-height:16px;margin:0 5px}.a2a_kit a{cursor:pointer;transition:none}.a2a_floating_style{background-color:#fff;border-radius:6px;position:fixed;z-index:9999995}.a2a_overlay_style{z-index:2147483647}.a2a_floating_style,.a2a_overlay_style{animation:a2aFadeIn .2s ease-in;padding:4px}.a2a_vertical_style:not(.a2a_flex_style) a{clear:left;display:block;overflow:hidden;padding:4px}.a2a_floating_style.a2a_default_style{bottom:0}.a2a_floating_style.a2a_default_style a,.a2a_overlay_style.a2a_default_style a{padding:4px}.a2a_count{background-color:#fff;border:1px solid #ccc;box-sizing:border-box;color:#2a2a2a;display:block;float:left;font:12px Arial,Helvetica,sans-serif;height:16px;margin-left:4px;position:relative;text-align:center;width:50px}.a2a_count:after,.a2a_count:before{border:solid transparent;border-width:4px 4px 4px 0;content:"";height:0;left:0;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:50%;width:0}.a2a_count:before{border-right-color:#ccc}.a2a_count:after{border-right-color:#fff;margin-left:-3px}.a2a_count span{animation:a2aFadeIn .14s ease-in}.a2a_vertical_style .a2a_counter img{display:block}.a2a_vertical_style .a2a_count{float:none;margin-left:0;margin-top:6px}.a2a_vertical_style .a2a_count:after,.a2a_vertical_style .a2a_count:before{border:solid transparent;border-width:0 4px 4px 4px;content:"";height:0;left:50%;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:0;width:0}.a2a_vertical_style .a2a_count:before{border-bottom-color:#ccc}.a2a_vertical_style .a2a_count:after{border-bottom-color:#fff;margin-top:-3px}.a2a_color_buttons .a2a_count,.a2a_color_buttons .a2a_count:after,.a2a_color_buttons .a2a_count:before,.a2a_color_buttons.a2a_vertical_style .a2a_count:after,.a2a_color_buttons.a2a_vertical_style .a2a_count:before{background-color:transparent;border:none;color:#fff;float:none;width:auto}.a2a_color_buttons.a2a_vertical_style .a2a_count{margin-top:0}.a2a_flex_style{display:flex;align-items:flex-start;gap:0}.a2a_default_style.a2a_flex_style{left:0;right:0;width:100%}.a2a_vertical_style.a2a_flex_style{flex-direction:column;top:0;bottom:0}.a2a_flex_style a{display:flex;justify-content:center;flex:1;padding:4px}.a2a_flex_style.a2a_vertical_style a{flex-direction:column}.a2a_floating_style.a2a_color_buttons,.a2a_floating_style.a2a_flex_style{border-radius:0;padding:0}.a2a_floating_style.a2a_default_style.a2a_flex_style{bottom:0}.a2a_kit.a2a_flex_style .a2a_counter img,.a2a_kit.a2a_flex_style .a2a_dd,.a2a_kit.a2a_flex_style .a2a_svg{float:none}.a2a_nowrap{white-space:nowrap}.a2a_note{margin:0 auto;padding:9px;font-size:12px;text-align:center}.a2a_note .a2a_note_note{margin:0;color:#2A2A2A}.a2a_wide a{display:block;margin-top:3px;border-top:1px solid #EEE;text-align:center}.a2a_label{position:absolute!important;clip-path:polygon(0px 0px,0px 0px,0px 0px);-webkit-clip-path:polygon(0px 0px,0px 0px,0px 0px);overflow:hidden;height:1px;width:1px}.a2a_kit,.a2a_menu,.a2a_modal,.a2a_overlay{-ms-touch-action:manipulation;touch-action:manipulation;outline:0}.a2a_dd{-webkit-user-drag:none}.a2a_dd img{border:0}.a2a_button_facebook_like iframe{max-width:none}</style><style></style><link href="https://crossmark-cdn.crossref.org/widget/v2.0/style.css" type="text/css" rel="stylesheet"></head>
<body class="pb-ui">
    <div class="skip">
        <a href="#page-body-id" id="skipNavigationLink" title="Skip to Main Content" tabindex="0" class="skipToContent">Skip to Main Content</a>
        <a href="#mega-menu-nav" id="skipToMainMenu" title="Skip to Main Menu" tabindex="0" class="skipToContent">Skip to Main Menu</a>
    </div>



    <div id="pb-page-content" data-ng-non-bindable="">
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="ux3-layout-widget" data-widget-id="832ad3f3-97ac-45ab-9af1-90c6f7bff54a" class="ux3">
        
    

        


    

            

            
                <div class="cell fonts-loaded">
            

            <div data-widget-id="832ad3f3-97ac-45ab-9af1-90c6f7bff54a" data-widget-name="ux3-layout-widget"><div>
    

        


    

            

            

            <div id="a1f1ba25-79af-4194-aaa9-66206104a800" class="widget loginPopup none widget-none widget-compact-all"><div class="wrapped"><div class="widget-body body body-none body-compact-all"><div role="dialog" aria-modal="true" aria-label="Login" class="popup login-popup hidden"><div class="content"><a href="#" aria-label="Close login popup" title="Close login popup" role="button" class="close"><i class="icon-close_thin"></i></a><h2 class="login-title">Login to your account</h2><div class="login-form"><p tabindex="-1" class="message error"></p><form action="/action/doLogin?redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901322-2" method="post"><input type="hidden" name="redirectUri" value="https://www.cell.com/cell/fulltext/S0092-8674(21)01322-2"><input type="hidden" name="referer" value="/cell/fulltext/S0092-8674(21)01322-2"><input type="hidden" name="ecommRedirect"><input type="hidden" name="code" value="cell-site"><input type="hidden" name="UX3LoginWidget" value="true"><input type="hidden" name="isPopup" value="true"><div class="input-group login-input--wrapper"><div class="label"><label for="login">Email/Username</label></div><input id="login" type="text" name="login" value="" size="15" class="login"><div role="alert" class="error-hint js--hidden"><div class="error-hint__text"><div class="error-text">Your email address is a required field.</div><div class="email-example">E.g., j.smith@mail.com</div></div></div></div><div class="input-group login-input--wrapper"><div class="label"><label for="password">Password</label></div><input id="password" type="password" name="password" value="" autocomplete="off" class="password"><a href="#" class="login__field__action js-show-password">Show</a><div role="alert" class="error-hint js--hidden"><span class="error-hint__text">Your password is a required field.</span></div><div class="actions"><a href="https://www.cell.com/action/requestResetPassword" class="link show-request-reset-password">Forgot password?</a></div></div><div class="remember"><input type="checkbox" name="savePassword" id="a1f1ba25-79af-4194-aaa9-66206104a800-remember" value="1" checked="checked"><label for="a1f1ba25-79af-4194-aaa9-66206104a800-remember">Remember me</label></div><div class="submit"><input type="submit" name="submit" value="Log in" class="button submit primary"></div></form></div><div class="create-account"><div>Don’t have an account?</div><a href="/action/registration?redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901322-2" class="show-registration">Create a Free Account</a></div></div></div></div></div></div>

            

        

    

        


    

            

            

            <div role="dialog" aria-modal="true" aria-label="Reset password" class="popup top-drawer request-reset-password-drawer hidden"><div class="content"><a href="#" aria-label="Close reset password popup" title="Close reset password popup" role="button" class="close"><i class="icon-close_thin"></i></a><div class="request-reset"><div class="form"><p class="sub">If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password</p><div tabindex="-1" class="message error"></div><form action="/action/requestResetPassword" method="post" class="request-reset-password-form"><input type="hidden" name="platform"><input type="hidden" name="requestResetPassword" value="true"><input type="hidden" name="codeSite" value="cell-site"><div class="input-group"><div class="label"><label for="reset-password-email">Email*</label></div><input id="reset-password-email" type="text" name="email" value="" size="15" class="email"></div><div class="submit" disabled="disabled"><input type="submit" name="submit" value="Submit" disabled="disabled" class="button primary submit"></div></form></div><div class="success-template hidden"><p>If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password</p></div></div><div class="request-reset-cancel"><a href="#" aria-label="Close reset password popup" title="Close reset password popup" class="cancel">Cancel</a></div></div></div>

            

        

    

        


    

            

            
                <div class="ux3-ads">
            

            <div class="pb-ad">
            <!-- Do Not Modify without contacting ELS-HSOnlineCampaign@elsevier.com -->
<!-- To be kept in sync with Global Commercial Publishing Operations-->
<!-- Start: GPT Async -->
<div id="gpt-Variables" data-adfile="CELLJOURNAL">
	<input type="hidden" id="gptSite" value="cell">
	<input type="hidden" id="gptLoggedIn" value="no">
	<input type="hidden" id="gptAccessType" value="ae:ANON_GUEST|ae:ANON_GUEST">
	<input type="hidden" id="gptDefaultSite" value="cell">
</div>
<div id="gpt-Interscroller" class="gpt-InScrollBox" style="display:none;">
	<div class="gpt-InScrollLabel">ADVERTISEMENT</div>
	<div class="gpt-InScrollContainer">
		<div class="gpt-InScrollWrapper">
			<div class="gpt-InScrollInner">
				<div class="gpt-adinterscroller" data-adsize="interscroller"></div>
			</div>
		</div>
	</div>
	<div class="gpt-InScrollLabel">SCROLL TO CONTINUE WITH CONTENT</div>
</div>
<div id="gpt-DebugDiv" class="gpt-DebugDiv" style="display:none;">
	<div style="width: 100%; display: table;">
		<div style="display: table-row">
			<div style="width: 200px; display: table-cell;">
				<button class="gpt-DebugBtn" onclick="gpt_ShowConsole()">Open GPT Console</button><br>
				<button id="gpt_GrapeShotDebugBtn" class="gpt-DebugBtn" onclick="gpt_GrapeShotDebug();">Open Oracle Keywords</button><br>
				<br>
				<button class="gpt-DebugBtn" onclick="gpt_LoadDebugValues()">Refresh Values</button>
			</div>
			<div style="display: table-cell;">
				<table class="gpt-DebugTable">
					<thead>
						<tr>
							<th>Property</th>
							<th>Value</th>
						</tr>
					</thead>
					<tbody>
						<tr><td class="gpt-DebugTitle">Status</td><td><div class="gptStatus_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Version</td><td><div class="gptVersion_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Ad File</td><td><div class="gptAdFile_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Disable Ads Flag</td><td><div class="gptDisableAds_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Environment</td><td><div class="gptTestENV_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Moat Init</td><td><div class="gptMoatInit_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Moat Ready</td><td><div class="gptMoatReady_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Ready</td><td><div class="gptContextualReady_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual URL</td><td><div class="gptContextualURL_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Initial Segments</td><td><div class="gptContextualInit_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Used Segments</td><td><div class="gptContextualResult_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">AdUnit</td><td><div class="gptSite_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">SubAdUnit</td><td><div class="gptPage_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Custom Targeting</td><td><div class="gptCustomTargeting_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Ad Events</td><td><div class="gptEvent_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Invalid Ad Sizes</td><td><div class="gptInvalidAdSize_Debug"></div></td></tr>
					</tbody>
				</table>
			</div>
		</div>
	</div>
</div>
<style type="text/css">
	.gpt-DebugBtn {
		display: inline-block;
		text-align: center;
		text-decoration: none;
		margin: 2px 0;
		border: solid 1px #122b40;
		border-radius: 0.4em;
		padding: 0.5em 1em;
		color: #ffffff;
		background-color: #204d74;
		font-weight: normal;
		font-size: 12px;
	}

	.gpt-DebugDiv {
		margin: 5px;
	}

	.gpt-DebugTitle {
		font-weight: bold;
	}

	.gpt-DebugTable {
		border: 1px solid #dddddd;
		border-collapse: collapse;
		margin: 5px;
		font-size: 0.9em;
		font-family: sans-serif;
		min-width: 400px;
		margin-bottom: 25px;
	}

		.gpt-DebugTable td:first-child {
			padding: 5px;
		}

		.gpt-DebugTable thead tr th {
			background-color: #d9edf7;
			color: #ffffff;
			text-align: left;
			padding: 5px;
			border-bottom: 2px solid #204d74;
		}

		.gpt-DebugTable th,
		.gpt-DebugTable td {
			padding: 5px;
		}

		.gpt-DebugTable tbody tr {
			border-bottom: 1px solid #dddddd;
		}

			.gpt-DebugTable tbody tr:nth-of-type(even) {
				background-color: #f3f3f3;
			}

			.gpt-DebugTable tbody tr:last-of-type {
				border-bottom: 2px solid #204d74;
			}

	.gpt-InScrollLabel {
		background-color: rgb(0, 0, 0);
		color: rgb(255, 255, 255);
		position: relative;
		max-width: 100vw;
		left: 50%;
		right: 50%;
		margin-left: -50vw;
		margin-right: -50vw;
		padding: 0;
		text-align: center;
		width: 100vw !important;
		font-size: 10px;
	}

	.gpt-InScrollBox {
		height: 100vh !important;
		width: 100vw;
		cursor: pointer;
		max-width: 100vw;
		position: relative;
		left: 50%;
		right: 50%;
		margin-left: -50vw;
		margin-right: -50vw;
		margin-bottom: 50px;
		padding-top: 5px;
		padding-bottom: 5px;
		z-index: 10001;
		background-color: white;
	}

		.gpt-InScrollBox .gpt-InScrollContainer {
			height: 95vh !important;
			position: relative;
		}

		.gpt-InScrollBox .gpt-InScrollWrapper {
			position: absolute !important;
			top: 0 !important;
			left: 0;
			width: 100%;
			height: 95vh !important;
			border: 0 !important;
			margin: 0 !important;
			padding: 0 !important;
			clip: rect(0, auto, auto, 0) !important;
			-webkit-clip-path: polygon(0px 0px, 100% 0px, 100% 100%, 0px 100%) !important;
			clip-path: polygon(0px 0px, 100% 0px, 100% 100%, 0px 100%) !important;
		}

		.gpt-InScrollBox .gpt-InScrollInner {
			position: fixed !important;
			top: 0 !important;
			left: 0 !important;
			bottom: 0;
			margin: auto;
			width: 100vw;
			height: 95vh;
			-webkit-transform: translateZ(0) !important;
			display: -webkit-box;
			display: -ms-flexbox;
			display: flex;
			-webkit-box-orient: vertical;
			-webkit-box-direction: normal;
			-ms-flex-direction: column;
			flex-direction: column;
			-webkit-box-align: center;
			-ms-flex-align: center;
			align-items: center;
			-webkit-box-pack: center;
			-ms-flex-pack: center;
			justify-content: center;
			text-align: center;
		}
</style>
<script class="optanon-category-4" type="text/plain">
	//--------------------------------------------------------------------------
	var gpt_Version = '04072023';
	var gpt_AdFile = $('#gpt-Variables').data('adfile');
	var gpt_MaxMOATInitAttempts = 11;
	var gpt_MaxMOATReadyAttempts = 11;
	var gpt_MaxContextualReadyAttempts = 21;
	var gpt_MOATInitAttempts = 0;
	var gpt_MOATReadyAttempts = 0;
	var gpt_ContextualReadyAttempts = 0;
	var gpt_IsProd = true;
	var gpt_StartTime;
	var gs_channels = 'DEFAULT';
	var gpt_ContextualReady = false;
	var gpt_ContextualURL = 'Not enabled outside of Production';
	var gpt_DisableAdsFlagFound = false;

	var gptEvent_Debug = '';
	var gptCustomTargeting_Debug = '';
	var gptSite_Debug = "";
	var gptPage_Debug = "";
	var gptContextualEnabled = false;
	var gptContextualResult_Debug = '';
	var gptContextualInit_Debug = '';
	var gptContextualURL_Debug = '';
	var gptContextualReady_Debug = '';
	var gptMoatReady_Debug = '';
	var gptMoatInit_Debug = '';
	var gptTestENV_Debug = '';
	var gptDisableAds_Debug = '';
	var gptStatus_Debug = 'GPT Still Loading - Refresh Values';
	var gptInvalidAdSize_Debug = '';
	//--------------------------------------------------------------------------
	$(document).ready(function () {
		//Check to see if we are on a development env
		gpt_CheckEnvironment();

		if (!gpt_DisableAdsFlagFound) {
			gpt_StartTime = new Date();
			if (gpt_AdFile !== "PU") {
				//Once the dom has loaded, begin the process to init the ads.
				gpt_InitScripts();
				gpt_CheckForMOATInit();
			}
		}
	});
</script>
<script type="text/javascript">
	function gpt_CheckEnvironment() {
		if ($('#gptDisableAds').length > 0) {
			gptDisableAds_Debug = 'Flag Detected - Ads Disabled';
			gpt_DisableAdsFlagFound = true;
		}
		else {
			gptDisableAds_Debug = 'Ads Enabled';
			gpt_DisableAdsFlagFound = false;
		}
		switch (gpt_AdFile) {
			case 'PU':
				gptContextualEnabled = true;
				if ($("#Environment").val() !== "Prod") {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
			case 'JBS':
			case 'LANCET':
				gptContextualEnabled = true;
				if ($(".gpt-ad").length > 0) {
					//Other ads exist, allow the Prestitial
					$(document.body).append("<div class='gpt-ad' data-adsize='prestitial'></div>");
				}
				if (window.location.hostname.toLowerCase().indexOf('.literatumonline.') >= 0) {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
			default:
				//Cell
				gptContextualEnabled = false;
				if (window.location.hostname.toLowerCase().indexOf('.literatumonline.') >= 0) {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
		}
	}
	//--------------------------------------------------------------------------
    function gpt_GetNonCMEArticle() {
        var url;
        $('.articleCitation').each(function (i, obj) {
            if ($(obj).find('.toc__item__detials').length > 0) {
                var itemDetails = $(obj).first().find('.toc__item__detials');
                var cmeFound = 0;
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='CME']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='(CME)']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='Education']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='education']").length; }
                if (cmeFound == 0) {
                    var itemLink = $(itemDetails).first().find('.toc__item__title');
                    var linkCount = $(itemLink).first().find("a:contains('CME')").length;
                    if (linkCount == 0) {
                        url = $(itemLink).first().find('a').attr('href');
                        return false;   //Found a URL, break the loop
                    }
                }
            }
        });
        return url;
    }
	//--------------------------------------------------------------------------
	function gpt_GetElapsedTime() {
		var endTime = new Date();
		var timeDiff = endTime - gpt_StartTime; //in ms
		// strip the ms
		timeDiff /= 1000;

		// get seconds
		return seconds = Math.round(timeDiff) + " seconds";
	}
	//--------------------------------------------------------------------------
	function gpt_CheckSSC() {
		//Check for ScreenShot Client
		var gpt_SSC = gpt_GetQuerystring('gpt_ssc', '');
		if (gpt_SSC == '1') {
			//it's the ScreenShotClient, disable MOAT IVT Detection
			$('#gpt-Variables').append('<input type="hidden" id="gptm_data">');
			$('#gptm_data').val(0);
			gpt_Target("m_data");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_LocalSS(adTypeId) {
		window.scrollTo(0, 0);
		gpt_Sleep(1000);
		gpt_ScrollToAd(adTypeId);
		gpt_PreTearsheet(adTypeId);
	}
	//--------------------------------------------------------------------------
	function gpt_InitScripts() {
		if (gpt_AdFile == "PU") {
			if (gpt_IsProd) {
				gpt_ContextualURL = gpt_CheckForNULL($('#canonicalurl').val());
				if (gpt_ContextualURL === null) {
					gpt_ContextualURL = window.location.href.split('?')[0].split('#')[0];
				}
				else {
					gpt_ContextualURL = window.location.origin + gpt_ContextualURL;
				}
				var useSSL = 'https:' == document.location.protocol;
				var gs = document.createElement('script');
				gs.async = true;
				gs.type = 'text/javascript';
				gs.src = (useSSL ? 'https:' : 'http:') + '//elsevier.gscontxt.net/multizone/channels.cgi?url=' + encodeURIComponent(gpt_ContextualURL);
				gs.onload = function () {
					gpt_ContextualReady = true;
				};
				document.head.appendChild(gs);
			}
		}
		else {
			//JBS-Cell-Lancet
			var useSSL = 'https:' == document.location.protocol;

			var gads = document.createElement('script');
			gads.async = true;
			gads.type = 'text/javascript';
			gads.src = (useSSL ? 'https:' : 'http:') + '//securepubads.g.doubleclick.net/tag/js/gpt.js';
			document.head.appendChild(gads);

			if (gpt_IsProd && gptContextualEnabled) {
				gpt_ContextualURL = window.location.href.split('?')[0].split('#')[0];
				var gs = document.createElement('script');
				gs.async = true;
				gs.type = 'text/javascript';
				gs.src = (useSSL ? 'https:' : 'http:') + '//elsevier.gscontxt.net/multizone/channels.cgi?url=' + encodeURIComponent(gpt_ContextualURL);
				gs.onload = function () {
					gpt_ContextualReady = true;
				};
				document.head.appendChild(gs);
			}

			var elsevierMoatHeader = document.createElement('link');
			elsevierMoatHeader.rel = 'preload';
			elsevierMoatHeader.as = 'script';
			elsevierMoatHeader.src = (useSSL ? 'https:' : 'http:') + '//z.moatads.com/elsevierheader150204004183/moatheader.js';
			document.head.appendChild(elsevierMoatHeader);

			var elsevierMoatAds = document.createElement('link');
			elsevierMoatAds.rel = 'preconnect';
			elsevierMoatAds.src = (useSSL ? 'https:' : 'http:') + '//mb.moatads.com';
			document.head.appendChild(elsevierMoatAds);

			var moatHeader = document.createElement('script');
			moatHeader.async = true; gads.type = 'text/javascript';
			moatHeader.src = (useSSL ? 'https:' : 'http:') + '//z.moatads.com/elsevierheader150204004183/moatheader.js';
			document.head.appendChild(moatHeader);
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_CheckForMOATInit() {
		//Check every 1/10 of a second until MOAT is Loaded or 1 second timeout
		if (gpt_MOATInitAttempts < gpt_MaxMOATInitAttempts) {
			gpt_MOATInitAttempts += 1;
			if (typeof window.moatPrebidApi === "object") {
				//MOAT LOADED
				gptMoatInit_Debug = '0.0' + gpt_MOATInitAttempts + ' seconds';
				gpt_CheckForMOATReady();
			}
			else {
				setTimeout(() => { gpt_CheckForMOATInit(); }, 100);
			}
		}
		else {
			//TIMEOUT: MOAT Not LOADED
			gptMoatInit_Debug = 'Timeout Expired';
			var googletag = googletag || {};
			googletag.cmd = googletag.cmd || [];
			gpt_CheckForContextualReady();
		}
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForMOATReady() {
		//Check every 1/10 of a second until MOAT is Ready or 1 second timeout
		if (gpt_MOATReadyAttempts < gpt_MaxMOATReadyAttempts) {
			gpt_MOATReadyAttempts += 1;
			if (window.moatPrebidApi.safetyDataAvailable()) {
				//MOAT Ready
				gptMoatReady_Debug = '0.0' + gpt_MOATReadyAttempts + " seconds";
				gpt_CheckForContextualReady();
			}
			else {
				setTimeout(() => { gpt_CheckForMOATReady(); }, 100);
			}
		}
		else {
			//TIMEOUT: MOAT Not Ready
			gptMoatReady_Debug = 'Timeout Expired';
			gpt_CheckForContextualReady();
		}
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForContextualReady() {
		//Check every 1/10 of a second until Contextual is Ready or 2 second timeout
		if (gpt_IsProd && gptContextualEnabled) {
			//Enabled
			if (gpt_ContextualReadyAttempts < gpt_MaxContextualReadyAttempts) {
				gpt_ContextualReadyAttempts += 1;
				if (gpt_ContextualReady) {
					//Contextual Ready
					gptContextualURL_Debug = gpt_ContextualURL;
					gptContextualReady_Debug = '0.0' + gpt_ContextualReadyAttempts + " seconds";
					gptContextualInit_Debug = gs_channels;
					gpt_InitAds();
				}
				else {
					setTimeout(() => { gpt_CheckForContextualReady(); }, 100);
				}
			}
			else {
				//LOG TIMEOUT error
				//REMOVE FOR NOW (SHOULD LOG TO A DIFF LOCATION)
				//TIMEOUT: Contextual Not Ready
				$('#gpt_GrapeShotDebugBtn').remove();
				gptContextualURL_Debug = gpt_ContextualURL;
				gptContextualReady_Debug = 'Timeout Expired';
				gptContextualInit_Debug = "";
				gpt_InitAds();
			}
		}
		else {
			//Not Enabled
			$('#gpt_GrapeShotDebugBtn').remove();
			switch (gpt_AdFile) {
				case 'PU':
				case 'LANCET':
				case 'JBS':
					gptContextualURL_Debug = 'Not enabled outside of Production';
					gptContextualReady_Debug = 'Not enabled outside of Production';
					gptContextualInit_Debug = 'Not enabled outside of Production';
					break;
				case "CELLJOURNAL":
				case "CELLBUCKET":
					gptContextualReady_Debug = 'Not enabled on Cell';
					gptContextualInit_Debug = 'Not enabled on Cell';
					gptContextualURL_Debug = 'Not enabled on Cell';
					break;
			}
			gpt_InitAds();
		}
	}
	//--------------------------------------------------------------------------
	function GPT_GetPageByURL() {
		var host = window.location.host.toLocaleLowerCase()
		var localpath = window.location.pathname.toLocaleLowerCase();

		///Check for Cell.com
		if (host.indexOf('cell.com') >= 0) {
			return null;
		}

		///Check for Cell.com (marlin-stag)
		if (host.indexOf('www-cell-com') >= 0) {
			return null;
		}

		///Check for Lancet
		if (host.indexOf('thelancet') >= 0) {
			return null;
		}

		if (localpath.indexOf('/article/') >= 0) {
			return 'article.fulltext';
		}

		if (localpath.indexOf('/action/dosearch') >= 0) {
			return 'search.searchResults';
		}

		if (localpath.indexOf('/content/') >= 0) {
			return 'periodical.editorial';
		}

		return 'periodical.home';
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForNULL(x, valueifnull) {
		if (typeof valueifnull == "undefined") {
			valueifnull = null;
		}

		if (typeof x == 'undefined') {
			return valueifnull;
		}
		if (x == null) {
			return valueifnull;
		}
		if (x == "null") {
			return valueifnull;
		}
		if ($.trim(x) == '') {
			return valueifnull;
		}

		return x;
	}
	//--------------------------------------------------------------------------
	function gpt_GetAdditionalTargeting() {
		//adds page level targeting of custom variables
		//the id (minus gpt) and the value will be used as a key-value pair
		//eg: <input type="hidden" id="gptissuepii" value="x" class="gpt-Target">
		//eg: target issuepii=x
		$(".gpt-Target").each(function (index) {
			var gptTargetId = $(this).attr('id');
			gptTargetId = gptTargetId.replace('gpt', '').toLowerCase();
			if (gptTargetId !== '') {
				gpt_Target(gptTargetId);
			}
		})
	}
	//--------------------------------------------------------------------------
	function gpt_GetQuerystring(key, default_) {
		//function to read querystring variables
		if (default_ === null) default_ = '';
		key = key.replace(/[\[]/, "\\\[").replace(/[\]]/, "\\\]");
		var regex = new RegExp("[\\?&]" + key + "=([^&#]*)");
		var qs = regex.exec(window.location.href);
		if (qs === null)
			return default_;
		else
			return qs[1];
	}
	//--------------------------------------------------------------------------
	function gpt_GetDFPTestId() {
		//Get any request for a test id from querystring and set custom targeting parameter
		var gptDFPTestId = gpt_GetQuerystring('dfptestid', '');
		if (gptDFPTestId !== '') {
			$('#gpt-Variables').append('<input type="hidden" id="gptDFPTestId">');
			$('#gptDFPTestId').val(gptDFPTestId);
			gpt_Target("DFPTestId");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Target(targetName) {
		//Set page level target if value is found
		if ($('#gpt' + targetName).length > 0) {
			var targetValue = $('#gpt' + targetName).val();

			if (targetValue !== '') {
				targetValue = targetValue.replace(/[^-a-z0-9]/ig, '');	//Only Allow a-z, 0-9
				googletag.pubads().setTargeting(targetName.toLowerCase(), targetValue.toLowerCase());
				gptCustomTargeting_Debug = gptCustomTargeting_Debug + targetName.toLowerCase() + ' = ' + targetValue.toLowerCase() + '<br>';
			}
		}
	}
	//--------------------------------------------------------------------------
	function gpt_TargetAccessType() {
		var currentAccessType = $('#gptAccessType').val();
		if (typeof currentAccessType == "undefined") {
			currentAccessType = "";
		}
		if (currentAccessType.indexOf('ANON_IP') >= 0) {
			googletag.pubads().setTargeting("loggedin", "yes");
		}
		else {
			gpt_Target("LoggedIn");
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_PreTearsheet(adTypeId) {
		if (typeof adTypeId === "undefined") {
			adTypeId = 0;
		}
		//Remove Elsevier Cookie Policy Notice
		if ($("#onetrust-consent-sdk").length > 0) {
			$("#onetrust-consent-sdk").remove();
		}

        //Mobile Nav
        $('#skip').remove();
        $('skipNavigationLink').remove();

		//JBS Modals
		if ($('.leadinModal').length > 0) {
			$('.leadinModal').remove();
		}
		if ($('.leadinModal').length > 0) {
			$('.leadinModal').remove();
		}
		if ($('.usabilla__overlay').length > 0) {
			$('.usabilla__overlay').remove();
		}

		//Pendo
		if ($('._pendo-step-container').length > 0) {
			$('._pendo-step-container').remove();
		}
		if ($('._pendo-guide-tt_').length > 0) {
			$('._pendo-guide-tt_').remove();
		}
		if ($('._pendo-image').length > 0) {
			$('._pendo-image').remove();
		}
		if ($('._pendo-badge-image').length > 0) {
			$('._pendo-badge-image').remove();
		}

		switch (gpt_AdFile) {
			case "CELLJOURNAL":
			case "CELLBUCKET":
				//Mobile Bug Fix on Cell
				if (parseInt(adTypeId) == 5) {
					$('.widget-horizontalAd').css('position', 'static');
					$('.body-horizontalAd').css('display', 'block');
				}
				break;
			case "JBS":
			case "LANCET":
				objLeaderboard = ".container-leaderboard";
				offset = 53;
				switch (parseInt(adTypeId)) {
					case 3: //MPU
					case 4: //SkyScraper
						//BUGFIX: Show Sidebar ad for JBS
						//skyscraper & mpu
						if ($('.widget-verticalAd').length > 0) {
							$('.widget-verticalAd').css('display', 'block');
						}
						$('#backgroundLayer').css('display', 'none');   //Hide any Prestitial
						break;
					case 6:     //Prestitial
						$('#backgroundLayer').css('display', 'block');
						break;
					default:
						$('#backgroundLayer').css('display', 'none');   //Hide any Prestitial
						break;
				}
				break;
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Sleep(ms) {
		return new Promise(resolve => setTimeout(resolve, ms));
	}
	//--------------------------------------------------------------------------
	async function gpt_ScrollToAd(adTypeId) {
		if (typeof adTypeId === "undefined") {
			adTypeId = 0;
		}
		var adId = "";
		var offset = 0;
		var objLeaderboard = "";
		var gpt_ScrollToAd = true;

		switch (gpt_AdFile) {
			case "PU": //PracticeUpdate
				var hideOtherAds = true;
				$('#modalPrestitial').modal('hide');
				$('.jumbotron-welcome').hide();
				objLeaderboard = ".container-leaderboard";
				offset = 53;
				switch (parseInt(adTypeId)) {
					case 2:
						//LeaderBoard, no Scroll Needed
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
					case 3:
						//MPU
						adId = "adSlot2";
						break;
					case 4:
						//SkyScraper
						adId = "adSlot3";
						$('.most-read').hide();
						break;
					case 5:
						//Mobile, no Scroll Needed
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
					case 6:
						//Interstitial
						gpt_ScrollToAd = false;
						adId = "adSlot15";
						await gpt_Sleep(1000);
						$(objLeaderboard).hide();
						$('#modalPrestitial').unbind();
						$('#modalPrestitial').modal();
						break;
					case 7:
						//Native Ad
						break;
					case 10:
						//Master Companion
						hideOtherAds = false;
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
				}
				if (hideOtherAds) {
					//Hide all other ads
					$('.ad-container').each(function (i, obj) {
						if (this.id !== adId) {
							var tempParent = this.id;
							tempParent = tempParent.replace("adSlot", "adParent");
							$("#" + tempParent).addClass('hide');
						}
					});
				}
				break;
			case "JBS":
				objLeaderboard = ".js__adToHide";
				offset = 80;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$(".widget-verticalAd").hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="sidebar"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					case 13:	    //Phone - Portrait
					case 14:        //Phone - Landscape
						$(objLeaderboard).hide();
						offset = 60;
						adId = 'gpt-Interscroller';
						gpt_ScrollToAd = true;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				break;
			case "CELLJOURNAL":
			case "CELLBUCKET":
				objLeaderboard = ".js__adToHide";
				offset = 260;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$('.body-verticalAd').hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="boombox"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				//Hide the second ad if found
				var tCount = 0;
				$(".widget.literatumAd.none.GPT-ad-placeholder.widget-horizontalAd.widget-compact-all").each(function (index) {
					tCount += 1;
					if (tCount !== 1) {
						$(this).hide();
					}
				});
				break;
			case "LANCET":
				objLeaderboard = ".js__adToHide";
				offset = 80;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$('.body-verticalAd').hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="skyscraper"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				break;
		}

		//Scroll to Top
		var gpt_container = $("html,body");
		gpt_container.animate({ scrollTop: 0, scrollLeft: 0 });

		if (gpt_ScrollToAd) {
			//If Adexists, scroll to it
			var gpt_scrollTo = $('#' + adId);
			if (gpt_scrollTo.length > 0) {
				//Scroll to the Ad
				var gpt_topPosition = gpt_scrollTo.offset().top - gpt_container.offset().top + gpt_container.scrollTop();
				if (gpt_topPosition > 0) {
					gpt_container.animate({ scrollTop: gpt_topPosition, scrollLeft: 0 });
					if (gpt_topPosition - offset > 0 && offset > 0) {
						gpt_container.animate({ scrollTop: gpt_topPosition - offset, scrollLeft: 0 });
					}
				}
			}
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_CheckForCookiePolicy() {
		var returnVal = false;
		if ($('#onetrust-accept-btn-handler').length > 0) {
			$('#onetrust-accept-btn-handler').click();
			returnVal = true;
		}
		return returnVal;
	}
	//--------------------------------------------------------------------------
	function gpt_InitAds() {
		var gpt_ResponsiveHomepage = false;

		switch (gpt_AdFile) {
			case "JBS":
			case "CELLJOURNAL":
			case "CELLBUCKET":
				//Responsive Check
				if ($('#hdrHomeBrand').length > 0) {
					gpt_ResponsiveHomepage = true;
				}
				break;
		}

		//InterScroller Check
		if (gpt_AdFile === "JBS") {
			var gpt_InterScrollerEnabled = false;
			var gpt_InterScrollerInsertObj;

			if ($("#articleHeader").length > 0) {
				//It's an article Page
				if ($('.article__sections > section').length > 0) {
					gpt_InterScrollerEnabled = true;
					gpt_InterScrollerInsertObj = $(".article__sections > section");
				}
			}
			else {
				if ($('.toc__section').length > 0) {
					//It's a TOC Page
					gpt_InterScrollerEnabled = true;
					gpt_InterScrollerInsertObj = $(".toc__section").first();
				}
			}

			//Add the Interscroller
			if (gpt_InterScrollerEnabled) {
				gpt_InterScrollerInsertObj.first().append($("#gpt-Interscroller").clone());
				$("#gpt-Interscroller").remove();
				$(".gpt-adinterscroller").addClass("gpt-ad");
			}
		}

		googletag.cmd.push(function () {
			var gptBoomBoxSizeMapping;
			var gptFluidMapping;
			var gptHomePageSidebarMapping;
			var gptCellHomePageSidebarMapping;
			var gptInterscrollerMapping;
			var gptLeaderboardSizeMapping;
			var gptMobileSizeMapping;
			var gptPrestitialMapping;
			var gptRectangleShortSizeMapping;
			var gptRectangleSizeMapping;
			var gptSideBarSizeMapping;
			var gptTallSizeMapping;
			var gptWideSizeMapping;
			var gptWideRectangleSizeMapping;

			//***********************************************
			//Start Define Size mapping based on client Viewport
			//***********************************************
			if (gpt_AdFile === 'PU') {
				gptTallSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 600], [160, 600], [120, 600]]).
					addSize([0, 0], []).
					build();

				gptRectangleSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 250]]).
					addSize([0, 0], []).
					build();

				gptRectangleShortSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 250], [320, 50], [300, 50]]).
					addSize([0, 0], [[300, 250], [320, 50], [300, 50]]).
					build();

				gptWideSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[728, 90]]).
					addSize([760, 0], [[728, 90], [320, 50], [300, 50]]).
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptWideRectangleSizeMapping = googletag.sizeMapping().
					addSize([992, 0], []).
					addSize([760, 0], [[320, 50], [300, 50], [300, 250]]).
					addSize([0, 0], [[320, 50], [300, 50], [300, 250]]).
					build();

				gptMobileSizeMapping = googletag.sizeMapping().
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptFluidMapping = googletag.sizeMapping().
					addSize([0, 0], ['fluid']).
					build();

				gptPrestitialMapping = googletag.sizeMapping().
					addSize([760, 0], [[1, 1]]).
					build();
			}
			else {
				//JBS-CELL-LANCET
				gptLeaderboardSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[728, 90]]).
					addSize([768, 0], [[728, 90]]).
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptHomePageSidebarMapping = googletag.sizeMapping().
					addSize([2090, 795], [[300, 600], [300, 250], [160, 600], [120, 600]]).
					addSize([1910, 795], [[160, 600], [120, 600]]).
                    addSize([1740, 795], [[120, 600]]).
					addSize([0, 0], []).
					build();

				gptCellHomePageSidebarMapping = googletag.sizeMapping().
                    addSize([2180, 795], [[300, 600], [160, 600], [120, 600], [300, 250], [336, 280]]).
					addSize([2180, 445], [[336, 280]]).
                    addSize([2090, 795], [[300, 600], [160, 600], [120, 600], [300, 250]]).
                    addSize([2090, 445], [[300, 250]]).
					addSize([1830, 795], [[160, 600], [120, 600]]).
                    addSize([1740, 795], [[120, 600]]).
					addSize([0, 0], []).
					build();

				gptSideBarSizeMapping = googletag.sizeMapping().
					addSize([1140, 795], [[300, 600], [160, 600], [120, 600], [300, 250]]).
					addSize([1140, 445], [[300, 250]]).
					addSize([0, 0], []). 				
					build();

				gptBoomBoxSizeMapping = googletag.sizeMapping().
					addSize([768, 0], [[300, 250], [336, 280]]).
					addSize([0, 0], []). 						
					build();

				gptFluidMapping = googletag.sizeMapping().
					addSize([0, 0], ['fluid']).
					build();

				gptPrestitialMapping = googletag.sizeMapping().
					addSize([600, 700], [[1, 1]]).
					addSize([0, 0], []).
					build();

				gptInterscrollerMapping = googletag.sizeMapping().
					addSize([1140, 445], []).
					addSize([1024, 768], [[1024, 768]]).
					addSize([768, 1024], [[768, 1024]]).
					addSize([480, 320], [[480, 320]]).
					addSize([320, 480], [[320, 480]]).
					build();
			}
			//***********************************************
			//End Define Size mapping based on client Viewport
			//***********************************************

			//***********************************************
			//Start detection for ad slots on page
			//***********************************************
			var gptMasterPage = gpt_CheckForNULL($('#gptPage').val());
			var gptMasterSite;

			if (gpt_AdFile === 'PU') {
				gptMasterSite = $('#gptSite').val();
			}
			else {
				//JBS-CELL-LANCET
				gptMasterSite = "dev";

				if (gpt_IsProd) {
					gptMasterSite = gpt_CheckForNULL($('#gptSite').val());

					//If there is no master site, check for a defaultsite
					if (gptMasterSite == null) {
						gptMasterSite = gpt_CheckForNULL($('#gptDefaultSite').val());
					}
				}
				else {
					//Dev ENV
					//If the page has no gptSite Value, assume no value which will disable ads
					if (gpt_CheckForNULL($('#gptSite').val()) === null) {
						gptMasterSite = null;
					}
				}

				//If there is no master Page, check for a Page using the URL
				if (gptMasterPage === null) {
					gptMasterPage = GPT_GetPageByURL();
				}
			}

			$(".gpt-ad").each(function (index) {
				var gptPage = '';
				var adSizeMapping = '';
				var gptPOS;
				var gptTC;
				var gptNative;
				var adId;
				var gptSite;
				var tempSlot = null;


                if (gpt_IsProd) {
					if (gpt_AdFile !== "CELLJOURNAL") {
						//Check if the ad slot has it's own site defined
						if (typeof $(this).data('site') === 'undefined') {
							gptSite = gptMasterSite;
						}
						else {
							gptSite = gpt_CheckForNULL($(this).data('site'));
						}
					}
					else {
						gptSite = gptMasterSite;
					}
                }
                else {
					gptSite = gptMasterSite;
                }



				if (gpt_AdFile === 'PU') {
					adId = $(this).attr('id');
				}
				else {
					//JBS-CELL-LANCET
					adId = 'gpt-ad-' + index + 1;
				}

				if (gpt_CheckForNULL(gptSite) !== null) {
					gptSite_Debug = gptSite;

					gptPOS = parseInt($(this).data('pos')) || -1;
					if (gptPOS === -1) {
						gptPOS = index + 1;
					}

					//Check if the ad slot has it's own page defined
					gptPage = $(this).data('page');
					if (gpt_CheckForNULL(gptPage) == null) {
						//Use the Master Page
						gptPage = gptMasterPage;
					}

					//If the page is not null, preceed it with a slash
					if (gptPage !== null) {
						gptPage = '/' + gptPage;
					}
					else {
						gptPage = '';
					}
					gptPage_Debug = gptPage;


					gptTC = $(this).data('tc');
					if (typeof gptTC === "undefined") {
						gptTC = '';
					}

					gptNative = $(this).data('native');
					if (typeof gptNative === "undefined") {
						gptNative = '';
					}

					//Determine sizemapping based on data-adsize
					if (gpt_AdFile === 'PU') {
						switch ($(this).data('adsize')) {
							case 'tall':
								adSizeMapping = gptTallSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600]], adId);
								break;
							case 'rectangle':
								adSizeMapping = gptRectangleSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								break;
							case 'rectangleshort':
								adSizeMapping = gptRectangleShortSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250], [320, 50], [300, 50]], adId);
								break;
							case 'wide':
								adSizeMapping = gptWideSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[728, 90], [320, 50], [300, 50]], adId);
								break;
							case 'widerectangle':
								adSizeMapping = gptWideRectangleSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 50], [300, 50], [300, 250]], adId);
								break;
							case 'mobile':
								adSizeMapping = gptMobileSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 50], [300, 50]], adId);
								break;
							case 'fluid':
								adSizeMapping = gptFluidMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
							case 'prestitial':
								adSizeMapping = gptPrestitialMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[1, 1]], adId);
								break;
						}
					}
					else {
						//JBS-CELL-LANCET
						switch ($(this).data('adsize')) {
							case 'cell-leaderboard':
							case 'leaderboard':
								adSizeMapping = gptLeaderboardSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[728, 90], [320, 50], [300, 50]], adId);
								break;
							case 'bottom':
								if (gpt_ResponsiveHomepage) {
									adSizeMapping = gptHomePageSidebarMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250]], adId);
								}
								else {
									adSizeMapping = gptBoomBoxSizeMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								}
								break;
							case 'boombox':
								if (gpt_AdFile === "CELLJOURNAL" || gpt_AdFile == "CELLBUCKET") {
									if (gpt_ResponsiveHomepage) {
										adSizeMapping = gptCellHomePageSidebarMapping;
										tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250], [336, 280]], adId);
									}
									else {
										adSizeMapping = gptBoomBoxSizeMapping;
										tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250], [336, 280]], adId);
									}
								}
								else {
									adSizeMapping = gptBoomBoxSizeMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								}
								break;
							case 'interscroller':
								adSizeMapping = gptInterscrollerMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 480], [480, 320], [768, 1024], [1024, 768]], adId);
								break;
							case 'sidebar':
							case 'skyscraper':
								adSizeMapping = gptSideBarSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250]], adId);
								break;
							case 'native':
							case 'fluid':
								adSizeMapping = gptFluidMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
							case 'prestitial':
								adSizeMapping = gptPrestitialMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
						}
					}
				}

				//Ignore any invalid adsizes that could be on the page
				if (adSizeMapping !== '') {
					$(this).addClass('gpt-ad-defined');
					if (gpt_AdFile !== 'PU') {
						$(this).attr('id', adId);
					}
					tempSlot.defineSizeMapping(adSizeMapping).addService(googletag.pubads()).setTargeting("pos", gptPOS);

					if (gptTC !== '') {
						tempSlot.setTargeting("tc", gptTC);
					}
					if (gptNative !== '') {
						tempSlot.setTargeting("native", gptNative);
					}
					gptEvent_Debug = gptEvent_Debug + $(this).data('adsize') + ' Requested<br>';
				}
				else {
					gptInvalidAdSize_Debug = gptInvalidAdSize_Debug + "Invalid Size Found, Id: " + $(this).prop('id') + ', adSize: ' + $(this).data('adsize') + '<br>';
					$(this).remove();
				}
			});
			if (gpt_CheckForNULL(gptInvalidAdSize_Debug) === null) {
				gptInvalidAdSize_Debug = "None Detected";
			}
			//***********************************************
			//End detection for ad slots on page
			//***********************************************

			//***********************************************
			//Start page level targeting
			//***********************************************
			if (gpt_AdFile !== 'PU') {
				//Logged in or IP Access
				gpt_TargetAccessType();

				//Check for Screenshot Client
				gpt_CheckSSC();
			}

			//Check for DFP Test
			gpt_GetDFPTestId();

			//Check for Additional Targeting
			gpt_GetAdditionalTargeting();

			if (gpt_IsProd && gptContextualEnabled) {
				var gpt_ContextualRetry = false;
				//Check for Contextual Targeting
				if (gs_channels !== "DEFAULT") {
					var gpt_ContextualCategories = Array.from(gs_channels);
					for (var i = 0; i < gpt_ContextualCategories.length; i++) {
						if (gpt_ContextualCategories[i] == 'gx_retry') {
							gpt_ContextualRetry = true;
						}
						if (!gpt_ContextualCategories[i].startsWith("custom_")) {
							//Remove any tag that is not custom
							gpt_ContextualCategories.splice(i, 1);
							i--;
						}
						else {
							//Strip the 'custom_' from the tag
							gpt_ContextualCategories[i] = gpt_ContextualCategories[i].replace("custom_", "")
						}
					}
					if (gpt_ContextualCategories.length > 0) {
						googletag.pubads().setTargeting("gs_cat", gpt_ContextualCategories);
					}
					else {
						gpt_ContextualCategories = 'none';
					}
					if (gpt_ContextualRetry) {
						gpt_ContextualCategories = "*Indexing*";
					}
					gptContextualResult_Debug = gpt_ContextualCategories;
				}
				else {
					gptContextualResult_Debug = 'No segments found';
				}
			}
			else {
				//Not Prod || Contextual not enabled
				gptContextualResult_Debug = 'Not enabled';
				
				if (!gpt_IsProd) {
                    var gpt_DevSite = gpt_CheckForNULL($('#gptSite').val(), "dev");
                    $('#gpt-Variables').append('<input type="hidden" id="gptEnvironment" value="' + gpt_DevSite + '">');
                    gpt_Target("Environment");
                }

			}
			//***********************************************
			//End page level targeting
			//***********************************************

			//Enable google dfp services
			if (parseInt($('#gptLazyLoading').val()) === 1) {
				googletag.pubads().enableLazyLoad({
					fetchMarginPercent: 200,
					renderMarginPercent: 0,
					mobileScaling: 2.0
				});
			}
			else {
				googletag.pubads().enableSingleRequest();
			}

			//Add Listener for RenderEnded
			googletag.pubads().addEventListener('slotRenderEnded', function (event) {
				if (!event.isEmpty) {
					if (typeof LocalAdLoaded === "function") {
						LocalAdLoaded(event);
					}
					if (gpt_ResponsiveHomepage) {
						if (typeof positionAd === "function") {
							positionAd();
						}
					}
					if (event.size[0] == "480" || event.size[1] == "480") {
						$('.gpt-InScrollBox').css('display', 'block');
						gptEvent_Debug = gptEvent_Debug + 'Interscroller ' + event.size + ' rendered: ' + gpt_GetElapsedTime() + '<br>';
					}
					else {
						gptEvent_Debug = gptEvent_Debug + event.size + ' rendered: ' + gpt_GetElapsedTime() + '<br>';
					}

				}
			});

			if (gpt_AdFile !== 'PU') {
				googletag.pubads().collapseEmptyDivs();
			}
			googletag.enableServices();

			//Populate Defined Ad Slots
			$(".gpt-ad-defined").each(function (index) {
				var adId = $(this).attr('id');
				googletag.cmd.push(function () { googletag.display(adId); });
			});

			gptStatus_Debug = 'GPT Complete';
		});
	}
	//--------------------------------------------------------------------------
	function gpt_DisplayDebug() {
		//Clone the template and append to Body
		$(document.body).append($('#gpt-DebugDiv').clone());
		$('#gpt-DebugDiv').remove();

		//Populate the Values
		gpt_LoadDebugValues();

		//Display and scroll to debug section
		$('.gpt-DebugDiv').css('display', 'block');
		window.scrollTo(0, document.body.scrollHeight);
	}
	//--------------------------------------------------------------------------
	function gpt_LoadDebugValues() {
		$('.gpt-DebugBtn').blur();
		$('.gptVersion_Debug').text(gpt_Version);
		$('.gptAdFile_Debug').html(gpt_AdFile);
		$('.gptEvent_Debug').html(gptEvent_Debug);
		$('.gptCustomTargeting_Debug').html(gptCustomTargeting_Debug);
		$('.gptSite_Debug').text(gptSite_Debug);
		$('.gptContextualResult_Debug').text(gptContextualResult_Debug);
		$('.gptContextualInit_Debug').text(gptContextualInit_Debug);
		$('.gptContextualURL_Debug').text(gptContextualURL_Debug);
		$('.gptContextualReady_Debug').text(gptContextualReady_Debug);
		$('.gptMoatReady_Debug').text(gptMoatReady_Debug);
		$('.gptMoatInit_Debug').text(gptMoatInit_Debug);
		$('.gptTestENV_Debug').text(gptTestENV_Debug);
		$('.gptDisableAds_Debug').text(gptDisableAds_Debug);
		$('.gptStatus_Debug').text(gptStatus_Debug);
		$('.gptPage_Debug').text(gptPage_Debug);
		$('.gptInvalidAdSize_Debug').html(gptInvalidAdSize_Debug);
	}
	//--------------------------------------------------------------------------
	function gpt_GrapeShotDebug() {
		$('.gpt-DebugBtn').blur();
		window.open("http://admin-elsevier.grapeshot.co.uk/custom/bookmarklet.cgi?blocking=1&vn=2&url=" + encodeURIComponent(document.location), "GRAPESHOT_POPUP", "width=650,height=600,scrollbars=yes,screenX=40,screenY=50,menubar=no,toolbar=no,resizable=yes", "Custom").focus();
	}
	//--------------------------------------------------------------------------
	function gpt_ShowConsole() {
		$('.gpt-DebugBtn').blur();
		googletag.openConsole();
	}
	//--------------------------------------------------------------------------
</script>
        </div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="912135d6-7135-4d45-b457-b503cacc3c8b" data-widget-name="ux3-layout-widget"><header class="header base fixed">
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header js__adToHide widget-horizontalAd" id="9d6062d7-fad6-4e64-81cc-7dd25d99b23d">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement">
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <!-- Beginning Async AdSlot 1 for Ad unit els.cellpress/cell  ### size: [[728,90]] -->
<div class="gpt-ad" data-adsize="cell-leaderboard" data-page="" data-site="cell" data-pos="1"></div>
<!-- End AdSlot 1 -->
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="3a83e2a6-2e7e-4931-892c-4ef43b6e3312" class="header__wrapper clearfix" data-db-parent-of="quickSearch"><div id="brandingRow"><a href="/" data-aa-name="science that inspires" data-aa-region="cp global header" title="Visit Cell.com">Science that inspires</a><p id="brandingRowRight"><a href="/" data-aa-name="cell press endorsement" data-aa-region="cp global header" title="Visit Cell.com">A Cell Press journal</a></p></div>
        
    

        


    

            

            

            <div data-widget-id="3a83e2a6-2e7e-4931-892c-4ef43b6e3312" data-widget-name="ux3-layout-widget"><div class="col-xs-6 header__left-side">
    

        


    

            

            
                <a href="/home" id="cpIconLnk" data-aa-name="cell press logo" data-aa-region="cp global header" title="Cell Press" target="_blank"><svg id="cp_logo" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 100 98.1" style="enable-background:new 0 0 100 98.1;" xml:space="preserve" height="100" width="98.1"><path style="fill:#FFFFFF;" d="M69.09,0.09c-4.01-0.6-7.83,1.94-8.78,5.89l-3.14,13.11c-0.76,3.19-3.44,5.56-6.7,5.93l-18.6,2.13          C11.83,29.31-2.53,47.66,0.37,67.78c2.3,15.96,15.18,27.77,30.54,30.08c4.01,0.6,7.83-1.94,8.78-5.89l3.14-13.11 c0.76-3.19,3.44-5.56,6.69-5.93l18.6-2.13c20.04-2.17,34.41-20.52,31.5-40.65C97.32,14.21,84.45,2.39,69.09,0.09z M65.06,47.2  l-11.75,1.4c-1.98,0.21-3.62,1.65-4.08,3.59l-3.43,14.3c-1.01,4.22-4.5,7.39-8.8,8c-6.66,0.72-12.63-4.2-13.15-10.92                c-0.51-6.5,4.6-12.11,11.08-12.81l11.75-1.39c1.98-0.22,3.62-1.65,4.08-3.59l3.43-14.3c1.01-4.22,4.5-7.39,8.8-8          c6.66-0.72,12.63,4.19,13.15,10.92C76.66,40.89,71.55,46.5,65.06,47.2z"></path></svg></a><div class="journal-logos">
            

            <span data-widget-id="35d8d734-3aa0-4ec8-9e2d-14babe803594" data-widget-name="ux3-general-image"><a href="/cell/home" title="Cell"><img alt="Cell" src="/pb-assets/ux3/logos/cell/Cell_white-1532516611593.svg"></a></span>

            
                </div>
            

        

    

        


    

            

            
                <div class="journal-logos">
            

            <span data-widget-id="3ffcbf1f-79fd-4ba3-85b5-bef10a63475f" data-widget-name="ux3-general-image"><a href="https://www.cell.com/open-access?utm_source=oa-label&amp;__hstc=109691226.e4e812b53ff324eccbdbdb2e4fb9a6ab.1644503737405.1644524234622.1644587109507.4&amp;__hssc=109691226.7.1644587109507&amp;__hsfp=3253153019" title="This journal offers authors two options (open access or subscription) to publish research"><img alt="This journal offers authors two options (open access or subscription) to publish research" src="/pb-assets/ux3/logos/cell/Supports_open_access_border-1645554937897.svg"></a></span>

            
                </div>
            

        
</div><div class="col-xs-6">
    

        


    

            

            

            <div data-widget-id="2555f6db-b333-4edb-8b15-ef9213f1f0a5" data-widget-name="ux3-layout-widget"><div class="header__nav row">
    

        


    

            

            

            <ul data-widget-id="52432d24-0331-4c9d-85f3-2033edc7208b" data-widget-name="UX3ProfileLinksWidget" class="rlist rlist--inline profile-links"><li class="profile-links__submit"><a data-adobe-name="Publish" class="profile-links__submit__btn" title="Submit" href="https://www.editorialmanager.com/cell" target="_self" data-aa-conversiondriver="jbs:global-header:submitpage" data-profile-link="true">Submit</a></li><li class="profile-links__login-dropdown"><div class="profile-links__user-list__wrapper"><button data-db-target-for="loginmenu-410839" aria-expanded="false" aria-controls="login-links-410839" title="Log in links dropdown" class="profile-links__username"><span>Log in</span></button><div data-db-target-of="loginmenu-410839" id="login-links--410839" class="profile-links__user-list__holder dropBlock__holder"><ul class="rlist profile-links__list"><li class="profile-links__login"><a data-adobe-name="Log In" class="profile-links__login__btn" title="Log in to Cell.com" href="https://www.cell.com/action/idLogin?type=login&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901322-2" target="_self" data-profile-link="true">Log in</a></li><li class="profile-links__institution"><a data-adobe-name="Get institutional access" class="profile-links__institution__btn" title="Institutional access" href="https://www.cell.com/action/idLogin?type=institution&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901322-2" target="_self" data-profile-link="true">Get Institutional Access</a></li></ul></div></div></li><li class="profile-links__register"><a data-adobe-name="Register" class="profile-links__register__btn" title="Register a username and password for free" href="https://www.cell.com/action/idLogin?type=registration&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901322-2" target="_self" data-profile-link="true">Register</a></li><li class="hidden-lg"> <div class="profile-links__controls"> <button aria-expanded="false" aria-controls="links-dialog-410839" data-opens="#links-dialog-410839" class="profile-links__btn--open"><span class="sr-only">open links dialog</span><i aria-hidden="true" class="icon-gizmo-person"></i></button></div><dialog id="links-dialog-410839" aria-modal="true"><button data-closes="#links-dialog-410839" class="profile-links__btn--close"><span class="sr-only">close links dialog</span><i aria-hidden="true" class="icon-close-solid"></i></button><ul>   <li class="profile-links__submit"><a data-adobe-name="Publish" class="profile-links__submit__btn" title="Submit" href="https://www.editorialmanager.com/cell" target="_self" data-aa-conversiondriver="jbs:global-header:submitpage" data-profile-link="true">Submit</a></li><li class="profile-links__login"><a data-adobe-name="Log In" class="profile-links__login__btn" title="Log in to Cell.com" href="https://www.cell.com/action/idLogin?type=login&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901322-2" target="_self" data-profile-link="true">Log in</a></li><li class="profile-links__institution"><a data-adobe-name="Get institutional access" class="profile-links__institution__btn" title="Institutional access" href="https://www.cell.com/action/idLogin?type=institution&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901322-2" target="_self" data-profile-link="true">Get Institutional Access</a></li><li class="profile-links__register"><a data-adobe-name="Register" class="profile-links__register__btn" title="Register a username and password for free" href="https://www.cell.com/action/idLogin?type=registration&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901322-2" target="_self" data-profile-link="true">Register</a></li></ul></dialog></li></ul>

            

        
</div></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasInstitutionBanner none  widget-none" id="51b7fa33-2137-4f58-9e98-9746c4400513" style="display: none;">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none "><div class="ui-state-highlight ui-corner-all csas-institution-banner hidden" data-doi="10.1016/j.cell.2021.11.007">
    <span class="ui-icon ui-icon-close banner-close"></span>
    <p>
        Access provided by <span class="accountName"></span>
    </p>
</div>

<style>
    .csas-institution-banner {
        padding: 10px 0 0 10px;
        margin: 5px;
    }

    .csas-institution-banner.ui-state-highlight .ui-icon {
        background-image: url("/templates/jsp/css/jquery-ui-1.10.2/base/images/ui-icons_454545_256x240.png");
        margin-right: 5px;
        margin-top: -4px;
    }

    .csas-institution-banner .banner-close {
        float: right;
    }
</style>

<script>

    function resetBanner(doi) {
        $.get('/action/getAccount?doi=' + doi, function(data) {
            if (data) {
                $(".csas-institution-banner p .accountName").html(data);
                $(".csasInstitutionBanner").fadeIn();
                $(".csas-institution-banner").fadeIn();
            }
        });
    }

    var flag = 0;
    $(document).ready(function() {
        if(!$(".csas-institution-banner").is(":visible")){
            $(".csasInstitutionBanner").hide();
        }

        $(".banner-close").click(function() {
            $.get("/action/dismissBanner", function(data) {
                $(".csasInstitutionBanner").fadeOut(function () {
                    if(typeof UX !== 'undefined') {
                        UX.pageBody.init();
                    }
                });
            });
        });

        $(".articleContent .tabs li[role='tab'].showFullText").click(function() {
           flag = 1;
        });

        $(document).on("reloadTabsContent", function() {
            var isSelected = $(".articleContent .tabs li[role='tab'].showFullText").hasClass("active");
            if (isSelected) {
                var isHidden =  $(".csas-institution-banner").is(".hidden");
                if (!isHidden) {
                    resetBanner($(".csas-institution-banner").data("doi"));
                    console.log("fadeIn");
                }
            } else {
                $(".csas-institution-banner").fadeOut();
                console.log("fadeOut");
            }
            flag = 0;
        });

        $(document).on("click", ".articleContent .tabs li[role='tab']", function() {

        });
    });
</script></div>
                </div>
                </div>

        
</header></div>

            

        










        <div data-widget-def="graphQueryWidget" data-widget-id="2a125dae-6dbc-4e76-a75e-3e563f1d3a1d" class="ux3">
        
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget graphQueryWidget none top-padding-handler noMargin axel-mega-menu widget-none widget-compact-all fonts-loaded" id="2a125dae-6dbc-4e76-a75e-3e563f1d3a1d" style="padding-top: 115.594px;">
                
                
                    
                

                <div class="wrapped " id="CP TOP LEVEL NAV MENU">
                    
                    <div class="widget-body body body-none  body-compact-all"><nav id="mega-menu-nav" role="navigation" class="mega-menu-nav">
  <!--.skip//a(href='#searchText' aria-label='Skip menu') Skip menu
  -->
  <div class="mega-menu-nav__wrapper">
    <button class="mega-menu__toggle"><span class="sr-only">Main menu</span><i aria-hidden="true" class="icon-gizmo-hamburger"></i></button>
    <ul role="menubar" class="mega-menu rlist">
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-1" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-1" data-item-link="main-menu-link-1" data-index="0" class="mega-menu__item-link menu-link"><span>This journal</span></a>
        <div id="main-menu-panel-1" aria-labelledby="main-menu-link-1" data-item-wrapper="main-menu-link-1" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <div aria-label="Menu dropzone section" tabindex="-1" class="listDropZone">
    

        


    

            

            

            <div class="cover-image"><div class="cover-image__thumb"><a href="/issue/S0092-8674(24)X0012-4" class="menu-link"><img src="/cms/asset/atypon:cms:attachment:img:d5e6:rev:1748270185670-389:pii:S0092867424X00124/cover.tif.jpg" alt="Cover Image - Cell, Volume 188, Issue 11"></a></div><div class="cover-image__meta"></div></div>

            

        
</div>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-1-2" class="sub-menu__heading">Read
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/newarticles" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Online now</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/current" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Current issue</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/archive" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Archive</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/action/showPreferences?menuTab=Alerts" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Publication alerts</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/sneakpeek" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Sneak Peek - preprints</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 3/5" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-1-3" class="sub-menu__heading">About
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-2">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/advisory-board" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Advisory board</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/aims" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Aims and scope</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/contact" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Contact</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/editors-and-staff" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Editors and staff</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/editorial-ethics" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Ethics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/information-for-authors/permissions" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Permissions</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/reviewers" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Reviewer instructions</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-2" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-2" data-item-link="main-menu-link-2" data-index="1" class="mega-menu__item-link menu-link"><span>Journals</span></a>
        <div id="main-menu-panel-2" aria-labelledby="main-menu-link-2" data-item-wrapper="main-menu-link-2" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/5" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-1" class="sub-menu__heading">Life &amp; medical sciences
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-4">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cancer-cell/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cancer Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-chemical-biology" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Chemical Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-genomics/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Genomics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-host-microbe/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Host &amp; Microbe</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-metabolism/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Metabolism</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-medicine/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Medicine</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-stem-cell/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Stem Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-systems/home" data-index="9" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Systems</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/current-biology/home" data-index="10" role="menuitem" class="sub-menu__item-link menu-link"><span>Current Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/developmental-cell/home" data-index="11" role="menuitem" class="sub-menu__item-link menu-link"><span>Developmental Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/immunity/home" data-index="12" role="menuitem" class="sub-menu__item-link menu-link"><span>Immunity</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/med/home" data-index="13" role="menuitem" class="sub-menu__item-link menu-link"><span>Med</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-cell/home" data-index="14" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/neuron/home" data-index="15" role="menuitem" class="sub-menu__item-link menu-link"><span>Neuron</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/structure/home" data-index="16" role="menuitem" class="sub-menu__item-link menu-link"><span>Structure</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/ajhg/home" data-index="17" role="menuitem" class="sub-menu__item-link menu-link"><span>American Journal of Human Genetics (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/biophysj/home" data-index="18" role="menuitem" class="sub-menu__item-link menu-link"><span>Biophysical Journal (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/biophysreports/home" data-index="19" role="menuitem" class="sub-menu__item-link menu-link"><span>Biophysical Reports (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/hgg-advances/home" data-index="20" role="menuitem" class="sub-menu__item-link menu-link"><span>Human Genetics and Genomics Advances (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-plant/home" data-index="21" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Plant (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/molecular-therapy/home" data-index="22" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/methods/home" data-index="23" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Methods &amp; Clinical Development (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/nucleic-acids/home" data-index="24" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Nucleic Acids (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/oncology/home" data-index="25" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Oncology (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/plant-communications/home" data-index="26" role="menuitem" class="sub-menu__item-link menu-link"><span>Plant Communications (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/stem-cell-reports/home" data-index="27" role="menuitem" class="sub-menu__item-link menu-link"><span>Stem Cell Reports (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/biochemical-sciences/home" data-index="28" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Biochemical Sciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cancer/home" data-index="29" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cancer</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cell-biology/home" data-index="30" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cell Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/ecology-evolution/home" data-index="31" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Ecology &amp; Evolution</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/endocrinology-metabolism/home" data-index="32" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Endocrinology &amp; Metabolism</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/genetics/home" data-index="33" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Genetics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/immunology/home" data-index="34" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Immunology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/microbiology/home" data-index="35" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Microbiology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/molecular-medicine/home" data-index="36" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Molecular Medicine</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/neurosciences/home" data-index="37" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Neurosciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/parasitology/home" data-index="38" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Parasitology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/pharmacological-sciences/home" data-index="39" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Pharmacological Sciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/plant-science/home" data-index="40" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Plant Science</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 5/6" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-2" class="sub-menu__heading">Physical sciences &amp; engineering
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-biomaterials/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Biomaterials</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-physical-science/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Physical Science</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/chem/home" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Chem</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/chem-catalysis/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Chem Catalysis</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/device/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Device</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/joule/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Joule</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/matter/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Matter</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/newton/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Newton</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/chemistry/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Chemistry</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 6/7" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-3" class="sub-menu__heading">Multidisciplinary
              </h4>
              <ul role="menubar" data-index="2" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-methods/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Methods</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-sustainability/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Sustainability</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/heliyon/home" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Heliyon</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/iscience/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>iScience</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/one-earth/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>One Earth</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/patterns/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Patterns</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/star-protocols/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>STAR Protocols</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/nexus/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Nexus (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/the-innovation/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>The Innovation (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/biotechnology/home" data-index="9" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Biotechnology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cognitive-sciences/home" data-index="10" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cognitive Sciences</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-3" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-3" data-item-link="main-menu-link-3" data-index="2" class="mega-menu__item-link menu-link"><span>Publish</span></a>
        <div id="main-menu-panel-3" aria-labelledby="main-menu-link-3" data-item-wrapper="main-menu-link-3" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-3-1" class="sub-menu__heading">Authors
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="https://www.editorialmanager.com/cell?__hstc=25856994.7201670a4397fa03148684920d4a8d38.1672762013831.1694716659709.1694718909620.146&amp;__hssc=25856994.15.1694718909620&amp;__hsfp=1366844671" data-index="0" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Submit article
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/information-for-authors" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Information for authors</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/open-access" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Open access</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/multi-journal-submission" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Multi-Journal Submission</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/information-for-authors/star-authors-guide" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>STAR Methods</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-3-2" class="sub-menu__heading">Reviewers
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/reviewers" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Information for reviewers</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-4" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-4" data-item-link="main-menu-link-4" data-index="3" class="mega-menu__item-link menu-link"><span>News &amp; events</span></a>
        <div id="main-menu-panel-4" aria-labelledby="main-menu-link-4" data-item-wrapper="main-menu-link-4" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/newsroom" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Newsroom</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/events" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Events</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/symposia" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Symposia</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/webinars" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Webinars</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/consortia" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Consortia Hub</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-5" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-5" data-item-link="main-menu-link-5" data-index="4" class="mega-menu__item-link menu-link"><span>About Cell Press</span></a>
        <div id="main-menu-panel-5" aria-labelledby="main-menu-link-5" data-item-wrapper="main-menu-link-5" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-1" class="sub-menu__heading">Cell Press
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/about" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>About Cell Press</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/contact" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Contact us</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="https://service.elsevier.com/app/overview/cell-press/" data-index="2" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Help &amp; support
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/open-access" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Open access at Cell Press</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/diversity" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Inclusion and diversity</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-press-50" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>50th anniversary</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-2" class="sub-menu__heading">Hubs
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/biotechnology-bioengineering" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Biotechnology and bioengineering</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-press-chemistry" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Chemistry</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/clinical-translational" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Clinical and translational</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/covid-19" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>COVID-19</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/fundamental-biology" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Fundamental biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/sustainability" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Sustainability</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 3/4" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-3" class="sub-menu__heading">Careers
              </h4>
              <ul role="menubar" data-index="2" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="https://relx.wd3.myworkdayjobs.com/en-US/ElsevierJobs" data-index="0" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Press careers
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
    </ul>
    <div class="mega-menu-nav__quick-search">
    

        


    

            

            

            <div data-widget-id="a1f05748-166f-41e0-b01a-ca8ac1cc95d4" data-widget-name="UX3QuickSearchWidget" class="quick-search"><div class="dropBlock"><form action="https://www.cell.com/action/doSearch?journalCode=cell" name="quickSearchBar" method="get" title="Quick Search"><input id="type" type="hidden" value="quicksearch" name="type"><div class="quick-search__toggle autoCompleteWrapper"><input id="searchText" type="text" name="text1" placeholder="Search for..." enterkeyhint="search" autocomplete="off" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" data-group-titles-conf="3" data-publication-items-conf="3" aria-label="Enter a search term" class="searchText searchText-autocomplete ui-autocomplete-input"><button type="submit" title="Search" aria-label="Submit the search form" class="btn quick-search__button icon-search"><span>Go search</span></button><a href="https://www.cell.com/search/advanced?SeriesKey=cell&amp;ISSN=0092-8674&amp;journalCode=cell" title="Advanced search" class="quick-search__advanced-link">Advanced search</a><ul id="ui-id-1" tabindex="0" class="ui-menu ui-widget ui-widget-content ui-autocomplete ui-front" unselectable="on" style="display: none;"></ul></div><div class="quick-search__box"><div class="quick-search__box-inner"><div class="quick-search__box-wrapper"><select name="field1" aria-label="Select a search area"><option value="AllField">All content</option><option value="Title">Article title</option><option value="Contrib">Authors</option><option value="Keyword">Keywords</option><option value="Abstract">Abstract</option><option value="AbstractTitleKeywordFilterField">Article title, abstract, keywords</option></select><input type="hidden" name="journalCode" value="cell"><div class="quick-search__scope-options"><span>Search within:</span><label title="This journal" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeSeries-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" title="This journal" value="cell" checked="checked" aria-label="Search within current journal"><span>This journal</span></label><label title="Full site" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeFullSite-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" value="" title="Full site" aria-label="Search within full site"><span>Full site</span></label></div><a href="https://www.cell.com/search/advanced?SeriesKey=cell&amp;ISSN=0092-8674&amp;journalCode=cell" title="Advanced search" class="quick-search__advanced-link">Advanced search</a></div><a href="javascript:void(0)" aria-label="Close search options" title="Close search options" class="quick-search__box-close"><i aria-hidden="true" class="icon-tools_close"></i></a></div></div><div class="quick-search__alert hidden"><p>Please enter a term before submitting your search.</p><a href="#" class="quick-search__alert--close"> Ok</a></div></form></div></div>

            

        
</div>
  </div>
</nav>
<div id="page-body-id" class="page-body-flag"></div></div>
                </div>
                </div>

        

        </div>
    

    

        


    

            

            

            <div data-widget-id="f8c6daf9-9df1-4fd9-ba3a-7f5d7b3d4466" data-widget-name="UX3HTMLWidget"><style>
.journal-logos:nth-of-type(2) img {
max-height: 30px !important;
}
.journal-logos:nth-of-type(3) img {
max-height: 30px !important;
}
.ux3 .journal-logos + .journal-logos {
margin-left: 30px;
}
.header__wrapper.clearfix .col-xs-6:first-of-type {
width: 55%;
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
width: 45%;
}
@media screen and (max-width: 1000px) {
.ux3 .journal-logos + .journal-logos {
display: none;
}
.header__wrapper.clearfix .col-xs-6:first-of-type {
width: 50%;
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
width: 50%;
}
}

.ux3 .journal-logos:first-of-type {
   max-width: 500px;
}

.profile-links {
   white-space: nowrap;
}

@media only screen and (min-width: 740px) and (max-width: 1600px) {
   .journal-logos:nth-of-type(2) img {
      max-width: 250px !important;
   }
}

@media only screen and (min-width: 1024px) and (max-width: 1600px) {
   .header__wrapper.clearfix .col-xs-6:first-of-type {
      width: 60% !important;
   }
   .header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
      width: 40% !important;
   }
}

@media only screen and (max-width: 1240px) {
   .ux3 .journal-logos + .journal-logos {
      display: none !important;
   }
}

</style></div>

            

        
</div></div>

            
                </div>
            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget axelPublicationContent none  widget-none" id="cadc9b41-a542-448a-9de4-8d0803320174">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none "><link id="build-style-article" rel="stylesheet" type="text/css" href="/products/marlin/cell/releasedAssets/css/build-article-b26f3342b722959c7931.css"><article xmlns="http://www.w3.org/1999/xhtml" data-design="pill" data-has="right-rail long-title" vocab="http://schema.org/" typeof="ScholarlyArticle" data-pii="S0092-8674(21)01322-2" lang="en" dir="ltr"><div data-core-wrapper="header"><header data-extent="frontmatter"><div class="core-container"><div data-article-access="free" data-article-access-type="open" class="meta-panel"><span class="meta-panel__left-content"><span class="meta-panel__type"><span>Article</span></span></span><span class="meta-panel__middle-content"><span class="meta-panel__volumeIssue"><a href="/cell/issue?pii=S0092-8674(20)X0026-2"><span>Volume 184</span>, <span>Issue 25</span></a></span><span class="meta-panel__pages"><span>p6101-6118.e13</span></span><span class="meta-panel__onlineDate">December 09, 2021</span></span><span class="meta-panel__right-content"><span class="meta-panel__access meta-panel__access--archive"><span>Open Archive</span></span></span><div class="article-header__download-full-issue"><button title="Download full issue" type="submit" formaction="/action/downloadMultiplePdf?action=downloadIssuePdf&amp;journal=cell&amp;volume=184&amp;issue=25&amp;pii=S0092-8674%2820%29X0026-2" class="btn--download-issue btn--cancel download-full-issue"><i class="icon-download-new"></i><span>Download Full Issue</span></button><div class="table-of-content__alert table-of-content__alert--download"><p>Download started</p><a href="#" class="table-of-content__alert--close">Ok</a></div></div></div><h1 property="name">Neoantigen-driven B cell and CD4&nbsp;T follicular helper cell collaboration promotes anti-tumor CD8 T&nbsp;cell responses</h1><div class="contributors"><span class="authors"><span role="list"><span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au1" aria-controls="axel_author_au1"><span property="givenName">Can</span> <span property="familyName">Cui</span></a><div id="au1" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Can</span> <span property="familyName">Cui</span> <a class="orcid-id" href="https://orcid.org/0000-0003-4736-4330" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0003-4736-4330</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Cui/Can" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au2" aria-controls="axel_author_au2"><span property="givenName">Jiawei</span> <span property="familyName">Wang</span></a><div id="au2" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Jiawei</span> <span property="familyName">Wang</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Program of Computational Biology and Bioinformatics, Yale University, New Haven, CT 06510, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Wang/Jiawei" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">2</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au3" aria-controls="axel_author_au3"><span property="givenName">Eric</span> <span property="familyName">Fagerberg</span></a><div id="au3" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Eric</span> <span property="familyName">Fagerberg</span> <a class="orcid-id" href="https://orcid.org/0000-0003-0313-3717" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0003-0313-3717</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Fagerberg/Eric" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span><span data-displayed-on="all"> ∙ … </span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au4" aria-controls="axel_author_au4"><span property="givenName">Ping-Min</span> <span property="familyName">Chen</span></a><div id="au4" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Ping-Min</span> <span property="familyName">Chen</span> <a class="orcid-id" href="https://orcid.org/0000-0001-6532-4549" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0001-6532-4549</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Chen/Ping-Min" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au5" aria-controls="axel_author_au5"><span property="givenName">Kelli A.</span> <span property="familyName">Connolly</span></a><div id="au5" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Kelli A.</span> <span property="familyName">Connolly</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Connolly/Kelli+A" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au6" aria-controls="axel_author_au6"><span property="givenName">Martina</span> <span property="familyName">Damo</span></a><div id="au6" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Martina</span> <span property="familyName">Damo</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Damo/Martina" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au7" aria-controls="axel_author_au7"><span property="givenName">Julie F.</span> <span property="familyName">Cheung</span></a><div id="au7" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Julie F.</span> <span property="familyName">Cheung</span> <a class="orcid-id" href="https://orcid.org/0000-0003-1346-0930" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0003-1346-0930</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Cheung/Julie+F" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au8" aria-controls="axel_author_au8"><span property="givenName">Tianyang</span> <span property="familyName">Mao</span></a><div id="au8" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Tianyang</span> <span property="familyName">Mao</span> <a class="orcid-id" href="https://orcid.org/0000-0001-9251-8592" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0001-9251-8592</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Mao/Tianyang" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au9" aria-controls="axel_author_au9"><span property="givenName">Adnan S.</span> <span property="familyName">Askari</span></a><div id="au9" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Adnan S.</span> <span property="familyName">Askari</span> <a class="orcid-id" href="https://orcid.org/0000-0001-9511-4702" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0001-9511-4702</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Askari/Adnan+S" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au10" aria-controls="axel_author_au10"><span property="givenName">Shuting</span> <span property="familyName">Chen</span></a><div id="au10" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Shuting</span> <span property="familyName">Chen</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Chen/Shuting" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au11" aria-controls="axel_author_au11"><span property="givenName">Brittany</span> <span property="familyName">Fitzgerald</span></a><div id="au11" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au11"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Brittany</span> <span property="familyName">Fitzgerald</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Fitzgerald/Brittany" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au12" aria-controls="axel_author_au12"><span property="givenName">Gena G.</span> <span property="familyName">Foster</span></a><div id="au12" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au12"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Gena G.</span> <span property="familyName">Foster</span> <a class="orcid-id" href="https://orcid.org/0000-0003-3482-0579" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0003-3482-0579</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Foster/Gena+G" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au13" aria-controls="axel_author_au13"><span property="givenName">Stephanie C.</span> <span property="familyName">Eisenbarth</span></a><div id="au13" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au13"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Stephanie C.</span> <span property="familyName">Eisenbarth</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Internal Medicine (Rheumatology, Allergy and Immunology), Yale University School of Medicine, New Haven, CT 06520, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Lab Medicine, Yale University School of Medicine, New Haven, CT 06519, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Eisenbarth/Stephanie+C" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">4</a></sup></span></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au14" aria-controls="axel_author_au14"><span property="givenName">Hongyu</span> <span property="familyName">Zhao</span></a><div id="au14" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au14"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Hongyu</span> <span property="familyName">Zhao</span> <a class="orcid-id" href="https://orcid.org/0000-0003-1195-9607" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0003-1195-9607</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Biostatistics, Yale School of Public Health, New Haven, CT 06510, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Zhao/Hongyu" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">5</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem" class="corresponding-author"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au15" aria-controls="axel_author_au15"><span property="givenName">Joseph</span> <span property="familyName">Craft</span></a><div id="au15" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au15"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Joseph</span> <span property="familyName">Craft</span></div><div class="content"><div class="core-author-emails"><div class="label">Correspondence</div><div>Corresponding author</div><div><a id="eadd0010" href="mailto:joseph.craft@yale.edu" property="email" title="Send email to Joseph Craft">joseph.craft@yale.edu</a></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Internal Medicine (Rheumatology, Allergy and Immunology), Yale University School of Medicine, New Haven, CT 06520, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Craft/Joseph" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a></sup> <a id="eadd0010" href="mailto:joseph.craft@yale.edu" property="email" title="Send email to Joseph Craft">joseph.craft@yale.edu</a></span> ∙ <span property="author" typeof="Person" role="listitem" class="corresponding-author"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au16" aria-controls="axel_author_au16"><span property="givenName">Nikhil S.</span> <span property="familyName">Joshi</span></a><div id="au16" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au16"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Nikhil S.</span> <span property="familyName">Joshi</span> <a class="orcid-id" href="https://orcid.org/0000-0002-7045-7837" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-7045-7837</a></div><div class="content"><div class="core-author-emails"><div class="label">Correspondence</div><div>Corresponding author</div><div><a id="eadd0015" href="mailto:nikhil.joshi@yale.edu" property="email" title="Send email to Nikhil S. Joshi">nikhil.joshi@yale.edu</a></div></div><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">6</div><div id="fn1"><div id="ntpara0010" role="paragraph">Lead contact</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Joshi/Nikhil+S" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a role="doc-noteref">6</a></sup> <a id="eadd0015" href="mailto:nikhil.joshi@yale.edu" property="email" title="Send email to Nikhil S. Joshi">nikhil.joshi@yale.edu</a></span><span data-displayed-on="all"> … <span><span data-action="reveal" tabindex="0" role="listitem">Show more</span></span> </span><span data-displayed-on="none" data-on-display="all" aria-hidden="true"> <span data-action="hide" tabindex="0" role="listitem">Show less</span></span></span></span></div><div class="core-self-citation"><div class="expandable-triggers"><button aria-controls="core-affiliations-notes" aria-expanded="false" tabindex="0" role="button"><span>Affiliations &amp; Notes</span><i class="icon-arrow_d_n" aria-hidden="true"></i></button><button aria-controls="core-content-info" aria-expanded="false" tabindex="0" role="button"><span>Article Info</span><i class="icon-arrow_d_n" aria-hidden="true"></i></button></div><div id="core-linked-content">
    

        

</div><div class="expandable-content"><div id="core-affiliations-notes" role="region" data-expandable="item" style="display: none;"><div class="affiliations"><div property="affiliation" typeof="Organization"><span class="label">1</span><span id="aff1" property="name">Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">2</span><span id="aff2" property="name">Program of Computational Biology and Bioinformatics, Yale University, New Haven, CT 06510, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">3</span><span id="aff3" property="name">Department of Internal Medicine (Rheumatology, Allergy and Immunology), Yale University School of Medicine, New Haven, CT 06520, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">4</span><span id="aff4" property="name">Department of Lab Medicine, Yale University School of Medicine, New Haven, CT 06519, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">5</span><span id="aff5" property="name">Department of Biostatistics, Yale School of Public Health, New Haven, CT 06510, USA</span></div></div><div class="core-authors-notes"><div role="doc-footnote" data-has="label"><div class="label">6</div><div id="fn1"><div id="ntpara0010" role="paragraph">Lead contact</div></div></div></div></div><div id="core-content-info" role="region" data-expandable="item" style="display: none;"><div class="history"><div>Publication History:</div><div><span>Received December 10, 2020</span>; <span>Revised July 21, 2021</span>; <span>Accepted November 5, 2021</span>; <span>Published online November 30, 2021</span></div></div><div class="core-links"><span class="doi">DOI: <a href="https://doi.org/10.1016/j.cell.2021.11.007" property="sameAs" target="_blank">10.1016/j.cell.2021.11.007 <span class="sr-only">External Link</span></a></span><span class="science-direct">Also available on <a href="https://www.sciencedirect.com/science/article/pii/S0092867421013222" target="_blank">ScienceDirect <span class="sr-only">External Link</span></a></span></div><div role="paragraph">Copyright: © 2021 Elsevier Inc.</div><div class="core-links"><span>User License: <a href="http://www.elsevier.com/open-access/userlicense/1.0/" target="_blank">Elsevier user license</a> | <a href="https://www.elsevier.com/open-access" target="_blank">Elsevier's open access license policy</a></span></div><div class="core-crossmark-badge"><a data-target="crossmark" href="#" title="Check for updates on crossmark" data-doi="10.1016/j.cell.2021.11.007" data-id="article-info-crossmark" class="crossmark__link" style="cursor: pointer;"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 290 58" height="22px" role="presentation"><path fill="url(#horizontal_crossmark)" stroke="#948F8F" stroke-miterlimit="10" stroke-width=".75" d="M287 1H3a2 2 0 0 0-2 2v52a2 2 0 0 0 2 2h284a2 2 0 0 0 2-2V3a2 2 0 0 0-2-2Z"></path><path fill="#535353" d="M80.3 23.58a6.395 6.395 0 0 0-.55-1.43 3.92 3.92 0 0 0-2.19-1.86 5.099 5.099 0 0 0-1.71-.29 5 5 0 0 0-2.46.58 4.831 4.831 0 0 0-1.69 1.54 6.921 6.921 0 0 0-1 2.19 10.16 10.16 0 0 0 0 5 6.921 6.921 0 0 0 1 2.19 4.83 4.83 0 0 0 1.69 1.5 5 5 0 0 0 2.46.58 4.44 4.44 0 0 0 1.85-.36 4.12 4.12 0 0 0 1.38-1c.39-.436.695-.942.9-1.49A7.094 7.094 0 0 0 80.4 29h3a8.46 8.46 0 0 1-.69 2.92 7.179 7.179 0 0 1-1.59 2.29 7 7 0 0 1-2.35 1.49 8.14 8.14 0 0 1-3 .52 8.43 8.43 0 0 1-3.59-.74 7.88 7.88 0 0 1-2.69-2 9.001 9.001 0 0 1-1.69-3 11.41 11.41 0 0 1 0-7.23 9.001 9.001 0 0 1 1.69-3 8.001 8.001 0 0 1 2.69-2 8.3 8.3 0 0 1 3.59-.75 9.44 9.44 0 0 1 2.83.41c.866.242 1.68.642 2.4 1.18A6.229 6.229 0 0 1 82.65 21a6.66 6.66 0 0 1 .78 2.58H80.3ZM85.9 17.9h2.85v6.63h.05a4.15 4.15 0 0 1 1.56-1.46 4.61 4.61 0 0 1 2.31-.59 4.83 4.83 0 0 1 3.33 1.1 4.21 4.21 0 0 1 1.22 3.3v8.88H94.4v-8.13a3.51 3.51 0 0 0-.65-2.21 2.36 2.36 0 0 0-1.87-.69 3.1 3.1 0 0 0-1.3.26 2.821 2.821 0 0 0-1 .73A3.41 3.41 0 0 0 89 26.8a3.88 3.88 0 0 0-.23 1.33v7.63H85.9V17.9ZM102.47 30c-.002.491.069.98.21 1.45.131.448.348.866.64 1.23a3.08 3.08 0 0 0 1.08.84 3.543 3.543 0 0 0 1.55.31 3.431 3.431 0 0 0 2-.54c.541-.402.94-.966 1.14-1.61h2.7A5.349 5.349 0 0 1 109.7 35a5.715 5.715 0 0 1-1.74.85 7 7 0 0 1-2 .29 6.848 6.848 0 0 1-2.7-.5 5.577 5.577 0 0 1-2-1.4A5.953 5.953 0 0 1 100 32a8.748 8.748 0 0 1-.41-2.75 7.768 7.768 0 0 1 .44-2.61 6.67 6.67 0 0 1 1.25-2.17 5.863 5.863 0 0 1 4.56-2 5.79 5.79 0 0 1 2.74.64c.783.41 1.466.986 2 1.69a6.824 6.824 0 0 1 1.16 2.41c.264.905.352 1.852.26 2.79h-9.53Zm6.65-1.87a4.605 4.605 0 0 0-.29-1.3c-.148-.4-.368-.77-.65-1.09a3.22 3.22 0 0 0-1-.75 3 3 0 0 0-1.31-.29 3.431 3.431 0 0 0-1.36.26 3.108 3.108 0 0 0-1 .73 3.594 3.594 0 0 0-.7 1.09 3.798 3.798 0 0 0-.29 1.35h6.65-.05ZM122.88 27.15a2.666 2.666 0 0 0-1-1.81 3.14 3.14 0 0 0-2-.61c-.4.005-.798.07-1.18.19-.435.136-.83.376-1.15.7a3.92 3.92 0 0 0-.87 1.43 6.783 6.783 0 0 0-.35 2.39c.002.539.065 1.076.19 1.6.113.509.316.993.6 1.43.273.41.635.752 1.06 1a3 3 0 0 0 1.58.39 2.872 2.872 0 0 0 2.06-.77 3.596 3.596 0 0 0 1-2.18h2.85a6.26 6.26 0 0 1-1.91 3.86 5.83 5.83 0 0 1-4 1.34 6.61 6.61 0 0 1-2.69-.51 5.695 5.695 0 0 1-2-1.4 6.001 6.001 0 0 1-1.21-2.11 8.279 8.279 0 0 1-.41-2.65 8.987 8.987 0 0 1 .4-2.72 6.237 6.237 0 0 1 1.2-2.21 5.614 5.614 0 0 1 2-1.47 6.7 6.7 0 0 1 2.79-.54 7.801 7.801 0 0 1 2.14.29 5.634 5.634 0 0 1 1.8.86c.529.386.969.88 1.29 1.45a5 5 0 0 1 .6 2.07h-2.85l.06-.02ZM128.13 17.9H131V28l5.15-5.22h3.5l-5 4.75 5.42 8.17h-3.47l-4-6.27-1.6 1.7v4.63h-2.85V17.9h-.02ZM147.15 22.83h2.13v-1.08a5.505 5.505 0 0 1 .3-2c.161-.456.436-.862.8-1.18.33-.273.721-.462 1.14-.55.44-.094.89-.141 1.34-.14a8.158 8.158 0 0 1 2 .18v2.24a4.113 4.113 0 0 0-.59-.11 6.343 6.343 0 0 0-.74 0 1.74 1.74 0 0 0-1 .27 1.204 1.204 0 0 0-.41 1.08v1.33h2.42V25h-2.42v10.8h-2.85V25h-2.12v-2.17ZM162.23 36.1a6.999 6.999 0 0 1-2.76-.51 5.877 5.877 0 0 1-2-1.41 5.998 5.998 0 0 1-1.33-2.18 8.775 8.775 0 0 1 0-5.48 6.008 6.008 0 0 1 1.27-2.15 5.894 5.894 0 0 1 2-1.41A7.71 7.71 0 0 1 165 23a5.894 5.894 0 0 1 2 1.41 6.003 6.003 0 0 1 1.28 2.15c.585 1.78.585 3.7 0 5.48a5.99 5.99 0 0 1-3.28 3.54 7.002 7.002 0 0 1-2.77.52Zm0-2.25a3.268 3.268 0 0 0 1.65-.4c.447-.262.83-.621 1.12-1.05.304-.444.528-.938.66-1.46a6.581 6.581 0 0 0 0-3.31 4.416 4.416 0 0 0-.66-1.46 3.526 3.526 0 0 0-1.15-1 3.6 3.6 0 0 0-3.3 0 3.526 3.526 0 0 0-1.15 1 4.414 4.414 0 0 0-.66 1.46 6.558 6.558 0 0 0 0 3.31c.132.522.356 1.016.66 1.46a3.47 3.47 0 0 0 1.15 1.05 3.26 3.26 0 0 0 1.68.4ZM171.13 22.83h2.67v2.5c.097-.362.264-.701.49-1 .251-.341.547-.647.88-.91a4.404 4.404 0 0 1 1.14-.66 3.41 3.41 0 0 1 1.28-.25c.23-.013.46-.013.69 0h.39v2.79l-.61-.09a5.173 5.173 0 0 0-.61 0 3.278 3.278 0 0 0-1.36.29 3.131 3.131 0 0 0-1.11.85 4.171 4.171 0 0 0-.75 1.39 6 6 0 0 0-.28 1.9v6.15h-2.85V22.83h.03ZM198.22 35.75h-2.8V34a3.907 3.907 0 0 1-1.56 1.56 4.25 4.25 0 0 1-2.11.59 4.742 4.742 0 0 1-3.75-1.31 5.537 5.537 0 0 1-1.12-3.84v-8.2h2.85v7.92a3.503 3.503 0 0 0 .65 2.4 2.38 2.38 0 0 0 1.83.7 3.599 3.599 0 0 0 1.5-.27 2.66 2.66 0 0 0 1-.74c.259-.326.444-.705.54-1.11a5.79 5.79 0 0 0 .16-1.4v-7.5h2.85v12.95h-.04ZM201.3 22.83h2.7v1.75a3.523 3.523 0 0 1 1.72-1.58 5.568 5.568 0 0 1 2.33-.49 6.17 6.17 0 0 1 2.66.54 5.246 5.246 0 0 1 1.89 1.47c.515.65.899 1.394 1.13 2.19.257.87.385 1.773.38 2.68.001.851-.114 1.7-.34 2.52a6.568 6.568 0 0 1-1 2.16 5.002 5.002 0 0 1-4.21 2.06c-.419 0-.837-.036-1.25-.11a5.39 5.39 0 0 1-1.2-.36A4.737 4.737 0 0 1 205 35a3.567 3.567 0 0 1-.81-.91v6.45h-2.89V22.83Zm10 6.47c0-.574-.078-1.146-.23-1.7a4.606 4.606 0 0 0-.67-1.46 3.475 3.475 0 0 0-1.12-1 3.06 3.06 0 0 0-1.55-.39A3.141 3.141 0 0 0 205 26a5.518 5.518 0 0 0-1 3.3c-.004.611.077 1.22.24 1.81.138.523.38 1.012.71 1.44a3.55 3.55 0 0 0 1.14 1 3.242 3.242 0 0 0 1.54.35 3.18 3.18 0 0 0 1.65-.4c.438-.25.817-.59 1.11-1 .299-.44.513-.931.63-1.45a7.38 7.38 0 0 0 .23-1.75h.05ZM228.67 35.75H226V34a3.38 3.38 0 0 1-1.67 1.61 5.668 5.668 0 0 1-2.33.49 6.17 6.17 0 0 1-2.66-.54 5.307 5.307 0 0 1-1.89-1.46 6.254 6.254 0 0 1-1.12-2.19 9.48 9.48 0 0 1-.37-2.71 8.67 8.67 0 0 1 .47-3 6.058 6.058 0 0 1 1.26-2.1 4.89 4.89 0 0 1 1.8-1.21 5.738 5.738 0 0 1 2.06-.39c.412 0 .824.037 1.23.11.413.073.815.194 1.2.36.38.166.736.381 1.06.64.32.255.594.562.81.91V17.9h2.85v17.85h-.03Zm-10-6.33c-.001.55.069 1.098.21 1.63.13.511.35.996.65 1.43.288.414.668.757 1.11 1a3.241 3.241 0 0 0 1.6.38 3.199 3.199 0 0 0 1.64-.4 3.398 3.398 0 0 0 1.13-1.05c.297-.447.517-.94.65-1.46.14-.542.211-1.1.21-1.66a5.227 5.227 0 0 0-1-3.35 3.175 3.175 0 0 0-2.61-1.2 3.23 3.23 0 0 0-1.69.41 3.478 3.478 0 0 0-1.12 1.07 4.494 4.494 0 0 0-.62 1.5 7.871 7.871 0 0 0-.11 1.7h-.05ZM242.6 32.88c-.018.258.03.516.14.75a.577.577 0 0 0 .54.23h.3c.135-.002.269-.019.4-.05v2l-.39.11-.49.08-.5.08h-.42a2.75 2.75 0 0 1-1.45-.35 1.731 1.731 0 0 1-.75-1.23 4.998 4.998 0 0 1-2.09 1.2 8.224 8.224 0 0 1-2.39.38 5.861 5.861 0 0 1-1.67-.24 4.394 4.394 0 0 1-1.41-.7 3.35 3.35 0 0 1-1-1.18 3.624 3.624 0 0 1-.36-1.66 3.84 3.84 0 0 1 .44-2 3.246 3.246 0 0 1 1.15-1.17 5.195 5.195 0 0 1 1.6-.61c.593-.127 1.19-.223 1.79-.29a14.77 14.77 0 0 1 1.47-.21 6.896 6.896 0 0 0 1.24-.21c.318-.077.611-.236.85-.46a1.286 1.286 0 0 0 .31-.94 1.458 1.458 0 0 0-.26-.9A1.759 1.759 0 0 0 239 25a2.807 2.807 0 0 0-.86-.25 6.941 6.941 0 0 0-.9-.06 3.58 3.58 0 0 0-2 .5 2 2 0 0 0-.87 1.55h-2.85c.021-.73.227-1.442.6-2.07.338-.54.797-.996 1.34-1.33a5.475 5.475 0 0 1 1.84-.7c.692-.134 1.395-.2 2.1-.2.632 0 1.262.067 1.88.2a5.337 5.337 0 0 1 1.66.65 3.6 3.6 0 0 1 1.19 1.16c.314.525.47 1.129.45 1.74v6.65l.02.04Zm-2.85-3.6a3.45 3.45 0 0 1-1.6.51c-.667.06-1.3.147-1.9.26a6.137 6.137 0 0 0-.87.21 2.64 2.64 0 0 0-.75.38c-.22.164-.395.38-.51.63a2.129 2.129 0 0 0-.19.94c-.011.29.085.575.27.8.182.215.407.388.66.51.269.128.555.216.85.26.277.05.558.076.84.08a4.63 4.63 0 0 0 1-.12 3.418 3.418 0 0 0 1-.43 2.73 2.73 0 0 0 .81-.76 1.93 1.93 0 0 0 .32-1.14v-2.14l.07.01ZM244.37 22.83h2.15V19h2.85v3.88h2.58V25h-2.58v6.9a7.064 7.064 0 0 0 0 .77c.016.194.074.381.17.55a.84.84 0 0 0 .41.34 2 2 0 0 0 .75.11h.6c.203-.01.404-.04.6-.09v2.2l-.93.1a8.403 8.403 0 0 1-.92 0 6.33 6.33 0 0 1-1.81-.21 2.421 2.421 0 0 1-1.08-.62 2.15 2.15 0 0 1-.52-1 7.791 7.791 0 0 1-.16-1.42V25h-2.15v-2.17h.04ZM256.22 30c-.002.491.069.98.21 1.45.131.448.348.866.64 1.23a3.08 3.08 0 0 0 1.08.84 3.543 3.543 0 0 0 1.55.31 3.431 3.431 0 0 0 2-.54c.541-.402.94-.966 1.14-1.61h2.7a5.352 5.352 0 0 1-2.1 3.26 5.715 5.715 0 0 1-1.74.85 7 7 0 0 1-2 .29 6.848 6.848 0 0 1-2.7-.5 5.577 5.577 0 0 1-2-1.4 5.947 5.947 0 0 1-1.21-2.18 8.754 8.754 0 0 1-.41-2.75 7.758 7.758 0 0 1 .44-2.61 6.67 6.67 0 0 1 1.25-2.17 5.863 5.863 0 0 1 4.56-2 5.79 5.79 0 0 1 2.74.64c.783.41 1.466.986 2 1.69a6.824 6.824 0 0 1 1.16 2.41c.243.916.308 1.87.19 2.81h-9.5V30Zm6.65-1.87a4.605 4.605 0 0 0-.29-1.3c-.148-.4-.368-.77-.65-1.09a3.22 3.22 0 0 0-1-.75 3 3 0 0 0-1.31-.29 3.431 3.431 0 0 0-1.36.26 3.108 3.108 0 0 0-1 .73 3.575 3.575 0 0 0-.7 1.09 3.798 3.798 0 0 0-.29 1.35h6.65-.05ZM270 31.6a2.154 2.154 0 0 0 .95 1.75c.607.35 1.3.524 2 .5.304-.002.608-.022.91-.06a3.943 3.943 0 0 0 1-.24c.286-.105.54-.28.74-.51a1.23 1.23 0 0 0 .26-.89 1.261 1.261 0 0 0-.4-.9 2.779 2.779 0 0 0-1-.56 9.315 9.315 0 0 0-1.34-.36l-1.5-.33a14.219 14.219 0 0 1-1.54-.42 4.937 4.937 0 0 1-1.33-.68 3.12 3.12 0 0 1-.94-1.09 3.472 3.472 0 0 1-.35-1.64 2.94 2.94 0 0 1 .51-1.76 3.913 3.913 0 0 1 1.3-1.15 5.66 5.66 0 0 1 1.75-.61 10.316 10.316 0 0 1 1.84-.17 8.418 8.418 0 0 1 1.91.21 5.19 5.19 0 0 1 1.65.69c.496.318.916.741 1.23 1.24.341.559.55 1.188.61 1.84h-3a1.783 1.783 0 0 0-.94-1.37 3.892 3.892 0 0 0-1.69-.35 6.093 6.093 0 0 0-.71 0 3.327 3.327 0 0 0-.78.19 1.642 1.642 0 0 0-.61.4 1 1 0 0 0-.25.69 1.093 1.093 0 0 0 .36.85c.294.245.634.428 1 .54.437.153.885.274 1.34.36l1.55.33a20.9 20.9 0 0 1 1.53.42c.479.157.931.386 1.34.68.41.277.751.643 1 1.07.255.494.379 1.045.36 1.6a3.48 3.48 0 0 1-.52 2 4.15 4.15 0 0 1-1.36 1.3 6.19 6.19 0 0 1-1.86.73 9.435 9.435 0 0 1-2 .23 8.823 8.823 0 0 1-2.26-.27 5.265 5.265 0 0 1-1.8-.84 4 4 0 0 1-1.2-1.4 4.445 4.445 0 0 1-.46-2h2.7v-.02Z"></path><path fill="#C72914" d="m21.94 38.74 18.12-12.08v-14.5H21.94v26.58Z"></path><path fill="#EF3340" d="M40.06 38.74 21.94 26.66v-14.5h18.12v26.58Z"></path><path fill="#3EB1C8" d="M31 9a20 20 0 1 0 0 40 20 20 0 0 0 0-40Zm0 35.1a15.1 15.1 0 1 1 0-30.2 15.1 15.1 0 0 1 0 30.2Z"></path><path fill="#FFC72C" d="M42.09 39.23A15.09 15.09 0 0 1 17 23.38l-4.2-2.64a20 20 0 0 0 33.49 21.14l-4.2-2.65Z"></path><defs><linearGradient id="horizontal_crossmark" x1="145" x2="145" y1="7.33" y2="56.82" gradientUnits="userSpaceOnUse"><stop stop-color="#fff"></stop><stop offset="1" stop-color="#c4c4c4"></stop></linearGradient></defs></svg></a></div><div class="core-content-info"></div></div></div></div></div></header><div class="core-header-aside">
    

        


    

            

            

            <div class="cover-image cover-image--axel"><div class="cover-image__thumb"><a href="https://www.cell.com/cell/issue?pii=S0092-8674(20)X0026-2"><img src="/cms/asset/0540b9ed-f4ad-4863-9830-19ca05143514/cov200h.gif" alt="Cover Image - Cell, Volume 184, Issue 25"></a></div></div>

            

        
</div></div><div data-core-wrapper="content"><div id="dummy-sticky-observer"></div><div data-core-nav="header" data-extent="frontmatter"><div class="core-nav-wrapper core-container" aria-label="Article navigation"><div class="navigation-menu-pdf">
    

        


    

            

            

            <div data-widget-id="ecff07e8-0bc4-4533-b1f1-49365e2ead20" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><a href="/action/showPdf?pii=S0092-8674%2821%2901322-2" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" role="menuitem" class="article-tools__item__pdf"><svg focusable="false" viewBox="0 0 32 32" width="20" height="20" title="PDF" class="pdf-icon"><path id="pdfwhite" d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path id="pdfda0000" d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path id="pdffff9f9" fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path id="pdff91d0a" d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="basic">Download PDF</span><span class="alternative">Download PDF</span></a></div>

            

        
</div><div class="core-sections-menu"><button data-id="article-toolbar-showhide" aria-controls="article_sections_menu" aria-expanded="false" aria-haspopup="true" aria-label="Toggle section navigation menu" style="margin-top: 0px;"><i class="icon-list" aria-hidden="true"></i><span>Outline</span></button><nav id="article_sections_menu" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><div class="heading">Outline<button aria-haspopup="true" aria-controls="article_sections_menu" title="Close outline menu"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div><ul><li><a href="#author-highlights-abstract">Highlights</a></li><li><a href="#author-abstract">Summary</a></li><li><a href="#graphical-abstract">Graphical abstract</a></li><li><a href="#keywords">Keywords</a></li><li><a href="#sec-1">Introduction</a></li><li><a href="#sec-2">Results</a></li><li><a href="#sec-3">Discussion</a></li><li><a href="#sec-4">STAR★Methods</a></li><li><a href="#acknowledgments">Acknowledgments</a></li><li><a href="#supplementary-material">Supplemental information (3)</a></li><li><a href="#data-availability">Data and code availability</a></li><li><a href="#references">References</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-metrics">Article metrics</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-relatedArticles">Related Articles</a></li></ul></nav></div><div class="navigation-menu-share">
    

        


    

            

            

            <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js"></script><script type="text/javascript">var a2a_config = a2a_config || {};
a2a_config.thanks = {
    postShare: false,
    ad: false,
};</script><script>var a2a_config = a2a_config || {};
let res = window.location.href.replace(/\(/g, "%28").replace(/\)/g, "%29");
a2a_config.templates = a2a_config.templates || {};

a2a_config.templates.email = {
    body: res
};
</script><div data-widget-id="5f978446-c80a-450c-a185-94d633df2db2" data-widget-name="UX3share" aria-hidden="false" role="group" class="article-tools__dropblock article-tools__share"><button aria-label="Toggle share menu" aria-expanded="false" aria-haspopup="true" role="menuitem" aria-controls="navigation_menu_share_block" aria-labelledby="share-label" class="article-tools__item__share"><i aria-hidden="true" class="icon-article-share"></i><span id="share-label">Share</span></button><div id="navigation_menu_share_block" role="menu" class="share__block axel-share article-tools__dropblock__holder"><h4 class="axel-share__title heading">Share<button title="Close share menu" aria-expanded="false" aria-haspopup="true" aria-controls="navigation_menu_share_block"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></h4><div class="axel-share__inner"><span class="sr-only">Share on</span><ul class="a2a__share-list rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-url="https://www.cell.com/cell/fulltext/S0092-8674%2821%2901322-2" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Email" class="a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email-plus"></i><span>Email</span></a></li><li class="a2a_listitem_custom"><a role="link" title="formerly known as Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-x-default"></i><span>X</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook-square-2"></i><span>Facebook</span></a></li><li class="a2a_listitem_custom"><a role="link" title="LinkedIn" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin-square"></i><span>LinkedIn</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Sina Weibo" class="a2a_button_sina_weibo" target="_blank" rel="nofollow noopener" href="/#sina_weibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Mendeley" class="a2a_button_mendeley" target="_blank" rel="nofollow noopener" href="/#mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley-2"></i><span>Mendeley</span></a></li><li class="a2a_listitem_custom"><a role="link" title="bluesky" class="a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><i aria-hidden="true" class="at-icon-wrapper icon-bluesky-logo"></i><span>bluesky</span></a></li><div style="clear: both;"></div></ul><div class="extra-links-drop-zone">
    

        


    

            

            

            <div data-widget-id="f1a208d3-ac5e-4db2-9c3a-40ef97ddfa10" data-widget-name="UX3HTMLWidget"><a class="axel-share__extra" target="_blank" href="/personalize/addFavoritePublication?doi=10.1016/j.cell.2021.11.007">
	<i class="icon-reading-list" aria-hidden="true"></i>
	<span>Add to my reading list</span>
</a></div>

            

        
</div></div></div></div>

            

        
</div><div><button data-id="article-nav-menubar-more" aria-controls="article_more_menu" aria-expanded="false" aria-haspopup="true" aria-label="Toggle more menu"><i aria-hidden="true" class="icon-more-mobile"></i><span>More</span></button><div class="info-panel"><div class="info-panel__left-content"><div class="info-panel__article_tools info-panel__item"><div id="article_more_menu" aria-label="More menu" data-core-nav="more"><div class="heading">More<button title="Close more menu" aria-controls="article_more_menu" aria-haspopup="true"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div>
    

        


    

            

            

            <ul data-widget-id="183a17a2-87b5-4e6f-bb85-6b5cda068c89" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><li class="article-tools__item article-tools__pdf"><a href="/action/showPdf?pii=S0092-8674%2821%2901322-2" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" class="article-tools__ctrl article-tools__item__pdf"><svg focusable="false" viewBox="0 0 32 32" width="20" height="20" title="PDF" class="pdf-icon"><path id="pdfwhite" d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path id="pdfda0000" d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path id="pdffff9f9" fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path id="pdff91d0a" d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="basic">Download PDF</span><span class="alternative">Download PDF</span></a></li><li><a href="https://www.cell.com/action/showCitFormats?doi=10.1016%2Fj.cell.2021.11.007&amp;pii=S0092-8674%2821%2901322-2" title="Cite" target="_blank" aria-label="Open Cite in new tab" class="article-tools__item__displayExportCitation"><i aria-hidden="true" class="icon-export-Citation"></i><span>Cite</span></a></li><li id="article_tools_share">
    

        


    

            

            

            <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js"></script><script type="text/javascript">var a2a_config = a2a_config || {};
a2a_config.thanks = {
    postShare: false,
    ad: false,
};</script><script>var a2a_config = a2a_config || {};
let res = window.location.href.replace(/\(/g, "%28").replace(/\)/g, "%29");
a2a_config.templates = a2a_config.templates || {};

a2a_config.templates.email = {
    body: res
};
</script><div data-widget-id="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" data-widget-name="UX3share" class="dropBlock article-tools__dropblock article-tools__share"><button data-db-target-for="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" aria-expanded="false" title="open Share menu" class="article-tools__ctrl share__ctrl"><i aria-hidden="true" class="icon-article-share"></i><span>Share</span></button><div data-db-target-of="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" id="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da_Pop" class="share__block axel-share dropBlock__holder article-tools__dropblock__holder"><h4 class="axel-share__title">Share</h4><div class="axel-share__inner"><span class="sr-only">Share on</span><ul class="a2a__share-list rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-url="https://www.cell.com/cell/fulltext/S0092-8674%2821%2901322-2" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Email" class="a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email-plus"></i><span>Email</span></a></li><li class="a2a_listitem_custom"><a role="link" title="formerly known as Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-x-default"></i><span>X</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook-square-2"></i><span>Facebook</span></a></li><li class="a2a_listitem_custom"><a role="link" title="LinkedIn" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin-square"></i><span>LinkedIn</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Sina Weibo" class="a2a_button_sina_weibo" target="_blank" rel="nofollow noopener" href="/#sina_weibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Mendeley" class="a2a_button_mendeley" target="_blank" rel="nofollow noopener" href="/#mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley-2"></i><span>Mendeley</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Bluesky" class="a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><i aria-hidden="true" class="at-icon-wrapper icon-bluesky-logo"></i><span>Bluesky</span></a></li><div style="clear: both;"></div></ul><div class="extra-links-drop-zone">
    

        


    

            

            

            <div data-widget-id="ae9bf5c5-a2ee-4f5c-8e41-9b21638b1a9f" data-widget-name="UX3HTMLWidget"><a class="axel-share__extra" target="_blank" href="/personalize/addFavoritePublication?doi=10.1016/j.cell.2021.11.007">
	<i class="icon-reading-list" aria-hidden="true"></i>
	<span>Add to my reading list</span>
</a></div>

            

        
</div></div></div></div>

            

        
</li><li><a href="https://www.cell.com/action/addCitationAlert?doi=10.1016%2Fj.cell.2021.11.007" title="Set Alert" target="_blank" aria-label="Open Set Alert in new tab" class="article-tools__item__displayCreateCitationAlert"><i aria-hidden="true" class="icon-set-alert"></i><span>Set Alert</span></a></li><li><a href="https://s100.copyright.com/AppDispatchServlet?publisherName=ELS&amp;contentID=S0092867421013222&amp;orderBeanReset=true&amp;orderSource=Phoenix" title="Get Rights" target="_blank" aria-label="Open Get Rights in new tab" class="article-tools__item__request"><i aria-hidden="true" class="icon-get-rights"></i><span>Get Rights</span></a></li><li><a href="https://www.contentednet.com/salesforce-form/?pii=S0092867421013222&amp;issn=00928674&amp;source=jbs" title="Reprints" target="_blank" aria-label="Open Reprints in new tab" class="article-tools__item__reprints"><i aria-hidden="true" class="icon-article-reprints"></i><span>Reprints</span></a></li></ul>

            

        
</div></div><div class="info-panel__download-issue info-panel__item"><div class="article-header__download-full-issue"><button title="Download full issue" type="submit" formaction="/action/downloadMultiplePdf?action=downloadIssuePdf&amp;journal=cell&amp;volume=184&amp;issue=25&amp;pii=S0092-8674%2820%29X0026-2" class="btn--download-issue btn--cancel download-full-issue"><i class="icon-download-new"></i><span>Download Full Issue</span></button><div class="table-of-content__alert table-of-content__alert--download"><p>Download started</p><a href="#" class="table-of-content__alert--close">Ok</a></div></div></div></div><div class="info-panel__right-content"><div class="info-panel__navigation info-panel__item"><div class="content-navigation"><a href="/cell/fulltext/S0092-8674(21)01331-3" aria-label="Previous article" aria-disabled="false" class="content-navigation__prev"><i aria-hidden="true" class="icon-arrow_l"></i><span>Previous article</span></a><a href="/cell/fulltext/S0092-8674(21)01332-5" aria-label="Next article" aria-disabled="false" class="content-navigation__next"><span>Next article</span><i aria-hidden="true" class="icon-arrow_r"></i></a></div></div></div></div></div></div></div><div class="core-sections-menu-outer"><div class="core-sections-menu"><button aria-controls="article_sections_menu-desktop" aria-haspopup="true" aria-expanded="false" aria-label="Toggle sections menu" data-id="article-toolbar-showhide"><i class="icon-show-outline" aria-hidden="true"></i><span>Show Outline</span></button><nav id="article_sections_menu-desktop" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><button aria-controls="article_sections_menu-desktop" aria-haspopup="true" aria-expanded="false" aria-label="Toggle sections menu" data-id="article-toolbar-showhide"><i class="icon-hide-outline" aria-hidden="true"></i><span>Hide Outline</span></button><ul><li><a href="#author-highlights-abstract">Highlights</a></li><li><a href="#author-abstract">Summary</a></li><li><a href="#graphical-abstract">Graphical abstract</a></li><li><a href="#keywords">Keywords</a></li><li><a href="#sec-1">Introduction</a></li><li><a href="#sec-2">Results</a></li><li><a href="#sec-3">Discussion</a></li><li><a href="#sec-4">STAR★Methods</a></li><li><a href="#acknowledgments">Acknowledgments</a></li><li><a href="#supplementary-material">Supplemental information (3)</a></li><li><a href="#data-availability">Data and code availability</a></li><li><a href="#references">References</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-metrics">Article metrics</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-relatedArticles">Related Articles</a></li></ul></nav></div></div><div><div class="core-content-inner"><div class="core-linked-content"></div><div id="abstracts" data-extent="frontmatter"><div class="core-container"><section id="author-highlights-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Highlights</h2><div id="abspara0020" role="paragraph"><div id="ulist0010" role="list"><div id="u0010" role="listitem"><div class="label">•</div><div class="content"><div id="p0010" role="paragraph">Enrichment of TFH and GC B cells correlates with favorable clinical outcomes of LUAD</div></div></div><div id="u0015" role="listitem"><div class="label">•</div><div class="content"><div id="p0015" role="paragraph">B cell-recognized neoantigens drive tumor-specific B cell and TFH cell responses</div></div></div><div id="u0020" role="listitem"><div class="label">•</div><div class="content"><div id="p0020" role="paragraph">Tumor-specific TFH cells produce IL-21</div></div></div><div id="u0025" role="listitem"><div class="label">•</div><div class="content"><div id="p0025" role="paragraph">IL-21 is critical for tumor control and tumor-infiltrating CD8 T&nbsp;cell effector function</div></div></div></div></div></section><section id="author-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Summary</h2><div id="abspara0010" role="paragraph">CD4&nbsp;T follicular helper (TFH) cells support B cells, which are critical for germinal center (GC) formation, but the importance of TFH-B cell interactions in cancer is unclear. We found enrichment of TFH cell transcriptional signature correlates with GC B cell signature and with prolonged survival in individuals with lung adenocarcinoma (LUAD). We further developed a murine LUAD model in which tumor cells express B cell- and T&nbsp;cell-recognized neoantigens. Interactions between tumor-specific TFH and GC B cells, as well as interleukin (IL)-21 primarily produced by TFH cells, are necessary for tumor control and effector CD8 T&nbsp;cell function. Development of TFH cells requires B cells and B cell-recognized neoantigens. Thus, tumor neoantigens can regulate the fate of tumor-specific CD4 T&nbsp;cells by facilitating their interactions with tumor-specific B cells, which in turn promote anti-tumor immunity by enhancing CD8 T&nbsp;cell effector functions.</div></section><section id="graphical-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Graphical abstract</h2><div id="abspara0015" role="paragraph"><div class="figure-wrap"><figure id="undfig1" class="graphic" data-figureviewer-ignore="true"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.007/asset/c32ca761-32c6-4ce1-96e4-ada0ea1f76d7/main.assets/fx1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx1" alt="Graphical abstract undfig1" src="/cms/10.1016/j.cell.2021.11.007/asset/26f89396-4c7a-4ea7-8c0f-cd635f260eb5/main.assets/fx1.jpg" height="375" width="375" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/c32ca761-32c6-4ce1-96e4-ada0ea1f76d7/main.assets/fx1_lrg.jpg" loading="lazy"></a></figure></div></div></section></div></div><div class="core-linked-content"></div><section id="keywords" property="keywords"><h2>Keywords</h2><ol><li><a href="/action/doSearch?AllField=&quot;lung+cancer&quot;" alt="Search on this keyword" rel="nofollow">lung cancer</a></li><li><a href="/action/doSearch?AllField=&quot;neoantigen&quot;" alt="Search on this keyword" rel="nofollow">neoantigen</a></li><li><a href="/action/doSearch?AllField=&quot;T+follicular+helper+cell&quot;" alt="Search on this keyword" rel="nofollow">T follicular helper cell</a></li><li><a href="/action/doSearch?AllField=&quot;B+cell&quot;" alt="Search on this keyword" rel="nofollow">B cell</a></li><li><a href="/action/doSearch?AllField=&quot;IL-21&quot;" alt="Search on this keyword" rel="nofollow">IL-21</a></li><li><a href="/action/doSearch?AllField=&quot;CD8+T+cell&quot;" alt="Search on this keyword" rel="nofollow">CD8 T cell</a></li></ol></section><div class="core-linked-content"></div><div class="core-linked-content"></div><section id="bodymatter" data-extent="bodymatter" property="articleBody" typeof="Text"><div class="core-container"><section id="sec-1"><h2>Introduction</h2><div id="p0035" role="paragraph">Lung cancer is the leading cause of cancer-related mortality worldwide, accounting for ∼1.8 million deaths annually (<span class="dropBlock reference-citations"><a id="body-ref-sref8" href="#" role="doc-biblioref" data-xml-rid="bib8" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref8" aria-controls="sref8">Bray et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">9.</div><div>Bray, F. ∙ Ferlay, J. ∙ Soerjomataram, I. ...</div><div><strong>Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</strong></div><div><em>CA Cancer J. Clin.</em> 2018; <strong>68</strong>:394-424</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=F.BrayJ.FerlayI.SoerjomataramR.L.SiegelL.A.TorreA.JemalGlobal+cancer+statistics+2018%3A+GLOBOCAN+estimates+of+incidence+and+mortality+worldwide+for+36+cancers+in+185+countriesCA+Cancer+J.+Clin.682018394424" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Lung adenocarcinoma (LUAD) is the most common form of non-small cell lung cancer (NSCLC; 40% of cases), and is most frequently associated with mutations in KRAS proto-oncogene (30% of cases) (<span class="dropBlock reference-citations"><a id="body-ref-sref122" href="#" role="doc-biblioref" data-xml-rid="bib122" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref122" aria-controls="sref122">Schabath and Cote, 2019</a><div class="dropBlock__holder" data-db-target-of="sref122"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">123.</div><div>Schabath, M.B. ∙ Cote, M.L.</div><div><strong>Cancer Progress and Priorities: Lung Cancer</strong></div><div><em>Cancer Epidemiol. Biomarkers Prev.</em> 2019; <strong>28</strong>:1563-1579</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.B.SchabathM.L.CoteCancer+Progress+and+Priorities%3A+Lung+CancerCancer+Epidemiol.+Biomarkers+Prev.28201915631579" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Traditionally, therapeutic options for KRAS mutant LUAD have been limited, but the successful application of immune checkpoint blockade (ICB) targeting the PD-1 pathway has changed the therapeutic landscape (<span class="dropBlock reference-citations"><a id="body-ref-sref31" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31" aria-controls="sref31">Ettinger et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref31"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">32.</div><div>Ettinger, D.S. ∙ Wood, D.E. ∙ Aggarwal, C. ..., OCN</div><div><strong>NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020</strong></div><div><em>J.&nbsp;Natl. Compr. Canc. Netw.</em> 2019; <strong>17</strong>:1464-1472</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.S.EttingerD.E.WoodC.AggarwalD.L.AisnerW.AkerleyJ.R.BaumanA.BharatD.S.BrunoJ.Y.ChangL.R.ChirieacOCNNCCN+Guidelines+Insights%3A+Non-Small+Cell+Lung+Cancer%2C+Version+1.2020J.%C2%A0Natl.+Compr.+Canc.+Netw.17201914641472" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref49" href="#" role="doc-biblioref" data-xml-rid="bib49" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref49" aria-controls="sref49">Hanna et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref49"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">50.</div><div>Hanna, N.H. ∙ Schneider, B.J. ∙ Temin, S. ...</div><div><strong>Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update</strong></div><div><em>J.&nbsp;Clin. Oncol.</em> 2020; <strong>38</strong>:1608-1632</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.H.HannaB.J.SchneiderS.TeminS.BakerJr.J.BrahmerP.M.EllisL.E.GasparR.Y.HaddadP.J.HeskethD.JainTherapy+for+Stage+IV+Non-Small-Cell+Lung+Cancer+Without+Driver+Alterations%3A+ASCO+and+OH+%28CCO%29+Joint+Guideline+UpdateJ.%C2%A0Clin.+Oncol.38202016081632" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The success of PD-1-blockade therapy has also changed the perception that LUAD is a non-immunogenic cancer type, because anti-PD-1/PD-L1 treatment potentiates the function of previously activated T&nbsp;cells, suggesting that therapy-responsive LUAD individuals had potent, ongoing anti-tumor immune responses at the time of therapy administration (<span class="dropBlock reference-citations"><a id="body-ref-sref34" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34" aria-controls="sref34">Forde et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref34"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">35.</div><div>Forde, P.M. ∙ Chaft, J.E. ∙ Smith, K.N. ...</div><div><strong>Neoadjuvant PD-1 Blockade in Resectable Lung Cancer</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2018; <strong>378</strong>:1976-1986</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=P.M.FordeJ.E.ChaftK.N.SmithV.AnagnostouT.R.CottrellM.D.HellmannM.ZahurakS.C.YangD.R.JonesS.BroderickNeoadjuvant+PD-1+Blockade+in+Resectable+Lung+CancerN.%C2%A0Engl.+J.+Med.378201819761986" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref41" href="#" role="doc-biblioref" data-xml-rid="bib41" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref41" aria-controls="sref41">Gettinger et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref41"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">42.</div><div>Gettinger, S.N. ∙ Choi, J. ∙ Mani, N. ...</div><div><strong>A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers</strong></div><div><em>Nat. Commun.</em> 2018; <strong>9</strong>:3196</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.N.GettingerJ.ChoiN.ManiM.F.SanmamedI.DatarR.SowellV.Y.DuE.KaftanS.GoldbergW.DongA+dormant+TIL+phenotype+defines+non-small+cell+lung+carcinomas+sensitive+to+immune+checkpoint+blockersNat.+Commun.920183196" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref80" href="#" role="doc-biblioref" data-xml-rid="bib80" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref80" aria-controls="sref80">Lizotte et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref80"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">81.</div><div>Lizotte, P.H. ∙ Ivanova, E.V. ∙ Awad, M.M. ...</div><div><strong>Multiparametric profiling of non-small-cell lung cancers reveals distinct immunophenotypes</strong></div><div><em>JCI Insight.</em> 2016; <strong>1</strong>:e89014</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=P.H.LizotteE.V.IvanovaM.M.AwadR.E.JonesL.KeoghH.LiuR.DriesC.AlmonteG.S.Herter-SprieA.SantosMultiparametric+profiling+of+non-small-cell+lung+cancers+reveals+distinct+immunophenotypesJCI+Insight12016e89014" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref137" href="#" role="doc-biblioref" data-xml-rid="bib137" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref137" aria-controls="sref137">Topalian et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref137"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">138.</div><div>Topalian, S.L. ∙ Hodi, F.S. ∙ Brahmer, J.R. ...</div><div><strong>Safety, activity, and immune correlates of anti-PD-1 antibody in cancer</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2012; <strong>366</strong>:2443-2454</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.L.TopalianF.S.HodiJ.R.BrahmerS.N.GettingerD.C.SmithD.F.McDermottJ.D.PowderlyR.D.CarvajalJ.A.SosmanM.B.AtkinsSafety%2C+activity%2C+and+immune+correlates+of+anti-PD-1+antibody+in+cancerN.%C2%A0Engl.+J.+Med.366201224432454" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Yet, only ∼20% of LUAD individuals benefit from ICB (<span class="dropBlock reference-citations"><a id="body-ref-sref38" href="#" role="doc-biblioref" data-xml-rid="bib38" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref38" aria-controls="sref38">Gandhi et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref38"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Gandhi, L. ∙ Rodríguez-Abreu, D. ∙ Gadgeel, S. ..., KEYNOTE-189 Investigators</div><div><strong>Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2018; <strong>378</strong>:2078-2092</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=L.GandhiD.Rodr%C3%ADguez-AbreuS.GadgeelE.EstebanE.FelipF.De+AngelisM.DomineP.ClinganM.J.HochmairS.F.PowellKEYNOTE-189+InvestigatorsPembrolizumab+plus+Chemotherapy+in+Metastatic+Non-Small-Cell+Lung+CancerN.%C2%A0Engl.+J.+Med.378201820782092" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref53" href="#" role="doc-biblioref" data-xml-rid="bib53" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref53" aria-controls="sref53">Herbst et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref53"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">54.</div><div>Herbst, R.S. ∙ Giaccone, G. ∙ de Marinis, F. ...</div><div><strong>Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2020; <strong>383</strong>:1328-1339</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.S.HerbstG.GiacconeF.de+MarinisN.ReinmuthA.VergnenegreC.H.BarriosM.MoriseE.FelipZ.AndricS.GeaterAtezolizumab+for+First-Line+Treatment+of+PD-L1-Selected+Patients+with+NSCLCN.%C2%A0Engl.+J.+Med.383202013281339" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref112" href="#" role="doc-biblioref" data-xml-rid="bib112" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref112" aria-controls="sref112">Reck et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref112"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">113.</div><div>Reck, M. ∙ Rodríguez-Abreu, D. ∙ Robinson, A.G. ..., KEYNOTE-024 Investigators</div><div><strong>Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2016; <strong>375</strong>:1823-1833</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.ReckD.Rodr%C3%ADguez-AbreuA.G.RobinsonR.HuiT.Cs%C5%91sziA.F%C3%BCl%C3%B6pM.GottfriedN.PeledA.TafreshiS.CuffeKEYNOTE-024+InvestigatorsPembrolizumab+versus+Chemotherapy+for+PD-L1-Positive+Non-Small-Cell+Lung+CancerN.%C2%A0Engl.+J.+Med.375201618231833" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and improving response rates will require a better understanding of the anti-tumor immune response, including how different types of tumor-infiltrating T&nbsp;cells interact with other immune cells and contribute to anti-tumor immunity.</div><div id="p0040" role="paragraph">A growing body of evidence has highlighted the potential importance of CD4&nbsp;T helper (Th) cells and B cells in cancer and immunotherapy (<span class="dropBlock reference-citations"><a id="body-ref-sref2-1" href="#" role="doc-biblioref" data-xml-rid="bib2" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref2-1" aria-controls="sref2-1">Alspach et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref2-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">2.</div><div>Alspach, E. ∙ Lussier, D.M. ∙ Miceli, A.P. ...</div><div><strong>MHC-II neoantigens shape tumour immunity and response to immunotherapy</strong></div><div><em>Nature.</em> 2019; <strong>574</strong>:696-701</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=E.AlspachD.M.LussierA.P.MiceliI.KizhvatovM.DuPageA.M.LuomaW.MengC.F.LichtiE.EsaulovaA.N.VomundMHC-II+neoantigens+shape+tumour+immunity+and+response+to+immunotherapyNature5742019696701" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref7-1" href="#" role="doc-biblioref" data-xml-rid="bib7" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref7-1" aria-controls="sref7-1">Borst et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref7-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">8.</div><div>Borst, J. ∙ Ahrends, T. ∙ Bąbała, N. ...</div><div><strong>CD4<sup>+</sup> T&nbsp;cell help in cancer immunology and immunotherapy</strong></div><div><em>Nat. Rev. Immunol.</em> 2018; <strong>18</strong>:635-647</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.BorstT.AhrendsN.B%C4%85ba%C5%82aC.J.M.MeliefW.Kastenm%C3%BCllerCD4%2B+T%C2%A0cell+help+in+cancer+immunology+and+immunotherapyNat.+Rev.+Immunol.182018635647" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref32" href="#" role="doc-biblioref" data-xml-rid="bib32" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref32" aria-controls="sref32">Ferris et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref32"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">33.</div><div>Ferris, S.T. ∙ Durai, V. ∙ Wu, R. ...</div><div><strong>cDC1 prime and are licensed by CD4<sup>+</sup> T&nbsp;cells to induce anti-tumour immunity</strong></div><div><em>Nature.</em> 2020; <strong>584</strong>:624-629</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.T.FerrisV.DuraiR.WuD.J.TheisenJ.P.WardM.D.BernJ.T.Davidson4thP.BagadiaT.LiuC.G.Brise%C3%B1ocDC1+prime+and+are+licensed+by+CD4%2B+T%C2%A0cells+to+induce+anti-tumour+immunityNature5842020624629" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref51-1" href="#" role="doc-biblioref" data-xml-rid="bib51" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref51-1" aria-controls="sref51-1">Helmink et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref51-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">52.</div><div>Helmink, B.A. ∙ Reddy, S.M. ∙ Gao, J. ...</div><div><strong>B cells and tertiary lymphoid structures promote immunotherapy response</strong></div><div><em>Nature.</em> 2020; <strong>577</strong>:549-555</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=B.A.HelminkS.M.ReddyJ.GaoS.ZhangR.BasarR.ThakurK.YizhakM.Sade-FeldmanJ.BlandoG.HanB+cells+and+tertiary+lymphoid+structures+promote+immunotherapy+responseNature5772020549555" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref138" href="#" role="doc-biblioref" data-xml-rid="bib138" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref138" aria-controls="sref138">Tran et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref138"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">139.</div><div>Tran, E. ∙ Turcotte, S. ∙ Gros, A. ...</div><div><strong>Cancer immunotherapy based on mutation-specific CD4+ T&nbsp;cells in a patient with epithelial cancer</strong></div><div><em>Science.</em> 2014; <strong>344</strong>:641-645</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=E.TranS.TurcotteA.GrosP.F.RobbinsY.C.LuM.E.DudleyJ.R.WunderlichR.P.SomervilleK.HoganC.S.HinrichsCancer+immunotherapy+based+on+mutation-specific+CD4%2B+T%C2%A0cells+in+a+patient+with+epithelial+cancerScience3442014641645" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref150-1" href="#" role="doc-biblioref" data-xml-rid="bib150" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref150-1" aria-controls="sref150-1">Wieland et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref150-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">151.</div><div>Wieland, A. ∙ Patel, M.R. ∙ Cardenas, M.A. ...</div><div><strong>Defining HPV-specific B cell responses in patients with head and neck cancer</strong></div><div><em>Nature.</em> 2021; <strong>597</strong>:274-278</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.WielandM.R.PatelM.A.CardenasC.S.EberhardtW.H.HudsonR.C.ObengC.C.GriffithX.WangZ.G.ChenH.T.KissickDefining+HPV-specific+B+cell+responses+in+patients+with+head+and+neck+cancerNature5972021274278" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Much of the mechanistic research on CD4 T&nbsp;cells has focused on Th1, Th2, and Th17 cells (<span class="dropBlock reference-citations"><a id="body-ref-sref37" href="#" role="doc-biblioref" data-xml-rid="bib37" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref37" aria-controls="sref37">Galon et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref37"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">38.</div><div>Galon, J. ∙ Angell, H.K. ∙ Bedognetti, D. ...</div><div><strong>The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures</strong></div><div><em>Immunity.</em> 2013; <strong>39</strong>:11-26</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.GalonH.K.AngellD.BedognettiF.M.MarincolaThe+continuum+of+cancer+immunosurveillance%3A+prognostic%2C+predictive%2C+and+mechanistic+signaturesImmunity3920131126" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref42-1" href="#" role="doc-biblioref" data-xml-rid="bib42" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref42-1" aria-controls="sref42-1">Goc et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref42-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">43.</div><div>Goc, J. ∙ Germain, C. ∙ Vo-Bourgais, T.K. ...</div><div><strong>Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T&nbsp;cells</strong></div><div><em>Cancer Res.</em> 2014; <strong>74</strong>:705-715</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.GocC.GermainT.K.Vo-BourgaisA.LupoC.KleinS.KnockaertL.de+ChaisemartinH.OuakrimE.BechtM.AlifanoDendritic+cells+in+tumor-associated+tertiary+lymphoid+structures+signal+a+Th1+cytotoxic+immune+contexture+and+license+the+positive+prognostic+value+of+infiltrating+CD8%2B+T%C2%A0cellsCancer+Res.742014705715" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref47-1" href="#" role="doc-biblioref" data-xml-rid="bib47" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref47-1" aria-controls="sref47-1">Guo et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref47-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">48.</div><div>Guo, X. ∙ Zhang, Y. ∙ Zheng, L. ...</div><div><strong>Global characterization of T&nbsp;cells in non-small-cell lung cancer by single-cell sequencing</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:978-985</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=X.GuoY.ZhangL.ZhengC.ZhengJ.SongQ.ZhangB.KangZ.LiuL.JinR.XingGlobal+characterization+of+T%C2%A0cells+in+non-small-cell+lung+cancer+by+single-cell+sequencingNat.+Med.242018978985" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref79" href="#" role="doc-biblioref" data-xml-rid="bib79" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref79" aria-controls="sref79">Liu et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref79"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">80.</div><div>Liu, M. ∙ Kuo, F. ∙ Capistrano, K.J. ...</div><div><strong>TGF-β suppresses type 2 immunity to cancer</strong></div><div><em>Nature.</em> 2020; <strong>587</strong>:115-120</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.LiuF.KuoK.J.CapistranoD.KangB.G.NixonW.ShiC.ChouM.H.DoE.G.StamatiadesS.GaoTGF-%CE%B2+suppresses+type+2+immunity+to+cancerNature5872020115120" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref85" href="#" role="doc-biblioref" data-xml-rid="bib85" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref85" aria-controls="sref85">Martin-Orozco et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref85"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">86.</div><div>Martin-Orozco, N. ∙ Muranski, P. ∙ Chung, Y. ...</div><div><strong>T helper 17 cells promote cytotoxic T&nbsp;cell activation in tumor immunity</strong></div><div><em>Immunity.</em> 2009; <strong>31</strong>:787-798</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.Martin-OrozcoP.MuranskiY.ChungX.O.YangT.YamazakiS.LuP.HwuN.P.RestifoW.W.OverwijkC.DongT+helper+17+cells+promote+cytotoxic+T%C2%A0cell+activation+in+tumor+immunityImmunity312009787798" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref101" href="#" role="doc-biblioref" data-xml-rid="bib101" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref101" aria-controls="sref101">Oh et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref101"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">102.</div><div>Oh, D.Y. ∙ Kwek, S.S. ∙ Raju, S.S. ...</div><div><strong>Intratumoral CD4(+) T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer</strong></div><div><em>Cell.</em> 2020; <strong>181</strong>:1612-1625</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.Y.OhS.S.KwekS.S.RajuT.LiE.McCarthyE.ChowD.AranA.IlanoC.S.PaiC.RancanIntratumoral+CD4%28%2B%29+T+Cells+Mediate+Anti-tumor+Cytotoxicity+in+Human+Bladder+CancerCell181202016121625" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and relatively little is known about the functional role of T follicular helper (TFH) cells in cancer. In non-cancer contexts, TFH cells provide necessary help for B cell maturation and function, and in a wide range of human cancers, the presence of B cells and TFH cells is correlated with prolonged survival and favorable therapeutic responses (<span class="dropBlock reference-citations"><a id="body-ref-sref5-1" href="#" role="doc-biblioref" data-xml-rid="bib5" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref5-1" aria-controls="sref5-1">Bindea et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref5-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">6.</div><div>Bindea, G. ∙ Mlecnik, B. ∙ Tosolini, M. ...</div><div><strong>Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer</strong></div><div><em>Immunity.</em> 2013; <strong>39</strong>:782-795</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.BindeaB.MlecnikM.TosoliniA.KirilovskyM.WaldnerA.C.ObenaufH.AngellT.FredriksenL.LafontaineA.BergerSpatiotemporal+dynamics+of+intratumoral+immune+cells+reveal+the+immune+landscape+in+human+cancerImmunity392013782795" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref12-1" href="#" role="doc-biblioref" data-xml-rid="bib12" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref12-1" aria-controls="sref12-1">Cabrita et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref12-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">13.</div><div>Cabrita, R. ∙ Lauss, M. ∙ Sanna, A. ...</div><div><strong>Tertiary lymphoid structures improve immunotherapy and survival in melanoma</strong></div><div><em>Nature.</em> 2020; <strong>577</strong>:561-565</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.CabritaM.LaussA.SannaM.DoniaM.Skaarup+LarsenS.MitraI.JohanssonB.PhungK.HarbstJ.Vallon-ChristerssonTertiary+lymphoid+structures+improve+immunotherapy+and+survival+in+melanomaNature5772020561565" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref17-1" href="#" role="doc-biblioref" data-xml-rid="bib17" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref17-1" aria-controls="sref17-1">Cillo et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref17-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">18.</div><div>Cillo, A.R. ∙ Kürten, C.H.L. ∙ Tabib, T. ...</div><div><strong>Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer</strong></div><div><em>Immunity.</em> 2020; <strong>52</strong>:183-199.e9</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.R.CilloC.H.L.K%C3%BCrtenT.TabibZ.QiS.OnkarT.WangA.LiuU.DuvvuriS.KimR.J.SooseImmune+Landscape+of+Viral-+and+Carcinogen-Driven+Head+and+Neck+CancerImmunity522020183199.e9" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref39" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39" aria-controls="sref39">Garaud et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref39"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">40.</div><div>Garaud, S. ∙ Buisseret, L. ∙ Solinas, C. ...</div><div><strong>Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer</strong></div><div><em>JCI Insight.</em> 2019; <strong>5</strong>:129641</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.GaraudL.BuisseretC.SolinasC.Gu-TrantienA.de+WindG.Van+den+EyndenC.NaveauxJ.N.LodewyckxA.BoissonH.DuvillierTumor+infiltrating+B-cells+signal+functional+humoral+immune+responses+in+breast+cancerJCI+Insight52019129641" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref40-1" href="#" role="doc-biblioref" data-xml-rid="bib40" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref40-1" aria-controls="sref40-1">Germain et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref40-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">41.</div><div>Germain, C. ∙ Gnjatic, S. ∙ Tamzalit, F. ...</div><div><strong>Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer</strong></div><div><em>Am. J. Respir. Crit. Care Med.</em> 2014; <strong>189</strong>:832-844</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.GermainS.GnjaticF.TamzalitS.KnockaertR.RemarkJ.GocA.LepelleyE.BechtS.KatsahianG.BizouardPresence+of+B+cells+in+tertiary+lymphoid+structures+is+associated+with+a+protective+immunity+in+patients+with+lung+cancerAm.+J.+Respir.+Crit.+Care+Med.1892014832844" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref44" href="#" role="doc-biblioref" data-xml-rid="bib44" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref44" aria-controls="sref44">Griss et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref44"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">45.</div><div>Griss, J. ∙ Bauer, W. ∙ Wagner, C. ...</div><div><strong>B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma</strong></div><div><em>Nat. Commun.</em> 2019; <strong>10</strong>:4186</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.GrissW.BauerC.WagnerM.SimonM.ChenK.Grabmeier-PfistershammerM.Maurer-GranofszkyF.RokaT.PenzC.BockB+cells+sustain+inflammation+and+predict+response+to+immune+checkpoint+blockade+in+human+melanomaNat.+Commun.1020194186" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref45-1" href="#" role="doc-biblioref" data-xml-rid="bib45" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref45-1" aria-controls="sref45-1">Gu-Trantien et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref45-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">46.</div><div>Gu-Trantien, C. ∙ Loi, S. ∙ Garaud, S. ...</div><div><strong>CD4<sup>+</sup> follicular helper T&nbsp;cell infiltration predicts breast cancer survival</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2013; <strong>123</strong>:2873-2892</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.Gu-TrantienS.LoiS.GaraudC.EqueterM.LibinA.de+WindM.RavoetH.Le+BuanecC.SibilleG.Manfouo-FoutsopCD4%2B+follicular+helper+T%C2%A0cell+infiltration+predicts+breast+cancer+survivalJ.%C2%A0Clin.+Invest.123201328732892" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>, <span class="dropBlock reference-citations"><a id="body-ref-sref46-1" href="#" role="doc-biblioref" data-xml-rid="bib46" href-manipulated="true" aria-label="Reference 2017" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref46-1" aria-controls="sref46-1">2017</a><div class="dropBlock__holder" data-db-target-of="sref46-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">47.</div><div>Gu-Trantien, C. ∙ Migliori, E. ∙ Buisseret, L. ...</div><div><strong>CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer</strong></div><div><em>JCI Insight.</em> 2017; <strong>2</strong>:91487</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.Gu-TrantienE.MiglioriL.BuisseretA.de+WindS.Broh%C3%A9eS.GaraudG.No%C3%ABlV.L.Dang+ChiJ.N.LodewyckxC.NaveauxCXCL13-producing+TFH+cells+link+immune+suppression+and+adaptive+memory+in+human+breast+cancerJCI+Insight2201791487" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref51-2" href="#" role="doc-biblioref" data-xml-rid="bib51" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref51-2" aria-controls="sref51-2">Helmink et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref51-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">52.</div><div>Helmink, B.A. ∙ Reddy, S.M. ∙ Gao, J. ...</div><div><strong>B cells and tertiary lymphoid structures promote immunotherapy response</strong></div><div><em>Nature.</em> 2020; <strong>577</strong>:549-555</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=B.A.HelminkS.M.ReddyJ.GaoS.ZhangR.BasarR.ThakurK.YizhakM.Sade-FeldmanJ.BlandoG.HanB+cells+and+tertiary+lymphoid+structures+promote+immunotherapy+responseNature5772020549555" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref52" href="#" role="doc-biblioref" data-xml-rid="bib52" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref52" aria-controls="sref52">Hennequin et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref52"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Hennequin, A. ∙ Derangère, V. ∙ Boidot, R. ...</div><div><strong>Tumor infiltration by Tbet+ effector T&nbsp;cells and CD20+ B cells is associated with survival in gastric cancer patients</strong></div><div><em>OncoImmunology.</em> 2015; <strong>5</strong>:e1054598</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.HennequinV.Derang%C3%A8reR.BoidotL.ApetohJ.VincentD.OrryJ.FraisseS.CauseretF.MartinL.ArnouldTumor+infiltration+by+Tbet%2B+effector+T%C2%A0cells+and+CD20%2B+B+cells+is+associated+with+survival+in+gastric+cancer+patientsOncoImmunology52015e1054598" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref54" href="#" role="doc-biblioref" data-xml-rid="bib54" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref54" aria-controls="sref54">Hollern et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref54"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">55.</div><div>Hollern, D.P. ∙ Xu, N. ∙ Thennavan, A. ...</div><div><strong>B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer</strong></div><div><em>Cell.</em> 2019; <strong>179</strong>:1191-1206.e21</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.P.HollernN.XuA.ThennavanC.GlodowskiS.Garcia-RecioK.R.MottX.HeJ.P.GarayK.Carey-EwendD.MarronB+Cells+and+T+Follicular+Helper+Cells+Mediate+Response+to+Checkpoint+Inhibitors+in+High+Mutation+Burden+Mouse+Models+of+Breast+CancerCell179201911911206.e21" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref69" href="#" role="doc-biblioref" data-xml-rid="bib69" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref69" aria-controls="sref69">Kroeger et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref69"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">70.</div><div>Kroeger, D.R. ∙ Milne, K. ∙ Nelson, B.H.</div><div><strong>Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer</strong></div><div><em>Clin. Cancer Res.</em> 2016; <strong>22</strong>:3005-3015</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.R.KroegerK.MilneB.H.NelsonTumor-Infiltrating+Plasma+Cells+Are+Associated+with+Tertiary+Lymphoid+Structures%2C+Cytolytic+T-Cell+Responses%2C+and+Superior+Prognosis+in+Ovarian+CancerClin.+Cancer+Res.22201630053015" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref81-1" href="#" role="doc-biblioref" data-xml-rid="bib81" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref81-1" aria-controls="sref81-1">Lu et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref81-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">82.</div><div>Lu, Y. ∙ Zhao, Q. ∙ Liao, J.Y. ...</div><div><strong>Complement Signals Determine Opposite Effects of B Cells in Chemotherapy-Induced Immunity</strong></div><div><em>Cell.</em> 2020; <strong>180</strong>:1081-1097.e24</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Y.LuQ.ZhaoJ.Y.LiaoE.SongQ.XiaJ.PanY.LiJ.LiB.ZhouY.YeComplement+Signals+Determine+Opposite+Effects+of+B+Cells+in+Chemotherapy-Induced+ImmunityCell180202010811097.e24" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref105-1" href="#" role="doc-biblioref" data-xml-rid="bib105" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref105-1" aria-controls="sref105-1">Petitprez et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref105-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">106.</div><div>Petitprez, F. ∙ de Reyniès, A. ∙ Keung, E.Z. ...</div><div><strong>B cells are associated with survival and immunotherapy response in sarcoma</strong></div><div><em>Nature.</em> 2020; <strong>577</strong>:556-560</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=F.PetitprezA.de+Reyni%C3%A8sE.Z.KeungT.W.ChenC.M.SunJ.CalderaroY.M.JengL.P.HsiaoL.LacroixA.Bougo%C3%BCinB+cells+are+associated+with+survival+and+immunotherapy+response+in+sarcomaNature5772020556560" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref139" href="#" role="doc-biblioref" data-xml-rid="bib139" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref139" aria-controls="sref139">Truxova et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref139"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">140.</div><div>Truxova, I. ∙ Kasikova, L. ∙ Hensler, M. ...</div><div><strong>Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients</strong></div><div><em>J.&nbsp;Immunother. Cancer.</em> 2018; <strong>6</strong>:139</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=I.TruxovaL.KasikovaM.HenslerP.SkapaJ.LacoL.PecenL.BelicovaI.PraznovecM.J.HalaskaT.BrtnickyMature+dendritic+cells+correlate+with+favorable+immune+infiltrate+and+improved+prognosis+in+ovarian+carcinoma+patientsJ.%C2%A0Immunother.+Cancer62018139" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref150-2" href="#" role="doc-biblioref" data-xml-rid="bib150" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref150-2" aria-controls="sref150-2">Wieland et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref150-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">151.</div><div>Wieland, A. ∙ Patel, M.R. ∙ Cardenas, M.A. ...</div><div><strong>Defining HPV-specific B cell responses in patients with head and neck cancer</strong></div><div><em>Nature.</em> 2021; <strong>597</strong>:274-278</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.WielandM.R.PatelM.A.CardenasC.S.EberhardtW.H.HudsonR.C.ObengC.C.GriffithX.WangZ.G.ChenH.T.KissickDefining+HPV-specific+B+cell+responses+in+patients+with+head+and+neck+cancerNature5972021274278" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). This correlation is especially strong when TFH cells and B cells are located in tumor-associated tertiary lymphoid structures (TLSs), because these structures could facilitate TFH-B cell interactions with subsequent effector functions in tumors (<span class="dropBlock reference-citations"><a id="body-ref-sref110-1" href="#" role="doc-biblioref" data-xml-rid="bib110" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref110-1" aria-controls="sref110-1">Rakaee et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref110-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">111.</div><div>Rakaee, M. ∙ Kilvaer, T.K. ∙ Jamaly, S. ...</div><div><strong>Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer</strong></div><div><em>Br. J. Cancer.</em> 2021; <strong>124</strong>:1680-1689</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.RakaeeT.K.KilvaerS.JamalyT.BergE.E.PaulsenM.BerglundE.RichardsenS.AndersenS.Al-SaadM.PoehlTertiary+lymphoid+structure+score%3A+a+promising+approach+to+refine+the+TNM+staging+in+resected+non-small+cell+lung+cancerBr.+J.+Cancer124202116801689" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref117-1" href="#" role="doc-biblioref" data-xml-rid="bib117" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref117-1" aria-controls="sref117-1">Ruffin et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref117-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">118.</div><div>Ruffin, A.T. ∙ Cillo, A.R. ∙ Tabib, T. ...</div><div><strong>B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma</strong></div><div><em>Nat. Commun.</em> 2021; <strong>12</strong>:3349</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.T.RuffinA.R.CilloT.TabibA.LiuS.OnkarS.R.KunningC.LampenfeldH.I.AtiyaI.AbecassisC.H.L.K%C3%BCrtenB+cell+signatures+and+tertiary+lymphoid+structures+contribute+to+outcome+in+head+and+neck+squamous+cell+carcinomaNat.+Commun.1220213349" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref120-1" href="#" role="doc-biblioref" data-xml-rid="bib120" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref120-1" aria-controls="sref120-1">Sautès-Fridman et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref120-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">121.</div><div>Sautès-Fridman, C. ∙ Lawand, M. ∙ Giraldo, N.A. ...</div><div><strong>Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention</strong></div><div><em>Front. Immunol.</em> 2016; <strong>7</strong>:407</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.Saut%C3%A8s-FridmanM.LawandN.A.GiraldoH.KaplonC.GermainW.H.FridmanM.C.Dieu-NosjeanTertiary+Lymphoid+Structures+in+Cancers%3A+Prognostic+Value%2C+Regulation%2C+and+Manipulation+for+Therapeutic+InterventionFront.+Immunol.72016407" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>, <span class="dropBlock reference-citations"><a id="body-ref-sref121-1" href="#" role="doc-biblioref" data-xml-rid="bib121" href-manipulated="true" aria-label="Reference 2019" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref121-1" aria-controls="sref121-1">2019</a><div class="dropBlock__holder" data-db-target-of="sref121-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">122.</div><div>Sautès-Fridman, C. ∙ Petitprez, F. ∙ Calderaro, J. ...</div><div><strong>Tertiary lymphoid structures in the era of cancer immunotherapy</strong></div><div><em>Nat. Rev. Cancer.</em> 2019; <strong>19</strong>:307-325</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.Saut%C3%A8s-FridmanF.PetitprezJ.CalderaroW.H.FridmanTertiary+lymphoid+structures+in+the+era+of+cancer+immunotherapyNat.+Rev.+Cancer192019307325" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref127" href="#" role="doc-biblioref" data-xml-rid="bib127" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref127" aria-controls="sref127">Sharonov et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref127"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">128.</div><div>Sharonov, G.V. ∙ Serebrovskaya, E.O. ∙ Yuzhakova, D.V. ...</div><div><strong>B cells, plasma cells and antibody repertoires in the tumour microenvironment</strong></div><div><em>Nat. Rev. Immunol.</em> 2020; <strong>20</strong>:294-307</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.V.SharonovE.O.SerebrovskayaD.V.YuzhakovaO.V.BritanovaD.M.ChudakovB+cells%2C+plasma+cells+and+antibody+repertoires+in+the+tumour+microenvironmentNat.+Rev.+Immunol.202020294307" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Yet, the functional importance of tumor-specific TFH cells remains uncertain, as does the importance of their interactions with B cells.</div><div id="p0045" role="paragraph">T cell-B cell interactions are necessary for the proper development and function of TFH cells and germinal center (GC) B cells in infection, vaccine responses, and autoimmune diseases (<span class="dropBlock reference-citations"><a id="body-ref-sref21-1" href="#" role="doc-biblioref" data-xml-rid="bib21" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref21-1" aria-controls="sref21-1">Crotty, 2019</a><div class="dropBlock__holder" data-db-target-of="sref21-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Crotty, S.</div><div><strong>T Follicular Helper Cell Biology: A Decade of Discovery and Diseases</strong></div><div><em>Immunity.</em> 2019; <strong>50</strong>:1132-1148</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.CrottyT+Follicular+Helper+Cell+Biology%3A+A+Decade+of+Discovery+and+DiseasesImmunity50201911321148" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref22" href="#" role="doc-biblioref" data-xml-rid="bib22" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref22" aria-controls="sref22">Cyster and Allen, 2019</a><div class="dropBlock__holder" data-db-target-of="sref22"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">23.</div><div>Cyster, J.G. ∙ Allen, C.D.C.</div><div><strong>B Cell Responses: Cell Interaction Dynamics and Decisions</strong></div><div><em>Cell.</em> 2019; <strong>177</strong>:524-540</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.G.CysterC.D.C.AllenB+Cell+Responses%3A+Cell+Interaction+Dynamics+and+DecisionsCell1772019524540" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In canonical T-dependent immune responses, TFH cell differentiation requires interactions with two types of antigen-presenting cells. Dendritic cells (DCs) prime naive CD4 T&nbsp;cells by providing antigen-MHC class II complexes in concert with co-stimulation, including that delivered by inducible co-stimulator (ICOS) via ICOS ligand (ICOSL) on DCs. These signals, plus cytokines, initiate a transcriptional program driven by the canonical TFH cell transcription factor B cell lymphoma 6 (Bcl-6) and a second transcription factor Achaete-scute complex homolog 2 (Ascl2), leading to downregulation of P-selectin glycoprotein ligand 1 (PSGL1) and upregulation of PD1 and the chemokine receptor CXCR5, because cells acquire the TFH precursor cell phenotype (CD44<sup>hi</sup> PSGL1<sup>lo</sup>) (<span class="dropBlock reference-citations"><a id="body-ref-sref15" href="#" role="doc-biblioref" data-xml-rid="bib15" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref15" aria-controls="sref15">Choi et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref15"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">16.</div><div>Choi, Y.S. ∙ Yang, J.A. ∙ Crotty, S.</div><div><strong>Dynamic regulation of Bcl6 in follicular helper CD4&nbsp;T (Tfh) cells</strong></div><div><em>Curr. Opin. Immunol.</em> 2013; <strong>25</strong>:366-372</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Y.S.ChoiJ.A.YangS.CrottyDynamic+regulation+of+Bcl6+in+follicular+helper+CD4%C2%A0T+%28Tfh%29+cellsCurr.+Opin.+Immunol.252013366372" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref98-1" href="#" role="doc-biblioref" data-xml-rid="bib98" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref98-1" aria-controls="sref98-1">Nurieva et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref98-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">99.</div><div>Nurieva, R.I. ∙ Chung, Y. ∙ Hwang, D. ...</div><div><strong>Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages</strong></div><div><em>Immunity.</em> 2008; <strong>29</strong>:138-149</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.I.NurievaY.ChungD.HwangX.O.YangH.S.KangL.MaY.H.WangS.S.WatowichA.M.JettenQ.TianC.DongGeneration+of+T+follicular+helper+cells+is+mediated+by+interleukin-21+but+independent+of+T+helper+1%2C+2%2C+or+17+cell+lineagesImmunity292008138149" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref109" href="#" role="doc-biblioref" data-xml-rid="bib109" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref109" aria-controls="sref109">Poholek et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref109"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">110.</div><div>Poholek, A.C. ∙ Hansen, K. ∙ Hernandez, S.G. ...</div><div><strong>In&nbsp;vivo regulation of Bcl6 and T follicular helper cell development</strong></div><div><em>J.&nbsp;Immunol.</em> 2010; <strong>185</strong>:313-326</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.C.PoholekK.HansenS.G.HernandezD.EtoA.ChandeleJ.S.WeinsteinX.DongJ.M.OdegardS.M.KaechA.L.DentIn%C2%A0vivo+regulation+of+Bcl6+and+T+follicular+helper+cell+developmentJ.%C2%A0Immunol.1852010313326" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Subsequent interactions with B cells provide additional antigen-MHC II and ICOSL signals and are required for further differentiation into mature TFH cells that are capable of migrating via CXCR5 to, and functioning within, the GC (<span class="dropBlock reference-citations"><a id="body-ref-sref20-1" href="#" role="doc-biblioref" data-xml-rid="bib20" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref20-1" aria-controls="sref20-1">Crotty, 2011</a><div class="dropBlock__holder" data-db-target-of="sref20-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">21.</div><div>Crotty, S.</div><div><strong>Follicular helper CD4 T&nbsp;cells (TFH)</strong></div><div><em>Annu. Rev. Immunol.</em> 2011; <strong>29</strong>:621-663</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.CrottyFollicular+helper+CD4+T%C2%A0cells+%28TFH%29Annu.+Rev.+Immunol.292011621663" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Mature TFH cells (CD44<sup>hi</sup> ICOS<sup>hi</sup> PSGL1<sup>lo</sup> PD1<sup>hi</sup> CXCR5<sup>hi</sup>) provide CD40 ligand (CD40L and CD154) and interleukin-21 (IL-21) to CD40<sup>+</sup> B cells, signals necessary for the differentiation and maturation of GC B cells to memory B cells and long-lived plasma cells (<span class="dropBlock reference-citations"><a id="body-ref-sref28" href="#" role="doc-biblioref" data-xml-rid="bib28" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref28" aria-controls="sref28">Elgueta et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref28"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">29.</div><div>Elgueta, R. ∙ Benson, M.J. ∙ de Vries, V.C. ...</div><div><strong>Molecular mechanism and function of CD40/CD40L engagement in the immune system</strong></div><div><em>Immunol. Rev.</em> 2009; <strong>229</strong>:152-172</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.ElguetaM.J.BensonV.C.de+VriesA.WasiukY.GuoR.J.NoelleMolecular+mechanism+and+function+of+CD40%2FCD40L+engagement+in+the+immune+systemImmunol.+Rev.2292009152172" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref77" href="#" role="doc-biblioref" data-xml-rid="bib77" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref77" aria-controls="sref77">Linterman et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref77"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">78.</div><div>Linterman, M.A. ∙ Beaton, L. ∙ Yu, D. ...</div><div><strong>IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2010; <strong>207</strong>:353-363</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.A.LintermanL.BeatonD.YuR.R.RamiscalM.SrivastavaJ.J.HoganN.K.VermaM.J.SmythR.J.RigbyC.G.VinuesaIL-21+acts+directly+on+B+cells+to+regulate+Bcl-6+expression+and+germinal+center+responsesJ.%C2%A0Exp.+Med.2072010353363" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref162" href="#" role="doc-biblioref" data-xml-rid="bib162" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref162" aria-controls="sref162">Zotos et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref162"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">163.</div><div>Zotos, D. ∙ Coquet, J.M. ∙ Zhang, Y. ...</div><div><strong>IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2010; <strong>207</strong>:365-378</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.ZotosJ.M.CoquetY.ZhangA.LightK.D%E2%80%99CostaA.KalliesL.M.CorcoranD.I.GodfreyK.M.ToellnerM.J.SmythIL-21+regulates+germinal+center+B+cell+differentiation+and+proliferation+through+a+B+cell-intrinsic+mechanismJ.%C2%A0Exp.+Med.2072010365378" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Thus, antigen-engaged, bidirectional TFH-B cell collaboration plays a pivotal role in the initiation and maintenance of robust humoral immune responses (<span class="dropBlock reference-citations"><a id="body-ref-sref88" href="#" role="doc-biblioref" data-xml-rid="bib88" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref88" aria-controls="sref88">Mesin et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref88"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">89.</div><div>Mesin, L. ∙ Ersching, J. ∙ Victora, G.D.</div><div><strong>Germinal Center B Cell Dynamics</strong></div><div><em>Immunity.</em> 2016; <strong>45</strong>:471-482</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=L.MesinJ.ErschingG.D.VictoraGerminal+Center+B+Cell+DynamicsImmunity452016471482" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Yet, the importance of interactions between tumor-specific TFH and B cells has not been studied in cancer. Nor is it clear whether anti-tumor TFH cells provide other functions in cancer beyond B cell help.</div><div id="p0050" role="paragraph">Studies in chronic viral infection and cancer have shown that CD4 T&nbsp;cells are critical to maintain effector CD8 T&nbsp;cell function (<span class="dropBlock reference-citations"><a id="body-ref-sref4" href="#" role="doc-biblioref" data-xml-rid="bib4" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref4" aria-controls="sref4">Battegay et&nbsp;al., 1994</a><div class="dropBlock__holder" data-db-target-of="sref4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">5.</div><div>Battegay, M. ∙ Moskophidis, D. ∙ Rahemtulla, A. ...</div><div><strong>Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice</strong></div><div><em>J.&nbsp;Virol.</em> 1994; <strong>68</strong>:4700-4704</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.BattegayD.MoskophidisA.RahemtullaH.HengartnerT.W.MakR.M.ZinkernagelEnhanced+establishment+of+a+virus+carrier+state+in+adult+CD4%2B+T-cell-deficient+miceJ.%C2%A0Virol.68199447004704" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref7-2" href="#" role="doc-biblioref" data-xml-rid="bib7" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref7-2" aria-controls="sref7-2">Borst et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref7-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">8.</div><div>Borst, J. ∙ Ahrends, T. ∙ Bąbała, N. ...</div><div><strong>CD4<sup>+</sup> T&nbsp;cell help in cancer immunology and immunotherapy</strong></div><div><em>Nat. Rev. Immunol.</em> 2018; <strong>18</strong>:635-647</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.BorstT.AhrendsN.B%C4%85ba%C5%82aC.J.M.MeliefW.Kastenm%C3%BCllerCD4%2B+T%C2%A0cell+help+in+cancer+immunology+and+immunotherapyNat.+Rev.+Immunol.182018635647" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref86" href="#" role="doc-biblioref" data-xml-rid="bib86" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref86" aria-controls="sref86">Matloubian et&nbsp;al., 1994</a><div class="dropBlock__holder" data-db-target-of="sref86"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">87.</div><div>Matloubian, M. ∙ Concepcion, R.J. ∙ Ahmed, R.</div><div><strong>CD4+ T&nbsp;cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection</strong></div><div><em>J.&nbsp;Virol.</em> 1994; <strong>68</strong>:8056-8063</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.MatloubianR.J.ConcepcionR.AhmedCD4%2B+T%C2%A0cells+are+required+to+sustain+CD8%2B+cytotoxic+T-cell+responses+during+chronic+viral+infectionJ.%C2%A0Virol.68199480568063" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref156" href="#" role="doc-biblioref" data-xml-rid="bib156" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref156" aria-controls="sref156">Zajac et&nbsp;al., 1998</a><div class="dropBlock__holder" data-db-target-of="sref156"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">157.</div><div>Zajac, A.J. ∙ Blattman, J.N. ∙ Murali-Krishna, K. ...</div><div><strong>Viral immune evasion due to persistence of activated T&nbsp;cells without effector function</strong></div><div><em>J.&nbsp;Exp. Med.</em> 1998; <strong>188</strong>:2205-2213</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.J.ZajacJ.N.BlattmanK.Murali-KrishnaD.J.SourdiveM.SureshJ.D.AltmanR.AhmedViral+immune+evasion+due+to+persistence+of+activated+T%C2%A0cells+without+effector+functionJ.%C2%A0Exp.+Med.188199822052213" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref158-1" href="#" role="doc-biblioref" data-xml-rid="bib158" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref158-1" aria-controls="sref158-1">Zander et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref158-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">159.</div><div>Zander, R. ∙ Schauder, D. ∙ Xin, G. ...</div><div><strong>CD4<sup>+</sup> T Cell Help Is Required for the Formation of a Cytolytic CD8<sup>+</sup> T Cell Subset that Protects against Chronic Infection and Cancer</strong></div><div><em>Immunity.</em> 2019; <strong>51</strong>:1028-1042.e4</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.ZanderD.SchauderG.XinC.NguyenX.WuA.ZajacW.CuiCD4%2B+T+Cell+Help+Is+Required+for+the+Formation+of+a+Cytolytic+CD8%2B+T+Cell+Subset+that+Protects+against+Chronic+Infection+and+CancerImmunity51201910281042.e4" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), with the latter necessary for viral or tumor control and therapeutic efficacy after ICB (<span class="dropBlock reference-citations"><a id="body-ref-sref35" href="#" role="doc-biblioref" data-xml-rid="bib35" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref35" aria-controls="sref35">Fridman et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref35"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">36.</div><div>Fridman, W.H. ∙ Zitvogel, L. ∙ Sautès-Fridman, C. ...</div><div><strong>The immune contexture in cancer prognosis and treatment</strong></div><div><em>Nat. Rev. Clin. Oncol.</em> 2017; <strong>14</strong>:717-734</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=W.H.FridmanL.ZitvogelC.Saut%C3%A8s-FridmanG.KroemerThe+immune+contexture+in+cancer+prognosis+and+treatmentNat.+Rev.+Clin.+Oncol.142017717734" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref56" href="#" role="doc-biblioref" data-xml-rid="bib56" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref56" aria-controls="sref56">Huang et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref56"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">57.</div><div>Huang, A.C. ∙ Postow, M.A. ∙ Orlowski, R.J. ...</div><div><strong>T-cell invigoration to tumour burden ratio associated with anti-PD-1 response</strong></div><div><em>Nature.</em> 2017; <strong>545</strong>:60-65</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.C.HuangM.A.PostowR.J.OrlowskiR.MickB.BengschS.ManneW.XuS.HarmonJ.R.GilesB.WenzT-cell+invigoration+to+tumour+burden+ratio+associated+with+anti-PD-1+responseNature54520176065" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref141" href="#" role="doc-biblioref" data-xml-rid="bib141" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref141" aria-controls="sref141">van der Leun et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref141"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">142.</div><div>van der Leun, A.M. ∙ Thommen, D.S. ∙ Schumacher, T.N.</div><div><strong>CD8<sup>+</sup> T&nbsp;cell states in human cancer: insights from single-cell analysis</strong></div><div><em>Nat. Rev. Cancer.</em> 2020; <strong>20</strong>:218-232</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.M.van+der+LeunD.S.ThommenT.N.SchumacherCD8%2B+T%C2%A0cell+states+in+human+cancer%3A+insights+from+single-cell+analysisNat.+Rev.+Cancer202020218232" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The mechanisms of how CD4 T&nbsp;cells provide necessary help to CD8 T&nbsp;cells remain uncertain, but one proposal involves CD4 T&nbsp;cells providing IL-21, which drives cytolytic effector CD8 T&nbsp;cell differentiation and prevents T&nbsp;cell exhaustion (<span class="dropBlock reference-citations"><a id="body-ref-sref29-1" href="#" role="doc-biblioref" data-xml-rid="bib29" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref29-1" aria-controls="sref29-1">Elsaesser et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref29-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">30.</div><div>Elsaesser, H. ∙ Sauer, K. ∙ Brooks, D.G.</div><div><strong>IL-21 is required to control chronic viral infection</strong></div><div><em>Science.</em> 2009; <strong>324</strong>:1569-1572</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=H.ElsaesserK.SauerD.G.BrooksIL-21+is+required+to+control+chronic+viral+infectionScience324200915691572" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref36-1" href="#" role="doc-biblioref" data-xml-rid="bib36" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref36-1" aria-controls="sref36-1">Fröhlich et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref36-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">37.</div><div>Fröhlich, A. ∙ Kisielow, J. ∙ Schmitz, I. ...</div><div><strong>IL-21R on T&nbsp;cells is critical for sustained functionality and control of chronic viral infection</strong></div><div><em>Science.</em> 2009; <strong>324</strong>:1576-1580</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.Fr%C3%B6hlichJ.KisielowI.SchmitzS.FreigangA.T.ShamshievJ.WeberB.J.MarslandA.OxeniusM.KopfIL-21R+on+T%C2%A0cells+is+critical+for+sustained+functionality+and+control+of+chronic+viral+infectionScience324200915761580" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref113-1" href="#" role="doc-biblioref" data-xml-rid="bib113" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref113-1" aria-controls="sref113-1">Ren et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref113-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">114.</div><div>Ren, H.M. ∙ Kolawole, E.M. ∙ Ren, M. ...</div><div><strong>IL-21 from high-affinity CD4 T&nbsp;cells drives differentiation of brain-resident CD8 T&nbsp;cells during persistent viral infection</strong></div><div><em>Sci. Immunol.</em> 2020; <strong>5</strong>:eabb5590</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=H.M.RenE.M.KolawoleM.RenG.JinC.S.Netherby-WinslowQ.WadeShwetankZ.S.M.RahmanB.D.EvavoldA.E.LukacherIL-21+from+high-affinity+CD4+T%C2%A0cells+drives+differentiation+of+brain-resident+CD8+T%C2%A0cells+during+persistent+viral+infectionSci.+Immunol.52020eabb5590" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref131-1" href="#" role="doc-biblioref" data-xml-rid="bib131" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref131-1" aria-controls="sref131-1">Snell et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref131-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">132.</div><div>Snell, L.M. ∙ MacLeod, B.L. ∙ Law, J.C. ...</div><div><strong>CD8<sup>+</sup> T Cell Priming in Established Chronic Viral Infection Preferentially Directs Differentiation of Memory-like Cells for Sustained Immunity</strong></div><div><em>Immunity.</em> 2018; <strong>49</strong>:678-694.e5</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=L.M.SnellB.L.MacLeodJ.C.LawI.OsokineH.J.ElsaesserK.HezavehR.J.DicksonM.A.GavinC.J.GuidosT.L.McGahaD.G.BrooksCD8%2B+T+Cell+Priming+in+Established+Chronic+Viral+Infection+Preferentially+Directs+Differentiation+of+Memory-like+Cells+for+Sustained+ImmunityImmunity492018678694.e5" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref151-1" href="#" role="doc-biblioref" data-xml-rid="bib151" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref151-1" aria-controls="sref151-1">Xin et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref151-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">152.</div><div>Xin, G. ∙ Schauder, D.M. ∙ Lainez, B. ...</div><div><strong>A Critical Role of IL-21-Induced BATF in Sustaining CD8-T-Cell-Mediated Chronic Viral Control</strong></div><div><em>Cell Rep.</em> 2015; <strong>13</strong>:1118-1124</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.XinD.M.SchauderB.LainezJ.S.WeinsteinZ.DaiY.ChenE.EspluguesR.WenD.WangI.A.ParishA+Critical+Role+of+IL-21-Induced+BATF+in+Sustaining+CD8-T-Cell-Mediated+Chronic+Viral+ControlCell+Rep.13201511181124" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref154-1" href="#" role="doc-biblioref" data-xml-rid="bib154" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref154-1" aria-controls="sref154-1">Yi et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref154-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">155.</div><div>Yi, J.S. ∙ Du, M. ∙ Zajac, A.J.</div><div><strong>A vital role for interleukin-21 in the control of a chronic viral infection</strong></div><div><em>Science.</em> 2009; <strong>324</strong>:1572-1576</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.S.YiM.DuA.J.ZajacA+vital+role+for+interleukin-21+in+the+control+of+a+chronic+viral+infectionScience324200915721576" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). IL-21 is the signature cytokine of TFH cells, although natural killer T (NKT) and Th17 cells can also produce it under certain conditions (<span class="dropBlock reference-citations"><a id="body-ref-sref16" href="#" role="doc-biblioref" data-xml-rid="bib16" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref16" aria-controls="sref16">Chtanova et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref16"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">17.</div><div>Chtanova, T. ∙ Tangye, S.G. ∙ Newton, R. ...</div><div><strong>T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells</strong></div><div><em>J.&nbsp;Immunol.</em> 2004; <strong>173</strong>:68-78</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=T.ChtanovaS.G.TangyeR.NewtonN.FrankM.R.HodgeM.S.RolphC.R.MackayT+follicular+helper+cells+express+a+distinctive+transcriptional+profile%2C+reflecting+their+role+as+non-Th1%2FTh2+effector+cells+that+provide+help+for+B+cellsJ.%C2%A0Immunol.17320046878" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref19" href="#" role="doc-biblioref" data-xml-rid="bib19" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref19" aria-controls="sref19">Coquet et&nbsp;al., 2007</a><div class="dropBlock__holder" data-db-target-of="sref19"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">20.</div><div>Coquet, J.M. ∙ Kyparissoudis, K. ∙ Pellicci, D.G. ...</div><div><strong>IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production</strong></div><div><em>J.&nbsp;Immunol.</em> 2007; <strong>178</strong>:2827-2834</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.M.CoquetK.KyparissoudisD.G.PellicciG.BesraS.P.BerzinsM.J.SmythD.I.GodfreyIL-21+is+produced+by+NKT+cells+and+modulates+NKT+cell+activation+and+cytokine+productionJ.%C2%A0Immunol.178200728272834" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref20-2" href="#" role="doc-biblioref" data-xml-rid="bib20" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref20-2" aria-controls="sref20-2">Crotty, 2011</a><div class="dropBlock__holder" data-db-target-of="sref20-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">21.</div><div>Crotty, S.</div><div><strong>Follicular helper CD4 T&nbsp;cells (TFH)</strong></div><div><em>Annu. Rev. Immunol.</em> 2011; <strong>29</strong>:621-663</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.CrottyFollicular+helper+CD4+T%C2%A0cells+%28TFH%29Annu.+Rev.+Immunol.292011621663" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref67" href="#" role="doc-biblioref" data-xml-rid="bib67" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref67" aria-controls="sref67">Korn et&nbsp;al., 2007</a><div class="dropBlock__holder" data-db-target-of="sref67"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">68.</div><div>Korn, T. ∙ Bettelli, E. ∙ Gao, W. ...</div><div><strong>IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells</strong></div><div><em>Nature.</em> 2007; <strong>448</strong>:484-487</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=T.KornE.BettelliW.GaoA.AwasthiA.J%C3%A4gerT.B.StromM.OukkaV.K.KuchrooIL-21+initiates+an+alternative+pathway+to+induce+proinflammatory+T%28H%2917+cellsNature4482007484487" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref97" href="#" role="doc-biblioref" data-xml-rid="bib97" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref97" aria-controls="sref97">Nurieva et&nbsp;al., 2007</a><div class="dropBlock__holder" data-db-target-of="sref97"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">98.</div><div>Nurieva, R. ∙ Yang, X.O. ∙ Martinez, G. ...</div><div><strong>Essential autocrine regulation by IL-21 in the generation of inflammatory T&nbsp;cells</strong></div><div><em>Nature.</em> 2007; <strong>448</strong>:480-483</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.NurievaX.O.YangG.MartinezY.ZhangA.D.PanopoulosL.MaK.SchlunsQ.TianS.S.WatowichA.M.JettenC.DongEssential+autocrine+regulation+by+IL-21+in+the+generation+of+inflammatory+T%C2%A0cellsNature4482007480483" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref134" href="#" role="doc-biblioref" data-xml-rid="bib134" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref134" aria-controls="sref134">Suto et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref134"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">135.</div><div>Suto, A. ∙ Kashiwakuma, D. ∙ Kagami, S. ...</div><div><strong>Development and characterization of IL-21-producing CD4+ T&nbsp;cells</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2008; <strong>205</strong>:1369-1379</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.SutoD.KashiwakumaS.KagamiK.HiroseN.WatanabeK.YokoteY.SaitoT.NakayamaM.J.GrusbyI.IwamotoH.NakajimaDevelopment+and+characterization+of+IL-21-producing+CD4%2B+T%C2%A0cellsJ.%C2%A0Exp.+Med.205200813691379" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref146" href="#" role="doc-biblioref" data-xml-rid="bib146" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref146" aria-controls="sref146">Wei et&nbsp;al., 2007</a><div class="dropBlock__holder" data-db-target-of="sref146"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">147.</div><div>Wei, L. ∙ Laurence, A. ∙ Elias, K.M. ...</div><div><strong>IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2007; <strong>282</strong>:34605-34610</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=L.WeiA.LaurenceK.M.EliasJ.J.O%E2%80%99SheaIL-21+is+produced+by+Th17+cells+and+drives+IL-17+production+in+a+STAT3-dependent+mannerJ.%C2%A0Biol.+Chem.28220073460534610" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The cellular resources of IL-21 in chronic infection and cancer are still not well characterized.</div><div id="p0055" role="paragraph">Given their potential importance in anti-tumor immunity, we studied the function of tumor-specific TFH cells in lung cancer and determined how their interactions with tumor-specific B cells and CD8 T&nbsp;cells impacted the anti-tumor immune responses.</div></section><section id="sec-2"><h2>Results</h2><section id="sec-2-1"><h3>GC B cells and TFH cells correlate with favorable clinical outcomes in LUAD individuals</h3><div id="p0060" role="paragraph">To investigate the potential importance of GC B cells and TFH cells in human LUAD, we first analyzed RNA sequencing data from 513 LUAD samples in The Cancer Genome Atlas (TCGA) database using CIBERSORT and LM22-referenced single-cell gene expression profile matrix (<span class="dropBlock reference-citations"><a id="body-ref-sref95-1" href="#" role="doc-biblioref" data-xml-rid="bib95" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref95-1" aria-controls="sref95-1">Newman et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref95-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">96.</div><div>Newman, A.M. ∙ Liu, C.L. ∙ Green, M.R. ...</div><div><strong>Robust enumeration of cell subsets from tissue expression profiles</strong></div><div><em>Nat. Methods.</em> 2015; <strong>12</strong>:453-457</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.M.NewmanC.L.LiuM.R.GreenA.J.GentlesW.FengY.XuC.D.HoangM.DiehnA.A.AlizadehRobust+enumeration+of+cell+subsets+from+tissue+expression+profilesNat.+Methods122015453457" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We found that several immune cell types were enriched, including myeloid populations and CD8 T&nbsp;cells (<a id="crosref0500" href="#fig1">Figure&nbsp;1</a>A), whereas B cell lineage and CD4 T&nbsp;cells were the first and third most abundant immune cell types, respectively (<a id="crosref0505" href="#fig1">Figure&nbsp;1</a>A). Although the LM22 matrix does not distinguish GC B cells, the algorithm suggested that TFH cells and activated memory CD4 T&nbsp;cells comprised a large proportion of the CD4 T&nbsp;cells in tumors (<a id="crosref0510" href="#figs1">Figure&nbsp;S1</a>A). To more specifically delineate which types of CD4&nbsp;T and B cells were present in LUAD, we analyzed published single-cell RNA sequencing data from a study that included 44 individual samples of treatment-naive LUAD from surgical resection or endobronchial ultrasound bronchoscopy biopsy (GSE131907) (<span class="dropBlock reference-citations"><a id="body-ref-sref65-1" href="#" role="doc-biblioref" data-xml-rid="bib65" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref65-1" aria-controls="sref65-1">Kim et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref65-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">66.</div><div>Kim, N. ∙ Kim, H.K. ∙ Lee, K. ...</div><div><strong>Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma</strong></div><div><em>Nat. Commun.</em> 2020; <strong>11</strong>:2285</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.KimH.K.KimK.LeeY.HongJ.H.ChoJ.W.ChoiJ.I.LeeY.L.SuhB.M.KuH.H.EumSingle-cell+RNA+sequencing+demonstrates+the+molecular+and+cellular+reprogramming+of+metastatic+lung+adenocarcinomaNat.+Commun.1120202285" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We cataloged 49,901 T/NK cells and 22,592 B cells from primary tumors (tLung), metastatic lymph nodes (mLN), normal lung tissues (nLung), and normal lymph nodes (nLN) based on their previous annotations. T/NK cells were grouped into 15 clusters and visualized by dimension reduction method uniform manifold approximation and projection (UMAP) (<a id="crosref0520" href="#fig1">Figure&nbsp;1</a>B). Eight clusters were distinguished as CD4 T&nbsp;cells, two of which displayed enrichment of TFH signature genes. Notably, both TFH-like clusters (cluster 14 and 10) had higher expression of the TFH signature cytokine IL-21 (arrow) and were more prominent in tLung than nLung (<a id="crosref0525" href="#fig1">Figure&nbsp;1</a>D). Likewise, from nine B cell clusters, we identified one GC B cell cluster (cluster 5) and two antibody-secreting cell (ASC) clusters (clusters 4 and 6), both of which were enriched in tLung, compared with nLung (<a id="crosref0530" href="#fig1">Figures 1</a>C and 1E; note, cluster numbers in <a id="crosref0535" href="#fig1">1</a>C and 1E do not correspond with those in <a id="crosref0540" href="#fig1">1</a>B and 1D). These data suggested that TFH and GC B cells are enriched in human LUAD tumor tissues.</div><div class="figure-wrap"><figure id="fig1" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.007/asset/bad149f1-339d-4a06-bd02-227f3645af24/main.assets/gr1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr1" src="/cms/10.1016/j.cell.2021.11.007/asset/6b64ef04-6763-4ac0-a8a6-24413285ba87/main.assets/gr1.jpg" height="808" width="750" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/bad149f1-339d-4a06-bd02-227f3645af24/main.assets/gr1_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig1-title" class="figure__title"><span class="label figure__label">Figure&nbsp;1</span> <span class="figure__title__text">GC B cells and TFH cells correlate with favorable clinical outcomes in LUAD individuals</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig1-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0015" role="paragraph">(A) Estimated fractions of immune cell subsets from bulk expression data of primary tumor tissues in TCGA-LUAD individual cohort (n&nbsp;= 513). CIBERSORT algorithm was used for deconvolution.</div><div id="fspara0020" role="paragraph">(B–E) Single cell RNA sequencing (scRNA-seq) analyses (GSE131907) (<span class="dropBlock reference-citations"><a id="body-ref-sref65-2" href="#" role="doc-biblioref" data-xml-rid="bib65" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref65-2" aria-controls="sref65-2">Kim et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref65-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">66.</div><div>Kim, N. ∙ Kim, H.K. ∙ Lee, K. ...</div><div><strong>Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma</strong></div><div><em>Nat. Commun.</em> 2020; <strong>11</strong>:2285</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.KimH.K.KimK.LeeY.HongJ.H.ChoJ.W.ChoiJ.I.LeeY.L.SuhB.M.KuH.H.EumSingle-cell+RNA+sequencing+demonstrates+the+molecular+and+cellular+reprogramming+of+metastatic+lung+adenocarcinomaNat.+Commun.1120202285" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) of T/NK and B cell clusters in treatment-naive human LUAD samples from primary sites (tLung), metastatic LNs (mLN), normal lung tissues (nLung), and normal LNs (nLN).</div><div id="fspara0025" role="paragraph">(B and C) UMAP displaying T/NK (B) and B cell clusters (C).</div><div id="fspara0030" role="paragraph">(D and E) Bar graphs displaying tissue origins (top) and heatmaps (bottom) showing relative abundance of signature genes in CD4 T&nbsp;cell (D) and B cell clusters (E).</div><div id="fspara0035" role="paragraph">(F and G) Survival analyses based on GC B cell signature (F) and TFH signature (G) in TCGA-LUAD individual cohort (n&nbsp;= 478). Log-rank Mantel-Cox test.</div><div id="fspara0040" role="paragraph">(H) Correlation analyses on GC B cell signature and TFH signature in TCGA-LUAD cohort. Two-tailed Pearson correlation test.</div><div id="fspara0045" role="paragraph">(I) Heatmap showing R values for the correlations among expression signatures of GC B cells, TFH, Th1, CD8 effector cells, Th17, and NK cells in TCGA-LUAD cohort. Two-tailed Pearson correlation test.</div><div id="fspara0050" role="paragraph">See also <a id="crosref1865" href="#figs1">Figure&nbsp;S1</a> and <a id="crosref1870" href="#mmc1">Table S1</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs1" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.007/asset/cd8369e7-5756-44ee-b7e5-b56fd76e43a8/main.assets/figs1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs1" src="/cms/10.1016/j.cell.2021.11.007/asset/84354a04-8ab0-4fa5-b9a7-4096a3ac2db3/main.assets/figs1.jpg" height="429" width="753" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/cd8369e7-5756-44ee-b7e5-b56fd76e43a8/main.assets/figs1_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs1-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S1</span> <span class="figure__title__text">Analyses of CD4 T&nbsp;cells and B cells in LUAD samples from TCGA, related to <a id="crosref1925" href="#fig1">Figure&nbsp;1</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs1-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0285" role="paragraph">A, Estimated fractions of subtypes in CD4 T&nbsp;cells and B cell lineage described in <a id="crosref1930" href="#fig1">Figure&nbsp;1</a>A, from CIBERSORT analyses of TCGA-LUAD samples (n&nbsp;= 513).</div><div id="fspara0290" role="paragraph">B, Survival analyses based on expression signatures of Th1, effector CD8 T&nbsp;cells, Th17, NK cells in TCGA-LUAD patient cohort (n&nbsp;= 478).</div><div id="fspara0295" role="paragraph">C, Correlation analyses among expression signatures of GC B cells, TFH, Th1, CD8 effector cells, Th17, NK cells in lung adenocarcinoma patients.</div><div id="fspara0300" role="paragraph">B, log-rank Mantel-Cox test. C, two-tailed Pearson correlation test.</div></div></div></div></figcaption></figure></div><div id="p0065" role="paragraph">To examine whether GC B cells and TFH cells associate with clinical outcomes of LUAD individuals, we established gene expression signatures for LUAD GC B cells and TFH cells. Analysis of 478 LUAD cases from TCGA showed significant correlations between prolonged overall survival in LUAD individuals and GC B cell or TFH signatures (<a id="crosref0545" href="#fig1">Figures 1</a>F and 1G, respectively). By contrast, Th1, Th17, or NK cell signatures did not correlate with overall survival, and effector CD8 T&nbsp;cell signature correlated with slightly increased early survival benefits (<a id="crosref0550" href="#figs1">Figure&nbsp;S1</a>B). We also identified a significant correlation between the GC B cell and TFH signatures (R&nbsp;= 0.84, p&nbsp;&lt; 0.0001), which suggested the co-existence of these two cell types in tumors (<a id="crosref0555" href="#fig1">Figure&nbsp;1</a>H). GC B cell and TFH signatures were also correlated with Th1 and CD8 effector T&nbsp;cell signatures (<a id="crosref0560" href="#fig1">Figures 1</a>I and <a id="crosref0565" href="#figs1">S1</a>C). The correlation of TFH and Th1 signatures was predicted, because these cell types likely share a common developmental origin (<span class="dropBlock reference-citations"><a id="body-ref-sref94" href="#" role="doc-biblioref" data-xml-rid="bib94" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref94" aria-controls="sref94">Nakayamada et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref94"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">95.</div><div>Nakayamada, S. ∙ Kanno, Y. ∙ Takahashi, H. ...</div><div><strong>Early Th1 cell differentiation is marked by a Tfh cell-like transition</strong></div><div><em>Immunity.</em> 2011; <strong>35</strong>:919-931</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.NakayamadaY.KannoH.TakahashiD.JankovicK.T.LuT.A.JohnsonH.W.SunG.VahediO.HakimR.HandonEarly+Th1+cell+differentiation+is+marked+by+a+Tfh+cell-like+transitionImmunity352011919931" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref100" href="#" role="doc-biblioref" data-xml-rid="bib100" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref100" aria-controls="sref100">O’Shea and Paul, 2010</a><div class="dropBlock__holder" data-db-target-of="sref100"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">101.</div><div>O’Shea, J.J. ∙ Paul, W.E.</div><div><strong>Mechanisms underlying lineage commitment and plasticity of helper CD4+ T&nbsp;cells</strong></div><div><em>Science.</em> 2010; <strong>327</strong>:1098-1102</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.J.O%E2%80%99SheaW.E.PaulMechanisms+underlying+lineage+commitment+and+plasticity+of+helper+CD4%2B+T%C2%A0cellsScience327201010981102" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). However, correlations between the signatures of GC B cells, TFH cells, and CD8 T&nbsp;cells were intriguing because they suggested potential connections between these three immune cell types. By contrast, neither the GC B cell nor TFH signatures were correlated with the signatures for Th17 cells or NK cells. Together, these data suggested that GC B cells and TFH cells are present in human lung cancer and contribute to anti-tumor immune responses.</div></section><section id="sec-2-2"><h3>TFH cells are enriched in murine cancer model</h3><div id="p0070" role="paragraph">Next, we studied whether TFH cells were enriched in the context of murine LUAD. For this, we used a LUAD cell line made from syngeneic Kras<sup>LSL-G12D</sup>; Trp53<sup>fl/fl</sup> (KP) mice (<span class="dropBlock reference-citations"><a id="body-ref-sref23-1" href="#" role="doc-biblioref" data-xml-rid="bib23" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref23-1" aria-controls="sref23-1">Damo et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref23-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">24.</div><div>Damo, M. ∙ Fitzgerald, B. ∙ Lu, Y. ...</div><div><strong>Inducible de novo expression of neoantigens in tumor cells and mice</strong></div><div><em>Nat. Biotechnol.</em> 2021; <strong>39</strong>:64-73</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.DamoB.FitzgeraldY.LuM.NaderI.WilliamJ.F.CheungK.A.ConnollyG.G.FosterE.Akama-GarrenD.Y.LeeInducible+de+novo+expression+of+neoantigens+in+tumor+cells+and+miceNat.+Biotechnol.3920216473" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We subcutaneously (s.c.) implanted 2&nbsp;× 10<sup>5</sup> KP cells into C57BL/6 (B6) recipients. As positive controls, we s.c. implanted MC38 or B16-F10, which have been previously shown to elicit TFH responses <i>in&nbsp;vivo</i> (<span class="dropBlock reference-citations"><a id="body-ref-sref3" href="#" role="doc-biblioref" data-xml-rid="bib3" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref3" aria-controls="sref3">Alvarez Arias et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">3.</div><div>Alvarez Arias, D.A. ∙ Kim, H.J. ∙ Zhou, P. ...</div><div><strong>Disruption of CD8+ Treg activity results in expansion of T follicular helper cells and enhanced antitumor immunity</strong></div><div><em>Cancer Immunol. Res.</em> 2014; <strong>2</strong>:207-216</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.A.Alvarez+AriasH.J.KimP.ZhouT.A.HolderriedX.WangG.DranoffH.CantorDisruption+of+CD8%2B+Treg+activity+results+in+expansion+of+T+follicular+helper+cells+and+enhanced+antitumor+immunityCancer+Immunol.+Res.22014207216" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref5-2" href="#" role="doc-biblioref" data-xml-rid="bib5" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref5-2" aria-controls="sref5-2">Bindea et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref5-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">6.</div><div>Bindea, G. ∙ Mlecnik, B. ∙ Tosolini, M. ...</div><div><strong>Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer</strong></div><div><em>Immunity.</em> 2013; <strong>39</strong>:782-795</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.BindeaB.MlecnikM.TosoliniA.KirilovskyM.WaldnerA.C.ObenaufH.AngellT.FredriksenL.LafontaineA.BergerSpatiotemporal+dynamics+of+intratumoral+immune+cells+reveal+the+immune+landscape+in+human+cancerImmunity392013782795" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref82" href="#" role="doc-biblioref" data-xml-rid="bib82" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref82" aria-controls="sref82">Magen et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref82"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">83.</div><div>Magen, A. ∙ Nie, J. ∙ Ciucci, T. ...</div><div><strong>Single-Cell Profiling Defines Transcriptomic Signatures Specific to Tumor-Reactive versus Virus-Responsive CD4<sup>+</sup> T Cells</strong></div><div><em>Cell Rep.</em> 2019; <strong>29</strong>:3019-3032.e6</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.MagenJ.NieT.CiucciS.TamoutounourY.ZhaoM.MehtaB.TranD.B.McGavernS.HannenhalliR.BosselutSingle-Cell+Profiling+Defines+Transcriptomic+Signatures+Specific+to+Tumor-Reactive+versus+Virus-Responsive+CD4%2B+T+CellsCell+Rep.29201930193032.e6" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref115" href="#" role="doc-biblioref" data-xml-rid="bib115" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref115" aria-controls="sref115">Roberti et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref115"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">116.</div><div>Roberti, M.P. ∙ Yonekura, S. ∙ Duong, C.P.M. ...</div><div><strong>Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer</strong></div><div><em>Nat. Med.</em> 2020; <strong>26</strong>:919-931</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.P.RobertiS.YonekuraC.P.M.DuongM.PicardG.FerrereM.Tidjani+AlouC.RauberV.IebbaC.H.K.LehmannL.AmonChemotherapy-induced+ileal+crypt+apoptosis+and+the+ileal+microbiome+shape+immunosurveillance+and+prognosis+of+proximal+colon+cancerNat.+Med.262020919931" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). After 10–12&nbsp;days, we analyzed TFH cells in tumor-draining LNs (dLNs) by flow cytometry. Consistent with a progressive development of CD4 T&nbsp;cell responses, we observed ∼3-fold increases in CD44<sup>hi</sup> PSGL1<sup>lo</sup> CD4 T&nbsp;cells in MC38 and B16-F10 tumor-bearing mice, compared to non-tumor bearing controls, and ∼11% of these PSGL1<sup>lo</sup> cells further displayed upregulated CXCR5 and PD-1, indicating development into mature TFH cells (<a id="crosref0605" href="#figs2">Figure&nbsp;S2</a>A) (<span class="dropBlock reference-citations"><a id="body-ref-sref148-1" href="#" role="doc-biblioref" data-xml-rid="bib148" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref148-1" aria-controls="sref148-1">Weinstein et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref148-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">149.</div><div>Weinstein, J.S. ∙ Laidlaw, B.J. ∙ Lu, Y. ...</div><div><strong>STAT4 and T-bet control follicular helper T&nbsp;cell development in viral infections</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2018; <strong>215</strong>:337-355</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.S.WeinsteinB.J.LaidlawY.LuJ.K.WangV.P.SchulzN.LiE.I.HermanS.M.KaechP.G.GallagherJ.CraftSTAT4+and+T-bet+control+follicular+helper+T%C2%A0cell+development+in+viral+infectionsJ.%C2%A0Exp.+Med.2152018337355" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). By contrast, only an ∼1.5-fold increase of CD44<sup>hi</sup> PSGL1<sup>lo</sup> CD4 T&nbsp;cells was observed in KP tumor-bearing mice, with TFH cells comprising ∼4% of these (<a id="crosref0615" href="#fig2">Figure&nbsp;2</a>D).</div><div class="figure-wrap"><figure id="fig2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.007/asset/9d5209a0-fea8-4983-8016-6bcde576814f/main.assets/gr2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr2" src="/cms/10.1016/j.cell.2021.11.007/asset/ac44ffbb-425b-4502-a610-ad1fdee34644/main.assets/gr2.jpg" height="804" width="661" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/9d5209a0-fea8-4983-8016-6bcde576814f/main.assets/gr2_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig2-title" class="figure__title"><span class="label figure__label">Figure&nbsp;2</span> <span class="figure__title__text">KP-HELLO tumor cells elicit tumor-specific CD4 T&nbsp;cell and B cell responses</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig2-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0060" role="paragraph">(A) KP-HELLO model design.</div><div id="fspara0065" role="paragraph">(B) CD86 expression (median fluorescence intensity [MFI]) on MD4 or C57BL/6 B cells (CD19<sup>+</sup> B220<sup>+</sup> TCRb<sup>−</sup>) after 48-h co-culture with KP or KP-HELLO supernatant or 500&nbsp;ng/mL HEL.</div><div id="fspara0070" role="paragraph">(C) CD44<sup>hi</sup> CD69<sup>hi</sup> frequency in SMARTA CD4 T&nbsp;cells, after 48-h co-culture with MD4 or C57BL/6 B cells, and KP or KP-HELLO supernatant, 500&nbsp;ng/mL HEL or 5&nbsp;μg/mL GP<sub>61–80</sub>.</div><div id="fspara0075" role="paragraph">(D and E) Representative flow plots (D) and frequency (E) of polyclonal CD4 TFH cells from tumor-draining LNs (dLNs) of KP or KP-HELLO tumor-bearing C57BL/6 mice.</div><div id="fspara0080" role="paragraph">(F and G) Representative flow plots (F) and frequency (G) of I-A<sup>b</sup>/GP<sub>66–77</sub>-specific (GP66-specific) CD4 TFH cells from dLNs of KP-NINJA or KP-HELLO tumor-bearing C57BL/6 mice.</div><div id="fspara0085" role="paragraph">(H and I) Representative flow plots (H) and frequency (I) of GC B cells from dLNs of KP-NINJA or KP-HELLO tumor-bearing C57BL/6 mice. No tumor C57BL/6 mice were used as negative controls.</div><div id="fspara0090" role="paragraph">Data (mean ± SD) were pooled, from 2–5 mice/group/experiment, and representative of at least 2 independent experiments. LN tissues were harvested on day 10–12. (B, C, E, G, and I) Unpaired t test with Welch’s correction. <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001.</div><div id="fspara0095" role="paragraph">See also <a id="crosref1990" href="#figs2">Figures S2</a>, <a id="crosref1995" href="#figs3">S3</a>, <a id="crosref2000" href="#figs4">S4</a>, and <a id="crosref2005" href="#figs6">S6</a> and <a id="crosref1875" href="#mmc2">Tables S2</a> and <a id="crosref1880" href="#mmc3">S3</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.007/asset/e7014dc2-c928-4f92-a801-4e3003eb3c89/main.assets/figs2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs2" src="/cms/10.1016/j.cell.2021.11.007/asset/9d9b3d4b-f5c8-4e9f-b1a9-ff8d6f27da6c/main.assets/figs2.jpg" height="269" width="499" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/e7014dc2-c928-4f92-a801-4e3003eb3c89/main.assets/figs2_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs2-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S2</span> <span class="figure__title__text">TFH cell responses in murine tumor models, related to <a id="crosref1935" href="#fig2">Figure&nbsp;2</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs2-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0310" role="paragraph">A, Representative flow plots showing TFH gating in tumor-draining LNs (dLNs) of MC38 or B16-F10 tumor-bearing C57BL/6 mice (pre-gated on TCRb<sup>+</sup> CD4). Flow cytometric analyses were performed on day 10 – 12. Data (mean ± SD) represented 4 – 5 mice/group.</div><div id="fspara0315" role="paragraph">B, Tumor growth curves: C57BL/6, RAG1 KO, CIITA KO and uMT mice were s.c. implanted with 2&nbsp;× 10<sup>5</sup> KP. Data (mean ± SD) were pooled, from 3 – 10 mice/group/experiment, and representative of at least 2 independent experiments. Two-way ANOVA. <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001.</div></div></div></div></figcaption></figure></div></section><section id="sec-2-3"><h3>Engineering KP cell lines to elicit antigen-specific T&nbsp;cell and B cell responses</h3><div id="p0075" role="paragraph">KP cell lines are notable in that they have low numbers of somatic mutations (<span class="dropBlock reference-citations"><a id="body-ref-sref27-1" href="#" role="doc-biblioref" data-xml-rid="bib27" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref27-1" aria-controls="sref27-1">DuPage et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref27-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">28.</div><div>DuPage, M. ∙ Cheung, A.F. ∙ Mazumdar, C. ...</div><div><strong>Endogenous T&nbsp;cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression</strong></div><div><em>Cancer Cell.</em> 2011; <strong>19</strong>:72-85</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.DuPageA.F.CheungC.MazumdarM.M.WinslowR.BronsonL.M.SchmidtD.CrowleyJ.ChenT.JacksEndogenous+T%C2%A0cell+responses+to+antigens+expressed+in+lung+adenocarcinomas+delay+malignant+tumor+progressionCancer+Cell1920117285" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref87-1" href="#" role="doc-biblioref" data-xml-rid="bib87" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref87-1" aria-controls="sref87-1">McFadden et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref87-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">88.</div><div>McFadden, D.G. ∙ Politi, K. ∙ Bhutkar, A. ...</div><div><strong>Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinoma</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2016; <strong>113</strong>:E6409-E6417</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.G.McFaddenK.PolitiA.BhutkarF.K.ChenX.SongM.PirunP.M.SantiagoC.Kim-KiselakJ.T.PlattE.LeeMutational+landscape+of+EGFR-%2C+MYC-%2C+and+Kras-driven+genetically+engineered+mouse+models+of+lung+adenocarcinomaProc.+Natl.+Acad.+Sci.+USA1132016E6409E6417" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref152" href="#" role="doc-biblioref" data-xml-rid="bib152" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref152" aria-controls="sref152">Yadav et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref152"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">153.</div><div>Yadav, M. ∙ Jhunjhunwala, S. ∙ Phung, Q.T. ...</div><div><strong>Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing</strong></div><div><em>Nature.</em> 2014; <strong>515</strong>:572-576</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.YadavS.JhunjhunwalaQ.T.PhungP.LupardusJ.TanguayS.BumbacaC.FranciT.K.CheungJ.FritscheT.WeinschenkPredicting+immunogenic+tumour+mutations+by+combining+mass+spectrometry+and+exome+sequencingNature5152014572576" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and they do not elicit meaningful T or B cell responses, as evidenced by their unaffected growth in T and/or B cell deficient animals (<a id="crosref0635" href="#figs2">Figure&nbsp;S2</a>B). Taking advantage of this, the KP tumor cell line provided a system where we could assess how engineered neoantigens might drive anti-tumor T and B cell responses and how these responses impact tumor growth.</div><div id="p0080" role="paragraph">We recently published the “NINJA” model and showed that the NINJA system could be used to program neoantigen-expressing KP lung tumors (<span class="dropBlock reference-citations"><a id="body-ref-sref18-1" href="#" role="doc-biblioref" data-xml-rid="bib18" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref18-1" aria-controls="sref18-1">Connolly et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref18-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>Connolly, K.A. ∙ Kuchroo, M. ∙ Venkat, A. ...</div><div><strong>A reservoir of stem-like CD8<sup>+</sup> T&nbsp;cells in the tumor-draining lymph node preserves the ongoing antitumor immune response</strong></div><div><em>Sci. Immunol.</em> 2021; <strong>6</strong>:eabg7836</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=K.A.ConnollyM.KuchrooA.VenkatA.KhatunJ.WangI.WilliamN.I.HornickB.L.FitzgeraldM.DamoM.Y.KasmaniA+reservoir+of+stem-like+CD8%2B+T%C2%A0cells+in+the+tumor-draining+lymph+node+preserves+the+ongoing+antitumor+immune+responseSci.+Immunol.62021eabg7836" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref23-2" href="#" role="doc-biblioref" data-xml-rid="bib23" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref23-2" aria-controls="sref23-2">Damo et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref23-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">24.</div><div>Damo, M. ∙ Fitzgerald, B. ∙ Lu, Y. ...</div><div><strong>Inducible de novo expression of neoantigens in tumor cells and mice</strong></div><div><em>Nat. Biotechnol.</em> 2021; <strong>39</strong>:64-73</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.DamoB.FitzgeraldY.LuM.NaderI.WilliamJ.F.CheungK.A.ConnollyG.G.FosterE.Akama-GarrenD.Y.LeeInducible+de+novo+expression+of+neoantigens+in+tumor+cells+and+miceNat.+Biotechnol.3920216473" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref33-1" href="#" role="doc-biblioref" data-xml-rid="bib33" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref33-1" aria-controls="sref33-1">Fitzgerald et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref33-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Fitzgerald, B. ∙ Connolly, K.A. ∙ Cui, C. ...</div><div><strong>A mouse model for the study of anti-tumor T&nbsp;cell responses in Kras-driven lung adenocarcinoma</strong></div><div><em>Cell Rep Methods.</em> 2021; <strong>1</strong>:100080</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=B.FitzgeraldK.A.ConnollyC.CuiE.FagerbergD.L.MariuzzaN.I.HornickG.G.FosterI.WilliamJ.F.CheungN.S.JoshiA+mouse+model+for+the+study+of+anti-tumor+T%C2%A0cell+responses+in+Kras-driven+lung+adenocarcinomaCell+Rep+Methods12021100080" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The cDNAs encoding NINJA neoantigens contain model antigens from the lymphocytic choriomeningitis virus (LCMV) glycoprotein: GP<sub>33–43</sub> and GP<sub>61–80</sub>, which are recognized by GP33-specific CD8 (P14) and GP66-specific CD4 (SMARTA) T&nbsp;cell receptor (TCR) transgenic T&nbsp;cells, respectively, separated by the FLAG peptide sequence and embedded within a flexible loop region between β strands 7 and 8 of GFP (called GFP-GP<sub>33–43</sub>/FLAG/GP<sub>61–80</sub>).The LCMV antigens were chosen because there is a wide array of immunologic tools that are available for studying T&nbsp;cell responses against these antigens (i.e., MHC class I and II tetramers and TCR transgenic mice). Moreover, we had previously engineered the sequence GP<sub>33–43</sub>/FLAG/GP<sub>61–80</sub> into GFP (called GFP-GP<sub>33–43</sub>/FLAG/GP<sub>61–80</sub> below) such that it allowed proper folding and fluorescence of GFP. Thus, we reasoned it would be an ideal starting point to design a neoantigen that was recognized by both T and B cells. Hen-egg lysozyme (HEL) is a widely used model B cell antigen, recognized by MD4 and SW<sub>HEL</sub> B cell receptor (BCR) transgenic B cells (<span class="dropBlock reference-citations"><a id="body-ref-sref43" href="#" role="doc-biblioref" data-xml-rid="bib43" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref43" aria-controls="sref43">Goodnow et&nbsp;al., 1988</a><div class="dropBlock__holder" data-db-target-of="sref43"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">44.</div><div>Goodnow, C.C. ∙ Crosbie, J. ∙ Adelstein, S. ...</div><div><strong>Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice</strong></div><div><em>Nature.</em> 1988; <strong>334</strong>:676-682</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.C.GoodnowJ.CrosbieS.AdelsteinT.B.LavoieS.J.Smith-GillR.A.BrinkH.Pritchard-BriscoeJ.S.WotherspoonR.H.LoblayK.RaphaelAltered+immunoglobulin+expression+and+functional+silencing+of+self-reactive+B+lymphocytes+in+transgenic+miceNature3341988676682" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref107" href="#" role="doc-biblioref" data-xml-rid="bib107" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref107" aria-controls="sref107">Phan et&nbsp;al., 2003</a><div class="dropBlock__holder" data-db-target-of="sref107"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">108.</div><div>Phan, T.G. ∙ Amesbury, M. ∙ Gardam, S. ...</div><div><strong>B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2003; <strong>197</strong>:845-860</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=T.G.PhanM.AmesburyS.GardamJ.CrosbieJ.HasboldP.D.HodgkinA.BastenR.BrinkB+cell+receptor-independent+stimuli+trigger+immunoglobulin+%28Ig%29+class+switch+recombination+and+production+of+IgG+autoantibodies+by+anergic+self-reactive+B+cellsJ.%C2%A0Exp.+Med.1972003845860" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Therefore, to facilitate the investigation of tumor-specific T&nbsp;cell and B cell responses, we created a fusion protein of HEL, LCMV GP<sub>33–43</sub>/FLAG/GP<sub>61–80</sub>, T2A, and codon-optimized mScarlet (<a id="crosref0665" href="#fig2">Figure&nbsp;2</a>A). This substrate was called&nbsp;HELLO and generated two polypeptides: the neoantigen fusion of&nbsp;HEL-GP<sub>33–43</sub>/FLAG/GP<sub>61–80</sub> and mScarlet, a bright red fluorescent protein to distinguish neoantigen-expressing tumor cells.</div><div id="p0085" role="paragraph">We transduced the KP tumor cell line with HELLO-encoding lentiviral vectors, in which HELLO was the only protein product, and sorted mScarlet-positive KP-HELLO tumor cells with fluorescence-activated cell sorting (FACS). We placed a signal peptide sequence in the HELLO construct prior to the neoantigen fusion HEL-GP<sub>33–43</sub>/FLAG/GP<sub>61–80</sub> so that it would be secreted by KP-HELLO cells, whereas mScarlet protein would remain in the cytoplasm (<a id="crosref0670" href="#fig2">Figure&nbsp;2</a>A). To validate this, we isolated HEL-specific MD4 B cells, or polyclonal B6 B cells that are not enriched in HEL-specific BCRs (negative control), and added either HEL protein (positive control), KP, or KP-HELLO supernatant into each condition. After 48&nbsp;h of culture, flow cytometric analyses showed activation of MD4 B cells, based on a significant increase in CD86 median fluorescence intensity (MFI), in samples where MD4 cells were incubated with KP-HELLO supernatant or HEL protein (<a id="crosref0675" href="#fig2">Figure&nbsp;2</a>B). By contrast, B cell activation was not observed in negative control conditions. Next, we tested if HEL-specific B cells could present GP<sub>66–77</sub> from HEL-GP<sub>33–43</sub>/FLAG/GP<sub>61–80</sub> to GP66-specific CD4 T&nbsp;cells. For this, we cultured naive SMARTA CD4 T&nbsp;cells with MD4 B cells, or as negative controls, SMARTA T&nbsp;cells alone or with polyclonal B cells from B6 mice. Into each co-culture, we added KP or KP-HELLO supernatant, HEL protein (negative control), or GP<sub>61–80</sub> peptide (positive control). After 48 h, there was a significant increase of CD44<sup>hi</sup> CD69<sup>hi</sup> (activated) CD4 T&nbsp;cells in GP<sub>61–80</sub>-containing samples, demonstrating that B6 and MD4 B cells were capable of presenting GP<sub>61–80</sub> to SMARTA CD4 T&nbsp;cells (<a id="crosref0680" href="#fig2">Figures 2</a>C and <a id="crosref0685" href="#figs3">S3</a>A). By contrast, when cultured with KP-HELLO supernatant, only MD4 B cells could activate SMARTA cells, demonstrating that a HEL-specific BCR was required for B cells to uptake, process, and present HEL-GP<sub>33–43</sub>/FLAG/GP<sub>61–80</sub> antigen to GP66-specific CD4 T&nbsp;cells. Of note, we could not detect robust GP33-specific CD8 T&nbsp;cell responses from KP-HELLO (<a id="crosref0690" href="#figs3">Figures S3</a>B–S3F). This was likely due to the biology of the GP<sub>33–43</sub> epitope in HELLO system (i.e., antigen processing), rather than a technical breakdown, and HEL-GP<sub>33–43</sub>/FLAG/GP<sub>61–80</sub> contained many other potential MHC class I restricted epitopes besides GP<sub>33–43</sub> (<a id="crosref0695" href="#mmc3">Table S3</a>). We focused on endogenous polyclonal CD8 T&nbsp;cell responses in following analyses.</div><div class="figure-wrap"><figure id="figs3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.007/asset/5f9da058-b02c-44dc-8ac8-12f41e8d79f1/main.assets/figs3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs3" src="/cms/10.1016/j.cell.2021.11.007/asset/2cebeb6e-8198-461f-8392-0212cba5f1ed/main.assets/figs3.jpg" height="450" width="753" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/5f9da058-b02c-44dc-8ac8-12f41e8d79f1/main.assets/figs3_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs3-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S3</span> <span class="figure__title__text">KP-HELLO LUAD cell line elicits GP66-specific CD4 T&nbsp;cell responses <i>in&nbsp;vitro</i>, while unable to elicit robust GP33-specific CD8&nbsp;T responses, related to <a id="crosref1940" href="#fig2">Figure&nbsp;2</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs3-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0325" role="paragraph">A, Representative flow plots showing CD69 and CD44 expression on SMARTA CD4 T&nbsp;cells, after 48-hour co-culture with MD4 or C57BL/6 B cells, and KP or KP-HELLO supernatant, 500ng/mL HEL or 5ug/mL GP<sub>61-80</sub>.</div><div id="fspara0330" role="paragraph">B, Chromatogram displaying DNA sequence of GP<sub>33-43</sub>/FLAG/GP<sub>61-80</sub> from the proviral insertion in the KP-HELLO tumor cell line. This demonstrated that the integrated provirus in KP-HELLO cells encodes the correct sequence for GP<sub>33-43</sub>/FLAG/GP<sub>61-80</sub>. The amino acid sequence is indicated above the chromatogram as a reference for translation. Results were repeated in 4 independent experiments.</div><div id="fspara0335" role="paragraph">C, <i>In&nbsp;vitro</i> co-culture of P14 T&nbsp;cells and antigen loaded DCs. Bar graphs displaying division and activation marker expression on P14 T&nbsp;cells under different experimental conditions. CFSE-labeled P14 cells were co-cultured with LPS-stimulated and antigen-loaded DCs. On day 3, cell culture was collected to assess P14 cell proliferation (by CFSE dilution) and activation (by CD44 upregulation or CD62L downregulation) by flow cytometry.</div><div id="fspara0340" role="paragraph">D – F, GP33-specific CD8<sup>+</sup> T&nbsp;cell responses in KP-HELLO models. (D) Frequency and representative flow plots displaying GP33-specific CD8<sup>+</sup> T&nbsp;cells in tumors (top) and dLNs (bottom). C57BL/6 and uMT mice were s.c. implanted with 2&nbsp;× 10<sup>5</sup> KP-HELLO. Tumors and dLNs were harvested on day 14 – 16. GP33 gating (red: pre-gated on singlets, TCRb<sup>+</sup> CD8<sup>+</sup>) was drawn based on FMO control (blue). (E) Frequency and representative flow plots displaying P14 tumor-specific CD8<sup>+</sup> T&nbsp;cells in tumors (top) and dLNs (bottom). 5&nbsp;× 10<sup>5</sup> Thy1.1 P14 T&nbsp;cells were transferred (i.v.) into C57BL/6 and uMT mice, one day prior to 5&nbsp;× 10<sup>5</sup> KP-HELLO s.c. implant. Tumors and dLNs were harvested on day 14. (F) Frequency and representative flow plots displaying GP33-specific CD8<sup>+</sup> T&nbsp;cells in tumor tissues (top) and dLNs (bottom). KP and uMT-KP mice were infected intratracheally with 5&nbsp;× 10<sup>4</sup> PFU Lenti-HELLO-Cre. Lung tumors were harvested 8&nbsp;weeks post-infection. GP33 gating (red: pre-gated on singlets, TCRb<sup>+</sup> ivCD45<sup>Neg</sup>, CD8<sup>+</sup>) was drawn based on FMO control (blue). Here, y axis of the bar graphs were adjusted based on figures and analyses of previous publications (<span class="dropBlock reference-citations"><a id="body-ref-sref18-2" href="#" role="doc-biblioref" data-xml-rid="bib18" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref18-2" aria-controls="sref18-2">Connolly et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref18-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>Connolly, K.A. ∙ Kuchroo, M. ∙ Venkat, A. ...</div><div><strong>A reservoir of stem-like CD8<sup>+</sup> T&nbsp;cells in the tumor-draining lymph node preserves the ongoing antitumor immune response</strong></div><div><em>Sci. Immunol.</em> 2021; <strong>6</strong>:eabg7836</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=K.A.ConnollyM.KuchrooA.VenkatA.KhatunJ.WangI.WilliamN.I.HornickB.L.FitzgeraldM.DamoM.Y.KasmaniA+reservoir+of+stem-like+CD8%2B+T%C2%A0cells+in+the+tumor-draining+lymph+node+preserves+the+ongoing+antitumor+immune+responseSci.+Immunol.62021eabg7836" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref33-2" href="#" role="doc-biblioref" data-xml-rid="bib33" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref33-2" aria-controls="sref33-2">Fitzgerald et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref33-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Fitzgerald, B. ∙ Connolly, K.A. ∙ Cui, C. ...</div><div><strong>A mouse model for the study of anti-tumor T&nbsp;cell responses in Kras-driven lung adenocarcinoma</strong></div><div><em>Cell Rep Methods.</em> 2021; <strong>1</strong>:100080</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=B.FitzgeraldK.A.ConnollyC.CuiE.FagerbergD.L.MariuzzaN.I.HornickG.G.FosterI.WilliamJ.F.CheungN.S.JoshiA+mouse+model+for+the+study+of+anti-tumor+T%C2%A0cell+responses+in+Kras-driven+lung+adenocarcinomaCell+Rep+Methods12021100080" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) to display the differences of GP33-specific responses in KP-HELLO versus KP-NINJA.</div></div></div></div></figcaption></figure></div></section><section id="sec-2-4"><h3>KP-HELLO tumors elicit tumor-specific TFH and GC B cell responses <i>in&nbsp;vivo</i></h3><div id="p0090" role="paragraph">To assess whether the introduction of HELLO neoantigens into KP tumors elicited TFH cell responses <i>in&nbsp;vivo</i>, we s.c. implanted 2&nbsp;× 10<sup>5</sup> KP or KP-HELLO tumor cells into B6 mice and analyzed endogenous CD4 T&nbsp;cells in dLNs using flow cytometry. On days 10–12, the frequency of CD44<sup>hi</sup> PSGL1<sup>lo</sup> polyclonal CD4 T&nbsp;cells increased ∼1.3-fold overall (KP-HELLO versus KP), while there were ∼4-fold increases in the frequency of these PSGL1<sup>lo</sup> cells that further upregulated PD-1 and CXCR5 (<a id="crosref0700" href="#fig2">Figure&nbsp;2</a>D), resulting in a significant increase in the frequency of TFH cells (<a id="crosref0705" href="#fig2">Figure&nbsp;2</a>E).</div><div id="p0095" role="paragraph">Next, we tested whether the linkage of GP<sub>61–80</sub> to a B cell antigen (HEL) elicited an increase in TFH cells among tumor-specific (GP66-specific) CD4 T&nbsp;cells. The GFP-GP<sub>33–43</sub>/FLAG/GP<sub>61–80</sub> in NINJA retains fluorescence and is recognized by conformation-specific anti-GFP antibodies. Thus, we reasoned that NINJA would be unlikely to elicit GFP-specific T or B cell responses in GFP-tolerant recipient mice (express GFP in an irrelevant location—we used <i>Il4</i><sup><i>GFP</i></sup> [<i>4get</i>] mice), yet, GFP-tolerant recipients were still able to mount GP66-specific CD4 T&nbsp;cell responses contained in NINJA (<span class="dropBlock reference-citations"><a id="body-ref-sref23-3" href="#" role="doc-biblioref" data-xml-rid="bib23" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref23-3" aria-controls="sref23-3">Damo et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref23-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">24.</div><div>Damo, M. ∙ Fitzgerald, B. ∙ Lu, Y. ...</div><div><strong>Inducible de novo expression of neoantigens in tumor cells and mice</strong></div><div><em>Nat. Biotechnol.</em> 2021; <strong>39</strong>:64-73</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.DamoB.FitzgeraldY.LuM.NaderI.WilliamJ.F.CheungK.A.ConnollyG.G.FosterE.Akama-GarrenD.Y.LeeInducible+de+novo+expression+of+neoantigens+in+tumor+cells+and+miceNat.+Biotechnol.3920216473" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Therefore, we could directly compare the differentiation of endogenous tumor-specific CD4 T&nbsp;cells under conditions where tumors expressed CD4 T&nbsp;cell-recognized neoantigens with different capabilities to elicit antigen-specific B cell responses (KP-NINJA versus KP-HELLO). We previously described KP-NINJA (KPN1.1) cell line, which was derived from an autochthonous KP-NINJA LUAD (<span class="dropBlock reference-citations"><a id="body-ref-sref33-3" href="#" role="doc-biblioref" data-xml-rid="bib33" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref33-3" aria-controls="sref33-3">Fitzgerald et&nbsp;al.<i>,</i> 2021</a><div class="dropBlock__holder" data-db-target-of="sref33-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Fitzgerald, B. ∙ Connolly, K.A. ∙ Cui, C. ...</div><div><strong>A mouse model for the study of anti-tumor T&nbsp;cell responses in Kras-driven lung adenocarcinoma</strong></div><div><em>Cell Rep Methods.</em> 2021; <strong>1</strong>:100080</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=B.FitzgeraldK.A.ConnollyC.CuiE.FagerbergD.L.MariuzzaN.I.HornickG.G.FosterI.WilliamJ.F.CheungN.S.JoshiA+mouse+model+for+the+study+of+anti-tumor+T%C2%A0cell+responses+in+Kras-driven+lung+adenocarcinomaCell+Rep+Methods12021100080" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0100" role="paragraph">We s.c. implanted KP-NINJA or KP-HELLO tumors into <i>Il4</i><sup><i>GFP</i></sup> mice and analyzed GP66-specific CD4 T&nbsp;cells for their expression of TFH markers. Endogenous GP66-specific CD4 T&nbsp;cells were identified in mice with KP-HELLO or KP-NINJA tumors using I-A<sup>b</sup>/GP<sub>66–77</sub>-specific tetramers between days 10–12 after implant (<a id="crosref0720" href="#fig2">Figures 2</a>G and <a id="crosref0725" href="#figs4">S4</a>A, ∼2-fold reduction in KP-NINJA). In KP-HELLO mice, ∼50%–60% of the GP66-specific CD4 T&nbsp;cells downregulated PSGL1, ∼30% of which further upregulated PD-1 and CXCR5 (TFH cells) (<a id="crosref0730" href="#fig2">Figure&nbsp;2</a>F). These TFH cells were also marked by upregulation of Bcl-6, which is required for TFH cell differentiation (<span class="dropBlock reference-citations"><a id="body-ref-sref61" href="#" role="doc-biblioref" data-xml-rid="bib61" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref61" aria-controls="sref61">Johnston et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref61"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>Johnston, R.J. ∙ Poholek, A.C. ∙ DiToro, D. ...</div><div><strong>Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation</strong></div><div><em>Science.</em> 2009; <strong>325</strong>:1006-1010</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.J.JohnstonA.C.PoholekD.DiToroI.YusufD.EtoB.BarnettA.L.DentJ.CraftS.CrottyBcl6+and+Blimp-1+are+reciprocal+and+antagonistic+regulators+of+T+follicular+helper+cell+differentiationScience325200910061010" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref99" href="#" role="doc-biblioref" data-xml-rid="bib99" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref99" aria-controls="sref99">Nurieva et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref99"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">100.</div><div>Nurieva, R.I. ∙ Chung, Y. ∙ Martinez, G.J. ...</div><div><strong>Bcl6 mediates the development of T follicular helper cells</strong></div><div><em>Science.</em> 2009; <strong>325</strong>:1001-1005</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.I.NurievaY.ChungG.J.MartinezX.O.YangS.TanakaT.D.MatskevitchY.H.WangC.DongBcl6+mediates+the+development+of+T+follicular+helper+cellsScience325200910011005" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref155" href="#" role="doc-biblioref" data-xml-rid="bib155" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref155" aria-controls="sref155">Yu et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref155"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">156.</div><div>Yu, D. ∙ Rao, S. ∙ Tsai, L.M. ...</div><div><strong>The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment</strong></div><div><em>Immunity.</em> 2009; <strong>31</strong>:457-468</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.YuS.RaoL.M.TsaiS.K.LeeY.HeE.L.SutcliffeM.SrivastavaM.LintermanL.ZhengN.SimpsonThe+transcriptional+repressor+Bcl-6+directs+T+follicular+helper+cell+lineage+commitmentImmunity312009457468" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (<a id="crosref0750" href="#fig2">Figure&nbsp;2</a>F). Comparatively, the frequency of GP66-specific TFH cells was 17-fold higher in KP-HELLO tumor-bearing mice than KP-NINJA (<a id="crosref0755" href="#fig2">Figure&nbsp;2</a>G). KP-HELLO tumors also potentiated GC B cell responses <i>in&nbsp;vivo</i>, because there was an ∼5-fold increase in the frequency of IgD<sup>lo</sup>-activated B cells compared with KP-NINJA, and ∼50%–60% of these cells were GL7<sup>+</sup> CD95<sup>+</sup>, consistent with a GC B cell phenotype (<a id="crosref0760" href="#fig2">Figure&nbsp;2</a>H). As a result, KP-HELLO tumors had ∼8.5-fold and ∼10.5-fold increases in the frequency and number, respectively, of GC B cells in dLN compared to KP-NINJA tumors (<a id="crosref0765" href="#fig2">Figure&nbsp;2</a>I). Similarly, when B6 mice containing adoptively transferred allotype-marked naive HEL-specific SW<sub>HEL</sub> B cells and SMARTA CD4 T&nbsp;cells were challenged with KP-HELLO tumor cells (<a id="crosref0770" href="#figs4">Figure&nbsp;S4</a>B), ∼50% of SMARTA cells were PSGL1<sup>lo</sup> and ∼25% of these were mature TFH cells (<a id="crosref0775" href="#figs4">Figure&nbsp;S4</a>C). Likewise, ∼30% of the adoptively transferred SW<sub>HEL</sub> B cells were IgD<sup>lo</sup>, ∼50% of which were GL7<sup>+</sup> CD95<sup>+</sup> Bcl-6<sup>hi</sup> (<a id="crosref0780" href="#figs4">Figure&nbsp;S4</a>D). Together, these data demonstrated that the B cell-containing neoantigens in KP-HELLO tumors were sufficient to elicit tumor-specific TFH and GC B cell responses.</div><div class="figure-wrap"><figure id="figs4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.007/asset/724eec53-72fc-4a80-a386-e68d951e10f2/main.assets/figs4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs4" src="/cms/10.1016/j.cell.2021.11.007/asset/d3cd22f3-be58-48c5-aee2-3ec69ea5ed88/main.assets/figs4.jpg" height="364" width="506" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/724eec53-72fc-4a80-a386-e68d951e10f2/main.assets/figs4_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs4-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S4</span> <span class="figure__title__text">KP-HELLO LUAD tumors elicit antigen-specific TFH and GC B cell responses <i>in&nbsp;vivo</i>, related to <a id="crosref1955" href="#fig2">Figure&nbsp;2</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs4-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0350" role="paragraph">(A), Representative flow plots of GP66-specific CD4 T&nbsp;cells from dLNs of KP-HELLO tumor-bearing C57BL/6 mice.</div><div id="fspara0355" role="paragraph">B, Experimental design of (C) and (D).</div><div id="fspara0360" role="paragraph">C – D, Representative flow plots showing tumor-specific SMARTA TFH cells (C) and SW<sub>HEL</sub> GC B cells (D) in dLNs of KP-HELLO bearing mice. As shown in Figure&nbsp;S4B, CD45.2/CD45.2 Thy1.2/Thy1.2 C57BL/6 recipient, transferred with 1&nbsp;× 10<sup>5</sup> CD45.1/CD45.2 HEL-specific SW<sub>HEL</sub> B cells and 1&nbsp;× 10<sup>5</sup> Thy1.1/Thy1.2 GP66-specific SMARTA CD4 T&nbsp;cells, were s.c. implanted with 5&nbsp;× 10<sup>5</sup> KP-HELLO. Flow cytometric analyses were performed on day 10 – 12. Data (mean ± SD) represented at least 2 independent experiments.</div></div></div></div></figcaption></figure></div></section><section id="sec-2-5"><h3>Introduction of HELLO induces TFH- and B cell-dependent tumor control</h3><div id="p0105" role="paragraph">KP-HELLO tumors displayed an increased growth rate in immunodeficient RAG1 knockout (KO) mice compared with B6 mice (<a id="crosref0785" href="#figs5">Figure&nbsp;S5</a>A). This was not due to a cell intrinsic growth defect, because parental KP and KP-HELLO tumors grew similarly in RAG1 KO mice (<a id="crosref0790" href="#figs5">Figure&nbsp;S5</a>B). Because KP tumor cells grow similarly in RAG1 KO and B6 hosts (<a id="crosref0795" href="#figs2">Figure&nbsp;S2</a>B), the reduced growth of KP-HELLO in B6 mice was due to the impact of adaptive immune cells responding to HELLO. To assess whether B cells, CD4 T&nbsp;cells, and specifically CD4 TFH cells were necessary for tumor control, we measured KP-HELLO tumor growth in uMT, CIITA KO mice (lacking mature B cells or CD4 T&nbsp;cells, respectively), and CD4-Cre Bcl6<sup>fl/fl</sup>, a commonly used TFH-deficient animal model (<span class="dropBlock reference-citations"><a id="body-ref-sref21-2" href="#" role="doc-biblioref" data-xml-rid="bib21" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref21-2" aria-controls="sref21-2">Crotty, 2019</a><div class="dropBlock__holder" data-db-target-of="sref21-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Crotty, S.</div><div><strong>T Follicular Helper Cell Biology: A Decade of Discovery and Diseases</strong></div><div><em>Immunity.</em> 2019; <strong>50</strong>:1132-1148</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.CrottyT+Follicular+Helper+Cell+Biology%3A+A+Decade+of+Discovery+and+DiseasesImmunity50201911321148" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref55" href="#" role="doc-biblioref" data-xml-rid="bib55" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref55" aria-controls="sref55">Hollister et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref55"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">56.</div><div>Hollister, K. ∙ Kusam, S. ∙ Wu, H. ...</div><div><strong>Insights into the role of Bcl6 in follicular Th cells using a new conditional mutant mouse model</strong></div><div><em>J.&nbsp;Immunol.</em> 2013; <strong>191</strong>:3705-3711</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=K.HollisterS.KusamH.WuN.CleggA.MondalD.V.SawantA.L.DentInsights+into+the+role+of+Bcl6+in+follicular+Th+cells+using+a+new+conditional+mutant+mouse+modelJ.%C2%A0Immunol.191201337053711" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We observed that CD4 T&nbsp;cells, TFH cells, and B cells were critical for optimal control over KP-HELLO tumor growth (<a id="crosref0810" href="#fig3">Figures 3</a>A–3C). By contrast, KP-NINJA tumor growth was not significantly different in B6 versus uMT hosts (<a id="crosref0815" href="#fig3">Figure&nbsp;3</a>E). We further analyzed CD4 T&nbsp;cell phenotypes in KP-HELLO tumor-bearing uMT and CD4-Cre Bcl6<sup>fl/fl</sup> mice. Endogenous GP66-specific CD4 T&nbsp;cell responses were readily detectable in dLNs from KP-HELLO tumor-bearing B6, uMT, and CD4-Cre Bcl6<sup>fl/fl</sup> mice (<a id="crosref0820" href="#figs5">Figures S5</a>C and S5F), but GP66-specific mature TFH cells were absent in uMT and CD4-Cre Bcl6<sup>fl/fl</sup> mice (<a id="crosref0825" href="#fig3">Figures 3</a>D, <a id="crosref0830" href="#figs5">S5</a>E, and S5G). Notably, the latter also had significant reductions in GP66-specific CD44<sup>hi</sup> PSGL1<sup>lo</sup> cells, which comprise both TFH-precursors and TFH cells (<a id="crosref0835" href="#figs5">Figures S5</a>D and S5G). These data demonstrated that B cells and TFH cells were necessary to reduce the growth of KP-HELLO tumors.</div><div class="figure-wrap"><figure id="fig3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.007/asset/8186bc6e-3ac2-4f5c-a41a-d8658999c118/main.assets/gr3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr3" src="/cms/10.1016/j.cell.2021.11.007/asset/b84018e4-3fcf-4f34-86b3-b938b75db490/main.assets/gr3.jpg" height="596" width="657" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/8186bc6e-3ac2-4f5c-a41a-d8658999c118/main.assets/gr3_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig3-title" class="figure__title"><span class="label figure__label">Figure&nbsp;3</span> <span class="figure__title__text">CD4 T&nbsp;cells, TFH cells, and B cells are necessary for optimal control over KP-HELLO tumors</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig3-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0105" role="paragraph">(A and C) Tumor growth curves: C57BL/6, CIITA KO, or uMT mice were subcutaneously (s.c.) implanted with 2&nbsp;× 10<sup>5</sup> KP-HELLO. Growth curves of C57BL/6 (n&nbsp;= 40) and uMT (n&nbsp;= 32), pooled from 8 independent experiments, were set as the baseline of analyses.</div><div id="fspara0110" role="paragraph">(B) Tumor growth curves: C57BL/6 or CD4-Cre Bcl6<sup>fl/fl</sup> mice were s.c. implanted with 5&nbsp;× 10<sup>5</sup> KP-HELLO.</div><div id="fspara0115" role="paragraph">(D) Representative flow plots of GP66-specific CD4 TFH cells from dLNs of KP-HELLO tumor-bearing C57BL/6 or uMT mice. Flow cytometric analyses were performed on days 10–12 and quantified in <a id="crosref1885" href="#figs5">Figure&nbsp;S5</a>. Flow plots were pre-gated on TCRb<sup>+</sup> CD4<sup>+</sup> GP66-tetramer<sup>+</sup> CD44<sup>hi</sup> PSGL1<sup>lo</sup>.</div><div id="fspara0120" role="paragraph">(E) Tumor growth curves: C57BL/6 or uMT mice were s.c. implanted with 5&nbsp;× 10<sup>5</sup> KP-NINJA. Each line represented one mouse.</div><div id="fspara0125" role="paragraph">(F) 1&nbsp;× 10<sup>6</sup> SW<sub>HEL</sub> or WT C57BL/6 B cells were adoptively transferred into uMT recipients, 1&nbsp;day prior to KP-HELLO s.c. implant. Graph shows tumor volumes on day 16.</div><div id="fspara0130" role="paragraph">(G–I) 1&nbsp;× 10<sup>5</sup> SMARTA CD4 T&nbsp;cells (Thy1.1/Thy1.1) or OT-II CD4 T&nbsp;cells (Thy1.1/Thy1.2) were adoptively transferred into CD4-Cre Bcl6<sup>fl/fl</sup> recipients (Thy1.2/Thy1.2), 1&nbsp;day prior to KP-HELLO s.c. implant.</div><div id="fspara0135" role="paragraph">(G) Tumor volumes on day 16 after s.c. implant.</div><div id="fspara0140" role="paragraph">(H and I) Representative flow plots (H) and frequency (I) of GP66-specific CD4 T&nbsp;cell subsets from dLNs of [CD4-Cre Bcl6<sup>fl/fl</sup>&nbsp;+ SMARTA] group, separated by transferred SMARTA and endogenous cells. Flow plots were pre-gated on TCRb<sup>+</sup> CD4<sup>+</sup> GP66-tetramer<sup>+</sup> CD44<sup>hi</sup>.</div><div id="fspara0145" role="paragraph">Data (mean ± SD) were pooled, from 3–10 mice/group/experiment, and representative of at least 2 independent experiments. (A–C and E) Two-way ANOVA. (F, G, and I) Unpaired t test with Welch’s correction. <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001.</div><div id="fspara0150" role="paragraph">See also <a id="crosref1890" href="#figs6">Figure&nbsp;S6</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.007/asset/0381234a-be29-46f7-b2e4-415b58b897ef/main.assets/figs5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs5" src="/cms/10.1016/j.cell.2021.11.007/asset/a095b0a0-50ed-4b37-ae52-294435bb9bff/main.assets/figs5.jpg" height="398" width="753" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/0381234a-be29-46f7-b2e4-415b58b897ef/main.assets/figs5_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs5-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S5</span> <span class="figure__title__text">B cells are required to drive tumor-specific TFH cell responses, related to <a id="crosref1960" href="#fig3">Figure&nbsp;3</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs5-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0370" role="paragraph">A – B, Tumor growth curves: RAG1 KO or C57BL/6 mice were s.c. implanted with 2&nbsp;× 10<sup>5</sup> KP or KP-HELLO. Growth curve of KP-HELLO in C57BL/6 (n&nbsp;= 40), pooled from 8 independent experiments, was set as the baseline of analyses.</div><div id="fspara0375" role="paragraph">C – G, Frequency and number of GP66-specific total CD4 T&nbsp;cells (C and F), TFH cells (CD44<sup>hi</sup> PSGL1<sup>lo</sup> Ly6C<sup>lo</sup> PD1<sup>hi</sup> CXCR5<sup>hi</sup>) (E and G), and other CD4<sup>+</sup> CD44<sup>hi</sup> T&nbsp;cell subsets (D and G) from dLNs of C57BL/6, uMT or CD4-Cre Bcl6<sup>fl/fl</sup> mice with KP-HELLO tumors.</div><div id="fspara0380" role="paragraph">H, Representative histogram displaying T-bet expression on naive, GP66-specific PSGL1<sup>hi</sup> Ly6C<sup>hi</sup> (TH1-like) and PSGL1<sup>lo</sup> Ly6C<sup>lo</sup> PD1<sup>hi</sup> CXCR5<sup>hi</sup> (TFH) T&nbsp;cells from dLNs of KP-HELLO tumor bearing mice.</div><div id="fspara0385" role="paragraph">Data (mean ± SD) were pooled, from 3–10 mice/group/experiment, and representative of at least 2 independent experiments. A – B, Two-way ANOVA. C – G, Unpaired t test with Welch’s correction. <sup>∗∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001.</div></div></div></div></figcaption></figure></div><div id="p0110" role="paragraph">It remained possible that TFH and B cells acted in a non-antigen driven fashion to promote anti-tumor immune response. To formally test whether tumor-specific B cells were sufficient to control KP-HELLO tumors, we performed a rescue experiment by adoptively transferring naive tumor-specific SW<sub>HEL</sub> or polyclonal wild-type (WT) B6 B cells into uMT recipients prior to KP-HELLO tumor initiation. Only adoptive transfer of the SW<sub>HEL</sub> B cells rescued tumor control in uMT mice back to the level observed in control mice (<a id="crosref0840" href="#fig3">Figure&nbsp;3</a>F). Likewise, adoptive-transfer of naive GP66-specific SMARTA CD4 T&nbsp;cells into CD4-Cre Bcl6<sup>fl/fl</sup> recipients, but not irrelevant-antigen-specific OT-II CD4 T&nbsp;cells, restored the ability of TFH-deficient animals to control KP-HELLO tumors (<a id="crosref0845" href="#fig3">Figure&nbsp;3</a>G). Approximately 50%–60% of these transferred SMARTA cells downregulated PSGL1, with ∼25% of these becoming mature TFH cells (<a id="crosref0850" href="#fig3">Figure&nbsp;3</a>H). In contrast, endogenous GP66-specific T&nbsp;cells from the same CD4-Cre Bcl6<sup>fl/fl</sup> animal were incapable of developing into mature TFH cells or even becoming TFH precursors (note 96% decrease in PSGL1<sup>lo</sup> cells; <a id="crosref0855" href="#fig3">Figure&nbsp;3</a>I). Thus, in the rescued CD4-Cre Bcl6<sup>fl/fl</sup> mice, the TFH compartment was solely comprised of SMARTA CD4 T&nbsp;cells. Lymphocyte antigen 6C (Ly6C) expression on CD44<sup>hi</sup> PSGL1<sup>hi</sup> has been widely used to discriminate TH1 from TFH cells, because Ly6C is regulated by TH1-specific transcription factor T-bet (<span class="dropBlock reference-citations"><a id="body-ref-sref48" href="#" role="doc-biblioref" data-xml-rid="bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48" aria-controls="sref48">Hale et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref48"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Hale, J.S. ∙ Youngblood, B. ∙ Latner, D.R. ...</div><div><strong>Distinct memory CD4+ T&nbsp;cells with commitment to T follicular helper- and T helper 1-cell lineages are generated after acute viral infection</strong></div><div><em>Immunity.</em> 2013; <strong>38</strong>:805-817</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.S.HaleB.YoungbloodD.R.LatnerA.U.MohammedL.YeR.S.AkondyT.WuS.S.IyerR.AhmedDistinct+memory+CD4%2B+T%C2%A0cells+with+commitment+to+T+follicular+helper-+and+T+helper+1-cell+lineages+are+generated+after+acute+viral+infectionImmunity382013805817" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref84" href="#" role="doc-biblioref" data-xml-rid="bib84" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref84" aria-controls="sref84">Marshall et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref84"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">85.</div><div>Marshall, H.D. ∙ Chandele, A. ∙ Jung, Y.W. ...</div><div><strong>Differential expression of Ly6C and T-bet distinguish effector and memory Th1 CD4(+) cell properties during viral infection</strong></div><div><em>Immunity.</em> 2011; <strong>35</strong>:633-646</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=H.D.MarshallA.ChandeleY.W.JungH.MengA.C.PoholekI.A.ParishR.RutishauserW.CuiS.H.KleinsteinJ.CraftS.M.KaechDifferential+expression+of+Ly6C+and+T-bet+distinguish+effector+and+memory+Th1+CD4%28%2B%29+cell+properties+during+viral+infectionImmunity352011633646" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref148-2" href="#" role="doc-biblioref" data-xml-rid="bib148" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref148-2" aria-controls="sref148-2">Weinstein et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref148-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">149.</div><div>Weinstein, J.S. ∙ Laidlaw, B.J. ∙ Lu, Y. ...</div><div><strong>STAT4 and T-bet control follicular helper T&nbsp;cell development in viral infections</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2018; <strong>215</strong>:337-355</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.S.WeinsteinB.J.LaidlawY.LuJ.K.WangV.P.SchulzN.LiE.I.HermanS.M.KaechP.G.GallagherJ.CraftSTAT4+and+T-bet+control+follicular+helper+T%C2%A0cell+development+in+viral+infectionsJ.%C2%A0Exp.+Med.2152018337355" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref153" href="#" role="doc-biblioref" data-xml-rid="bib153" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref153" aria-controls="sref153">Yamanouchi et&nbsp;al., 1998</a><div class="dropBlock__holder" data-db-target-of="sref153"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">154.</div><div>Yamanouchi, S. ∙ Kuwahara, K. ∙ Sakata, A. ...</div><div><strong>A T&nbsp;cell activation antigen, Ly6C, induced on CD4+ Th1 cells mediates an inhibitory signal for secretion of IL-2 and proliferation in peripheral immune responses</strong></div><div><em>Eur. J. Immunol.</em> 1998; <strong>28</strong>:696-707</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.YamanouchiK.KuwaharaA.SakataT.EzakiS.MatsuokaJ.MiyazakiS.HiroseT.TamuraH.NariuchiN.SakaguchiA+T%C2%A0cell+activation+antigen%2C+Ly6C%2C+induced+on+CD4%2B+Th1+cells+mediates+an+inhibitory+signal+for+secretion+of+IL-2+and+proliferation+in+peripheral+immune+responsesEur.+J.+Immunol.281998696707" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref157" href="#" role="doc-biblioref" data-xml-rid="bib157" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref157" aria-controls="sref157">Zander et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref157"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">158.</div><div>Zander, R.A. ∙ Vijay, R. ∙ Pack, A.D. ...</div><div><strong>Th1-like Plasmodium-Specific Memory CD4<sup>+</sup> T Cells Support Humoral Immunity</strong></div><div><em>Cell Rep.</em> 2018; <strong>23</strong>:1230-1237</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.A.ZanderR.VijayA.D.PackJ.J.GuthmillerA.C.GrahamS.E.LindnerA.M.VaughanS.H.I.KappeN.S.ButlerTh1-like+Plasmodium-Specific+Memory+CD4%2B+T+Cells+Support+Humoral+ImmunityCell+Rep.23201812301237" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Compared to the transferred SMARTA CD4 T&nbsp;cells, the endogenous GP66-specific T&nbsp;cells in CD4-Cre Bcl6<sup>fl/fl</sup> mice had increased frequencies of both PSGL1<sup>hi</sup> Ly6C<sup>lo</sup> and PSGL1<sup>hi</sup> Ly6C<sup>hi</sup> TH1-like cells, the latter of which expressed higher amounts of T-bet than their TFH counterparts (<a id="crosref0885" href="#fig3">Figures 3</a>H, 3I, <a id="crosref0890" href="#figs5">S5</a>G, and S5H). Similar results were seen from endogenous GP66-specific T&nbsp;cells in CD4-Cre Bcl6<sup>fl/fl</sup> mice that had not received SMARTA CD4 T&nbsp;cells.</div></section><section id="sec-2-6"><h3>TFH cells, B cells, and B cell-recognized neoantigens are critical for anti-tumor effector CD8 T&nbsp;cell responses</h3><div id="p0115" role="paragraph">Given that differences in tumor growth were apparent between WT mice and B or T&nbsp;cell-deficient mice at relatively early time points after tumor implant (8–12&nbsp;days), we focused on whether CD8 T&nbsp;cells were impacted by B and T&nbsp;cell deficiency. First, we determined whether CD8 T&nbsp;cells were necessary for optimal tumor control in our model by examining KP-HELLO tumor growth in B6 mice with or without anti-CD8a antibody depletion. CD8 T&nbsp;cell depletion was efficient (data not shown) and led to impaired tumor control in mice (<a id="crosref0895" href="#fig4">Figure&nbsp;4</a>A). We next examined the impact of TFH deficiency on CD8 T&nbsp;cells. In KP-HELLO tumor-bearing WT mice, ∼40% of the tumor-infiltrating CD8 T&nbsp;cells were granzyme B<sup>hi</sup>, consistent with an effector phenotype (<a id="crosref0900" href="#fig4">Figure&nbsp;4</a>B). In line with this, most of these granzyme B<sup>hi</sup> cells expressed PD-1. In comparison, TFH-deficient mice had a significant reduction in the frequency and number of tumor-infiltrating PD-1<sup>hi</sup> granzyme B<sup>hi</sup> CD8 T&nbsp;cells (<a id="crosref0905" href="#fig4">Figure&nbsp;4</a>B, see <a id="crosref0910" href="#fig6">Figures 6</a>O–6P for further quantification). Similarly, there was a significant reduction in the frequency and number of tumor-infiltrating PD-1<sup>hi</sup> granzyme B<sup>hi</sup> CD8 T&nbsp;cells in uMT mice (<a id="crosref0915" href="#fig4">Figures 4</a>C–4E). These data supported a model where TFH cells and B cells support the function of tumor-infiltrating CD8 T&nbsp;cells, but to test this further, we compared CD8 T&nbsp;cell function in WT and uMT KP-NINJA tumor-bearing mice, because these tumors did not elicit TFH or GC B cell responses. Critically, B cell-deficiency did not impact granzyme B expression by tumor-infiltrating CD8 T&nbsp;cells in KP-NINJA tumors (<a id="crosref0920" href="#fig4">Figures 4</a>F–4H). These data demonstrated that B cell antigens can drive effector CD8 T&nbsp;cell responses via a TFH cell- and B cell-dependent mechanism.</div><div class="figure-wrap"><figure id="fig4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.007/asset/d258f2b9-79f6-4dc7-a1f7-4b2a261188f3/main.assets/gr4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr4" src="/cms/10.1016/j.cell.2021.11.007/asset/7a537c23-f45e-452e-80b0-a014a22c6c08/main.assets/gr4.jpg" height="553" width="507" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/d258f2b9-79f6-4dc7-a1f7-4b2a261188f3/main.assets/gr4_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig4-title" class="figure__title"><span class="label figure__label">Figure&nbsp;4</span> <span class="figure__title__text">TFH and B cells are critical to drive anti-tumor effector CD8 T&nbsp;cell responses</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig4-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0160" role="paragraph">(A) Control and anti-CD8a treated C57BL/6 mice were s.c. implanted with 2&nbsp;× 10<sup>5</sup> KP-HELLO. Growth curve of C57BL/6 (n&nbsp;= 40), pooled from 8 independent experiments, was set as the baseline of analyses.</div><div id="fspara0165" role="paragraph">(B) Representative flow plots of tumor-infiltrating PD1<sup>hi</sup> Granzyme B<sup>hi</sup> CD8 T&nbsp;cells from KP-HELLO tumors in C57BL/6 or CD4-Cre Bcl6<sup>fl/fl</sup> mice, further quantified in <a id="crosref1895" href="#fig6">Figures 6</a>O and 6P.</div><div id="fspara0170" role="paragraph">(C–E) Representative flow plots (C), frequency (D), and number/mg tumor (E) of tumor-infiltrating PD1<sup>hi</sup> granzyme B<sup>hi</sup> CD8 T&nbsp;cells from KP-HELLO tumors in C57BL/6 or uMT mice.</div><div id="fspara0175" role="paragraph">(F–H) Representative flow plots (F), frequency (G), and number/mg tumor (H) of tumor-infiltrating PD1<sup>hi</sup> granzyme B<sup>hi</sup> CD8 T&nbsp;cells from KP-NINJA tumors in C57BL/6 or uMT mice.</div><div id="fspara0180" role="paragraph">Data (mean ± SD) were pooled from 3–5 mice/group/experiment and representative of at least 2 independent experiments. Tumors were harvested on days 15–16. (A) Two-way ANOVA. (D, E, G, and H) Unpaired t test with Welch’s correction. <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001.</div><div id="fspara0185" role="paragraph">See also <a id="crosref1900" href="#figs6">Figure&nbsp;S6</a>.</div></div></div></div></figcaption></figure></div></section><section id="sec-2-7"><h3>B cells are required to drive effective TFH and CD8 T&nbsp;cell responses in autochthonous tumors</h3><div id="p0120" role="paragraph">In addition to s.c. implant tumor model, we also tested whether TFH and CD8 T&nbsp;cell responses required the presence of B cells in the autochthonous Kras<sup>LSL-G12D</sup>;Trp53<sup>fl/fl</sup> (KP) mouse LUAD model. KP tumors recapitulate cancers that lack neoantigens (<span class="dropBlock reference-citations"><a id="body-ref-sref87-2" href="#" role="doc-biblioref" data-xml-rid="bib87" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref87-2" aria-controls="sref87-2">McFadden et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref87-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">88.</div><div>McFadden, D.G. ∙ Politi, K. ∙ Bhutkar, A. ...</div><div><strong>Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinoma</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2016; <strong>113</strong>:E6409-E6417</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.G.McFaddenK.PolitiA.BhutkarF.K.ChenX.SongM.PirunP.M.SantiagoC.Kim-KiselakJ.T.PlattE.LeeMutational+landscape+of+EGFR-%2C+MYC-%2C+and+Kras-driven+genetically+engineered+mouse+models+of+lung+adenocarcinomaProc.+Natl.+Acad.+Sci.+USA1132016E6409E6417" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) but have been programmed to express T&nbsp;cell neoantigens using lentiviral vectors (LV) (<span class="dropBlock reference-citations"><a id="body-ref-sref27-2" href="#" role="doc-biblioref" data-xml-rid="bib27" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref27-2" aria-controls="sref27-2">DuPage et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref27-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">28.</div><div>DuPage, M. ∙ Cheung, A.F. ∙ Mazumdar, C. ...</div><div><strong>Endogenous T&nbsp;cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression</strong></div><div><em>Cancer Cell.</em> 2011; <strong>19</strong>:72-85</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.DuPageA.F.CheungC.MazumdarM.M.WinslowR.BronsonL.M.SchmidtD.CrowleyJ.ChenT.JacksEndogenous+T%C2%A0cell+responses+to+antigens+expressed+in+lung+adenocarcinomas+delay+malignant+tumor+progressionCancer+Cell1920117285" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref62-1" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-1" aria-controls="sref62-1">Joshi et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref62-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>Joshi, N.S. ∙ Akama-Garren, E.H. ∙ Lu, Y. ...</div><div><strong>Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses</strong></div><div><em>Immunity.</em> 2015; <strong>43</strong>:579-590</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.S.JoshiE.H.Akama-GarrenY.LuD.Y.LeeG.P.ChangA.LiM.DuPageT.TammelaN.R.KerperA.F.FaragoRegulatory+T+Cells+in+Tumor-Associated+Tertiary+Lymphoid+Structures+Suppress+Anti-tumor+T+Cell+ResponsesImmunity432015579590" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref106" href="#" role="doc-biblioref" data-xml-rid="bib106" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref106" aria-controls="sref106">Pfirschke et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref106"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">107.</div><div>Pfirschke, C. ∙ Engblom, C. ∙ Rickelt, S. ...</div><div><strong>Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy</strong></div><div><em>Immunity.</em> 2016; <strong>44</strong>:343-354</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.PfirschkeC.EngblomS.RickeltV.Cortez-RetamozoC.GarrisF.PucciT.YamazakiV.Poirier-ColameA.NewtonY.RedouaneImmunogenic+Chemotherapy+Sensitizes+Tumors+to+Checkpoint+Blockade+TherapyImmunity442016343354" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Thus, we engineered non-replicating Lenti-HELLO-Cre LV, encoding both the HELLO fusion protein and Cre recombinase, and administered them intratracheally into KP and B cell-deficient uMT-KP mice (<a id="crosref0945" href="#figs6">Figure&nbsp;S6</a>A). This resulted in autochthonous HELLO-expressing lung tumors for analysis after 8&nbsp;weeks. The lungs of mice are highly vascularized, so to distinguish lung tissue-infiltrating immune cells from circulating cells for flow cytometric analyses, we performed <i>in&nbsp;vivo</i>-labeling of circulating immune cells with PE-CF594 conjugated anti-CD45 (lung-tissue immune cells are CD45i.v.<sup>Neg</sup>) (<a id="crosref0950" href="#figs6">Figure&nbsp;S6</a>B). In non-tumor-bearing mice, &lt;1% of B, CD4 T, and CD8 T&nbsp;cells were in lung tissue, but in HELLO tumor-bearing mice, this increased to ∼13% of B cells, ∼60% of CD4 T&nbsp;cells, and ∼40% of CD8 T&nbsp;cells (<a id="crosref0955" href="#figs6">Figure&nbsp;S6</a>C). Endogenous GP66-specific mature TFH cells were observed in the tumor lung tissues and dLNs of HELLO tumor-bearing KP mice, but not in uMT-KP mice (<a id="crosref0960" href="#figs6">Figure&nbsp;S6</a>D). Likewise, analysis of activated CD19<sup>+</sup> B220<sup>+</sup> IgD<sup>lo</sup> B cells showed ∼2% and ∼50% of these cells expressed GC B cell markers (IgD<sup>lo</sup> GL7<sup>+</sup> CD95<sup>+</sup> Bcl6<sup>hi</sup>) in lung and dLN, respectively (<a id="crosref0965" href="#figs6">Figure&nbsp;S6</a>E). Finally, the absence of B cells led to a significant drop in tumor-infiltrating CD44<sup>hi</sup> PD1<sup>hi</sup> effector CD8 T&nbsp;cells (<a id="crosref0970" href="#figs6">Figure&nbsp;S6</a>F). These data were consistent with our findings in s.c. implanted KP-HELLO tumors.</div><div class="figure-wrap"><figure id="figs6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.007/asset/3b8dd9c4-17cc-4025-9aaa-9db2154f50b9/main.assets/figs6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs6" src="/cms/10.1016/j.cell.2021.11.007/asset/92a8a0f7-5080-49e4-8f71-fae83fafa0f8/main.assets/figs6.jpg" height="467" width="753" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/3b8dd9c4-17cc-4025-9aaa-9db2154f50b9/main.assets/figs6_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs6-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S6</span> <span class="figure__title__text">B cells are required to drive tumor-specific TFH cell responses and tumor-infiltrating effector CD8 T&nbsp;cell responses in KP-HELLO autochthonous lung tumor model, related to <a id="crosref1965" href="#fig2">Figures 2</a>, <a id="crosref1970" href="#fig3">3</a>, and <a id="crosref1975" href="#fig4">4</a> and <a id="crosref1980" href="#sec-4">STAR Methods</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs6-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0395" role="paragraph">A, Design of KP-HELLO autochthonous lung tumor model. KP or uMT-KP mice were intratracheally infected with 5&nbsp;× 10<sup>4</sup> PFU Lenti-HELLO-Cre. Tumor lung tissues and dLNs were harvested at 8&nbsp;weeks post-infection.</div><div id="fspara0400" role="paragraph">B, Diagram showing the technique to label circulating immune cells in lung tissues for flow cytometric analyses. 2–3&nbsp;minutes prior to sacrifice, PE-CF594-conjugated CD45 antibodies were injected intravenously. Immune cells in circulation were labeled, while the time was not enough for antibodies to diffuse into tissue and bind to tumor-infiltrating immune cells.</div><div id="fspara0405" role="paragraph">C, Gating strategy and representative histogram of CD45-PE-CF594 (<i>in&nbsp;vivo</i> labeling) showing tissue-infiltrating B cells, CD4 T&nbsp;cells and CD8 T&nbsp;cells in non-tumor-bearing mice, or tumor-bearing KP and uMT-KP mice.</div><div id="fspara0410" role="paragraph">D, Representative flow plots and frequency of GP66-specific CD4 TFH cells (CD44<sup>hi</sup> PSGL1<sup>lo</sup> PD1<sup>hi</sup> CXCR5<sup>hi</sup>) from tumor lung tissues and dLNs of KP or uMT-KP mice. Flow plots were pre-gated on CD45i.v.<sup>Neg</sup> TCRb<sup>+</sup> CD4<sup>+</sup> GP66-tetramer<sup>+</sup> CD44<sup>hi</sup> PSGL1<sup>lo</sup>.</div><div id="fspara0415" role="paragraph">E, Representative flow plots showing GC B cells in tumor lung tissues and dLNs of KP mice (pre-gated on CD45i.v.<sup>Neg</sup> CD19<sup>+</sup> B220<sup>+</sup> IgD<sup>lo</sup>).</div><div id="fspara0420" role="paragraph">F, Representative flow plots and frequency of tumor-infiltrating CD44<sup>hi</sup> PD1<sup>hi</sup> CD8<sup>+</sup> T&nbsp;cells in KP or uMT-KP mice.</div><div id="fspara0425" role="paragraph">Data (mean ± SD) were pooled, from 3–10 mice/group/experiment, and representative of at least 2 independent experiments. D – F, Unpaired t test with Welch’s correction. <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001.</div></div></div></div></figcaption></figure></div></section><section id="sec-2-8"><h3>TFH- and B cell-dependent IL-21 production is required for robust effector CD8 T&nbsp;cell responses in KP-HELLO tumors</h3><div id="p0125" role="paragraph">We next investigated the mechanism for how TFH and B cells promote the effector functions of tumor-infiltrating CD8 T&nbsp;cells. We reasoned this could be via IL-21, a signature cytokine of TFH cells (<span class="dropBlock reference-citations"><a id="body-ref-sref20-3" href="#" role="doc-biblioref" data-xml-rid="bib20" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref20-3" aria-controls="sref20-3">Crotty, 2011</a><div class="dropBlock__holder" data-db-target-of="sref20-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">21.</div><div>Crotty, S.</div><div><strong>Follicular helper CD4 T&nbsp;cells (TFH)</strong></div><div><em>Annu. Rev. Immunol.</em> 2011; <strong>29</strong>:621-663</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.CrottyFollicular+helper+CD4+T%C2%A0cells+%28TFH%29Annu.+Rev.+Immunol.292011621663" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) that can drive effector function of CD8 T&nbsp;cells (<span class="dropBlock reference-citations"><a id="body-ref-sref158-2" href="#" role="doc-biblioref" data-xml-rid="bib158" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref158-2" aria-controls="sref158-2">Zander et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref158-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">159.</div><div>Zander, R. ∙ Schauder, D. ∙ Xin, G. ...</div><div><strong>CD4<sup>+</sup> T Cell Help Is Required for the Formation of a Cytolytic CD8<sup>+</sup> T Cell Subset that Protects against Chronic Infection and Cancer</strong></div><div><em>Immunity.</em> 2019; <strong>51</strong>:1028-1042.e4</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.ZanderD.SchauderG.XinC.NguyenX.WuA.ZajacW.CuiCD4%2B+T+Cell+Help+Is+Required+for+the+Formation+of+a+Cytolytic+CD8%2B+T+Cell+Subset+that+Protects+against+Chronic+Infection+and+CancerImmunity51201910281042.e4" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We first examined which cells in the dLN express IL-21 by s.c. implanting KP-HELLO into <i>Il21-Katushka</i> (<i>Kat</i>) reporter mice (<span class="dropBlock reference-citations"><a id="body-ref-sref147-1" href="#" role="doc-biblioref" data-xml-rid="bib147" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref147-1" aria-controls="sref147-1">Weinstein et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref147-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">148.</div><div>Weinstein, J.S. ∙ Herman, E.I. ∙ Lainez, B. ...</div><div><strong>TFH cells progressively differentiate to regulate the germinal center response</strong></div><div><em>Nat. Immunol.</em> 2016; <strong>17</strong>:1197-1205</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.S.WeinsteinE.I.HermanB.LainezP.Licona-Lim%C3%B3nE.EspluguesR.FlavellJ.CraftTFH+cells+progressively+differentiate+to+regulate+the+germinal+center+responseNat.+Immunol.17201611971205" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). IL-21 expression was only detected from mice with KP-HELLO tumors, but not KP tumors, demonstrating that IL-21 expression required the presence of the HELLO neoantigens (<a id="crosref0990" href="#fig5">Figure&nbsp;5</a>A). Greater than 95% of the IL-21 expressing cells were CD4 T&nbsp;cells and ∼85% of these were PSGL1<sup>lo</sup> with ∼70% expressing mature TFH cell markers (<a id="crosref0995" href="#fig5">Figure&nbsp;5</a>A). We next addressed whether IL-21 expression on T&nbsp;cells was B cell-dependent using <i>Il21</i><sup><i>Kat/Kat</i></sup> x uMT mice. In the absence of B cells, we observed ∼70% reduction in the frequency of IL-21-expressing GP66-specific CD44<sup>hi</sup> CD4 T&nbsp;cells in dLNs and ∼35% reduction in tumors (<a id="crosref1000" href="#fig5">Figures 5</a>B and 5C). Likewise, B cell-recognized neoantigens were required for IL-21 expression as KP-NINJA tumors exhibited ∼70% reduction in the frequency of IL-21 expressing GP66-specific CD44<sup>hi</sup> CD4 T&nbsp;cells (<a id="crosref1005" href="#fig5">Figures 5</a>D and 5E). Thus, the induction and/or maintenance of IL-21 in TFH cells by tumors required B cells and B cell-recognized neoantigens.</div><div class="figure-wrap"><figure id="fig5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.007/asset/86eec7af-fa14-479d-853a-2e8bcca6a0c6/main.assets/gr5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr5" src="/cms/10.1016/j.cell.2021.11.007/asset/ff8b9428-9d27-4b20-b642-60c367d20692/main.assets/gr5.jpg" height="718" width="753" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/86eec7af-fa14-479d-853a-2e8bcca6a0c6/main.assets/gr5_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig5-title" class="figure__title"><span class="label figure__label">Figure&nbsp;5</span> <span class="figure__title__text">IL-21 production is dependent on B cells and B cell-recognized neoantigens and is required for effector CD8 T&nbsp;cell responses</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig5-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0195" role="paragraph">(A) Representative flow plots showing IL-21-producing cells in dLNs of KP or KP-HELLO tumor-bearing mice.</div><div id="fspara0200" role="paragraph">(B and C) Representative flow plots (B) and frequency (C) of IL-21 producers in GP66-specific CD44<sup>hi</sup> CD4 T&nbsp;cells from dLNs and tumors of KP-HELLO tumor-bearing WT or uMT mice.</div><div id="fspara0205" role="paragraph">(D and E) Representative flow plots (D) and frequency (E) of IL-21 producers in GP66-specific CD44<sup>hi</sup> CD4 T&nbsp;cells from dLNs of KP-HELLO or KP-NINJA tumor-bearing WT mice</div><div id="fspara0210" role="paragraph">(F) IL-21 receptor expression on CD8 T&nbsp;cell subsets from dLNs and tumors of KP-HELLO tumor-bearing mice. Gate was drawn based on FMO in CD44<sup>hi</sup> PD1<sup>hi</sup> tumor-infiltrating CD8 T&nbsp;cells.</div><div id="fspara0215" role="paragraph">(G) Tumor growth curves: C57BL/6 and IL21R KO mice were s.c. implanted with 2&nbsp;× 10<sup>5</sup> KP-HELLO. Growth curve of C57BL/6 (n&nbsp;= 40), pooled from 8 independent experiments, was set as the baseline of analyses.</div><div id="fspara0220" role="paragraph">(H–J) Representative flow plots (H), frequency (I) and number/mg tumor (J) of tumor-infiltrating PD1<sup>hi</sup> granzyme B<sup>hi</sup> CD8 T&nbsp;cells from KP-HELLO tumors in C57BL/6 or IL21R KO mice.</div><div id="fspara0225" role="paragraph">Data (mean ± SD) were pooled from 3–10 mice/group/experiment and were representative of at least 2 independent experiments. (C, E, I, and J) Unpaired t test with Welch’s correction. (G) Two-way ANOVA. <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001.</div></div></div></div></figcaption></figure></div><div id="p0130" role="paragraph">The receptor for IL-21 (IL21R) was expressed on CD44<sup>hi</sup> PD1<sup>hi</sup> effector CD8 T&nbsp;cells in both tumors and dLNs (<a id="crosref1010" href="#fig5">Figure&nbsp;5</a>F). To test if IL-21 was important for KP-HELLO tumor growth, we s.c. implanted KP-HELLO tumor cells into B6 or IL-21R KO mice. KP-HELLO tumors grew more rapidly in IL-21R KO than B6 mice (<a id="crosref1015" href="#fig5">Figure&nbsp;5</a>G). There was also an ∼60% and ∼80% reduction in the frequency and number of PD-1<sup>hi</sup> granzyme B<sup>hi</sup> tumor-infiltrating CD8 T&nbsp;cells in IL-21R KO mice, respectively (<a id="crosref1020" href="#fig5">Figures 5</a>H–5J). These findings were in line with data from other groups showing that IL-21 acts on CD8 T&nbsp;cells to drive the effector functions (<span class="dropBlock reference-citations"><a id="body-ref-sref29-2" href="#" role="doc-biblioref" data-xml-rid="bib29" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref29-2" aria-controls="sref29-2">Elsaesser et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref29-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">30.</div><div>Elsaesser, H. ∙ Sauer, K. ∙ Brooks, D.G.</div><div><strong>IL-21 is required to control chronic viral infection</strong></div><div><em>Science.</em> 2009; <strong>324</strong>:1569-1572</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=H.ElsaesserK.SauerD.G.BrooksIL-21+is+required+to+control+chronic+viral+infectionScience324200915691572" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref36-2" href="#" role="doc-biblioref" data-xml-rid="bib36" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref36-2" aria-controls="sref36-2">Fröhlich et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref36-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">37.</div><div>Fröhlich, A. ∙ Kisielow, J. ∙ Schmitz, I. ...</div><div><strong>IL-21R on T&nbsp;cells is critical for sustained functionality and control of chronic viral infection</strong></div><div><em>Science.</em> 2009; <strong>324</strong>:1576-1580</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.Fr%C3%B6hlichJ.KisielowI.SchmitzS.FreigangA.T.ShamshievJ.WeberB.J.MarslandA.OxeniusM.KopfIL-21R+on+T%C2%A0cells+is+critical+for+sustained+functionality+and+control+of+chronic+viral+infectionScience324200915761580" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref75-1" href="#" role="doc-biblioref" data-xml-rid="bib75" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref75-1" aria-controls="sref75-1">Li et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref75-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">76.</div><div>Li, Y. ∙ Cong, Y. ∙ Jia, M. ...</div><div><strong>Targeting IL-21 to tumor-reactive T&nbsp;cells enhances memory T&nbsp;cell responses and anti-PD-1 antibody therapy</strong></div><div><em>Nat. Commun.</em> 2021; <strong>12</strong>:951</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Y.LiY.CongM.JiaQ.HeH.ZhongY.ZhaoH.LiM.YanJ.YouJ.LiuTargeting+IL-21+to+tumor-reactive+T%C2%A0cells+enhances+memory+T%C2%A0cell+responses+and+anti-PD-1+antibody+therapyNat.+Commun.122021951" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref131-2" href="#" role="doc-biblioref" data-xml-rid="bib131" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref131-2" aria-controls="sref131-2">Snell et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref131-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">132.</div><div>Snell, L.M. ∙ MacLeod, B.L. ∙ Law, J.C. ...</div><div><strong>CD8<sup>+</sup> T Cell Priming in Established Chronic Viral Infection Preferentially Directs Differentiation of Memory-like Cells for Sustained Immunity</strong></div><div><em>Immunity.</em> 2018; <strong>49</strong>:678-694.e5</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=L.M.SnellB.L.MacLeodJ.C.LawI.OsokineH.J.ElsaesserK.HezavehR.J.DicksonM.A.GavinC.J.GuidosT.L.McGahaD.G.BrooksCD8%2B+T+Cell+Priming+in+Established+Chronic+Viral+Infection+Preferentially+Directs+Differentiation+of+Memory-like+Cells+for+Sustained+ImmunityImmunity492018678694.e5" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref154-2" href="#" role="doc-biblioref" data-xml-rid="bib154" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref154-2" aria-controls="sref154-2">Yi et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref154-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">155.</div><div>Yi, J.S. ∙ Du, M. ∙ Zajac, A.J.</div><div><strong>A vital role for interleukin-21 in the control of a chronic viral infection</strong></div><div><em>Science.</em> 2009; <strong>324</strong>:1572-1576</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.S.YiM.DuA.J.ZajacA+vital+role+for+interleukin-21+in+the+control+of+a+chronic+viral+infectionScience324200915721576" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref158-3" href="#" role="doc-biblioref" data-xml-rid="bib158" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref158-3" aria-controls="sref158-3">Zander et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref158-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">159.</div><div>Zander, R. ∙ Schauder, D. ∙ Xin, G. ...</div><div><strong>CD4<sup>+</sup> T Cell Help Is Required for the Formation of a Cytolytic CD8<sup>+</sup> T Cell Subset that Protects against Chronic Infection and Cancer</strong></div><div><em>Immunity.</em> 2019; <strong>51</strong>:1028-1042.e4</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.ZanderD.SchauderG.XinC.NguyenX.WuA.ZajacW.CuiCD4%2B+T+Cell+Help+Is+Required+for+the+Formation+of+a+Cytolytic+CD8%2B+T+Cell+Subset+that+Protects+against+Chronic+Infection+and+CancerImmunity51201910281042.e4" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and confirmed the critical role of IL-21 in potentiating anti-tumor CD8 T&nbsp;cell responses in KP-HELLO tumors.</div></section><section id="sec-2-9"><h3>Interactions of TFH and B cells are required to induce anti-tumor immune response</h3><div id="p0135" role="paragraph">To close the loop between TFH, B cells, IL-21 signals, and effector CD8 T&nbsp;cell responses, we first assessed whether T&nbsp;cell-B cell interactions were necessary for anti-tumor immunity. In T-dependent immune responses, CD40/CD40L-deficient and ICOS/ICOSL-deficient mice are not able to form GC B cells or mature TFH cells due to defects in the ability of T&nbsp;cells and B cells to provide mutual help (<span class="dropBlock reference-citations"><a id="body-ref-sref14" href="#" role="doc-biblioref" data-xml-rid="bib14" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref14" aria-controls="sref14">Choi et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref14"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">15.</div><div>Choi, Y.S. ∙ Kageyama, R. ∙ Eto, D. ...</div><div><strong>ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6</strong></div><div><em>Immunity.</em> 2011; <strong>34</strong>:932-946</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Y.S.ChoiR.KageyamaD.EtoT.C.EscobarR.J.JohnstonL.MonticelliC.LaoS.CrottyICOS+receptor+instructs+T+follicular+helper+cell+versus+effector+cell+differentiation+via+induction+of+the+transcriptional+repressor+Bcl6Immunity342011932946" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref59" href="#" role="doc-biblioref" data-xml-rid="bib59" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref59" aria-controls="sref59">Ise et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref59"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">60.</div><div>Ise, W. ∙ Fujii, K. ∙ Shiroguchi, K. ...</div><div><strong>T Follicular Helper Cell-Germinal Center B Cell Interaction Strength Regulates Entry into Plasma Cell or Recycling Germinal Center Cell Fate</strong></div><div><em>Immunity.</em> 2018; <strong>48</strong>:702-715.e4</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=W.IseK.FujiiK.ShiroguchiA.ItoK.KometaniK.TakedaE.KawakamiK.YamashitaK.SuzukiT.OkadaT.KurosakiT+Follicular+Helper+Cell-Germinal+Center+B+Cell+Interaction+Strength+Regulates+Entry+into+Plasma+Cell+or+Recycling+Germinal+Center+Cell+FateImmunity482018702715.e4" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref78" href="#" role="doc-biblioref" data-xml-rid="bib78" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref78" aria-controls="sref78">Liu et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref78"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">79.</div><div>Liu, D. ∙ Xu, H. ∙ Shih, C. ...</div><div><strong>T-B-cell entanglement and ICOSL-driven feed-forward regulation of germinal centre reaction</strong></div><div><em>Nature.</em> 2015; <strong>517</strong>:214-218</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.LiuH.XuC.ShihZ.WanX.MaW.MaD.LuoH.QiT-B-cell+entanglement+and+ICOSL-driven+feed-forward+regulation+of+germinal+centre+reactionNature5172015214218" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref98-2" href="#" role="doc-biblioref" data-xml-rid="bib98" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref98-2" aria-controls="sref98-2">Nurieva et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref98-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">99.</div><div>Nurieva, R.I. ∙ Chung, Y. ∙ Hwang, D. ...</div><div><strong>Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages</strong></div><div><em>Immunity.</em> 2008; <strong>29</strong>:138-149</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.I.NurievaY.ChungD.HwangX.O.YangH.S.KangL.MaY.H.WangS.S.WatowichA.M.JettenQ.TianC.DongGeneration+of+T+follicular+helper+cells+is+mediated+by+interleukin-21+but+independent+of+T+helper+1%2C+2%2C+or+17+cell+lineagesImmunity292008138149" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref114" href="#" role="doc-biblioref" data-xml-rid="bib114" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref114" aria-controls="sref114">Renshaw et&nbsp;al., 1994</a><div class="dropBlock__holder" data-db-target-of="sref114"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">115.</div><div>Renshaw, B.R. ∙ Fanslow, 3rd, W.C. ∙ Armitage, R.J. ...</div><div><strong>Humoral immune responses in CD40 ligand-deficient mice</strong></div><div><em>J.&nbsp;Exp. Med.</em> 1994; <strong>180</strong>:1889-1900</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=B.R.RenshawW.C.Fanslow3rdR.J.ArmitageK.A.CampbellD.LiggittB.WrightB.L.DavisonC.R.MaliszewskiHumoral+immune+responses+in+CD40+ligand-deficient+miceJ.%C2%A0Exp.+Med.180199418891900" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref159" href="#" role="doc-biblioref" data-xml-rid="bib159" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref159" aria-controls="sref159">Zhang et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref159"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">160.</div><div>Zhang, B. ∙ Liu, E. ∙ Gertie, J.A. ...</div><div><strong>Divergent T follicular helper cell requirement for IgA and IgE production to peanut during allergic sensitization</strong></div><div><em>Sci. Immunol.</em> 2020; <strong>5</strong>:eaay2754</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=B.ZhangE.LiuJ.A.GertieJ.JosephL.XuE.Y.PinkerD.A.WaizmanJ.CatanzaroK.H.HamzaK.LahlDivergent+T+follicular+helper+cell+requirement+for+IgA+and+IgE+production+to+peanut+during+allergic+sensitizationSci.+Immunol.52020eaay2754" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Deficiencies in ICOS and CD40L led to more rapid growth of KP-HELLO tumors, on par with the changes observed in uMT mice (<a id="crosref1085" href="#fig6">Figures 6</a>A and 6B). Mature TFH and GC B cell responses were impaired in ICOS-deficient mice (data not shown). ICOS deficiency could impact many cell types, but adoptive transfer of WT SMARTA T&nbsp;cells into ICOS-deficient hosts rescued KP-HELLO tumor control, whereas transfer of OT-II T&nbsp;cells did not (<a id="crosref1090" href="#fig6">Figure&nbsp;6</a>C). These data are consistent with the idea that T&nbsp;cell and B cell interactions are necessary for control over the growth of KP-HELLO tumors.</div><div class="figure-wrap"><figure id="fig6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.007/asset/4cec0ded-a475-4dcc-85f5-592120898cd1/main.assets/gr6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr6" src="/cms/10.1016/j.cell.2021.11.007/asset/e6b0aa8e-c5b4-400e-a7b0-3e712f00d11b/main.assets/gr6.jpg" height="716" width="753" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/4cec0ded-a475-4dcc-85f5-592120898cd1/main.assets/gr6_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig6-title" class="figure__title"><span class="label figure__label">Figure&nbsp;6</span> <span class="figure__title__text">Collaborations between CD4 T&nbsp;cells and B cells are critical for anti-tumor immune responses</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig6-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0235" role="paragraph">(A and B) Tumor growth curves: C57BL/6, ICOS KO, or CD40L KO mice were s.c. implanted with 2&nbsp;× 10<sup>5</sup> KP-HELLO. Growth curve of C57BL/6 (n&nbsp;= 40), pooled from 8 independent experiments, was set as the baseline of analyses.</div><div id="fspara0240" role="paragraph">(C) 1&nbsp;× 10<sup>5</sup> SMARTA CD4 T&nbsp;cells or OT-II CD4 T&nbsp;cells were adoptively transferred to ICOS KO recipients prior to KP-HELLO s.c. implant. Graph shows tumor volumes on day 16.</div><div id="fspara0245" role="paragraph">(D and E) Representative flow plots (D) and frequency (E) of GC B cells in dLNs of KP-HELLO tumors in C57BL/6, CD4-Cre Bcl6<sup>fl/fl</sup> mice, or CD4-Cre Bcl6<sup>fl/fl</sup> recipients following transfer of 1&nbsp;× 10<sup>5</sup> SMARTA T&nbsp;cells or OT-II T&nbsp;cells (as described in <a id="crosref1905" href="#fig3">Figure&nbsp;3</a>G).</div><div id="fspara0250" role="paragraph">(F and G) Representative flow plots (F) and frequency (G) of GP66-specific CD4 T&nbsp;cell subsets from dLNs of KP-HELLO tumor-bearing WT or uMT mice.</div><div id="fspara0255" role="paragraph">(J and K) Representative flow plots (J) and frequency (K) of GP66-specific CD4 T&nbsp;cell subsets from dLNs of KP-HELLO or KP-NINJA tumor-bearing WT mice.</div><div id="fspara0260" role="paragraph">(H, I, L, and M) Histograms displaying IL-21 or Bcl-6 expression on naive and GP66-specific CD4 T&nbsp;cell subsets. Gating strategy is shown in (F), (J), and <a id="crosref1910" href="#fig3">Figure&nbsp;3</a>D.</div><div id="fspara0265" role="paragraph">(N–P) Representative flow plots (N), frequency (O) and number/mg tumor (P) of tumor-infiltrating PD1<sup>hi</sup> Granzyme B<sup>hi</sup> CD8 T&nbsp;cells from KP-HELLO tumors in C57BL/6, CD4-Cre Bcl6<sup>fl/fl</sup> mice, or CD4-Cre Bcl6<sup>fl/fl</sup> recipients following transfer of 1&nbsp;× 10<sup>5</sup> SMARTA T&nbsp;cells or OT-II T&nbsp;cells (as described in <a id="crosref1915" href="#fig3">Figure&nbsp;3</a>G).</div><div id="fspara0270" role="paragraph">Data (mean ± SD) were pooled, from 3–5 mice/group/experiment, and representative of at least 2 independent experiments. (A and B) Two-way ANOVA. (C, E, G, K, O, and P) Unpaired t test with Welch’s correction. <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001.</div><div id="fspara0275" role="paragraph">See also <a id="crosref1920" href="#figs7">Figure&nbsp;S7</a>.</div></div></div></div></figcaption></figure></div><div id="p0140" role="paragraph">Next, we assessed the impact of SMARTA T&nbsp;cell rescue on B cells and CD8 T&nbsp;cells in TFH-deficient mice, because under this experimental setting, the only functional TFH cells were transferred GP66-specific SMARTA cells (<a id="crosref1095" href="#fig3">Figures 3</a>G–3I). Polyclonal GC B cell responses in CD4-Cre Bcl6<sup>fl/fl</sup> mice were significantly reduced compared to B6 controls and this was rescued by adoptive transfer of SMARTA but not OT-II T&nbsp;cells (<a id="crosref1100" href="#fig6">Figures 6</a>D and 6E). This ∼9-fold increase in polyclonal GC B cell frequency was particularly striking, because the rescue only restored TFH cells with a single specificity (GP66-specific) and was consistent with potent interactions between B cells and tumor-specific TFH cells in KP-HELLO tumor model. To assess the functional role of T&nbsp;cell-B cell interactions, we used flow cytometry to analyze how the differentiation programs of tumor-specific CD4 T&nbsp;cells were altered when tumor-bearing mice lacked B cells (B6 versus uMT), or B cell-recognized neoantigens (KP-HELLO versus KP-NINJA). In both cases, tumor-specific TFH cell responses were significantly compromised (<a id="crosref1105" href="#fig2">Figures 2</a>F, 2G,<a id="crosref1110" href="#fig3">3</a>D, and <a id="crosref1115" href="#figs5">S5</a>E), but there was also a significant reduction of PSGL1<sup>lo</sup> Ly6C<sup>lo</sup> cells (<a id="crosref1120" href="#fig6">Figure&nbsp;6</a>F – 6G and 6J – 6K). These data are consistent with the hypothesis that B cells and B cell-recognized neoantigens control the developmental fates of tumor-specific CD4 T&nbsp;cells by promoting the TFH differentiation program (beginning with downregulation of PSGL1). To assess the impact of T&nbsp;cell-B cell interactions over the course of TFH differentiation, we analyzed Bcl-6 and IL-21 expression at the different stages of CD4 T&nbsp;cell differentiation (based on markers) in B6 versus uMT or KP-HELLO versus KP-NINJA. We found that both Bcl-6 and IL-21 expression were compromised at each stage in the absence of TFH-B cell interactions (<a id="crosref1125" href="#fig6">Figures 6</a>H, 6I, 6L, and 6M, gating strategy in <a id="crosref1130" href="#fig3">3</a>D, <a id="crosref1135" href="#fig6">6</a>F, and 6J). Similar data were seen in mice with MC38 and B16-F10 tumors (<a id="crosref1140" href="#figs7">Figures S7</a>A–S7C). Finally, to assess the functional impact of TFH-B cell interactions on tumor-infiltrating CD8 T&nbsp;cells, we analyzed their phenotypes in the context of rescue of TFH-deficient mice adoptively transferred with WT SMARTA CD4 T&nbsp;cells. The significant decrease in PD-1<sup>hi</sup> granzyme B<sup>hi</sup> among tumor-infiltrating CD8 T&nbsp;cells in TFH-deficient mice was rescued to WT levels by SMARTA T&nbsp;cell transfer, but not by OT-II T&nbsp;cell transfer, both in terms of frequency and number (<a id="crosref1145" href="#fig6">Figures 6</a>N–6P). Thus, the presence of tumor-specific TFH cells was sufficient to drive effector functions in tumor-infiltrating CD8 T&nbsp;cells.</div><div class="figure-wrap"><figure id="figs7" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.007/asset/2c5b72de-0539-4a63-be65-fdf60026d00f/main.assets/figs7_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs7" src="/cms/10.1016/j.cell.2021.11.007/asset/49a6a637-4c59-47a0-9b7b-0c9e87e27e62/main.assets/figs7.jpg" height="193" width="753" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/2c5b72de-0539-4a63-be65-fdf60026d00f/main.assets/figs7_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs7-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S7</span> <span class="figure__title__text">TFH-derived IL-21 in murine tumor models, related to <a id="crosref1985" href="#fig6">Figure&nbsp;6</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs7-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0435" role="paragraph">A – B, Representative flow plots showing IL-21-expressing TFH cells (A) and histogram displaying IL-21 expression through different stages of TFH differentiation (B) in dLNs of MC38 and B16-F10 tumor-bearing mice. Flow cytometric analyses were performed on day 10 – 12.</div><div id="fspara0440" role="paragraph">C, IL-21 expression by TFH cells (CD44<sup>hi</sup> PSGL1<sup>lo</sup> PD1<sup>hi</sup> CXCR5<sup>hi</sup>) in dLNs of KP, MC38, B16-F10 and KP-HELLO tumors.</div><div id="fspara0445" role="paragraph">Data (mean ± SD) were pooled, from 3 – 5 mice/group/experiment, and representative of 2 independent experiments. C, Unpaired t test with Welch’s correction. <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001.</div></div></div></div></figcaption></figure></div></section></section><section id="sec-3"><h2>Discussion</h2><div id="p0145" role="paragraph">We have identified a mechanism by which interactions between tumor-specific CD4 T&nbsp;cells and B cells are necessary for the generation of IL-21-producing TFH cells, and this leads to increased granzyme B expression by tumor-infiltrating CD8 T&nbsp;cells. We provided evidence for this B cell-TFH cell-IL21 axis through analyses of LUAD individuals and animal models. We also demonstrated that this pathway can be driven by B cell-recognized neoantigens, underscoring a mechanism by which tumor neoantigens can guide CD4 T&nbsp;cell differentiation.</div><div id="p0150" role="paragraph">Our findings on tumor-infiltrating TFH cells and GC B cells in human LUAD are in line with previous observations that NSCLC and other cancer types contain tumor-associated TFH-like cells with an enriched TFH signature (i.e., <i>PDCD1</i>, <i>ICOS</i>, <i>CD200</i>, <i>MAF</i>, and <i>IL21</i>) (<span class="dropBlock reference-citations"><a id="body-ref-sref5-3" href="#" role="doc-biblioref" data-xml-rid="bib5" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref5-3" aria-controls="sref5-3">Bindea et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref5-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">6.</div><div>Bindea, G. ∙ Mlecnik, B. ∙ Tosolini, M. ...</div><div><strong>Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer</strong></div><div><em>Immunity.</em> 2013; <strong>39</strong>:782-795</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.BindeaB.MlecnikM.TosoliniA.KirilovskyM.WaldnerA.C.ObenaufH.AngellT.FredriksenL.LafontaineA.BergerSpatiotemporal+dynamics+of+intratumoral+immune+cells+reveal+the+immune+landscape+in+human+cancerImmunity392013782795" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref17-2" href="#" role="doc-biblioref" data-xml-rid="bib17" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref17-2" aria-controls="sref17-2">Cillo et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref17-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">18.</div><div>Cillo, A.R. ∙ Kürten, C.H.L. ∙ Tabib, T. ...</div><div><strong>Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer</strong></div><div><em>Immunity.</em> 2020; <strong>52</strong>:183-199.e9</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.R.CilloC.H.L.K%C3%BCrtenT.TabibZ.QiS.OnkarT.WangA.LiuU.DuvvuriS.KimR.J.SooseImmune+Landscape+of+Viral-+and+Carcinogen-Driven+Head+and+Neck+CancerImmunity522020183199.e9" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref45-2" href="#" role="doc-biblioref" data-xml-rid="bib45" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref45-2" aria-controls="sref45-2">Gu-Trantien et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref45-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">46.</div><div>Gu-Trantien, C. ∙ Loi, S. ∙ Garaud, S. ...</div><div><strong>CD4<sup>+</sup> follicular helper T&nbsp;cell infiltration predicts breast cancer survival</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2013; <strong>123</strong>:2873-2892</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.Gu-TrantienS.LoiS.GaraudC.EqueterM.LibinA.de+WindM.RavoetH.Le+BuanecC.SibilleG.Manfouo-FoutsopCD4%2B+follicular+helper+T%C2%A0cell+infiltration+predicts+breast+cancer+survivalJ.%C2%A0Clin.+Invest.123201328732892" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>, <span class="dropBlock reference-citations"><a id="body-ref-sref46-2" href="#" role="doc-biblioref" data-xml-rid="bib46" href-manipulated="true" aria-label="Reference 2017" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref46-2" aria-controls="sref46-2">2017</a><div class="dropBlock__holder" data-db-target-of="sref46-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">47.</div><div>Gu-Trantien, C. ∙ Migliori, E. ∙ Buisseret, L. ...</div><div><strong>CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer</strong></div><div><em>JCI Insight.</em> 2017; <strong>2</strong>:91487</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.Gu-TrantienE.MiglioriL.BuisseretA.de+WindS.Broh%C3%A9eS.GaraudG.No%C3%ABlV.L.Dang+ChiJ.N.LodewyckxC.NaveauxCXCL13-producing+TFH+cells+link+immune+suppression+and+adaptive+memory+in+human+breast+cancerJCI+Insight2201791487" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref47-2" href="#" role="doc-biblioref" data-xml-rid="bib47" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref47-2" aria-controls="sref47-2">Guo et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref47-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">48.</div><div>Guo, X. ∙ Zhang, Y. ∙ Zheng, L. ...</div><div><strong>Global characterization of T&nbsp;cells in non-small-cell lung cancer by single-cell sequencing</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:978-985</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=X.GuoY.ZhangL.ZhengC.ZhengJ.SongQ.ZhangB.KangZ.LiuL.JinR.XingGlobal+characterization+of+T%C2%A0cells+in+non-small-cell+lung+cancer+by+single-cell+sequencingNat.+Med.242018978985" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref74" href="#" role="doc-biblioref" data-xml-rid="bib74" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref74" aria-controls="sref74">Li et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref74"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">75.</div><div>Li, H. ∙ van der Leun, A.M. ∙ Yofe, I. ...</div><div><strong>Dysfunctional CD8&nbsp;T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma</strong></div><div><em>Cell.</em> 2019; <strong>176</strong>:775-789.e18</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=H.LiA.M.van+der+LeunI.YofeY.LublingD.Gelbard-SolodkinA.C.J.van+AkkooiM.van+den+BraberE.A.RozemanJ.B.A.G.HaanenC.U.BlankDysfunctional+CD8%C2%A0T+Cells+Form+a+Proliferative%2C+Dynamically+Regulated+Compartment+within+Human+MelanomaCell1762019775789.e18" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref96-1" href="#" role="doc-biblioref" data-xml-rid="bib96" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref96-1" aria-controls="sref96-1">Noël et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref96-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">97.</div><div>Noël, G. ∙ Fontsa, M.L. ∙ Garaud, S. ...</div><div><strong>Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2021; <strong>131</strong>:e139905</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.No%C3%ABlM.L.FontsaS.GaraudP.De+SilvaA.de+WindG.G.Van+den+EyndenR.SalgadoA.BoissonH.LocyN.ThomasFunctional+Th1-oriented+T+follicular+helper+cells+that+infiltrate+human+breast+cancer+promote+effective+adaptive+immunityJ.%C2%A0Clin.+Invest.1312021e139905" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref119" href="#" role="doc-biblioref" data-xml-rid="bib119" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref119" aria-controls="sref119">Satpathy et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref119"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">120.</div><div>Satpathy, A.T. ∙ Granja, J.M. ∙ Yost, K.E. ...</div><div><strong>Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral T&nbsp;cell exhaustion</strong></div><div><em>Nat. Biotechnol.</em> 2019; <strong>37</strong>:925-936</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.T.SatpathyJ.M.GranjaK.E.YostY.QiF.MeschiG.P.McDermottB.N.OlsenM.R.MumbachS.E.PierceM.R.CorcesMassively+parallel+single-cell+chromatin+landscapes+of+human+immune+cell+development+and+intratumoral+T%C2%A0cell+exhaustionNat.+Biotechnol.372019925936" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref136" href="#" role="doc-biblioref" data-xml-rid="bib136" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref136" aria-controls="sref136">Thommen et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref136"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">137.</div><div>Thommen, D.S. ∙ Koelzer, V.H. ∙ Herzig, P. ...</div><div><strong>A transcriptionally and functionally distinct PD-1<sup>+</sup> CD8<sup>+</sup> T&nbsp;cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:994-1004</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.S.ThommenV.H.KoelzerP.HerzigA.RollerM.TrefnyS.DimeloeA.KiialainenJ.HanhartC.SchillC.HessA+transcriptionally+and+functionally+distinct+PD-1%2B+CD8%2B+T%C2%A0cell+pool+with+predictive+potential+in+non-small-cell+lung+cancer+treated+with+PD-1+blockadeNat.+Med.2420189941004" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref160" href="#" role="doc-biblioref" data-xml-rid="bib160" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref160" aria-controls="sref160">Zhang et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref160"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">161.</div><div>Zhang, Y. ∙ Chen, H. ∙ Mo, H. ...</div><div><strong>Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer</strong></div><div><em>Cancer Cell.</em> 2021;</div><div>Published online October 5, 2021</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Y.ZhangH.ChenH.MoX.HuR.GaoY.ZhaoB.LiuL.NiuX.SunX.YuSingle-cell+analyses+reveal+key+immune+cell+subsets+associated+with+response+to+PD-L1+blockade+in+triple-negative+breast+cancerCancer+Cell202110.1016%2Fj.ccell.2021.09.010Published+online+October+5%2C+2021" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In human studies including autoimmune diseases, TFH-like cells have been shown to express CXCL13, the ligand of CXCR5, which was associated with CXCR5<sup>+</sup> B cell infiltration and TLS formation (<span class="dropBlock reference-citations"><a id="body-ref-sref6" href="#" role="doc-biblioref" data-xml-rid="bib6" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref6" aria-controls="sref6">Bocharnikov et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">7.</div><div>Bocharnikov, A.V. ∙ Keegan, J. ∙ Wacleche, V.S. ..., Accelerating Medicines Partnership (AMP) RA/SLE Network</div><div><strong>PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21</strong></div><div><em>JCI Insight.</em> 2019; <strong>4</strong>:130062</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.V.BocharnikovJ.KeeganV.S.WaclecheY.CaoC.Y.FonsekaG.WangE.S.MuiseK.X.ZhangA.AraziG.KerasAccelerating+Medicines+Partnership+%28AMP%29+RA%2FSLE+NetworkPD-1hiCXCR5-+T+peripheral+helper+cells+promote+B+cell+responses+in+lupus+via+MAF+and+IL-21JCI+Insight42019130062" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref73" href="#" role="doc-biblioref" data-xml-rid="bib73" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref73" aria-controls="sref73">Li et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref73"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">74.</div><div>Li, Y.J. ∙ Zhang, F. ∙ Qi, Y. ...</div><div><strong>Association of circulating follicular helper T&nbsp;cells with disease course of NMO spectrum disorders</strong></div><div><em>J.&nbsp;Neuroimmunol.</em> 2015; <strong>278</strong>:239-246</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Y.J.LiF.ZhangY.QiG.Q.ChangY.FuL.SuY.ShenN.SunA.BorazanciC.YangAssociation+of+circulating+follicular+helper+T%C2%A0cells+with+disease+course+of+NMO+spectrum+disordersJ.%C2%A0Neuroimmunol.2782015239246" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref83" href="#" role="doc-biblioref" data-xml-rid="bib83" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref83" aria-controls="sref83">Manzo et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref83"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">84.</div><div>Manzo, A. ∙ Vitolo, B. ∙ Humby, F. ...</div><div><strong>Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint</strong></div><div><em>Arthritis Rheum.</em> 2008; <strong>58</strong>:3377-3387</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.ManzoB.VitoloF.HumbyR.CaporaliD.JarrossayF.Dell%E2%80%99accioL.CiardelliM.UguccioniC.MontecuccoC.PitzalisMature+antigen-experienced+T+helper+cells+synthesize+and+secrete+the+B+cell+chemoattractant+CXCL13+in+the+inflammatory+environment+of+the+rheumatoid+jointArthritis+Rheum.58200833773387" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref93" href="#" role="doc-biblioref" data-xml-rid="bib93" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref93" aria-controls="sref93">Morita et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref93"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">94.</div><div>Morita, R. ∙ Schmitt, N. ∙ Bentebibel, S.E. ...</div><div><strong>Human blood CXCR5(+)CD4(+) T&nbsp;cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion</strong></div><div><em>Immunity.</em> 2011; <strong>34</strong>:108-121</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.MoritaN.SchmittS.E.BentebibelR.RanganathanL.BourderyG.ZurawskiE.FoucatM.DullaersS.OhN.SabzghabaeiHuman+blood+CXCR5%28%2B%29CD4%28%2B%29+T%C2%A0cells+are+counterparts+of+T+follicular+cells+and+contain+specific+subsets+that+differentially+support+antibody+secretionImmunity342011108121" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref111" href="#" role="doc-biblioref" data-xml-rid="bib111" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref111" aria-controls="sref111">Rao et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref111"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">112.</div><div>Rao, D.A. ∙ Gurish, M.F. ∙ Marshall, J.L. ...</div><div><strong>Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis</strong></div><div><em>Nature.</em> 2017; <strong>542</strong>:110-114</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.A.RaoM.F.GurishJ.L.MarshallK.SlowikowskiC.Y.FonsekaY.LiuL.T.DonlinL.A.HendersonK.WeiF.MizoguchiPathologically+expanded+peripheral+T+helper+cell+subset+drives+B+cells+in+rheumatoid+arthritisNature5422017110114" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The presence of TLSs correlates with favorable clinical outcomes in many types of human cancers (<span class="dropBlock reference-citations"><a id="body-ref-sref12-2" href="#" role="doc-biblioref" data-xml-rid="bib12" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref12-2" aria-controls="sref12-2">Cabrita et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref12-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">13.</div><div>Cabrita, R. ∙ Lauss, M. ∙ Sanna, A. ...</div><div><strong>Tertiary lymphoid structures improve immunotherapy and survival in melanoma</strong></div><div><em>Nature.</em> 2020; <strong>577</strong>:561-565</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.CabritaM.LaussA.SannaM.DoniaM.Skaarup+LarsenS.MitraI.JohanssonB.PhungK.HarbstJ.Vallon-ChristerssonTertiary+lymphoid+structures+improve+immunotherapy+and+survival+in+melanomaNature5772020561565" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref25" href="#" role="doc-biblioref" data-xml-rid="bib25" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref25" aria-controls="sref25">Dieu-Nosjean et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref25"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">26.</div><div>Dieu-Nosjean, M.C. ∙ Antoine, M. ∙ Danel, C. ...</div><div><strong>Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures</strong></div><div><em>J.&nbsp;Clin. Oncol.</em> 2008; <strong>26</strong>:4410-4417</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.C.Dieu-NosjeanM.AntoineC.DanelD.HeudesM.WislezV.PoulotN.RabbeL.LauransE.TartourL.de+ChaisemartinLong-term+survival+for+patients+with+non-small-cell+lung+cancer+with+intratumoral+lymphoid+structuresJ.%C2%A0Clin.+Oncol.26200844104417" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref40-2" href="#" role="doc-biblioref" data-xml-rid="bib40" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref40-2" aria-controls="sref40-2">Germain et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref40-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">41.</div><div>Germain, C. ∙ Gnjatic, S. ∙ Tamzalit, F. ...</div><div><strong>Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer</strong></div><div><em>Am. J. Respir. Crit. Care Med.</em> 2014; <strong>189</strong>:832-844</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.GermainS.GnjaticF.TamzalitS.KnockaertR.RemarkJ.GocA.LepelleyE.BechtS.KatsahianG.BizouardPresence+of+B+cells+in+tertiary+lymphoid+structures+is+associated+with+a+protective+immunity+in+patients+with+lung+cancerAm.+J.+Respir.+Crit.+Care+Med.1892014832844" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref42-2" href="#" role="doc-biblioref" data-xml-rid="bib42" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref42-2" aria-controls="sref42-2">Goc et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref42-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">43.</div><div>Goc, J. ∙ Germain, C. ∙ Vo-Bourgais, T.K. ...</div><div><strong>Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T&nbsp;cells</strong></div><div><em>Cancer Res.</em> 2014; <strong>74</strong>:705-715</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.GocC.GermainT.K.Vo-BourgaisA.LupoC.KleinS.KnockaertL.de+ChaisemartinH.OuakrimE.BechtM.AlifanoDendritic+cells+in+tumor-associated+tertiary+lymphoid+structures+signal+a+Th1+cytotoxic+immune+contexture+and+license+the+positive+prognostic+value+of+infiltrating+CD8%2B+T%C2%A0cellsCancer+Res.742014705715" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref51-3" href="#" role="doc-biblioref" data-xml-rid="bib51" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref51-3" aria-controls="sref51-3">Helmink et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref51-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">52.</div><div>Helmink, B.A. ∙ Reddy, S.M. ∙ Gao, J. ...</div><div><strong>B cells and tertiary lymphoid structures promote immunotherapy response</strong></div><div><em>Nature.</em> 2020; <strong>577</strong>:549-555</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=B.A.HelminkS.M.ReddyJ.GaoS.ZhangR.BasarR.ThakurK.YizhakM.Sade-FeldmanJ.BlandoG.HanB+cells+and+tertiary+lymphoid+structures+promote+immunotherapy+responseNature5772020549555" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref81-2" href="#" role="doc-biblioref" data-xml-rid="bib81" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref81-2" aria-controls="sref81-2">Lu et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref81-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">82.</div><div>Lu, Y. ∙ Zhao, Q. ∙ Liao, J.Y. ...</div><div><strong>Complement Signals Determine Opposite Effects of B Cells in Chemotherapy-Induced Immunity</strong></div><div><em>Cell.</em> 2020; <strong>180</strong>:1081-1097.e24</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Y.LuQ.ZhaoJ.Y.LiaoE.SongQ.XiaJ.PanY.LiJ.LiB.ZhouY.YeComplement+Signals+Determine+Opposite+Effects+of+B+Cells+in+Chemotherapy-Induced+ImmunityCell180202010811097.e24" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref105-2" href="#" role="doc-biblioref" data-xml-rid="bib105" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref105-2" aria-controls="sref105-2">Petitprez et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref105-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">106.</div><div>Petitprez, F. ∙ de Reyniès, A. ∙ Keung, E.Z. ...</div><div><strong>B cells are associated with survival and immunotherapy response in sarcoma</strong></div><div><em>Nature.</em> 2020; <strong>577</strong>:556-560</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=F.PetitprezA.de+Reyni%C3%A8sE.Z.KeungT.W.ChenC.M.SunJ.CalderaroY.M.JengL.P.HsiaoL.LacroixA.Bougo%C3%BCinB+cells+are+associated+with+survival+and+immunotherapy+response+in+sarcomaNature5772020556560" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref120-2" href="#" role="doc-biblioref" data-xml-rid="bib120" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref120-2" aria-controls="sref120-2">Sautès-Fridman et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref120-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">121.</div><div>Sautès-Fridman, C. ∙ Lawand, M. ∙ Giraldo, N.A. ...</div><div><strong>Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention</strong></div><div><em>Front. Immunol.</em> 2016; <strong>7</strong>:407</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.Saut%C3%A8s-FridmanM.LawandN.A.GiraldoH.KaplonC.GermainW.H.FridmanM.C.Dieu-NosjeanTertiary+Lymphoid+Structures+in+Cancers%3A+Prognostic+Value%2C+Regulation%2C+and+Manipulation+for+Therapeutic+InterventionFront.+Immunol.72016407" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>, <span class="dropBlock reference-citations"><a id="body-ref-sref121-2" href="#" role="doc-biblioref" data-xml-rid="bib121" href-manipulated="true" aria-label="Reference 2019" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref121-2" aria-controls="sref121-2">2019</a><div class="dropBlock__holder" data-db-target-of="sref121-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">122.</div><div>Sautès-Fridman, C. ∙ Petitprez, F. ∙ Calderaro, J. ...</div><div><strong>Tertiary lymphoid structures in the era of cancer immunotherapy</strong></div><div><em>Nat. Rev. Cancer.</em> 2019; <strong>19</strong>:307-325</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.Saut%C3%A8s-FridmanF.PetitprezJ.CalderaroW.H.FridmanTertiary+lymphoid+structures+in+the+era+of+cancer+immunotherapyNat.+Rev.+Cancer192019307325" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref144" href="#" role="doc-biblioref" data-xml-rid="bib144" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref144" aria-controls="sref144">Voabil et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref144"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">145.</div><div>Voabil, P. ∙ de Bruijn, M. ∙ Roelofsen, L.M. ...</div><div><strong>An ex&nbsp;vivo tumor fragment platform to dissect response to PD-1 blockade in cancer</strong></div><div><em>Nat. Med.</em> 2021; <strong>27</strong>:1250-1261</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=P.VoabilM.de+BruijnL.M.RoelofsenS.H.HendriksS.BrokampM.van+den+BraberA.BroeksJ.SandersP.HerzigA.ZippeliusAn+ex%C2%A0vivo+tumor+fragment+platform+to+dissect+response+to+PD-1+blockade+in+cancerNat.+Med.27202112501261" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref150-3" href="#" role="doc-biblioref" data-xml-rid="bib150" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref150-3" aria-controls="sref150-3">Wieland et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref150-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">151.</div><div>Wieland, A. ∙ Patel, M.R. ∙ Cardenas, M.A. ...</div><div><strong>Defining HPV-specific B cell responses in patients with head and neck cancer</strong></div><div><em>Nature.</em> 2021; <strong>597</strong>:274-278</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.WielandM.R.PatelM.A.CardenasC.S.EberhardtW.H.HudsonR.C.ObengC.C.GriffithX.WangZ.G.ChenH.T.KissickDefining+HPV-specific+B+cell+responses+in+patients+with+head+and+neck+cancerNature5972021274278" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and the TLSs containing mature GCs were further associated with more clinical benefits for many types of human cancers (<span class="dropBlock reference-citations"><a id="body-ref-sref110-2" href="#" role="doc-biblioref" data-xml-rid="bib110" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref110-2" aria-controls="sref110-2">Rakaee et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref110-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">111.</div><div>Rakaee, M. ∙ Kilvaer, T.K. ∙ Jamaly, S. ...</div><div><strong>Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer</strong></div><div><em>Br. J. Cancer.</em> 2021; <strong>124</strong>:1680-1689</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.RakaeeT.K.KilvaerS.JamalyT.BergE.E.PaulsenM.BerglundE.RichardsenS.AndersenS.Al-SaadM.PoehlTertiary+lymphoid+structure+score%3A+a+promising+approach+to+refine+the+TNM+staging+in+resected+non-small+cell+lung+cancerBr.+J.+Cancer124202116801689" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref117-2" href="#" role="doc-biblioref" data-xml-rid="bib117" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref117-2" aria-controls="sref117-2">Ruffin et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref117-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">118.</div><div>Ruffin, A.T. ∙ Cillo, A.R. ∙ Tabib, T. ...</div><div><strong>B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma</strong></div><div><em>Nat. Commun.</em> 2021; <strong>12</strong>:3349</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.T.RuffinA.R.CilloT.TabibA.LiuS.OnkarS.R.KunningC.LampenfeldH.I.AtiyaI.AbecassisC.H.L.K%C3%BCrtenB+cell+signatures+and+tertiary+lymphoid+structures+contribute+to+outcome+in+head+and+neck+squamous+cell+carcinomaNat.+Commun.1220213349" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref129" href="#" role="doc-biblioref" data-xml-rid="bib129" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref129" aria-controls="sref129">Siliņa et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref129"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">130.</div><div>Siliņa, K. ∙ Soltermann, A. ∙ Attar, F.M. ...</div><div><strong>Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma</strong></div><div><em>Cancer Res.</em> 2018; <strong>78</strong>:1308-1320</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=K.Sili%C5%86aA.SoltermannF.M.AttarR.CasanovaZ.M.UckeleyH.ThutM.WandresS.IsajevsP.ChengA.Curioni-FontecedroGerminal+Centers+Determine+the+Prognostic+Relevance+of+Tertiary+Lymphoid+Structures+and+Are+Impaired+by+Corticosteroids+in+Lung+Squamous+Cell+CarcinomaCancer+Res.78201813081320" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref142" href="#" role="doc-biblioref" data-xml-rid="bib142" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref142" aria-controls="sref142">Vanhersecke et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref142"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">143.</div><div>Vanhersecke, L. ∙ Brunet, M. ∙ Guégan, J.-P. ...</div><div><strong>Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression</strong></div><div><em>Nat. Cancer.</em> 2021; <strong>2</strong>:794-802</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=L.VanherseckeM.BrunetJ.-P.Gu%C3%A9ganC.ReyA.BougouinS.CousinS.Le+MoulecB.BesseY.LoriotM.LarroquetteMature+tertiary+lymphoid+structures+predict+immune+checkpoint+inhibitor+efficacy+in+solid+tumors+independently+of+PD-L1+expressionNat.+Cancer22021794802" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). These studies suggested tumor-specific antibody production as an important output of GC responses. However, our data suggested an alternative possibility that TLS could promote tumor-specific T&nbsp;cell-B cell collaborations that would support the effector functions of tumor-infiltrating CD8 T&nbsp;cells via IL-21.</div><div id="p0155" role="paragraph">Based on our data, we believe that TFH cells are a key physiological source of IL-21 for tumor-infiltrating effector CD8 T&nbsp;cells and that this is one mechanism for how TFH cells promote better outcomes in LUAD individuals. A critical question arising from our work is how and where TFH cells provide IL-21 to CD8 T&nbsp;cells. Several studies in chronic LCMV infection have focused on the critical role of CD4 T&nbsp;cell-derived IL-21 in promoting stem-like CXCR5<sup>+</sup> TCF1<sup>+</sup> CD8 T&nbsp;cells (TSL) to differentiate toward a granzyme B<sup>hi</sup> effector cytolytic T&nbsp;cell fate (<span class="dropBlock reference-citations"><a id="body-ref-sref13-1" href="#" role="doc-biblioref" data-xml-rid="bib13" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref13-1" aria-controls="sref13-1">Chen et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref13-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Chen, Y. ∙ Zander, R.A. ∙ Wu, X. ...</div><div><strong>BATF regulates progenitor to cytolytic effector CD8<sup>+</sup> T&nbsp;cell transition during chronic viral infection</strong></div><div><em>Nat. Immunol.</em> 2021; <strong>22</strong>:996-1007</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Y.ChenR.A.ZanderX.WuD.M.SchauderM.Y.KasmaniJ.ShenS.ZhengR.BurnsE.J.TaparowskyW.CuiBATF+regulates+progenitor+to+cytolytic+effector+CD8%2B+T%C2%A0cell+transition+during+chronic+viral+infectionNat.+Immunol.2220219961007" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref29-3" href="#" role="doc-biblioref" data-xml-rid="bib29" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref29-3" aria-controls="sref29-3">Elsaesser et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref29-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">30.</div><div>Elsaesser, H. ∙ Sauer, K. ∙ Brooks, D.G.</div><div><strong>IL-21 is required to control chronic viral infection</strong></div><div><em>Science.</em> 2009; <strong>324</strong>:1569-1572</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=H.ElsaesserK.SauerD.G.BrooksIL-21+is+required+to+control+chronic+viral+infectionScience324200915691572" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref36-3" href="#" role="doc-biblioref" data-xml-rid="bib36" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref36-3" aria-controls="sref36-3">Fröhlich et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref36-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">37.</div><div>Fröhlich, A. ∙ Kisielow, J. ∙ Schmitz, I. ...</div><div><strong>IL-21R on T&nbsp;cells is critical for sustained functionality and control of chronic viral infection</strong></div><div><em>Science.</em> 2009; <strong>324</strong>:1576-1580</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.Fr%C3%B6hlichJ.KisielowI.SchmitzS.FreigangA.T.ShamshievJ.WeberB.J.MarslandA.OxeniusM.KopfIL-21R+on+T%C2%A0cells+is+critical+for+sustained+functionality+and+control+of+chronic+viral+infectionScience324200915761580" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref113-2" href="#" role="doc-biblioref" data-xml-rid="bib113" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref113-2" aria-controls="sref113-2">Ren et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref113-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">114.</div><div>Ren, H.M. ∙ Kolawole, E.M. ∙ Ren, M. ...</div><div><strong>IL-21 from high-affinity CD4 T&nbsp;cells drives differentiation of brain-resident CD8 T&nbsp;cells during persistent viral infection</strong></div><div><em>Sci. Immunol.</em> 2020; <strong>5</strong>:eabb5590</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=H.M.RenE.M.KolawoleM.RenG.JinC.S.Netherby-WinslowQ.WadeShwetankZ.S.M.RahmanB.D.EvavoldA.E.LukacherIL-21+from+high-affinity+CD4+T%C2%A0cells+drives+differentiation+of+brain-resident+CD8+T%C2%A0cells+during+persistent+viral+infectionSci.+Immunol.52020eabb5590" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref131-3" href="#" role="doc-biblioref" data-xml-rid="bib131" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref131-3" aria-controls="sref131-3">Snell et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref131-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">132.</div><div>Snell, L.M. ∙ MacLeod, B.L. ∙ Law, J.C. ...</div><div><strong>CD8<sup>+</sup> T Cell Priming in Established Chronic Viral Infection Preferentially Directs Differentiation of Memory-like Cells for Sustained Immunity</strong></div><div><em>Immunity.</em> 2018; <strong>49</strong>:678-694.e5</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=L.M.SnellB.L.MacLeodJ.C.LawI.OsokineH.J.ElsaesserK.HezavehR.J.DicksonM.A.GavinC.J.GuidosT.L.McGahaD.G.BrooksCD8%2B+T+Cell+Priming+in+Established+Chronic+Viral+Infection+Preferentially+Directs+Differentiation+of+Memory-like+Cells+for+Sustained+ImmunityImmunity492018678694.e5" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref151-2" href="#" role="doc-biblioref" data-xml-rid="bib151" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref151-2" aria-controls="sref151-2">Xin et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref151-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">152.</div><div>Xin, G. ∙ Schauder, D.M. ∙ Lainez, B. ...</div><div><strong>A Critical Role of IL-21-Induced BATF in Sustaining CD8-T-Cell-Mediated Chronic Viral Control</strong></div><div><em>Cell Rep.</em> 2015; <strong>13</strong>:1118-1124</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.XinD.M.SchauderB.LainezJ.S.WeinsteinZ.DaiY.ChenE.EspluguesR.WenD.WangI.A.ParishA+Critical+Role+of+IL-21-Induced+BATF+in+Sustaining+CD8-T-Cell-Mediated+Chronic+Viral+ControlCell+Rep.13201511181124" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref154-3" href="#" role="doc-biblioref" data-xml-rid="bib154" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref154-3" aria-controls="sref154-3">Yi et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref154-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">155.</div><div>Yi, J.S. ∙ Du, M. ∙ Zajac, A.J.</div><div><strong>A vital role for interleukin-21 in the control of a chronic viral infection</strong></div><div><em>Science.</em> 2009; <strong>324</strong>:1572-1576</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.S.YiM.DuA.J.ZajacA+vital+role+for+interleukin-21+in+the+control+of+a+chronic+viral+infectionScience324200915721576" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref158-4" href="#" role="doc-biblioref" data-xml-rid="bib158" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref158-4" aria-controls="sref158-4">Zander et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref158-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">159.</div><div>Zander, R. ∙ Schauder, D. ∙ Xin, G. ...</div><div><strong>CD4<sup>+</sup> T Cell Help Is Required for the Formation of a Cytolytic CD8<sup>+</sup> T Cell Subset that Protects against Chronic Infection and Cancer</strong></div><div><em>Immunity.</em> 2019; <strong>51</strong>:1028-1042.e4</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.ZanderD.SchauderG.XinC.NguyenX.WuA.ZajacW.CuiCD4%2B+T+Cell+Help+Is+Required+for+the+Formation+of+a+Cytolytic+CD8%2B+T+Cell+Subset+that+Protects+against+Chronic+Infection+and+CancerImmunity51201910281042.e4" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Moreover, ∼30% of splenic TSL cells are in B cell follicles whereas ∼50%–60% are in T&nbsp;cell zones in LCMV infected mice (<span class="dropBlock reference-citations"><a id="body-ref-sref50" href="#" role="doc-biblioref" data-xml-rid="bib50" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref50" aria-controls="sref50">He et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref50"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">51.</div><div>He, R. ∙ Hou, S. ∙ Liu, C. ...</div><div><strong>Follicular CXCR5- expressing CD8(+) T&nbsp;cells curtail chronic viral infection</strong></div><div><em>Nature.</em> 2016; <strong>537</strong>:412-428</div></div><div class="external-links"><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.007&amp;key=2-s2.0-84988410229" target="_blank" aria-label="Open Scopus in new tab">Scopus (344)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.HeS.HouC.LiuA.ZhangQ.BaiM.HanY.YangG.WeiT.ShenX.YangFollicular+CXCR5-+expressing+CD8%28%2B%29+T%C2%A0cells+curtail+chronic+viral+infectionNature5372016412428" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref57" href="#" role="doc-biblioref" data-xml-rid="bib57" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref57" aria-controls="sref57">Im et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref57"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">58.</div><div>Im, S.J. ∙ Hashimoto, M. ∙ Gerner, M.Y. ...</div><div><strong>Defining CD8+ T&nbsp;cells that provide the proliferative burst after PD-1 therapy</strong></div><div><em>Nature.</em> 2016; <strong>537</strong>:417-421</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.J.ImM.HashimotoM.Y.GernerJ.LeeH.T.KissickM.C.BurgerQ.ShanJ.S.HaleJ.LeeT.H.NastiDefining+CD8%2B+T%C2%A0cells+that+provide+the+proliferative+burst+after+PD-1+therapyNature5372016417421" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>, <span class="dropBlock reference-citations"><a id="body-ref-sref58" href="#" role="doc-biblioref" data-xml-rid="bib58" href-manipulated="true" aria-label="Reference 2020" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref58" aria-controls="sref58">2020</a><div class="dropBlock__holder" data-db-target-of="sref58"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">59.</div><div>Im, S.J. ∙ Konieczny, B.T. ∙ Hudson, W.H. ...</div><div><strong>PD-1+ stemlike CD8 T&nbsp;cells are resident in lymphoid tissues during persistent LCMV infection</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2020; <strong>117</strong>:4292-4299</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.J.ImB.T.KoniecznyW.H.HudsonD.MasopustR.AhmedPD-1%2B+stemlike+CD8+T%C2%A0cells+are+resident+in+lymphoid+tissues+during+persistent+LCMV+infectionProc.+Natl.+Acad.+Sci.+USA117202042924299" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref72" href="#" role="doc-biblioref" data-xml-rid="bib72" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref72" aria-controls="sref72">Leong et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref72"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">73.</div><div>Leong, Y.A. ∙ Chen, Y. ∙ Ong, H.S. ...</div><div><strong>CXCR5(+) follicular cytotoxic T&nbsp;cells control viral infection in B cell follicles</strong></div><div><em>Nat. Immunol.</em> 2016; <strong>17</strong>:1187-1196</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Y.A.LeongY.ChenH.S.OngD.WuK.ManC.DeleageM.MinnichB.J.MeckiffY.WeiZ.HouCXCR5%28%2B%29+follicular+cytotoxic+T%C2%A0cells+control+viral+infection+in+B+cell+folliclesNat.+Immunol.17201611871196" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The infrastructure to promote interactions between CXCR5<sup>+</sup> IL-21-producing TFH cells and CXCR5<sup>+</sup> TCF1<sup>+</sup> TSL cells likely resides in B cell follicles of secondary lymphoid organs (LNs and spleens) and/or in tumor-associated TLSs that have GCs. In line with this, CXCR5<sup>+</sup> TCF1<sup>+</sup> TSL cells are enriched in tumors from NSCLC individuals, and this correlates with tumor infiltration of CXCR5<sup>+</sup> TFH cells and CD19<sup>+</sup> B cells (<span class="dropBlock reference-citations"><a id="body-ref-sref9" href="#" role="doc-biblioref" data-xml-rid="bib9" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref9" aria-controls="sref9">Brummelman et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">10.</div><div>Brummelman, J. ∙ Mazza, E.M.C. ∙ Alvisi, G. ...</div><div><strong>High-dimensional single cell analysis identifies stem-like cytotoxic CD8<sup>+</sup> T&nbsp;cells infiltrating human tumors</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2018; <strong>215</strong>:2520-2535</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.BrummelmanE.M.C.MazzaG.AlvisiF.S.ColomboA.GrilliJ.MikulakD.MavilioM.AlloisioF.FerrariE.LopciHigh-dimensional+single+cell+analysis+identifies+stem-like+cytotoxic+CD8%2B+T%C2%A0cells+infiltrating+human+tumorsJ.%C2%A0Exp.+Med.215201825202535" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref96-2" href="#" role="doc-biblioref" data-xml-rid="bib96" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref96-2" aria-controls="sref96-2">Noël et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref96-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">97.</div><div>Noël, G. ∙ Fontsa, M.L. ∙ Garaud, S. ...</div><div><strong>Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2021; <strong>131</strong>:e139905</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.No%C3%ABlM.L.FontsaS.GaraudP.De+SilvaA.de+WindG.G.Van+den+EyndenR.SalgadoA.BoissonH.LocyN.ThomasFunctional+Th1-oriented+T+follicular+helper+cells+that+infiltrate+human+breast+cancer+promote+effective+adaptive+immunityJ.%C2%A0Clin.+Invest.1312021e139905" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We and others have also recently demonstrated that draining LN associated with lung adenocarcinoma maintains a stable reservoir of tumor-specific TSLs throughout tumor development, and migration of these cells from dLNs to tumors is required to maintain TCF1<sup>+</sup> CD8 T&nbsp;cells in tumors (<span class="dropBlock reference-citations"><a id="body-ref-sref18-3" href="#" role="doc-biblioref" data-xml-rid="bib18" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref18-3" aria-controls="sref18-3">Connolly et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref18-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>Connolly, K.A. ∙ Kuchroo, M. ∙ Venkat, A. ...</div><div><strong>A reservoir of stem-like CD8<sup>+</sup> T&nbsp;cells in the tumor-draining lymph node preserves the ongoing antitumor immune response</strong></div><div><em>Sci. Immunol.</em> 2021; <strong>6</strong>:eabg7836</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=K.A.ConnollyM.KuchrooA.VenkatA.KhatunJ.WangI.WilliamN.I.HornickB.L.FitzgeraldM.DamoM.Y.KasmaniA+reservoir+of+stem-like+CD8%2B+T%C2%A0cells+in+the+tumor-draining+lymph+node+preserves+the+ongoing+antitumor+immune+responseSci.+Immunol.62021eabg7836" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref123" href="#" role="doc-biblioref" data-xml-rid="bib123" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref123" aria-controls="sref123">Schenkel et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref123"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">124.</div><div>Schenkel, J.M. ∙ Herbst, R.H. ∙ Canner, D. ...</div><div><strong>Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1<sup>+</sup> CD8<sup>+</sup> T&nbsp;cells in tumor-draining lymph nodes</strong></div><div><em>Immunity.</em> 2021; <strong>54</strong>:2338-2353.e6</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.M.SchenkelR.H.HerbstD.CannerA.LiM.HillmanS.L.ShanahanG.GibbonsO.C.SmithJ.Y.KimP.WestcottConventional+type+I+dendritic+cells+maintain+a+reservoir+of+proliferative+tumor-antigen+specific+TCF-1%2B+CD8%2B+T%C2%A0cells+in+tumor-draining+lymph+nodesImmunity54202123382353.e6" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We have also found tumor-associated TLSs in our autochthonous tumor models (<span class="dropBlock reference-citations"><a id="body-ref-sref33-4" href="#" role="doc-biblioref" data-xml-rid="bib33" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref33-4" aria-controls="sref33-4">Fitzgerald et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref33-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Fitzgerald, B. ∙ Connolly, K.A. ∙ Cui, C. ...</div><div><strong>A mouse model for the study of anti-tumor T&nbsp;cell responses in Kras-driven lung adenocarcinoma</strong></div><div><em>Cell Rep Methods.</em> 2021; <strong>1</strong>:100080</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=B.FitzgeraldK.A.ConnollyC.CuiE.FagerbergD.L.MariuzzaN.I.HornickG.G.FosterI.WilliamJ.F.CheungN.S.JoshiA+mouse+model+for+the+study+of+anti-tumor+T%C2%A0cell+responses+in+Kras-driven+lung+adenocarcinomaCell+Rep+Methods12021100080" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref62-2" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-2" aria-controls="sref62-2">Joshi et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref62-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>Joshi, N.S. ∙ Akama-Garren, E.H. ∙ Lu, Y. ...</div><div><strong>Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses</strong></div><div><em>Immunity.</em> 2015; <strong>43</strong>:579-590</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.S.JoshiE.H.Akama-GarrenY.LuD.Y.LeeG.P.ChangA.LiM.DuPageT.TammelaN.R.KerperA.F.FaragoRegulatory+T+Cells+in+Tumor-Associated+Tertiary+Lymphoid+Structures+Suppress+Anti-tumor+T+Cell+ResponsesImmunity432015579590" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; and data not shown), and TLSs are less likely to form in subcutaneously transplanted tumors given the spatial, temporal, chemokine, and vasculature requirements of TLS formation/maintenance (<span class="dropBlock reference-citations"><a id="body-ref-sref30" href="#" role="doc-biblioref" data-xml-rid="bib30" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref30" aria-controls="sref30">Engelhard et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref30"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Engelhard, V.H. ∙ Rodriguez, A.B. ∙ Mauldin, I.S. ...</div><div><strong>Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity</strong></div><div><em>J.&nbsp;Immunol.</em> 2018; <strong>200</strong>:432-442</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=V.H.EngelhardA.B.RodriguezI.S.MauldinA.N.WoodsJ.D.PeskeC.L.SlingluffJr.Immune+Cell+Infiltration+and+Tertiary+Lymphoid+Structures+as+Determinants+of+Antitumor+ImmunityJ.%C2%A0Immunol.2002018432442" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref108" href="#" role="doc-biblioref" data-xml-rid="bib108" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref108" aria-controls="sref108">Pitzalis et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref108"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">109.</div><div>Pitzalis, C. ∙ Jones, G.W. ∙ Bombardieri, M. ...</div><div><strong>Ectopic lymphoid-like structures in infection, cancer and autoimmunity</strong></div><div><em>Nat. Rev. Immunol.</em> 2014; <strong>14</strong>:447-462</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.PitzalisG.W.JonesM.BombardieriS.A.JonesEctopic+lymphoid-like+structures+in+infection%2C+cancer+and+autoimmunityNat.+Rev.+Immunol.142014447462" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref116" href="#" role="doc-biblioref" data-xml-rid="bib116" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref116" aria-controls="sref116">Ruddle, 2014</a><div class="dropBlock__holder" data-db-target-of="sref116"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">117.</div><div>Ruddle, N.H.</div><div><strong>Lymphatic vessels and tertiary lymphoid organs</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2014; <strong>124</strong>:953-959</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.H.RuddleLymphatic+vessels+and+tertiary+lymphoid+organsJ.%C2%A0Clin.+Invest.1242014953959" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref140" href="#" role="doc-biblioref" data-xml-rid="bib140" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref140" aria-controls="sref140">van de Pavert and Mebius, 2010</a><div class="dropBlock__holder" data-db-target-of="sref140"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">141.</div><div>van de Pavert, S.A. ∙ Mebius, R.E.</div><div><strong>New insights into the development of lymphoid tissues</strong></div><div><em>Nat. Rev. Immunol.</em> 2010; <strong>10</strong>:664-674</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.A.van+de+PavertR.E.MebiusNew+insights+into+the+development+of+lymphoid+tissuesNat.+Rev.+Immunol.102010664674" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Thus, we hypothesize that TFH cell-CD8 T&nbsp;cell interactions are likely to occur in the dLNs of s.c. implanted KP-HELLO tumors, but these could also occur in tumor-associated TLS when GCs present. Further research will be necessary to elucidate the site of action for B cell-TFH cell-IL21 interactions in different tumor contexts.</div><div id="p0160" role="paragraph">Studies of neoantigen immunogenicity generally focus on metrics such as neoantigen abundance, MHC binding, and T&nbsp;cell recognition to identify candidate neoantigens for therapeutic efforts (<span class="dropBlock reference-citations"><a id="body-ref-sref124" href="#" role="doc-biblioref" data-xml-rid="bib124" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref124" aria-controls="sref124">Schumacher and Hacohen, 2016</a><div class="dropBlock__holder" data-db-target-of="sref124"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">125.</div><div>Schumacher, T.N. ∙ Hacohen, N.</div><div><strong>Neoantigens encoded in the cancer genome</strong></div><div><em>Curr. Opin. Immunol.</em> 2016; <strong>41</strong>:98-103</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=T.N.SchumacherN.HacohenNeoantigens+encoded+in+the+cancer+genomeCurr.+Opin.+Immunol.41201698103" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref125" href="#" role="doc-biblioref" data-xml-rid="bib125" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref125" aria-controls="sref125">Schumacher et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref125"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">126.</div><div>Schumacher, T.N. ∙ Scheper, W. ∙ Kvistborg, P.</div><div><strong>Cancer Neoantigens</strong></div><div><em>Annu. Rev. Immunol.</em> 2019; <strong>37</strong>:173-200</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=T.N.SchumacherW.ScheperP.KvistborgCancer+NeoantigensAnnu.+Rev.+Immunol.372019173200" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref149" href="#" role="doc-biblioref" data-xml-rid="bib149" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref149" aria-controls="sref149">Wells et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref149"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">150.</div><div>Wells, D.K. ∙ van Buuren, M.M. ∙ Dang, K.K. ..., Tumor Neoantigen Selection Alliance</div><div><strong>Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction</strong></div><div><em>Cell.</em> 2020; <strong>183</strong>:818-834.e13</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.K.WellsM.M.van+BuurenK.K.DangV.M.Hubbard-LuceyK.C.F.SheehanK.M.CampbellA.LambJ.P.WardJ.SidneyA.B.BlazquezTumor+Neoantigen+Selection+AllianceKey+Parameters+of+Tumor+Epitope+Immunogenicity+Revealed+Through+a+Consortium+Approach+Improve+Neoantigen+PredictionCell1832020818834.e13" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Our findings, however, raise the possibility that other aspects of neoantigens should also be considered. These include the assessment of mutation sites and whether they would result in structural alterations that are able to change BCR binding and B cell recognition. B cell-recognized neoantigens were unique in that they were sufficient to potentiate TFH cell differentiation pathways, which provided non-redundant help for anti-tumor CD8 T&nbsp;cell responses via IL-21 in our model. This is in line with multiple studies showing that the presence of both cognate B cells and antigens with B cell- and CD4 T&nbsp;cell-recognized epitopes was required for IL-21 production by PD1<sup>hi</sup> CXCR5<sup>hi</sup> TFH cells (<span class="dropBlock reference-citations"><a id="body-ref-sref63" href="#" role="doc-biblioref" data-xml-rid="bib63" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref63" aria-controls="sref63">Kerfoot et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref63"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Kerfoot, S.M. ∙ Yaari, G. ∙ Patel, J.R. ...</div><div><strong>Germinal center B cell and T follicular helper cell development initiates in the interfollicular zone</strong></div><div><em>Immunity.</em> 2011; <strong>34</strong>:947-960</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.M.KerfootG.YaariJ.R.PatelK.L.JohnsonD.G.GonzalezS.H.KleinsteinA.M.HabermanGerminal+center+B+cell+and+T+follicular+helper+cell+development+initiates+in+the+interfollicular+zoneImmunity342011947960" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref128" href="#" role="doc-biblioref" data-xml-rid="bib128" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref128" aria-controls="sref128">Shulman et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref128"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">129.</div><div>Shulman, Z. ∙ Gitlin, A.D. ∙ Weinstein, J.S. ...</div><div><strong>Dynamic signaling by T follicular helper cells during germinal center B cell selection</strong></div><div><em>Science.</em> 2014; <strong>345</strong>:1058-1062</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Z.ShulmanA.D.GitlinJ.S.WeinsteinB.LainezE.EspluguesR.A.FlavellJ.E.CraftM.C.NussenzweigDynamic+signaling+by+T+follicular+helper+cells+during+germinal+center+B+cell+selectionScience345201410581062" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Moreover, the principle of intermolecular help, in which antigen-engaged B cells are able to internalize and process whole antigenic proteins and subsequently present different MHCII epitopes to CD4 T&nbsp;cells, ensures that rare, cognate interactions between tumor-specific B and CD4 T&nbsp;cells are enabled and augmented by B cell-recognized neoantigens (<span class="dropBlock reference-citations"><a id="body-ref-sref89" href="#" role="doc-biblioref" data-xml-rid="bib89" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref89" aria-controls="sref89">Milich et&nbsp;al., 1987</a><div class="dropBlock__holder" data-db-target-of="sref89"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">90.</div><div>Milich, D.R. ∙ McLachlan, A. ∙ Thornton, G.B. ...</div><div><strong>Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T&nbsp;cell site</strong></div><div><em>Nature.</em> 1987; <strong>329</strong>:547-549</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.R.MilichA.McLachlanG.B.ThorntonJ.L.HughesAntibody+production+to+the+nucleocapsid+and+envelope+of+the+hepatitis+B+virus+primed+by+a+single+synthetic+T%C2%A0cell+siteNature3291987547549" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref91" href="#" role="doc-biblioref" data-xml-rid="bib91" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref91" aria-controls="sref91">Mitchison, 1971a</a><div class="dropBlock__holder" data-db-target-of="sref91"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">92.</div><div>Mitchison, N.A.</div><div><strong>The carrier effect in the secondary response to hapten-protein conjugates. I. Measurement of the effect with transferred cells and objections to the local environment hypothesis</strong></div><div><em>Eur. J. Immunol.</em> 1971; <strong>1</strong>:10-17</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.A.MitchisonThe+carrier+effect+in+the+secondary+response+to+hapten-protein+conjugates.+I.+Measurement+of+the+effect+with+transferred+cells+and+objections+to+the+local+environment+hypothesisEur.+J.+Immunol.119711017" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>, <span class="dropBlock reference-citations"><a id="body-ref-sref92" href="#" role="doc-biblioref" data-xml-rid="bib92" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref92" aria-controls="sref92">1971b</a><div class="dropBlock__holder" data-db-target-of="sref92"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">93.</div><div>Mitchison, N.A.</div><div><strong>The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation</strong></div><div><em>Eur. J. Immunol.</em> 1971; <strong>1</strong>:18-27</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.A.MitchisonThe+carrier+effect+in+the+secondary+response+to+hapten-protein+conjugates.+II.+Cellular+cooperationEur.+J.+Immunol.119711827" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref118" href="#" role="doc-biblioref" data-xml-rid="bib118" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref118" aria-controls="sref118">Russell and Liew, 1979</a><div class="dropBlock__holder" data-db-target-of="sref118"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">119.</div><div>Russell, S.M. ∙ Liew, F.Y.</div><div><strong>T cells primed by influenza virion internal components can cooperate in the antibody response to haemagglutinin</strong></div><div><em>Nature.</em> 1979; <strong>280</strong>:147-148</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.M.RussellF.Y.LiewT+cells+primed+by+influenza+virion+internal+components+can+cooperate+in+the+antibody+response+to+haemagglutininNature2801979147148" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref126" href="#" role="doc-biblioref" data-xml-rid="bib126" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref126" aria-controls="sref126">Sette et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref126"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">127.</div><div>Sette, A. ∙ Moutaftsi, M. ∙ Moyron-Quiroz, J. ...</div><div><strong>Selective CD4+ T&nbsp;cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities</strong></div><div><em>Immunity.</em> 2008; <strong>28</strong>:847-858</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.SetteM.MoutaftsiJ.Moyron-QuirozM.M.McCauslandD.H.DaviesR.J.JohnstonB.PetersM.Rafii-El-Idrissi+BenhniaJ.HoffmannH.P.SuSelective+CD4%2B+T%C2%A0cell+help+for+antibody+responses+to+a+large+viral+pathogen%3A+deterministic+linkage+of+specificitiesImmunity282008847858" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). MHC-II restricted neoantigens, recognized by CD4 T&nbsp;cells, have been shown to be indispensable for successful anti-tumor responses (<span class="dropBlock reference-citations"><a id="body-ref-sref2-2" href="#" role="doc-biblioref" data-xml-rid="bib2" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref2-2" aria-controls="sref2-2">Alspach et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref2-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">2.</div><div>Alspach, E. ∙ Lussier, D.M. ∙ Miceli, A.P. ...</div><div><strong>MHC-II neoantigens shape tumour immunity and response to immunotherapy</strong></div><div><em>Nature.</em> 2019; <strong>574</strong>:696-701</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=E.AlspachD.M.LussierA.P.MiceliI.KizhvatovM.DuPageA.M.LuomaW.MengC.F.LichtiE.EsaulovaA.N.VomundMHC-II+neoantigens+shape+tumour+immunity+and+response+to+immunotherapyNature5742019696701" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref68" href="#" role="doc-biblioref" data-xml-rid="bib68" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref68" aria-controls="sref68">Kreiter et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref68"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">69.</div><div>Kreiter, S. ∙ Vormehr, M. ∙ van de Roemer, N. ...</div><div><strong>Mutant MHC class II epitopes drive therapeutic immune responses to cancer</strong></div><div><em>Nature.</em> 2015; <strong>520</strong>:692-696</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.KreiterM.VormehrN.van+de+RoemerM.DikenM.L%C3%B6werJ.DiekmannS.BoegelB.Schr%C3%B6rsF.VascottoJ.C.CastleMutant+MHC+class+II+epitopes+drive+therapeutic+immune+responses+to+cancerNature5202015692696" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref76" href="#" role="doc-biblioref" data-xml-rid="bib76" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref76" aria-controls="sref76">Linnemann et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref76"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">77.</div><div>Linnemann, C. ∙ van Buuren, M.M. ∙ Bies, L. ...</div><div><strong>High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T&nbsp;cells in human melanoma</strong></div><div><em>Nat. Med.</em> 2015; <strong>21</strong>:81-85</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.LinnemannM.M.van+BuurenL.BiesE.M.VerdegaalR.SchotteJ.J.CalisS.BehjatiA.VeldsH.HilkmannD.E.AtmiouiHigh-throughput+epitope+discovery+reveals+frequent+recognition+of+neo-antigens+by+CD4%2B+T%C2%A0cells+in+human+melanomaNat.+Med.2120158185" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), but less is known about how individual neoantigens, or their structures, could impact fate decisions by anti-tumor CD4 T&nbsp;cells. We found B cell-recognized epitopes were necessary for TFH cell development, and concurrently, co-existence of GC B cells and TFH cells in many human cancers strongly suggests that many tumors could express B cell-recognized neoantigens. Here, it is possible that the B cell-recognized portions are neoepitopes or are non-mutated epitopes connected to neoantigens recognized by CD4 T&nbsp;cells. Thus, tumors not only shape T&nbsp;cell responses via their production of chemokines, cytokines, and innate immune signaling modulators (i.e., STING/ RIG-I), but also via structural features of their neoantigens. Gaining a better understanding of how various features of neoantigens drive different CD4 T&nbsp;cell fates could help to design therapies that leverage a wider variety of immune cell functions. Our approach provides an easily adaptable platform to investigate different aspects of B and T&nbsp;cell neoantigens, such as&nbsp;secreted/membrane-bound/intracellular features, and BCR binding affinity, of which available tools have already been established from many studies (<span class="dropBlock reference-citations"><a id="body-ref-sref11" href="#" role="doc-biblioref" data-xml-rid="bib11" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref11" aria-controls="sref11">Burnett et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref11"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">12.</div><div>Burnett, D.L. ∙ Langley, D.B. ∙ Schofield, P. ...</div><div><strong>Germinal center antibody mutation trajectories are determined by rapid self/foreign discrimination</strong></div><div><em>Science.</em> 2018; <strong>360</strong>:223-226</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.L.BurnettD.B.LangleyP.SchofieldJ.R.HermesT.D.ChanJ.JacksonK.BourneJ.H.ReedK.PattersonB.T.PorebskiGerminal+center+antibody+mutation+trajectories+are+determined+by+rapid+self%2Fforeign+discriminationScience3602018223226" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref104" href="#" role="doc-biblioref" data-xml-rid="bib104" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref104" aria-controls="sref104">Paus et&nbsp;al., 2006</a><div class="dropBlock__holder" data-db-target-of="sref104"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">105.</div><div>Paus, D. ∙ Phan, T.G. ∙ Chan, T.D. ...</div><div><strong>Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2006; <strong>203</strong>:1081-1091</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.PausT.G.PhanT.D.ChanS.GardamA.BastenR.BrinkAntigen+recognition+strength+regulates+the+choice+between+extrafollicular+plasma+cell+and+germinal+center+B+cell+differentiationJ.%C2%A0Exp.+Med.203200610811091" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0165" role="paragraph">Given the pivotal functional role of T&nbsp;cell-B cell interactions in controlling tumors, demonstrated by our work and others, the B cell-TFH cell-IL21 axis could provide an entry point for therapeutic manipulation. Preclinical studies and phase I clinical trials of personalized neoantigen vaccines, utilizing MHC class I binding epitopes, have successfully demonstrated the induction of <i>de novo</i> neoantigen-specific CD4 and CD8 T&nbsp;cell responses in individuals with NSCLC, bladder cancer, melanoma, and glioblastoma (<span class="dropBlock reference-citations"><a id="body-ref-sref64" href="#" role="doc-biblioref" data-xml-rid="bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64" aria-controls="sref64">Keskin et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref64"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">65.</div><div>Keskin, D.B. ∙ Anandappa, A.J. ∙ Sun, J. ...</div><div><strong>Neoantigen vaccine generates intratumoral T&nbsp;cell responses in phase Ib glioblastoma trial</strong></div><div><em>Nature.</em> 2019; <strong>565</strong>:234-239</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.B.KeskinA.J.AnandappaJ.SunI.TiroshN.D.MathewsonS.LiG.OliveiraA.Giobbie-HurderK.FeltE.GjiniNeoantigen+vaccine+generates+intratumoral+T%C2%A0cell+responses+in+phase+Ib+glioblastoma+trialNature5652019234239" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref102" href="#" role="doc-biblioref" data-xml-rid="bib102" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref102" aria-controls="sref102">Ott et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref102"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">103.</div><div>Ott, P.A. ∙ Hu, Z. ∙ Keskin, D.B. ...</div><div><strong>An immunogenic personal neoantigen vaccine for patients with melanoma</strong></div><div><em>Nature.</em> 2017; <strong>547</strong>:217-221</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=P.A.OttZ.HuD.B.KeskinS.A.ShuklaJ.SunD.J.BozymW.ZhangA.LuomaA.Giobbie-HurderL.PeterAn+immunogenic+personal+neoantigen+vaccine+for+patients+with+melanomaNature5472017217221" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>, <span class="dropBlock reference-citations"><a id="body-ref-sref103" href="#" role="doc-biblioref" data-xml-rid="bib103" href-manipulated="true" aria-label="Reference 2020" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref103" aria-controls="sref103">2020</a><div class="dropBlock__holder" data-db-target-of="sref103"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">104.</div><div>Ott, P.A. ∙ Hu-Lieskovan, S. ∙ Chmielowski, B. ...</div><div><strong>A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer</strong></div><div><em>Cell.</em> 2020; <strong>183</strong>:347-362.e24</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=P.A.OttS.Hu-LieskovanB.ChmielowskiR.GovindanA.NaingN.BhardwajK.MargolinM.M.AwadM.D.HellmannJ.J.LinA+Phase+Ib+Trial+of+Personalized+Neoantigen+Therapy+Plus+Anti-PD-1+in+Patients+with+Advanced+Melanoma%2C+Non-small+Cell+Lung+Cancer%2C+or+Bladder+CancerCell1832020347362.e24" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Here, one possibility could be to modify these personalized neoantigen vaccines to include epitopes recognized by both B and T&nbsp;cells. We predict that this would boost responses by neoantigen-specific TFH cells, facilitate their IL-21 production, and promote anti-tumor responses by effector CD8 T&nbsp;cells. Alternatively, one study found that B cell-based neoantigen vaccines could promote checkpoint blockade efficacy by activating autologous CD8 T&nbsp;cells in animal models of glioblastoma (<span class="dropBlock reference-citations"><a id="body-ref-sref71" href="#" role="doc-biblioref" data-xml-rid="bib71" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref71" aria-controls="sref71">Lee-Chang et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref71"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">72.</div><div>Lee-Chang, C. ∙ Miska, J. ∙ Hou, D. ...</div><div><strong>Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2021; <strong>218</strong>:e20200913</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.Lee-ChangJ.MiskaD.HouA.RashidiP.ZhangR.A.BurgaI.Jusu%C3%A9-TorresT.XiaoV.A.ArrietaD.Y.ZhangActivation+of+4-1BBL%2B+B+cells+with+CD40+agonism+and+IFN%CE%B3+elicits+potent+immunity+against+glioblastomaJ.%C2%A0Exp.+Med.2182021e20200913" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Beyond vaccines, agonist antibodies or cytokines targeting the B cell-TFH cell-IL21 axis could also provide therapeutic benefits. Anti-ICOS agonist antibody (GSK3359609) is currently in phase II/III clinical trials in combination with PD-1 or PD-L1 blockade. Moreover, combining engineered IL-21 with existing immunotherapies can elicit robust anti-tumor immune responses (<span class="dropBlock reference-citations"><a id="body-ref-sref24" href="#" role="doc-biblioref" data-xml-rid="bib24" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref24" aria-controls="sref24">Deng et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref24"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Deng, S. ∙ Sun, Z. ∙ Qiao, J. ...</div><div><strong>Targeting tumors with IL-21 reshapes the tumor microenvironment by proliferating PD-1intTim-3-CD8+ T&nbsp;cells</strong></div><div><em>JCI Insight.</em> 2020; <strong>5</strong>:132000</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.DengZ.SunJ.QiaoY.LiangL.LiuC.DongA.ShenY.WangH.TangY.X.FuH.PengTargeting+tumors+with+IL-21+reshapes+the+tumor+microenvironment+by+proliferating+PD-1intTim-3-CD8%2B+T%C2%A0cellsJCI+Insight52020132000" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref75-2" href="#" role="doc-biblioref" data-xml-rid="bib75" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref75-2" aria-controls="sref75-2">Li et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref75-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">76.</div><div>Li, Y. ∙ Cong, Y. ∙ Jia, M. ...</div><div><strong>Targeting IL-21 to tumor-reactive T&nbsp;cells enhances memory T&nbsp;cell responses and anti-PD-1 antibody therapy</strong></div><div><em>Nat. Commun.</em> 2021; <strong>12</strong>:951</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Y.LiY.CongM.JiaQ.HeH.ZhongY.ZhaoH.LiM.YanJ.YouJ.LiuTargeting+IL-21+to+tumor-reactive+T%C2%A0cells+enhances+memory+T%C2%A0cell+responses+and+anti-PD-1+antibody+therapyNat.+Commun.122021951" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref130" href="#" role="doc-biblioref" data-xml-rid="bib130" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref130" aria-controls="sref130">Singh et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref130"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">131.</div><div>Singh, H. ∙ Figliola, M.J. ∙ Dawson, M.J. ...</div><div><strong>Reprogramming CD19-specific T&nbsp;cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies</strong></div><div><em>Cancer Res.</em> 2011; <strong>71</strong>:3516-3527</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=H.SinghM.J.FigliolaM.J.DawsonH.HulsS.OlivaresK.SwitzerT.MiS.MaitiP.KebriaeiD.A.LeeReprogramming+CD19-specific+T%C2%A0cells+with+IL-21+signaling+can+improve+adoptive+immunotherapy+of+B-lineage+malignanciesCancer+Res.71201135163527" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref132" href="#" role="doc-biblioref" data-xml-rid="bib132" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref132" aria-controls="sref132">Søndergaard and Skak, 2009</a><div class="dropBlock__holder" data-db-target-of="sref132"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">133.</div><div>Søndergaard, H. ∙ Skak, K.</div><div><strong>IL-21: roles in immunopathology and cancer therapy</strong></div><div><em>Tissue Antigens.</em> 2009; <strong>74</strong>:467-479</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=H.S%C3%B8ndergaardK.SkakIL-21%3A+roles+in+immunopathology+and+cancer+therapyTissue+Antigens742009467479" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref145" href="#" role="doc-biblioref" data-xml-rid="bib145" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref145" aria-controls="sref145">Wang et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref145"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">146.</div><div>Wang, Y. ∙ Jiang, H. ∙ Luo, H. ...</div><div><strong>An IL-4/21 Inverted Cytokine Receptor Improving CAR-T Cell Potency in Immunosuppressive Solid-Tumor Microenvironment</strong></div><div><em>Front. Immunol.</em> 2019; <strong>10</strong>:1691</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Y.WangH.JiangH.LuoY.SunB.ShiR.SunZ.LiAn+IL-4%2F21+Inverted+Cytokine+Receptor+Improving+CAR-T+Cell+Potency+in+Immunosuppressive+Solid-Tumor+MicroenvironmentFront.+Immunol.1020191691" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref133" href="#" role="doc-biblioref" data-xml-rid="bib133" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref133" aria-controls="sref133">Štach et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref133"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">134.</div><div>Štach, M. ∙ Musil, J. ∙ Cetkovsky, P. ...</div><div><strong>Interleukin 21 Enhances Survival and Expansion of CAR T Cells Via Inhibition of Their Terminal Differentiation during Interaction with Tumor Target Cells</strong></div><div><em>Blood.</em> 2018; <strong>132</strong>:4545</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.%C5%A0tachJ.MusilP.CetkovskyP.OtahalInterleukin+21+Enhances+Survival+and+Expansion+of+CAR+T+Cells+Via+Inhibition+of+Their+Terminal+Differentiation+during+Interaction+with+Tumor+Target+CellsBlood13220184545" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Taken together, these data suggested that therapeutic designs leveraging the B cell-TFH cell-IL21 axis could advance existing immunotherapies and lead to improved response rates for individuals with lung and other cancers.</div><section id="sec-3-1"><h3>Limitations of the study</h3><div id="p0170" role="paragraph">We showed the importance of T and B cell collaborations on driving IL-21-producing CD4 T&nbsp;cells in detail but relied on previous work demonstrating how IL-21 helps to sustain cytolytic effector functions of CD8 T&nbsp;cells (<span class="dropBlock reference-citations"><a id="body-ref-sref13-2" href="#" role="doc-biblioref" data-xml-rid="bib13" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref13-2" aria-controls="sref13-2">Chen et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref13-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Chen, Y. ∙ Zander, R.A. ∙ Wu, X. ...</div><div><strong>BATF regulates progenitor to cytolytic effector CD8<sup>+</sup> T&nbsp;cell transition during chronic viral infection</strong></div><div><em>Nat. Immunol.</em> 2021; <strong>22</strong>:996-1007</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Y.ChenR.A.ZanderX.WuD.M.SchauderM.Y.KasmaniJ.ShenS.ZhengR.BurnsE.J.TaparowskyW.CuiBATF+regulates+progenitor+to+cytolytic+effector+CD8%2B+T%C2%A0cell+transition+during+chronic+viral+infectionNat.+Immunol.2220219961007" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref29-4" href="#" role="doc-biblioref" data-xml-rid="bib29" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref29-4" aria-controls="sref29-4">Elsaesser et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref29-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">30.</div><div>Elsaesser, H. ∙ Sauer, K. ∙ Brooks, D.G.</div><div><strong>IL-21 is required to control chronic viral infection</strong></div><div><em>Science.</em> 2009; <strong>324</strong>:1569-1572</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=H.ElsaesserK.SauerD.G.BrooksIL-21+is+required+to+control+chronic+viral+infectionScience324200915691572" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref36-4" href="#" role="doc-biblioref" data-xml-rid="bib36" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref36-4" aria-controls="sref36-4">Fröhlich et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref36-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">37.</div><div>Fröhlich, A. ∙ Kisielow, J. ∙ Schmitz, I. ...</div><div><strong>IL-21R on T&nbsp;cells is critical for sustained functionality and control of chronic viral infection</strong></div><div><em>Science.</em> 2009; <strong>324</strong>:1576-1580</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.Fr%C3%B6hlichJ.KisielowI.SchmitzS.FreigangA.T.ShamshievJ.WeberB.J.MarslandA.OxeniusM.KopfIL-21R+on+T%C2%A0cells+is+critical+for+sustained+functionality+and+control+of+chronic+viral+infectionScience324200915761580" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref113-3" href="#" role="doc-biblioref" data-xml-rid="bib113" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref113-3" aria-controls="sref113-3">Ren et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref113-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">114.</div><div>Ren, H.M. ∙ Kolawole, E.M. ∙ Ren, M. ...</div><div><strong>IL-21 from high-affinity CD4 T&nbsp;cells drives differentiation of brain-resident CD8 T&nbsp;cells during persistent viral infection</strong></div><div><em>Sci. Immunol.</em> 2020; <strong>5</strong>:eabb5590</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=H.M.RenE.M.KolawoleM.RenG.JinC.S.Netherby-WinslowQ.WadeShwetankZ.S.M.RahmanB.D.EvavoldA.E.LukacherIL-21+from+high-affinity+CD4+T%C2%A0cells+drives+differentiation+of+brain-resident+CD8+T%C2%A0cells+during+persistent+viral+infectionSci.+Immunol.52020eabb5590" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref131-4" href="#" role="doc-biblioref" data-xml-rid="bib131" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref131-4" aria-controls="sref131-4">Snell et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref131-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">132.</div><div>Snell, L.M. ∙ MacLeod, B.L. ∙ Law, J.C. ...</div><div><strong>CD8<sup>+</sup> T Cell Priming in Established Chronic Viral Infection Preferentially Directs Differentiation of Memory-like Cells for Sustained Immunity</strong></div><div><em>Immunity.</em> 2018; <strong>49</strong>:678-694.e5</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=L.M.SnellB.L.MacLeodJ.C.LawI.OsokineH.J.ElsaesserK.HezavehR.J.DicksonM.A.GavinC.J.GuidosT.L.McGahaD.G.BrooksCD8%2B+T+Cell+Priming+in+Established+Chronic+Viral+Infection+Preferentially+Directs+Differentiation+of+Memory-like+Cells+for+Sustained+ImmunityImmunity492018678694.e5" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref151-3" href="#" role="doc-biblioref" data-xml-rid="bib151" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref151-3" aria-controls="sref151-3">Xin et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref151-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">152.</div><div>Xin, G. ∙ Schauder, D.M. ∙ Lainez, B. ...</div><div><strong>A Critical Role of IL-21-Induced BATF in Sustaining CD8-T-Cell-Mediated Chronic Viral Control</strong></div><div><em>Cell Rep.</em> 2015; <strong>13</strong>:1118-1124</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.XinD.M.SchauderB.LainezJ.S.WeinsteinZ.DaiY.ChenE.EspluguesR.WenD.WangI.A.ParishA+Critical+Role+of+IL-21-Induced+BATF+in+Sustaining+CD8-T-Cell-Mediated+Chronic+Viral+ControlCell+Rep.13201511181124" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref154-4" href="#" role="doc-biblioref" data-xml-rid="bib154" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref154-4" aria-controls="sref154-4">Yi et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref154-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">155.</div><div>Yi, J.S. ∙ Du, M. ∙ Zajac, A.J.</div><div><strong>A vital role for interleukin-21 in the control of a chronic viral infection</strong></div><div><em>Science.</em> 2009; <strong>324</strong>:1572-1576</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.S.YiM.DuA.J.ZajacA+vital+role+for+interleukin-21+in+the+control+of+a+chronic+viral+infectionScience324200915721576" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref158-5" href="#" role="doc-biblioref" data-xml-rid="bib158" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref158-5" aria-controls="sref158-5">Zander et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref158-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">159.</div><div>Zander, R. ∙ Schauder, D. ∙ Xin, G. ...</div><div><strong>CD4<sup>+</sup> T Cell Help Is Required for the Formation of a Cytolytic CD8<sup>+</sup> T Cell Subset that Protects against Chronic Infection and Cancer</strong></div><div><em>Immunity.</em> 2019; <strong>51</strong>:1028-1042.e4</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.ZanderD.SchauderG.XinC.NguyenX.WuA.ZajacW.CuiCD4%2B+T+Cell+Help+Is+Required+for+the+Formation+of+a+Cytolytic+CD8%2B+T+Cell+Subset+that+Protects+against+Chronic+Infection+and+CancerImmunity51201910281042.e4" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Our studies did not delve into the location where IL-21 is provided to CD8 T&nbsp;cells or which CD8 T&nbsp;cell types receive the IL-21. We discuss the idea that this may differ depending on the presence of tumor-associated TLSs. Further studies will be necessary to dissect the spatial and temporal dynamics of TFH-IL21-CD8 T&nbsp;cell interactions.</div></section></section><section id="sec-4"><h2>STAR★Methods</h2><section id="sec-4-1"><h3>Key resources table</h3><div id="p0185" role="paragraph"><div class="figure-wrap"><figure id="undtbl1" class="table" data-figureviewer-ignore="true"><div class="table-wrap"><table data-figureviewer-ignore="true" tabindex="0"><thead><tr class="rowsep"><th>REAGENT or RESOURCE</th><th>SOURCE</th><th>IDENTIFIER</th></tr></thead><tbody><tr class="rowsep"><td colspan="3"><b>Antibodies</b></td></tr><tr><td>BUV395 anti-mouse CD4</td><td>BD Biosciences</td><td>Cat#: 563790; RRID: <a id="intref0025" href="https://antibodyregistry.org/AB_2738426" target="_blank">AB_2738426</a></td></tr><tr><td>BV711 anti-mouse CD4</td><td>BioLegend</td><td>Cat#: 100550; RRID: <a id="intref0030" href="https://antibodyregistry.org/AB_2562099" target="_blank">AB_2562099</a></td></tr><tr><td>BV510 anti-mouse CD4</td><td>BioLegend</td><td>Cat#: 100559; RRID: <a id="intref0035" href="https://antibodyregistry.org/AB_2562608" target="_blank">AB_2562608</a></td></tr><tr><td>PE-CF594 anti-mouse CD4</td><td>BD Biosciences</td><td>Cat#: 562285; RRID: <a id="intref0040" href="https://antibodyregistry.org/AB_11154410" target="_blank">AB_11154410</a></td></tr><tr><td>BUV395 anti-mouse CD8a</td><td>BD Biosciences</td><td>Cat#: 563786; RRID: <a id="intref0045" href="https://antibodyregistry.org/AB_2732919" target="_blank">AB_2732919</a></td></tr><tr><td>BV711 anti-mouse CD8a</td><td>BioLegend</td><td>Cat#: 100748; RRID: <a id="intref0050" href="https://antibodyregistry.org/AB_2562100" target="_blank">AB_2562100</a></td></tr><tr><td>FITC anti-mouse CD8a</td><td>BioLegend</td><td>Cat#: 100706; RRID: <a id="intref0055" href="https://antibodyregistry.org/AB_312745" target="_blank">AB_312745</a></td></tr><tr><td>FITC anti-mouse CD8b.2</td><td>BioLegend</td><td>Cat#: 140404; RRID: <a id="intref0060" href="https://antibodyregistry.org/AB_10643587" target="_blank">AB_10643587</a></td></tr><tr><td>BV421 anti-mouse CD3</td><td>BioLegend</td><td>Cat#: 100228; RRID: <a id="intref0065" href="https://antibodyregistry.org/AB_2562553" target="_blank">AB_2562553</a></td></tr><tr><td>BV510 anti-mouse TCRb</td><td>BioLegend</td><td>Cat#: 109234; RRID: <a id="intref0070" href="https://antibodyregistry.org/AB_2562350" target="_blank">AB_2562350</a></td></tr><tr><td>BV711 anti-mouse TCRb</td><td>BD Biosciences</td><td>Cat#: 563135; RRID: <a id="intref0075" href="https://antibodyregistry.org/AB_2738023" target="_blank">AB_2738023</a></td></tr><tr><td>BV510 anti-mouse CD90.2</td><td>BioLegend</td><td>Cat#: 140319; RRID: <a id="intref0080" href="https://antibodyregistry.org/AB_2561395" target="_blank">AB_2561395</a></td></tr><tr><td>FITC anti-mouse CD90.2</td><td>BD Biosciences</td><td>Cat#: 553004; RRID: <a id="intref0085" href="https://antibodyregistry.org/AB_394542" target="_blank">AB_394542</a></td></tr><tr><td>BV510 anti-mouse CD90.1</td><td>BioLegend</td><td>Cat#: 202535; RRID: <a id="intref0090" href="https://antibodyregistry.org/AB_2562643" target="_blank">AB_2562643</a></td></tr><tr><td>PE-CF594 anti-mouse CD45</td><td>BD Biosciences</td><td>Cat#: 562420; RRID: <a id="intref0095" href="https://antibodyregistry.org/AB_11154401" target="_blank">AB_11154401</a></td></tr><tr><td>PE/Dazzle 594 anti-mouse CD45.2</td><td>BioLegend</td><td>Cat#: 109846; RRID: <a id="intref0100" href="https://antibodyregistry.org/AB_2564177" target="_blank">AB_2564177</a></td></tr><tr><td>PE anti-mouse CD45.2</td><td>Thermo Fisher</td><td>Cat#: 12-0454-83; RRID: <a id="intref0105" href="https://antibodyregistry.org/AB_465678" target="_blank">AB_465678</a></td></tr><tr><td>Alexa Fluor 647 anti-mouse CD45.2</td><td>BioLegend</td><td>Cat#: 109818; RRID: <a id="intref0110" href="https://antibodyregistry.org/AB_492870" target="_blank">AB_492870</a></td></tr><tr><td>APC anti-mouse CD45.1</td><td>BioLegend</td><td>Cat#: 110714; RRID: <a id="intref0115" href="https://antibodyregistry.org/AB_313503" target="_blank">AB_313503</a></td></tr><tr><td>APC-eFluor 780 anti-mouse CD44</td><td>Thermo Fisher</td><td>Cat#: 47-0441-82; RRID: <a id="intref0120" href="https://antibodyregistry.org/AB_1272244" target="_blank">AB_1272244</a></td></tr><tr><td>BV605 anti-mouse CD44</td><td>BioLegend</td><td>Cat#: 103047; RRID: <a id="intref0125" href="https://antibodyregistry.org/AB_2562451" target="_blank">AB_2562451</a></td></tr><tr><td>BV711 anti-mouse CD44</td><td>BioLegend</td><td>Cat#: 103057; RRID: <a id="intref0130" href="https://antibodyregistry.org/AB_2564214" target="_blank">AB_2564214</a></td></tr><tr><td>BV711 anti-mouse Ly6C</td><td>BioLegend</td><td>Cat#: 128037; RRID: <a id="intref0135" href="https://antibodyregistry.org/AB_2562630" target="_blank">AB_2562630</a></td></tr><tr><td>BV421 anti-mouse CD162 (PSGL1)</td><td>BD Biosciences</td><td>Cat#: 562807; RRID: <a id="intref0140" href="https://antibodyregistry.org/AB_2737808" target="_blank">AB_2737808</a></td></tr><tr><td>PE-Cy7 anti-mouse CD279 (PD-1)</td><td>BioLegend</td><td>Cat#: 109110; RRID: <a id="intref0145" href="https://antibodyregistry.org/AB_572017" target="_blank">AB_572017</a></td></tr><tr><td>BV421 anti-mouse CD279 (PD-1)</td><td>BioLegend</td><td>Cat#: 109121; RRID: <a id="intref0150" href="https://antibodyregistry.org/AB_2687080" target="_blank">AB_2687080</a></td></tr><tr><td>BV421 anti-mouse CD279 (PD-1)</td><td>BioLegend</td><td>Cat#: 135217; RRID: <a id="intref0155" href="https://antibodyregistry.org/AB_10900085" target="_blank">AB_10900085</a></td></tr><tr><td>BV605 anti-mouse CD185 (CXCR5)</td><td>BioLegend</td><td>Cat#: 145513; RRID: <a id="intref0160" href="https://antibodyregistry.org/AB_2562208" target="_blank">AB_2562208</a></td></tr><tr><td>PE anti-mouse Bcl-6</td><td>BD Biosciences</td><td>Cat#: 561522; RRID: <a id="intref0165" href="https://antibodyregistry.org/AB_10717126" target="_blank">AB_10717126</a></td></tr><tr><td>PE anti-mouse T-bet</td><td>Thermo Fisher</td><td>Cat#: 12-5825-82; RRID: <a id="intref0170" href="https://antibodyregistry.org/AB_925761" target="_blank">AB_925761</a></td></tr><tr><td>PE anti-mouse/human Granzyme B</td><td>Thermo Fisher</td><td>Cat#: GRB04; RRID: <a id="intref0175" href="https://antibodyregistry.org/AB_2536538" target="_blank">AB_2536538</a></td></tr><tr><td>PE anti-mouse CD360 (IL-21 receptor)</td><td>BD Biosciences</td><td>Cat#: 558607; RRID: <a id="intref0180" href="https://antibodyregistry.org/AB_647215" target="_blank">AB_647215</a></td></tr><tr><td>BUV395 anti-mouse CD19</td><td>BD Biosciences</td><td>Cat#: 563557; RRID: <a id="intref0185" href="https://antibodyregistry.org/AB_2722495" target="_blank">AB_2722495</a></td></tr><tr><td>PE-Cy7 anti-mouse CD19</td><td>Thermo Fisher</td><td>Cat#: 25-0193-82; RRID: <a id="intref0190" href="https://antibodyregistry.org/AB_657663" target="_blank">AB_657663</a></td></tr><tr><td>BV421 anti-mouse B220</td><td>BioLegend</td><td>Cat#: 103240; RRID: <a id="intref0195" href="https://antibodyregistry.org/AB_11203896" target="_blank">AB_11203896</a></td></tr><tr><td>BV605 anti-mouse IgD</td><td>BioLegend</td><td>Cat#: 405727; RRID: <a id="intref0200" href="https://antibodyregistry.org/AB_2562887" target="_blank">AB_2562887</a></td></tr><tr><td>FITC anti-mouse GL-7</td><td>BD Biosciences</td><td>Cat#: 553666; RRID: <a id="intref0205" href="https://antibodyregistry.org/AB_394981" target="_blank">AB_394981</a></td></tr><tr><td>PE-Cy7 anti-mouse CD95</td><td>BD Biosciences</td><td>Cat#: 557653; RRID: <a id="intref0210" href="https://antibodyregistry.org/AB_396768" target="_blank">AB_396768</a></td></tr><tr><td>APC anti-mouse CD138</td><td>BD Biosciences</td><td>Cat#: 558626; RRID: <a id="intref0215" href="https://antibodyregistry.org/AB_1645216" target="_blank">AB_1645216</a></td></tr><tr><td>FITC anti-mouse CD86</td><td>Thermo Fisher</td><td>Cat#: 11-0862-81; RRID: <a id="intref0220" href="https://antibodyregistry.org/AB_465147" target="_blank">AB_465147</a></td></tr><tr><td>PE anti-mouse CD69</td><td>BioLegend</td><td>Cat#: 104508; RRID: <a id="intref0225" href="https://antibodyregistry.org/AB_313111" target="_blank">AB_313111</a></td></tr><tr><td>PerCP-Cy5.5 anti-mouse CD62L</td><td>BioLegend</td><td>Cat#: 104432; RRID: <a id="intref0230" href="https://antibodyregistry.org/AB_2285839" target="_blank">AB_2285839</a></td></tr><tr class="rowsep"><td><i>InVivo</i>mAb anti-mouse CD8α</td><td>Bio X Cell</td><td>Cat#: BE0004-1; RRID: <a id="intref0235" href="https://antibodyregistry.org/AB_1107671" target="_blank">AB_1107671</a></td></tr><tr class="rowsep"><td colspan="3"><b>Bacterial and virus strains</b></td></tr><tr><td>pGK-Cre Lentiviral Vector</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref62-3" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-3" aria-controls="sref62-3">Joshi et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref62-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>Joshi, N.S. ∙ Akama-Garren, E.H. ∙ Lu, Y. ...</div><div><strong>Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses</strong></div><div><em>Immunity.</em> 2015; <strong>43</strong>:579-590</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.S.JoshiE.H.Akama-GarrenY.LuD.Y.LeeG.P.ChangA.LiM.DuPageT.TammelaN.R.KerperA.F.FaragoRegulatory+T+Cells+in+Tumor-Associated+Tertiary+Lymphoid+Structures+Suppress+Anti-tumor+T+Cell+ResponsesImmunity432015579590" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr class="rowsep"><td>pGK-HELLO-T2A-Cre Lentiviral Vector</td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Chemicals, peptides, and recombinant proteins</b></td></tr><tr><td>Lipopolysaccharides from <i>Escherichia coli</i> O55:B5</td><td>Sigma-Aldrich</td><td>Cat#: L2880</td></tr><tr><td>Recombinant Mouse BAFF/BLyS/TNFSF13B Protein</td><td>R&amp;D Systems</td><td>Cat#: 8876-BF-010</td></tr><tr><td>Hen Egg Lysozyme</td><td>Sigma Aldrich</td><td>Cat#: L3790</td></tr><tr><td>I-A(b) LCMV GP66-77 DIYKGVYQFKSV (APC-labeled Tetramer)</td><td>NIH Tetramer Core Facility</td><td>N/A</td></tr><tr><td>H-2D(b) LCMV GP33-41 KAVYNFATC (APC-labeled Tetramer)</td><td>NIH Tetramer Core Facility</td><td>N/A</td></tr><tr><td>LCMV gp61–80 peptide</td><td>Anaspec</td><td>Cat#: AS-64851</td></tr><tr class="rowsep"><td>LCMV gp33–41 peptide</td><td>Anaspec</td><td>Cat#: AS-61296</td></tr><tr class="rowsep"><td colspan="3"><b>Critical commercial assays</b></td></tr><tr><td>Foxp3 / Transcription Factor Staining Buffer Set</td><td>Thermo Fisher</td><td>Cat#: 00-5523-00</td></tr><tr><td>Fixation/Permeablization Kit</td><td>BD Bioscience</td><td>Cat#: 554714</td></tr><tr><td>LipoD293 <i>In&nbsp;Vitro</i> DNA Transfection Reagent</td><td>SignaGen Laboratories</td><td>Cat#: SL100668</td></tr><tr><td>CD45 (TIL) MicroBeads, mouse</td><td>Miltenyi Biotec</td><td>Cat#: 130-110-618</td></tr><tr><td>LS Columns</td><td>Miltenyi Biotec</td><td>Cat#: 130-042-401</td></tr><tr><td>MS Columns</td><td>Miltenyi Biotec</td><td>Cat#: 130-042-201</td></tr><tr><td>OctoMACS Separator</td><td>Miltenyi Biotec</td><td>Cat#: 130-042-108</td></tr><tr><td>EasySep Mouse CD4<sup>+</sup> T Cell Isolation Kit</td><td>STEMCELL Technologies</td><td>Cat#: 19852</td></tr><tr><td>EasySep Mouse CD8<sup>+</sup> T Cell Isolation Kit</td><td>STEMCELL Technologies</td><td>Cat#: 19853</td></tr><tr><td>EasySep Mouse B Cell Isolation Kit</td><td>STEMCELL Technologies</td><td>Cat#: 19854</td></tr><tr><td>EasySep Mouse Pan-DC Enrichment Kit</td><td>STEMCELL Technologies</td><td>Cat#: 19763</td></tr><tr><td>CellTrace CFSE Cell Proliferation Kit, for flow cytometry</td><td>ThermoFisher</td><td>Cat#: C34554</td></tr><tr class="rowsep"><td>LIVE/DEAD Fixable Aqua Dead Cell Stain Kit, for 405&nbsp;nm excitation</td><td>Thermo Fisher</td><td>Cat#: L34966</td></tr><tr class="rowsep"><td colspan="3"><b>Deposited data</b></td></tr><tr class="rowsep"><td>scRNA-Seq of human lung adenocarcinoma samples</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref65-3" href="#" role="doc-biblioref" data-xml-rid="bib65" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref65-3" aria-controls="sref65-3">Kim et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref65-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">66.</div><div>Kim, N. ∙ Kim, H.K. ∙ Lee, K. ...</div><div><strong>Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma</strong></div><div><em>Nat. Commun.</em> 2020; <strong>11</strong>:2285</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.KimH.K.KimK.LeeY.HongJ.H.ChoJ.W.ChoiJ.I.LeeY.L.SuhB.M.KuH.H.EumSingle-cell+RNA+sequencing+demonstrates+the+molecular+and+cellular+reprogramming+of+metastatic+lung+adenocarcinomaNat.+Commun.1120202285" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>GEO: <a id="intref0240" href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE131907" target="_blank">GSE131907</a></td></tr><tr class="rowsep"><td colspan="3"><b>Experimental models: cell lines</b></td></tr><tr><td>KP</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref23-4" href="#" role="doc-biblioref" data-xml-rid="bib23" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref23-4" aria-controls="sref23-4">Damo et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref23-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">24.</div><div>Damo, M. ∙ Fitzgerald, B. ∙ Lu, Y. ...</div><div><strong>Inducible de novo expression of neoantigens in tumor cells and mice</strong></div><div><em>Nat. Biotechnol.</em> 2021; <strong>39</strong>:64-73</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.DamoB.FitzgeraldY.LuM.NaderI.WilliamJ.F.CheungK.A.ConnollyG.G.FosterE.Akama-GarrenD.Y.LeeInducible+de+novo+expression+of+neoantigens+in+tumor+cells+and+miceNat.+Biotechnol.3920216473" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>KP-NINJA (KPN1.1)</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref33-5" href="#" role="doc-biblioref" data-xml-rid="bib33" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref33-5" aria-controls="sref33-5">Fitzgerald et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref33-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Fitzgerald, B. ∙ Connolly, K.A. ∙ Cui, C. ...</div><div><strong>A mouse model for the study of anti-tumor T&nbsp;cell responses in Kras-driven lung adenocarcinoma</strong></div><div><em>Cell Rep Methods.</em> 2021; <strong>1</strong>:100080</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=B.FitzgeraldK.A.ConnollyC.CuiE.FagerbergD.L.MariuzzaN.I.HornickG.G.FosterI.WilliamJ.F.CheungN.S.JoshiA+mouse+model+for+the+study+of+anti-tumor+T%C2%A0cell+responses+in+Kras-driven+lung+adenocarcinomaCell+Rep+Methods12021100080" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>KP-HELLO</td><td>This paper</td><td>N/A</td></tr><tr><td>MC38</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref60-1" href="#" role="doc-biblioref" data-xml-rid="bib60" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref60-1" aria-controls="sref60-1">Jiang et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref60-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">61.</div><div>Jiang, X. ∙ Muthusamy, V. ∙ Fedorova, O. ...</div><div><strong>Intratumoral delivery of RIG-I agonist SLR14 induces robust antitumor responses</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2019; <strong>216</strong>:2854-2868</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=X.JiangV.MuthusamyO.FedorovaY.KongD.J.KimM.BosenbergA.M.PyleA.IwasakiIntratumoral+delivery+of+RIG-I+agonist+SLR14+induces+robust+antitumor+responsesJ.%C2%A0Exp.+Med.216201928542868" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr class="rowsep"><td>B16-F10</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref161-1" href="#" role="doc-biblioref" data-xml-rid="bib161" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref161-1" aria-controls="sref161-1">Zhou et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref161-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">162.</div><div>Zhou, T. ∙ Damsky, W. ∙ Weizman, O.E. ...</div><div><strong>IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy</strong></div><div><em>Nature.</em> 2020; <strong>583</strong>:609-614</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=T.ZhouW.DamskyO.E.WeizmanM.K.McGearyK.P.HartmannC.E.RosenS.FischerR.JacksonR.A.FlavellJ.WangIL-18BP+is+a+secreted+immune+checkpoint+and+barrier+to+IL-18+immunotherapyNature5832020609614" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>ATCC: CRL-6475</td></tr><tr class="rowsep"><td colspan="3"><b>Experimental models: organisms/strains</b></td></tr><tr><td>Mouse: C57BL/6</td><td>Charles River</td><td>N/A</td></tr><tr><td>Mouse: C57BL/6</td><td>The Jackson Laboratory</td><td>N/A</td></tr><tr><td>Mouse: CD45.1<sup>+</sup> C57BL/6</td><td>The Jackson Laboratory</td><td>N/A</td></tr><tr><td>Mouse: SWHEL</td><td>Robert Brink Laboratory</td><td>N/A</td></tr><tr><td>Mouse: Rag1 KO</td><td>David Schatz Laboratory</td><td>N/A</td></tr><tr><td>Mouse: CD4-Cre Bcl6<sup>fl/fl</sup></td><td>Stephanie Eisenbarth Laboratory</td><td>N/A</td></tr><tr><td>Mouse: B6.129S2-<i>Ciita</i><sup><i>tm1Ccum</i></sup>/J | CIITA KO</td><td>Stephanie Eisenbarth Laboratory</td><td>JAX: 003239</td></tr><tr><td>Mouse: B6.129S2-<i>Cd40lg</i><sup><i>tm1Imx</i></sup>/J | CD40 ligand KO</td><td>Stephanie Eisenbarth Laboratory</td><td>JAX: 002770</td></tr><tr><td>Mouse: B6.129S2-<i>Ighm</i><sup><i>tm1Cgn</i></sup>/J | muMt<sup>-</sup></td><td>The Jackson Laboratory</td><td>JAX: 002288</td></tr><tr><td>Mouse: B6.129P2-<i>Icos</i><sup><i>tm1Mak</i></sup>/J | ICOS KO</td><td>The Jackson Laboratory</td><td>JAX: 004859</td></tr><tr><td>Mouse: B6.129-<i>Il21r</i><sup><i>tm1Kopf</i></sup>/J | IL21R KO</td><td>The Jackson Laboratory</td><td>JAX: 019115</td></tr><tr><td>Mouse: C57BL/6-Tg(IghelMD4)4Ccg/J</td><td>The Jackson Laboratory</td><td>JAX: 002595</td></tr><tr><td>Mouse: Kras<sup>LSL-G12D</sup>; Trp53<sup>fl/fl</sup> (KP)</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref62-4" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-4" aria-controls="sref62-4">Joshi et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref62-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>Joshi, N.S. ∙ Akama-Garren, E.H. ∙ Lu, Y. ...</div><div><strong>Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses</strong></div><div><em>Immunity.</em> 2015; <strong>43</strong>:579-590</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.S.JoshiE.H.Akama-GarrenY.LuD.Y.LeeG.P.ChangA.LiM.DuPageT.TammelaN.R.KerperA.F.FaragoRegulatory+T+Cells+in+Tumor-Associated+Tertiary+Lymphoid+Structures+Suppress+Anti-tumor+T+Cell+ResponsesImmunity432015579590" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Mouse: uMT-KP</td><td>This paper</td><td>N/A</td></tr><tr><td>Mouse: SMARTA</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref23-5" href="#" role="doc-biblioref" data-xml-rid="bib23" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref23-5" aria-controls="sref23-5">Damo et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref23-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">24.</div><div>Damo, M. ∙ Fitzgerald, B. ∙ Lu, Y. ...</div><div><strong>Inducible de novo expression of neoantigens in tumor cells and mice</strong></div><div><em>Nat. Biotechnol.</em> 2021; <strong>39</strong>:64-73</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.DamoB.FitzgeraldY.LuM.NaderI.WilliamJ.F.CheungK.A.ConnollyG.G.FosterE.Akama-GarrenD.Y.LeeInducible+de+novo+expression+of+neoantigens+in+tumor+cells+and+miceNat.+Biotechnol.3920216473" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Mouse: P14</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref23-6" href="#" role="doc-biblioref" data-xml-rid="bib23" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref23-6" aria-controls="sref23-6">Damo et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref23-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">24.</div><div>Damo, M. ∙ Fitzgerald, B. ∙ Lu, Y. ...</div><div><strong>Inducible de novo expression of neoantigens in tumor cells and mice</strong></div><div><em>Nat. Biotechnol.</em> 2021; <strong>39</strong>:64-73</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.DamoB.FitzgeraldY.LuM.NaderI.WilliamJ.F.CheungK.A.ConnollyG.G.FosterE.Akama-GarrenD.Y.LeeInducible+de+novo+expression+of+neoantigens+in+tumor+cells+and+miceNat.+Biotechnol.3920216473" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Mouse: OT-II</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref147-2" href="#" role="doc-biblioref" data-xml-rid="bib147" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref147-2" aria-controls="sref147-2">Weinstein et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref147-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">148.</div><div>Weinstein, J.S. ∙ Herman, E.I. ∙ Lainez, B. ...</div><div><strong>TFH cells progressively differentiate to regulate the germinal center response</strong></div><div><em>Nat. Immunol.</em> 2016; <strong>17</strong>:1197-1205</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.S.WeinsteinE.I.HermanB.LainezP.Licona-Lim%C3%B3nE.EspluguesR.FlavellJ.CraftTFH+cells+progressively+differentiate+to+regulate+the+germinal+center+responseNat.+Immunol.17201611971205" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Mouse: Il21<sup>Kat/Kat</sup> Il4<sup>GFP/GFP</sup> double reporter</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref147-3" href="#" role="doc-biblioref" data-xml-rid="bib147" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref147-3" aria-controls="sref147-3">Weinstein et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref147-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">148.</div><div>Weinstein, J.S. ∙ Herman, E.I. ∙ Lainez, B. ...</div><div><strong>TFH cells progressively differentiate to regulate the germinal center response</strong></div><div><em>Nat. Immunol.</em> 2016; <strong>17</strong>:1197-1205</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.S.WeinsteinE.I.HermanB.LainezP.Licona-Lim%C3%B3nE.EspluguesR.FlavellJ.CraftTFH+cells+progressively+differentiate+to+regulate+the+germinal+center+responseNat.+Immunol.17201611971205" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr class="rowsep"><td>Mouse: uMT-Il21<sup>Kat/Kat</sup> reporter</td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Recombinant DNA</b></td></tr><tr><td>pGK-Cre LV plasmid</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref62-5" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-5" aria-controls="sref62-5">Joshi et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref62-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>Joshi, N.S. ∙ Akama-Garren, E.H. ∙ Lu, Y. ...</div><div><strong>Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses</strong></div><div><em>Immunity.</em> 2015; <strong>43</strong>:579-590</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.S.JoshiE.H.Akama-GarrenY.LuD.Y.LeeG.P.ChangA.LiM.DuPageT.TammelaN.R.KerperA.F.FaragoRegulatory+T+Cells+in+Tumor-Associated+Tertiary+Lymphoid+Structures+Suppress+Anti-tumor+T+Cell+ResponsesImmunity432015579590" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr class="rowsep"><td>pGK-HELLO-T2A-Cre LV plasmid</td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Software and algorithms</b></td></tr><tr><td>R 4.0.0</td><td>N/A</td><td><a id="intref0245" href="https://www.r-project.org/" target="_blank">https://www.r-project.org/</a></td></tr><tr><td>Seurat 3.1.0</td><td>Satija Laboratory</td><td><a id="intref0250" href="http://satijalab.org/seurat" target="_blank">http://satijalab.org/seurat</a></td></tr><tr><td>GEPIA 2</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref135-1" href="#" role="doc-biblioref" data-xml-rid="bib135" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref135-1" aria-controls="sref135-1">Tang et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref135-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">136.</div><div>Tang, Z. ∙ Kang, B. ∙ Li, C. ...</div><div><strong>GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis</strong></div><div><em>Nucleic Acids Res.</em> 2019; <strong>47</strong>:W556-W560</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Z.TangB.KangC.LiT.ChenZ.ZhangGEPIA2%3A+an+enhanced+web+server+for+large-scale+expression+profiling+and+interactive+analysisNucleic+Acids+Res.47W12019W556W560" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0255" href="http://gepia2.cancer-pku.cn/" target="_blank">http://gepia2.cancer-pku.cn/</a></td></tr><tr><td>CIBERSORT</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref95-2" href="#" role="doc-biblioref" data-xml-rid="bib95" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref95-2" aria-controls="sref95-2">Newman et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref95-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">96.</div><div>Newman, A.M. ∙ Liu, C.L. ∙ Green, M.R. ...</div><div><strong>Robust enumeration of cell subsets from tissue expression profiles</strong></div><div><em>Nat. Methods.</em> 2015; <strong>12</strong>:453-457</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.M.NewmanC.L.LiuM.R.GreenA.J.GentlesW.FengY.XuC.D.HoangM.DiehnA.A.AlizadehRobust+enumeration+of+cell+subsets+from+tissue+expression+profilesNat.+Methods122015453457" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0260" href="https://cibersort.stanford.edu/" target="_blank">https://cibersort.stanford.edu/</a></td></tr><tr><td>NetMHC 4.0</td><td><span class="dropBlock reference-citations"><a id="body-ref-optJrMrYB9kpE" href="#" role="doc-biblioref" data-xml-rid="bib163" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="optJrMrYB9kpE" aria-controls="optJrMrYB9kpE">Andreatta and Nielsen, 2016</a><div class="dropBlock__holder" data-db-target-of="optJrMrYB9kpE"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">4.</div><div>Andreatta, M. ∙ Nielsen, M.</div><div><strong>Gapped sequence alignment using artificial neural networks: application to the MHC class I system</strong></div><div><em>Bioinformatics.</em> 2016; <strong>32</strong>:511-517</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.AndreattaM.NielsenGapped+sequence+alignment+using+artificial+neural+networks%3A+application+to+the+MHC+class+I+systemBioinformatics32201651151710.1093%2Fbioinformatics%2Fbtv639" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0265" href="https://services.healthtech.dtu.dk/service.php?NetMHC-4.0" target="_blank">https://services.healthtech.dtu.dk/service.php?NetMHC-4.0</a></td></tr><tr><td>FlowJo 10.7.1</td><td>Treestar</td><td><a id="intref0270" href="https://www.flowjo.com/" target="_blank">https://www.flowjo.com/</a></td></tr><tr><td>Prism 9</td><td>Graphpad</td><td><a id="intref0275" href="https://www.graphpad.com/" target="_blank">https://www.graphpad.com/</a></td></tr></tbody></table></div><figcaption><div class="core-table-tools"><ul><li><a class="core-table-show-action" href="/action/showFullTableHTML?isHtml=true&amp;tableId=undtbl1&amp;pii=S0092-8674%2821%2901322-2" target="_blank">Open table in a new tab</a></li></ul></div></figcaption></figure></div></div></section><section id="sec-4-2"><h3>Resource availability</h3><section id="sec-4-2-1"><h4>Lead contact</h4><div id="p0190" role="paragraph">Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Nikhil Joshi (<a id="intref0280" href="mailto:nikhil.joshi@yale.edu">nikhil.joshi@yale.edu</a>).</div></section><section id="sec-4-2-2"><h4>Materials availability</h4><div id="p0195" role="paragraph">Cell lines and plasmids generated in this study will be deposited to ATCC and Addgene for public requests. See <a id="intref0285" href="http://www.nikjoshilab.org/reagents" target="_blank">http://www.nikjoshilab.org/reagents</a> for details.</div></section></section><section id="sec-4-3"><h3>Experimental model and subject details</h3><section id="sec-4-3-1"><h4>Mice</h4><div id="p0200" role="paragraph">All mice were housed in pathogen-free conditions at Yale School of Medicine (New Haven, CT). CD45.2 WT C57BL/6 mice, and CD45.1 allotype-marked mice were purchased from the Jackson Laboratory and Charles River Laboratory. uMT, ICOS KO, IL21R KO, and MD4 mice were obtained from the Jackson Laboratory. Class II major histocompatibility complex (MHCII) transactivator (CIITA) KO, CD40 ligand KO, CD4-cre Bcl6<sup>fl/fl</sup> mice were provided by Stephanie Eisenbarth (Yale University), and RAG1 KO by David Schatz (Yale University). SMARTA, OT-II, P14 and KP mice were described previously (<span class="dropBlock reference-citations"><a id="body-ref-sref23-7" href="#" role="doc-biblioref" data-xml-rid="bib23" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref23-7" aria-controls="sref23-7">Damo et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref23-7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">24.</div><div>Damo, M. ∙ Fitzgerald, B. ∙ Lu, Y. ...</div><div><strong>Inducible de novo expression of neoantigens in tumor cells and mice</strong></div><div><em>Nat. Biotechnol.</em> 2021; <strong>39</strong>:64-73</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.DamoB.FitzgeraldY.LuM.NaderI.WilliamJ.F.CheungK.A.ConnollyG.G.FosterE.Akama-GarrenD.Y.LeeInducible+de+novo+expression+of+neoantigens+in+tumor+cells+and+miceNat.+Biotechnol.3920216473" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref27-3" href="#" role="doc-biblioref" data-xml-rid="bib27" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref27-3" aria-controls="sref27-3">DuPage et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref27-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">28.</div><div>DuPage, M. ∙ Cheung, A.F. ∙ Mazumdar, C. ...</div><div><strong>Endogenous T&nbsp;cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression</strong></div><div><em>Cancer Cell.</em> 2011; <strong>19</strong>:72-85</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.DuPageA.F.CheungC.MazumdarM.M.WinslowR.BronsonL.M.SchmidtD.CrowleyJ.ChenT.JacksEndogenous+T%C2%A0cell+responses+to+antigens+expressed+in+lung+adenocarcinomas+delay+malignant+tumor+progressionCancer+Cell1920117285" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref62-6" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-6" aria-controls="sref62-6">Joshi et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref62-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>Joshi, N.S. ∙ Akama-Garren, E.H. ∙ Lu, Y. ...</div><div><strong>Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses</strong></div><div><em>Immunity.</em> 2015; <strong>43</strong>:579-590</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.S.JoshiE.H.Akama-GarrenY.LuD.Y.LeeG.P.ChangA.LiM.DuPageT.TammelaN.R.KerperA.F.FaragoRegulatory+T+Cells+in+Tumor-Associated+Tertiary+Lymphoid+Structures+Suppress+Anti-tumor+T+Cell+ResponsesImmunity432015579590" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref147-4" href="#" role="doc-biblioref" data-xml-rid="bib147" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref147-4" aria-controls="sref147-4">Weinstein et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref147-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">148.</div><div>Weinstein, J.S. ∙ Herman, E.I. ∙ Lainez, B. ...</div><div><strong>TFH cells progressively differentiate to regulate the germinal center response</strong></div><div><em>Nat. Immunol.</em> 2016; <strong>17</strong>:1197-1205</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.S.WeinsteinE.I.HermanB.LainezP.Licona-Lim%C3%B3nE.EspluguesR.FlavellJ.CraftTFH+cells+progressively+differentiate+to+regulate+the+germinal+center+responseNat.+Immunol.17201611971205" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). SW<sub>HEL</sub> mice were provided by Robert Brink (Garvan Institute of Medical Research). <i>Il21</i><sup><i>Kat/Kat</i></sup> and <i>Il4</i><sup><i>GFP</i></sup> <i>[4get]</i> reporter was described previously (<span class="dropBlock reference-citations"><a id="body-ref-sref147-5" href="#" role="doc-biblioref" data-xml-rid="bib147" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref147-5" aria-controls="sref147-5">Weinstein et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref147-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">148.</div><div>Weinstein, J.S. ∙ Herman, E.I. ∙ Lainez, B. ...</div><div><strong>TFH cells progressively differentiate to regulate the germinal center response</strong></div><div><em>Nat. Immunol.</em> 2016; <strong>17</strong>:1197-1205</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.S.WeinsteinE.I.HermanB.LainezP.Licona-Lim%C3%B3nE.EspluguesR.FlavellJ.CraftTFH+cells+progressively+differentiate+to+regulate+the+germinal+center+responseNat.+Immunol.17201611971205" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). uMT-<i>IL21</i> <sup><i>Kat/Kat</i></sup> reporter and uMT-KP were bred in-house. All studies were carried out in male and female recipients to account for sex as a biological variable and no differences were noted. All mice were used in accordance with protocols approved by the Institutional Animal Care and Use Committees of Yale University.</div></section><section id="sec-4-3-2"><h4><i>In&nbsp;vitro</i> T&nbsp;cell and B cell co-culture</h4><div id="p0205" role="paragraph"><i>In&nbsp;vitro</i> co-cultures were modeled after previously reported systems (<span class="dropBlock reference-citations"><a id="body-ref-sref10" href="#" role="doc-biblioref" data-xml-rid="bib10" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref10" aria-controls="sref10">Bruno et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">11.</div><div>Bruno, T.C. ∙ Ebner, P.J. ∙ Moore, B.L. ...</div><div><strong>Antigen-Presenting Intratumoral B Cells Affect CD4<sup>+</sup> TIL Phenotypes in Non-Small Cell Lung Cancer Patients</strong></div><div><em>Cancer Immunol. Res.</em> 2017; <strong>5</strong>:898-907</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=T.C.BrunoP.J.EbnerB.L.MooreO.G.SquallsK.A.WaughE.B.EruslanovS.SinghalJ.D.MitchellW.A.FranklinD.T.MerrickAntigen-Presenting+Intratumoral+B+Cells+Affect+CD4%2B+TIL+Phenotypes+in+Non-Small+Cell+Lung+Cancer+PatientsCancer+Immunol.+Res.52017898907" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref66" href="#" role="doc-biblioref" data-xml-rid="bib66" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref66" aria-controls="sref66">Kolenbrander et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref66"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">67.</div><div>Kolenbrander, A. ∙ Grewe, B. ∙ Nemazee, D. ...</div><div><strong>Generation of T follicular helper cells in&nbsp;vitro: requirement for B-cell receptor cross-linking and cognate B- and T-cell interaction</strong></div><div><em>Immunology.</em> 2018; <strong>153</strong>:214-224</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.KolenbranderB.GreweD.NemazeeK.%C3%9CberlaV.TemchuraGeneration+of+T+follicular+helper+cells+in%C2%A0vitro%3A+requirement+for+B-cell+receptor+cross-linking+and+cognate+B-+and+T-cell+interactionImmunology1532018214224" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref70" href="#" role="doc-biblioref" data-xml-rid="bib70" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref70" aria-controls="sref70">Lapointe et&nbsp;al., 2003</a><div class="dropBlock__holder" data-db-target-of="sref70"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">71.</div><div>Lapointe, R. ∙ Bellemare-Pelletier, A. ∙ Housseau, F. ...</div><div><strong>CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T&nbsp;cells</strong></div><div><em>Cancer Res.</em> 2003; <strong>63</strong>:2836-2843</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.LapointeA.Bellemare-PelletierF.HousseauJ.ThibodeauP.HwuCD40-stimulated+B+lymphocytes+pulsed+with+tumor+antigens+are+effective+antigen-presenting+cells+that+can+generate+specific+T%C2%A0cellsCancer+Res.63200328362843" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). KP and KP-HELLO cells had been cultured at 37°C and 5% CO2, in complete RPMI-1640 (10% HI-FBS&nbsp;+ 1% Penicillin &amp; Streptomycin&nbsp;+ 1x L-Glutamine&nbsp;+ 55&nbsp;μM β-mercaptoethanol) for 2&nbsp;days. Supernatant of KP and KP-HELLO were filtered with 0.45&nbsp;μm filters. Naive CD4<sup>+</sup> T&nbsp;cells and B cells were separated from spleens by negative selection with EasySep Mouse CD4<sup>+</sup> T Cell Isolation Kit and Mouse B Cell Isolation Kit, respectively (STEMCELL technologies), according to the manufacturer’s protocol. 1&nbsp;× 10<sup>6</sup>/mL B cells were plated with CD4<sup>+</sup> T&nbsp;cells in a ratio of B:T&nbsp;= 1:2, and co-cultured with the supernatant of KP or KP-HELLO, or complete RPMI-1640 supplemented with LCMV GP<sub>61-80</sub> peptide GLKGPDIYKGVYQFKSVEFD (5&nbsp;μg/mL, Anaspec) or HEL (0.5&nbsp;μg/mL, Sigma-Aldrich). BAFF (10ng/mL, R&amp;D Systems) were added in all the co-culture experimental conditions. Flow cytometric analysis were performed after 48 hours of co-culture.</div></section><section id="sec-4-3-3"><h4>Tumor cell line and growth studies</h4><div id="p0210" role="paragraph">The KP cell line had been described previously (<span class="dropBlock reference-citations"><a id="body-ref-sref23-8" href="#" role="doc-biblioref" data-xml-rid="bib23" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref23-8" aria-controls="sref23-8">Damo et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref23-8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">24.</div><div>Damo, M. ∙ Fitzgerald, B. ∙ Lu, Y. ...</div><div><strong>Inducible de novo expression of neoantigens in tumor cells and mice</strong></div><div><em>Nat. Biotechnol.</em> 2021; <strong>39</strong>:64-73</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.DamoB.FitzgeraldY.LuM.NaderI.WilliamJ.F.CheungK.A.ConnollyG.G.FosterE.Akama-GarrenD.Y.LeeInducible+de+novo+expression+of+neoantigens+in+tumor+cells+and+miceNat.+Biotechnol.3920216473" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and was derived from an Ad-CRE-infected Kras<sup>G12D</sup>, p53<sup>fl/fl</sup> mouse (<span class="dropBlock reference-citations"><a id="body-ref-sref26" href="#" role="doc-biblioref" data-xml-rid="bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26" aria-controls="sref26">DuPage et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref26"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">27.</div><div>DuPage, M. ∙ Dooley, A.L. ∙ Jacks, T.</div><div><strong>Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase</strong></div><div><em>Nat. Protoc.</em> 2009; <strong>4</strong>:1064-1072</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.DuPageA.L.DooleyT.JacksConditional+mouse+lung+cancer+models+using+adenoviral+or+lentiviral+delivery+of+Cre+recombinaseNat.+Protoc.4200910641072" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). KP-NINJA (KPN1.1) has been described previously (<span class="dropBlock reference-citations"><a id="body-ref-sref33-6" href="#" role="doc-biblioref" data-xml-rid="bib33" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref33-6" aria-controls="sref33-6">Fitzgerald et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref33-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Fitzgerald, B. ∙ Connolly, K.A. ∙ Cui, C. ...</div><div><strong>A mouse model for the study of anti-tumor T&nbsp;cell responses in Kras-driven lung adenocarcinoma</strong></div><div><em>Cell Rep Methods.</em> 2021; <strong>1</strong>:100080</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=B.FitzgeraldK.A.ConnollyC.CuiE.FagerbergD.L.MariuzzaN.I.HornickG.G.FosterI.WilliamJ.F.CheungN.S.JoshiA+mouse+model+for+the+study+of+anti-tumor+T%C2%A0cell+responses+in+Kras-driven+lung+adenocarcinomaCell+Rep+Methods12021100080" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). MC38 and B16-F10 cells were obtained from Akiko Iwasaki laboratory (<span class="dropBlock reference-citations"><a id="body-ref-sref60-2" href="#" role="doc-biblioref" data-xml-rid="bib60" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref60-2" aria-controls="sref60-2">Jiang et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref60-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">61.</div><div>Jiang, X. ∙ Muthusamy, V. ∙ Fedorova, O. ...</div><div><strong>Intratumoral delivery of RIG-I agonist SLR14 induces robust antitumor responses</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2019; <strong>216</strong>:2854-2868</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=X.JiangV.MuthusamyO.FedorovaY.KongD.J.KimM.BosenbergA.M.PyleA.IwasakiIntratumoral+delivery+of+RIG-I+agonist+SLR14+induces+robust+antitumor+responsesJ.%C2%A0Exp.+Med.216201928542868" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and Aaron M. Ring laboratory (<span class="dropBlock reference-citations"><a id="body-ref-sref161-2" href="#" role="doc-biblioref" data-xml-rid="bib161" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref161-2" aria-controls="sref161-2">Zhou et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref161-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">162.</div><div>Zhou, T. ∙ Damsky, W. ∙ Weizman, O.E. ...</div><div><strong>IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy</strong></div><div><em>Nature.</em> 2020; <strong>583</strong>:609-614</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=T.ZhouW.DamskyO.E.WeizmanM.K.McGearyK.P.HartmannC.E.RosenS.FischerR.JacksonR.A.FlavellJ.WangIL-18BP+is+a+secreted+immune+checkpoint+and+barrier+to+IL-18+immunotherapyNature5832020609614" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), respectively. KP, KP-HELLO, KP-NINJA, MC38 and B16-F10 cells were cultured at 37°C and 5% CO2, in complete DMEM (4.5g/L D-glucose&nbsp;+ L-glutamine&nbsp;+ 110mg/L sodium pyruvate&nbsp;+ 10% HI-FBS&nbsp;+ 1% Penicillin &amp; Streptomycin). For tumor growth measurements and FACS analysis, mice were subcutaneously (s.c.) implanted with 2&nbsp;× 10<sup>5</sup> or 5&nbsp;× 10<sup>5</sup> KP, KP-HELLO, KP-NINJA cells (individual numbers in figure legends), or 5&nbsp;× 10<sup>5</sup> MC38, B16-F10 cells. Tumor volume was measured as [(Width<sup>2</sup> × Length)/2], every four days with a digital caliper. Growth curves of C57BL/6 (n&nbsp;= 40) and uMT (n&nbsp;= 32) mice that were challenged with 2&nbsp;× 10<sup>5</sup> KP-HELLO cells, pooled from 8 independent experiments, were set as the baseline of tumor growth analyses. Mice with ≧ 1cm<sup>3</sup> or ulcerated tumors were euthanized in accordance with the protocols approved by the Institutional Animal Care and Use Committees of Yale University.</div></section></section><section id="sec-4-4"><h3>Method details</h3><section id="sec-4-4-1"><h4>Generation of KP-HELLO cell line</h4><div id="p0215" role="paragraph">KP was transduced with HELLO Lentiviral vector (LV). The LV backbone for HELLO has been described previously (<span class="dropBlock reference-citations"><a id="body-ref-sref1" href="#" role="doc-biblioref" data-xml-rid="bib1" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref1" aria-controls="sref1">Akama-Garren et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Akama-Garren, E.H. ∙ Joshi, N.S. ∙ Tammela, T. ...</div><div><strong>A Modular Assembly Platform for Rapid Generation of DNA Constructs</strong></div><div><em>Sci. Rep.</em> 2016; <strong>6</strong>:16836</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=E.H.Akama-GarrenN.S.JoshiT.TammelaG.P.ChangB.L.WagnerD.Y.LeeW.M.Rideout3rdT.PapagiannakopoulosW.XueT.JacksA+Modular+Assembly+Platform+for+Rapid+Generation+of+DNA+ConstructsSci.+Rep.6201616836" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). HELLO-LV contains HELLO driven by phosphoglycerate kinase (pGK) promoter. HELLO was generated as a protein fusion of codon-optimized hen egg lysozyme (HEL), LCMVgp<sub>33-43</sub> (KAVYNFATCGI), LCMVgp<sub>61-80</sub> (GLNGPDIYKGVYQFKSVEFD), and 2A peptide-linked mScarlet. The DNA and amino acid sequences of HELLO construct are available in <a id="crosref1715" href="#mmc2">Table S2</a>. NET MHC4.0 web server was used to predict MHC class I binding peptides (H-2Db and H-2Kb) in HELLO, with results summarized in <a id="crosref1720" href="#mmc3">Table S3</a>. KP cells were transduced with HELLO-LV produced by co-transfection of 293FS<sup>∗</sup> cells with HELLO, PSPax2 (gag/pol) and VSV-G (vesicular stomatitis virus glycoprotein) vectors as described previously (<span class="dropBlock reference-citations"><a id="body-ref-sref23-9" href="#" role="doc-biblioref" data-xml-rid="bib23" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref23-9" aria-controls="sref23-9">Damo et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref23-9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">24.</div><div>Damo, M. ∙ Fitzgerald, B. ∙ Lu, Y. ...</div><div><strong>Inducible de novo expression of neoantigens in tumor cells and mice</strong></div><div><em>Nat. Biotechnol.</em> 2021; <strong>39</strong>:64-73</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.DamoB.FitzgeraldY.LuM.NaderI.WilliamJ.F.CheungK.A.ConnollyG.G.FosterE.Akama-GarrenD.Y.LeeInducible+de+novo+expression+of+neoantigens+in+tumor+cells+and+miceNat.+Biotechnol.3920216473" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Transduced LGKP cells were FACS-sorted, yielding a pure mScarlet population of KP-HELLO cells. 25 frozen aliquots of KP-HELLO were generated after 2 passages and were named as “G0.” Based on 1 aliquot of “G0,” 20 frozen aliquots of “G1” were generated after 2 passages, and so as “G2” based on “G1.” For each experiment, one fresh aliquot of “G2” was thawed and used within 2 passages. After 6-7 passages described above, &gt; 99% of KP-HELLO “G2” cells were still mScarlet positive with flow cytometric analysis, which suggested the stable expression of HELLO protein in KP-HELLO cell line.</div></section><section id="sec-4-4-2"><h4>KP-HELLO cell line proviral sequence validation</h4><div id="p0220" role="paragraph">Genomic DNA was extracted from two separate cultures of KP-HELLO (2&nbsp;× 10<sup>6</sup> cells for each lysis) using the Takara Bio NucleoSpin Tissue kit (Cat#: 740952.50). PCR (Takara Bio High Fidelity PCR EcoDry Premix, Cat. # 639280) was performed to amplify the proviral DNA sequences encoding the GP<sub>33-43</sub>/FLAG/GP<sub>61-80</sub> from the KP-HELLO cell genomic DNA. Amplified products were purified using the Takara Bio NucleoSpin Gel and PCR Clean-up kit (Cat. #740609.50) and were subsequently sequenced with Sanger sequencing using 2 different sets of specific primers.</div></section><section id="sec-4-4-3"><h4>Lentiviral vector production and administration</h4><div id="p0225" role="paragraph">“Lenti-HELLO-Cre” plasmids were generated by cloning Cre into HELLO-LV. Lentiviral vectors were produced by transfecting 293FS<sup>∗</sup> cells with Lenti-HELLO-Cre, PSPax2 and VSV-G vectors at a 4:3:1 ratio, of which supernatant was harvested at 100,000&nbsp;g for 2 hours (20°C), after 32-hour incubation at 37°C, as described previously (<span class="dropBlock reference-citations"><a id="body-ref-sref62-7" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-7" aria-controls="sref62-7">Joshi et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref62-7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>Joshi, N.S. ∙ Akama-Garren, E.H. ∙ Lu, Y. ...</div><div><strong>Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses</strong></div><div><em>Immunity.</em> 2015; <strong>43</strong>:579-590</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.S.JoshiE.H.Akama-GarrenY.LuD.Y.LeeG.P.ChangA.LiM.DuPageT.TammelaN.R.KerperA.F.FaragoRegulatory+T+Cells+in+Tumor-Associated+Tertiary+Lymphoid+Structures+Suppress+Anti-tumor+T+Cell+ResponsesImmunity432015579590" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). LV titer was quantified by transducing GreenGo cell line (10<sup>5</sup> cells/well) in serial dilutions to 1mL of final volume and calculated with the formula: (% fluorescent cells x 10<sup>5</sup> x Dilution Factor)/100 (pfu/mL). For autochthonous KP-HELLO tumor initiation, 5&nbsp;× 10<sup>4</sup> pfu Lenti-HELLO-Cre were administered intratracheally to KP mice.</div></section><section id="sec-4-4-4"><h4>Antibody depletion and adoptive transfer</h4><div id="p0230" role="paragraph">To deplete CD8&nbsp;T Cells, 200ug/mouse anti-CD8a antibodies (clone: 53-6.7; InVivoMab) were diluted in PBS, and injected intraperitoneally every three days, 10&nbsp;days prior to tumor initiation until the end point of experiments. For adoptive transfer, naive CD8<sup>+</sup> T&nbsp;cells, CD4<sup>+</sup> T&nbsp;cells and/or B cells were separated from spleens by negative selection with EasySep Mouse CD8<sup>+</sup> T Cell Isolation Kit, Mouse CD4<sup>+</sup> T Cell Isolation Kit and/or Mouse B Cell Isolation Kit, respectively (STEMCELL technologies). For rescue experiments, 1&nbsp;× 10<sup>6</sup> SW<sub>HEL</sub> or WT C57BL/6 B cells were transferred into age- and sex-matched uMT mice, and 1&nbsp;× 10<sup>5</sup> SMARTA or OT-II T&nbsp;cells were transferred into age- and sex-matched CD4-cre Bcl6<sup>fl/fl</sup> mice, with 2&nbsp;× 10<sup>5</sup> KP-HELLO s.c. implanted one day later. For co-transfer experiments, CD45.1/CD45.2 or Thy1.1/Thy1.2 allotype-marked P14 (5&nbsp;× 10<sup>5</sup> /mouse), SMARTA (1&nbsp;× 10<sup>5</sup> /mouse) and SW<sub>HEL</sub> (1&nbsp;× 10<sup>5</sup> /mouse) cells were co-transferred into naive CD45.2/CD45.2 Thy1.2/Thy1.2 mice one day prior to tumor initiation.</div></section><section id="sec-4-4-5"><h4>Immune cell isolation from implanted or lung tumors and lymphoid organs</h4><div id="p0235" role="paragraph">Subcutaneously implanted solid tumors were dissected, cut into small pieces and digested with 5mL Collagenase IV buffer (1x HEPES buffer, 0.5mg/mL Collagenase IV, 20&nbsp;μg/mL DNase in 1x HBSS with MgCl<sub>2</sub> and CaCl<sub>2</sub>) for 30-40&nbsp;minutes at 37°C, as described previously (<span class="dropBlock reference-citations"><a id="body-ref-sref18-4" href="#" role="doc-biblioref" data-xml-rid="bib18" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref18-4" aria-controls="sref18-4">Connolly et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref18-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>Connolly, K.A. ∙ Kuchroo, M. ∙ Venkat, A. ...</div><div><strong>A reservoir of stem-like CD8<sup>+</sup> T&nbsp;cells in the tumor-draining lymph node preserves the ongoing antitumor immune response</strong></div><div><em>Sci. Immunol.</em> 2021; <strong>6</strong>:eabg7836</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=K.A.ConnollyM.KuchrooA.VenkatA.KhatunJ.WangI.WilliamN.I.HornickB.L.FitzgeraldM.DamoM.Y.KasmaniA+reservoir+of+stem-like+CD8%2B+T%C2%A0cells+in+the+tumor-draining+lymph+node+preserves+the+ongoing+antitumor+immune+responseSci.+Immunol.62021eabg7836" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref33-7" href="#" role="doc-biblioref" data-xml-rid="bib33" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref33-7" aria-controls="sref33-7">Fitzgerald et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref33-7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Fitzgerald, B. ∙ Connolly, K.A. ∙ Cui, C. ...</div><div><strong>A mouse model for the study of anti-tumor T&nbsp;cell responses in Kras-driven lung adenocarcinoma</strong></div><div><em>Cell Rep Methods.</em> 2021; <strong>1</strong>:100080</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=B.FitzgeraldK.A.ConnollyC.CuiE.FagerbergD.L.MariuzzaN.I.HornickG.G.FosterI.WilliamJ.F.CheungN.S.JoshiA+mouse+model+for+the+study+of+anti-tumor+T%C2%A0cell+responses+in+Kras-driven+lung+adenocarcinomaCell+Rep+Methods12021100080" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref62-8" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-8" aria-controls="sref62-8">Joshi et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref62-8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>Joshi, N.S. ∙ Akama-Garren, E.H. ∙ Lu, Y. ...</div><div><strong>Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses</strong></div><div><em>Immunity.</em> 2015; <strong>43</strong>:579-590</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.S.JoshiE.H.Akama-GarrenY.LuD.Y.LeeG.P.ChangA.LiM.DuPageT.TammelaN.R.KerperA.F.FaragoRegulatory+T+Cells+in+Tumor-Associated+Tertiary+Lymphoid+Structures+Suppress+Anti-tumor+T+Cell+ResponsesImmunity432015579590" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Samples were then run on the default lung_02 program on a gentleMACS Dissociator instrument (Miltenyi Biotec). Digestion was neutralized by adding 5mL 1% HI-FBS RPMI-1640. Tumor samples were filtered with 70&nbsp;μm cell strainers and washed with 1% HI-FBS RPMI-1640. Cell suspensions were then processed with Mouse CD45 (TIL) MicroBeads (Miltenyi Biotec) to enrich for CD45<sup>+</sup> TILs. For autochthonous lung tumors, mice were injected intravenously with CD45-PE-CF594 (1:100 diluted in PBS, clone: 30-F11), 2-3&nbsp;minutes before sacrifice as described previously (<span class="dropBlock reference-citations"><a id="body-ref-sref62-9" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-9" aria-controls="sref62-9">Joshi et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref62-9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>Joshi, N.S. ∙ Akama-Garren, E.H. ∙ Lu, Y. ...</div><div><strong>Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses</strong></div><div><em>Immunity.</em> 2015; <strong>43</strong>:579-590</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.S.JoshiE.H.Akama-GarrenY.LuD.Y.LeeG.P.ChangA.LiM.DuPageT.TammelaN.R.KerperA.F.FaragoRegulatory+T+Cells+in+Tumor-Associated+Tertiary+Lymphoid+Structures+Suppress+Anti-tumor+T+Cell+ResponsesImmunity432015579590" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Lungs were harvested, run on lung_01 program with gentleMACS Dissociator and digested with Collagenase IV buffer as described above, for 30-40&nbsp;minutes at 37°C. Samples were then run on the lung_02 program, neutralized by 1% HI-FBS RPMI-1640, filtered with 70&nbsp;μm cell strainers, washed with 1% HI-FBS RPMI-1640 and treated with RBC lysis buffer (eBioscience) to remove red blood cells. Tumor-draining lymph nodes were harvested, filtered with 70&nbsp;μm cell strainers and processed as described previously (<span class="dropBlock reference-citations"><a id="body-ref-sref23-10" href="#" role="doc-biblioref" data-xml-rid="bib23" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref23-10" aria-controls="sref23-10">Damo et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref23-10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">24.</div><div>Damo, M. ∙ Fitzgerald, B. ∙ Lu, Y. ...</div><div><strong>Inducible de novo expression of neoantigens in tumor cells and mice</strong></div><div><em>Nat. Biotechnol.</em> 2021; <strong>39</strong>:64-73</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.DamoB.FitzgeraldY.LuM.NaderI.WilliamJ.F.CheungK.A.ConnollyG.G.FosterE.Akama-GarrenD.Y.LeeInducible+de+novo+expression+of+neoantigens+in+tumor+cells+and+miceNat.+Biotechnol.3920216473" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref62-10" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-10" aria-controls="sref62-10">Joshi et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref62-10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>Joshi, N.S. ∙ Akama-Garren, E.H. ∙ Lu, Y. ...</div><div><strong>Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses</strong></div><div><em>Immunity.</em> 2015; <strong>43</strong>:579-590</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.S.JoshiE.H.Akama-GarrenY.LuD.Y.LeeG.P.ChangA.LiM.DuPageT.TammelaN.R.KerperA.F.FaragoRegulatory+T+Cells+in+Tumor-Associated+Tertiary+Lymphoid+Structures+Suppress+Anti-tumor+T+Cell+ResponsesImmunity432015579590" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section><section id="sec-4-4-6"><h4>Flow cytometry</h4><div id="p0240" role="paragraph">Single cell suspensions were stained with antibodies for surface markers. For I-Ab/GP<sub>66-77</sub>-specific tetramer (NIH Tetramer Core Facility) staining, cells were incubated 2-3 hours at 37°C prior to surface staining. For intracellular staining, cells were processed using either Foxp3/Transcription Factor Staining Buffer Set (eBioscience) for transcription factors, or Fixation/Permeabilization Solution Kit (BD Cytofix/Cytoperm) for cytokines. Cells were washed and resuspended in FACS Buffers (PBS&nbsp;+ 0.5% HI-FBS) until data collection. Flow cytometry was performed with LSR II flow cytometer (BD Bioscience), and analyzed by FlowJo software (version 10, TreeStar). For MFI quantification, median was applied to logarithmic histogram for specific molecules.</div></section><section id="sec-4-4-7"><h4><i>In&nbsp;vitro</i> P14 T&nbsp;cell and antigen-loaded DC co-culture</h4><div id="p0245" role="paragraph">P14 CD8<sup>+</sup> T&nbsp;cells were isolated with EasySep Mouse CD8&nbsp;T Cell Isolation Kit (StemCell). After isolation, P14 cells were resuspend in 5&nbsp;mL warm PBS at 2&nbsp;× 10<sup>6</sup> cells/mL. 5&nbsp;mL of 2 uM CFSE (ThermoFisher) staining buffer (2&nbsp;× ) was freshly prepared in warm PBS and then added to P14 suspension drop by drop during vortex. CFSE labeling was allowed at 37 C for 5&nbsp;minutes and quenched with 5&nbsp;mL of 100% FBS at 37 C for another minute. CFSE-labeled P14 cells were washed and resuspended in complete RPMI and ready to be used for DC-P14 coculture. DCs were isolated from pooled spleens and LNs using the EasySep Mouse Pan-DC Enrichment Kit (StemCell) per manufacturer’s instruction. 2&nbsp;× 10<sup>4</sup> DCs were stimulated by 100&nbsp;ng/mL LPS in complete RPMI for 16 hours in a 96-well format. LPS-stimulated DCs were then incubated with 5 ug/mL GP33 peptide or HELLO cell culture supernatant for 2 hours (unless indicated otherwise). Following LPS stimulation and antigen loading, 2&nbsp;× 10<sup>5</sup> CFSE-labeled P14 cells were added to each well and cocultured with DC in complete RPMI media. Media was replaced once 2&nbsp;days following coculture. On day 3, cell culture was collected to assess P14 cell proliferation (by CFSE dilution) and activation (by CD44/CD69 upregulation or CD62L downregulation) by flow cytometry. Note, we could not detect robust GP33-specific CD8<sup>+</sup> T&nbsp;cell responses with either <i>in&nbsp;vitro</i> (<a id="crosref1765" href="#figs3">Figure&nbsp;S3</a>C) or <i>in&nbsp;vivo</i> (<a id="crosref1770" href="#figs3">Figures S3</a>D–S3F) assays, which was unlike what we observed in NINJA-expressing tumors (<span class="dropBlock reference-citations"><a id="body-ref-sref18-5" href="#" role="doc-biblioref" data-xml-rid="bib18" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref18-5" aria-controls="sref18-5">Connolly et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref18-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>Connolly, K.A. ∙ Kuchroo, M. ∙ Venkat, A. ...</div><div><strong>A reservoir of stem-like CD8<sup>+</sup> T&nbsp;cells in the tumor-draining lymph node preserves the ongoing antitumor immune response</strong></div><div><em>Sci. Immunol.</em> 2021; <strong>6</strong>:eabg7836</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=K.A.ConnollyM.KuchrooA.VenkatA.KhatunJ.WangI.WilliamN.I.HornickB.L.FitzgeraldM.DamoM.Y.KasmaniA+reservoir+of+stem-like+CD8%2B+T%C2%A0cells+in+the+tumor-draining+lymph+node+preserves+the+ongoing+antitumor+immune+responseSci.+Immunol.62021eabg7836" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref23-11" href="#" role="doc-biblioref" data-xml-rid="bib23" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref23-11" aria-controls="sref23-11">Damo et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref23-11"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">24.</div><div>Damo, M. ∙ Fitzgerald, B. ∙ Lu, Y. ...</div><div><strong>Inducible de novo expression of neoantigens in tumor cells and mice</strong></div><div><em>Nat. Biotechnol.</em> 2021; <strong>39</strong>:64-73</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.DamoB.FitzgeraldY.LuM.NaderI.WilliamJ.F.CheungK.A.ConnollyG.G.FosterE.Akama-GarrenD.Y.LeeInducible+de+novo+expression+of+neoantigens+in+tumor+cells+and+miceNat.+Biotechnol.3920216473" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref33-8" href="#" role="doc-biblioref" data-xml-rid="bib33" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref33-8" aria-controls="sref33-8">Fitzgerald et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref33-8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Fitzgerald, B. ∙ Connolly, K.A. ∙ Cui, C. ...</div><div><strong>A mouse model for the study of anti-tumor T&nbsp;cell responses in Kras-driven lung adenocarcinoma</strong></div><div><em>Cell Rep Methods.</em> 2021; <strong>1</strong>:100080</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=B.FitzgeraldK.A.ConnollyC.CuiE.FagerbergD.L.MariuzzaN.I.HornickG.G.FosterI.WilliamJ.F.CheungN.S.JoshiA+mouse+model+for+the+study+of+anti-tumor+T%C2%A0cell+responses+in+Kras-driven+lung+adenocarcinomaCell+Rep+Methods12021100080" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). This was not a technical breakdown, as the proviral sequence from KP-HELLO tumor cell line was correct (<a id="crosref1790" href="#figs3">Figure&nbsp;S3</a>B) and GP<sub>61-80</sub> was presented to SMARTA CD4 T&nbsp;cells (<a id="crosref1795" href="#fig2">Figure&nbsp;2</a>C).</div></section><section id="sec-4-4-8"><h4>CIBERSORT analysis</h4><div id="p0250" role="paragraph">Fractions of different cell types were estimated with CIBERSORT (<span class="dropBlock reference-citations"><a id="body-ref-sref95-3" href="#" role="doc-biblioref" data-xml-rid="bib95" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref95-3" aria-controls="sref95-3">Newman et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref95-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">96.</div><div>Newman, A.M. ∙ Liu, C.L. ∙ Green, M.R. ...</div><div><strong>Robust enumeration of cell subsets from tissue expression profiles</strong></div><div><em>Nat. Methods.</em> 2015; <strong>12</strong>:453-457</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.M.NewmanC.L.LiuM.R.GreenA.J.GentlesW.FengY.XuC.D.HoangM.DiehnA.A.AlizadehRobust+enumeration+of+cell+subsets+from+tissue+expression+profilesNat.+Methods122015453457" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), a cell type deconvolution program that derives cell type-specific abundances from bulk RNA-seq data. Here bulk RNA-seq data were downloaded from the whole TCGA LUAD cohort. Among the 594 samples with FPKM data, the first sample was used for each series of primary tumor samples. In total, 513 samples of primary tumor from different cases were selected for deconvolution. Reference marker gene expression profile (GEP) matrix was assigned with a widely used leukocyte signature matrix LM22 (<span class="dropBlock reference-citations"><a id="body-ref-sref95-4" href="#" role="doc-biblioref" data-xml-rid="bib95" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref95-4" aria-controls="sref95-4">Newman et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref95-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">96.</div><div>Newman, A.M. ∙ Liu, C.L. ∙ Green, M.R. ...</div><div><strong>Robust enumeration of cell subsets from tissue expression profiles</strong></div><div><em>Nat. Methods.</em> 2015; <strong>12</strong>:453-457</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.M.NewmanC.L.LiuM.R.GreenA.J.GentlesW.FengY.XuC.D.HoangM.DiehnA.A.AlizadehRobust+enumeration+of+cell+subsets+from+tissue+expression+profilesNat.+Methods122015453457" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) provided by CIBERSORT program. Quantile normalization was disabled, and 100 permutations were used as default to calculate P values. From 22 cell subsets of CIBERSORT output using LM22 matrix, “B cells naïve,” “B cells memory” and “plasma cells” were combined as “B cell lineage”; “T cells CD4 memory resting” and “T cells CD4 memory activated” were combined as “CD4 memory T&nbsp;cells”; “NK cells resting” and&nbsp;“NK cells activated” were combined as “NK cells”; “macrophages M0,” “macrophages M1,” and “macrophages M2” were combined as “macrophages”; “dendritic cells resting” and “dendritic cells activated” were combined as “dendritic cells”; “mast cells resting” and “mast cells activated” were combined as “mast cells.”</div></section><section id="sec-4-4-9"><h4>Single-cell RNA sequencing analysis</h4><div id="p0255" role="paragraph">Data was downloaded from GEO with accession code GSE131907 (<span class="dropBlock reference-citations"><a id="body-ref-sref65-4" href="#" role="doc-biblioref" data-xml-rid="bib65" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref65-4" aria-controls="sref65-4">Kim et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref65-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">66.</div><div>Kim, N. ∙ Kim, H.K. ∙ Lee, K. ...</div><div><strong>Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma</strong></div><div><em>Nat. Commun.</em> 2020; <strong>11</strong>:2285</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.KimH.K.KimK.LeeY.HongJ.H.ChoJ.W.ChoiJ.I.LeeY.L.SuhB.M.KuH.H.EumSingle-cell+RNA+sequencing+demonstrates+the+molecular+and+cellular+reprogramming+of+metastatic+lung+adenocarcinomaNat.+Commun.1120202285" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The raw UMI count matrix and annotations were used. Data normalization and analysis were performed with R package Seurat (version 3.1.0) and only cells from lungs or lymph nodes were used with original annotations “nLung,” “tLung,” “nLN,” or “mLN.” For the analysis of CD4<sup>+</sup> T&nbsp;cells and B cells, 49,901 cells with original annotation “T/NK cells” and 22,592 cells with original annotations “B lymphocytes” were selected for the following analysis. UMI counts were log-normalized using function <i>NormalizeData</i> with parameter <i>normalization.method</i> set to “LogNormalize.” PCA was run based on the normalized data and clusters were called with <i>FindNeighbors</i> and <i>FindClusters</i> using the top 20 PCs and resolution set to 0.5 or 0.25 for T/NK cells or B cells, respectively. For both T/NK cells and B cells, dimension reduction and visualization were performed with UMAP using the top 15 PCs. Relative abundances for marker genes were calculated as Z-scaled average of log2(RC+1), where RC is relative counts that is calculated with <i>NormalizeData</i> and <i>normalization.method</i> set to “RC.”</div></section><section id="sec-4-4-10"><h4>Survival analysis and correlation analysis</h4><div id="p0260" role="paragraph">Survival analysis and pairwise correlation analysis of gene expression signatures were performed using web server GEPIA2 (<span class="dropBlock reference-citations"><a id="body-ref-sref135-2" href="#" role="doc-biblioref" data-xml-rid="bib135" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref135-2" aria-controls="sref135-2">Tang et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref135-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">136.</div><div>Tang, Z. ∙ Kang, B. ∙ Li, C. ...</div><div><strong>GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis</strong></div><div><em>Nucleic Acids Res.</em> 2019; <strong>47</strong>:W556-W560</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Z.TangB.KangC.LiT.ChenZ.ZhangGEPIA2%3A+an+enhanced+web+server+for+large-scale+expression+profiling+and+interactive+analysisNucleic+Acids+Res.47W12019W556W560" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), based on TCGA and GTEx databases. 478 LUAD tumor samples were included in survival analysis. We established gene expression signatures for GC B cells and TFH cells based on previous human studies in lymphoid tissues and cancers (<span class="dropBlock reference-citations"><a id="body-ref-sref12-3" href="#" role="doc-biblioref" data-xml-rid="bib12" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref12-3" aria-controls="sref12-3">Cabrita et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref12-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">13.</div><div>Cabrita, R. ∙ Lauss, M. ∙ Sanna, A. ...</div><div><strong>Tertiary lymphoid structures improve immunotherapy and survival in melanoma</strong></div><div><em>Nature.</em> 2020; <strong>577</strong>:561-565</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.CabritaM.LaussA.SannaM.DoniaM.Skaarup+LarsenS.MitraI.JohanssonB.PhungK.HarbstJ.Vallon-ChristerssonTertiary+lymphoid+structures+improve+immunotherapy+and+survival+in+melanomaNature5772020561565" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref17-3" href="#" role="doc-biblioref" data-xml-rid="bib17" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref17-3" aria-controls="sref17-3">Cillo et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref17-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">18.</div><div>Cillo, A.R. ∙ Kürten, C.H.L. ∙ Tabib, T. ...</div><div><strong>Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer</strong></div><div><em>Immunity.</em> 2020; <strong>52</strong>:183-199.e9</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.R.CilloC.H.L.K%C3%BCrtenT.TabibZ.QiS.OnkarT.WangA.LiuU.DuvvuriS.KimR.J.SooseImmune+Landscape+of+Viral-+and+Carcinogen-Driven+Head+and+Neck+CancerImmunity522020183199.e9" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref90" href="#" role="doc-biblioref" data-xml-rid="bib90" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref90" aria-controls="sref90">Milpied et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref90"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">91.</div><div>Milpied, P. ∙ Cervera-Marzal, I. ∙ Mollichella, M.L. ...</div><div><strong>Human germinal center transcriptional programs are de-synchronized in B cell lymphoma</strong></div><div><em>Nat. Immunol.</em> 2018; <strong>19</strong>:1013-1024</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=P.MilpiedI.Cervera-MarzalM.L.MollichellaB.TessonG.BrisouA.Traverse-GlehenG.SallesL.SpinelliB.NadelHuman+germinal+center+transcriptional+programs+are+de-synchronized+in+B+cell+lymphomaNat.+Immunol.19201810131024" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref143" href="#" role="doc-biblioref" data-xml-rid="bib143" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref143" aria-controls="sref143">Vella et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref143"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">144.</div><div>Vella, L.A. ∙ Buggert, M. ∙ Manne, S. ...</div><div><strong>T follicular helper cells in human efferent lymph retain lymphoid characteristics</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2019; <strong>129</strong>:3185-3200</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=L.A.VellaM.BuggertS.ManneR.S.HeratiI.SayinL.Kuri-CervantesI.Bukh+BrodyK.C.O%E2%80%99BoyleH.KaprielianJ.R.GilesT+follicular+helper+cells+in+human+efferent+lymph+retain+lymphoid+characteristicsJ.%C2%A0Clin.+Invest.129201931853200" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and refined them based on the data in <a id="crosref1840" href="#fig1">Figures 1</a>D and 1E to reflect the gene expression of GC B cells and TFH cells in LUAD. For each signature gene set, LUAD cohort was divided into high and low expression groups by median value (50% cut-off). GC B cell: <i>AICDA, BATF, BACH2, BCL6, CD79A, CD79B, CD86, DOCK8, IRF4, IRF8, MYC.</i> TFH: <i>ASCL2, BCL6, CD4, CD200, CXCR5, IL4, IL21, IL6ST, MAF, PDCD1, SH2D1A, TOX2.</i> Th1: <i>BHLHE40, CXCR3, CD4, IFNG, IL2, IL12RB2, STAT4, TBX21</i>. CD8 effector cell: <i>CD8A, CD8B, CX3CR1, GZMA, GZMB, KLRG1, PRF1, ZEB2</i>. Th17: <i>CD4, IL6R, IL17A, IL17F, IL23R, RORA, RORC, STAT3</i>. NK cell: <i>CD160, CD244, GNLY, GZMB, KLRC3, KLRF1, NKG2A, NKG7</i>. Survival analyses were performed with log-rank Mantel-Cox test. Pairwise correlation analyses of gene expression signature were performed with two-tailed Pearson correlation test.</div></section></section><section id="sec-4-5"><h3>Quantification and statistical analysis</h3><div id="p0265" role="paragraph">Prism 9 (GraphPad software) was used for quantification and statistical analysis. Methods of statistical analysis, number of mice used per experiment per group, number of experimental repeats and P values were indicated in figure legends. p&nbsp;&lt; 0.05 was considered statistically significant.</div></section></section><section id="acknowledgments" role="doc-acknowledgments"><h2>Acknowledgments</h2><div id="p0270" role="paragraph">We thank the N.S.J. and J.C. laboratory members for reviewing the manuscript; Z. Chen, C. Yang, and N. Ruddle for helpful discussions; and W. Wei for important guidance on statistical analysis. We also thank the Yale Flow Cytometry Core, Yale Keck DNA Sequencing Facility, Yale School of Medicine Histology Facility, and NIH Tetramer Core Facility. SW<sub>HEL</sub> mice were kindly provided by Dr. Robert Brink. <a id="crosref1845" href="#fig2">Figures 2</a>A, <a id="crosref1850" href="#figs4">S4</a>B, <a id="crosref1855" href="#figs6">S6</a>A, and S6B and the graphical abstract were created with <a id="intref0290" href="https://www.biorender.com" target="_blank">https://www.biorender.com</a>. This work was supported by grants from the NCI (K22CA200912 and 1RO1CA237037-01A1 to N.S.J.), NIH (R37AR40072 and AR074545 to J.C.), and Yale SPORE in Lung Cancer (1P50CA196530 1P50CA196530 to N.S.J. and J.C.) and a Pilot Grant from Yale Cancer Center (to N.S.J. and J.C.). C.C. was supported by the Gruber Science Fellowship and Richard K. Gershon Research Fellowship. J.F.C., K.A.C., and B.F. were supported by the Yale Immunobiology NIH T32 training grant (5T32AI007019).</div><section id="sec-5"><h3>Author contributions</h3><div id="p0275" role="paragraph">C.C., J.C., and N.S.J. designed the study and wrote the manuscript. C.C., E.F., J.F.C., T.M., A.S.A., S.C., and B.F. performed experiments and generated primary data. C.C. and J.W. performed computational analysis of human data. P.-M.C., K.A.C., M.D., G.G.F., S.C.E., and H.Z. provided helpful insights and contributed key reagents. J.C. and N.S.J. supervised data analysis and experiments.</div></section><section id="sec-6"><h3>Declaration of interests</h3><div id="p0280" role="paragraph">The authors declare no competing interests.</div></section></section><section id="supplementary-material" data-type="supplementary-materials"><h2>Supplemental information (3)</h2><div id="p0290" role="paragraph"><div class="core-supplementary-material"><div class="core-link"><button class="downloadAllSupplementary"><span>Download all</span></button></div></div><div id="mmc1" class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="/cms/10.1016/j.cell.2021.11.007/attachment/8960940c-499e-4ec1-add7-81c969942a9b/mmc1.xlsx" download="mmc1.xlsx" aria-labelledby="mmc1-heading mmc1-link"><span id="mmc1-link">Spreadsheet (36.28 KB)</span></a></div><div class="core-description"><div id="mmc1-heading" class="heading">Table S1. Differentially expressed genes in T/NK cell clusters and B cell clusters (GEO: GSE131907), related to Figure&nbsp;1</div></div></div><div id="mmc2" class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="/cms/10.1016/j.cell.2021.11.007/attachment/71526570-6a11-43c0-bf6c-60d4aefb3fbf/mmc2.pdf" download="mmc2.pdf" aria-labelledby="mmc2-heading mmc2-link"><span id="mmc2-link">PDF (41.15 KB)</span></a></div><div class="core-description"><div id="mmc2-heading" class="heading">Table S2. DNA and amino acid sequences of HELLO construct, related to Figure&nbsp;2 and STAR Methods</div></div></div><div id="mmc3" class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="/cms/10.1016/j.cell.2021.11.007/attachment/653652e4-0638-456e-adf3-3499e0e3998a/mmc3.pdf" download="mmc3.pdf" aria-labelledby="mmc3-heading mmc3-link"><span id="mmc3-link">PDF (35.65 KB)</span></a></div><div class="core-description"><div id="mmc3-heading" class="heading">Table S3. Prediction of CD8 T&nbsp;cell epitopes in HELLO neoantigen, related to Figure&nbsp;2 and STAR Methods</div></div></div></div></section></div></section><div class="core-linked-content">
    

        

</div><section id="backmatter" data-extent="backmatter"><div class="core-container"><section id="data-availability" class="core-data-availability"><h2>Data and code availability</h2><div id="p0030" role="paragraph">This paper analyzed existing, publicly available scRNA-seq data (GEO: <a id="intref0010" href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE131907" target="_blank">GSE131907</a>). Code is available at <a id="intref0015" href="https://github.com/wangjw17/TfhInLungCancer" target="_blank">https://github.com/wangjw17/TfhInLungCancer</a> (DOI: <a id="intref0020" href="https://zenodo.org/record/5590959" target="_blank">https://zenodo.org/record/5590959</a>). All data reported in this paper will be shared by the lead contact upon request.</div></section><section id="references"><h2>References</h2><div id="bibliography" role="doc-bibliography"><div role="list"><div role="listitem" data-has="label"><div id="bib1" class="citations"><div id="sref1" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref1" title="View in article">1.</a></div><div>Akama-Garren, E.H. ∙ Joshi, N.S. ∙ Tammela, T. ...</div><div><strong>A Modular Assembly Platform for Rapid Generation of DNA Constructs</strong></div><div><em>Sci. Rep.</em> 2016; <strong>6</strong>:16836</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=E.H.Akama-GarrenN.S.JoshiT.TammelaG.P.ChangB.L.WagnerD.Y.LeeW.M.Rideout3rdT.PapagiannakopoulosW.XueT.JacksA+Modular+Assembly+Platform+for+Rapid+Generation+of+DNA+ConstructsSci.+Rep.6201616836" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib2" class="citations"><div id="sref2" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref2-1" title="View in article">2.</a></div><div>Alspach, E. ∙ Lussier, D.M. ∙ Miceli, A.P. ...</div><div><strong>MHC-II neoantigens shape tumour immunity and response to immunotherapy</strong></div><div><em>Nature.</em> 2019; <strong>574</strong>:696-701</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=E.AlspachD.M.LussierA.P.MiceliI.KizhvatovM.DuPageA.M.LuomaW.MengC.F.LichtiE.EsaulovaA.N.VomundMHC-II+neoantigens+shape+tumour+immunity+and+response+to+immunotherapyNature5742019696701" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib3" class="citations"><div id="sref3" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref3" title="View in article">3.</a></div><div>Alvarez Arias, D.A. ∙ Kim, H.J. ∙ Zhou, P. ...</div><div><strong>Disruption of CD8+ Treg activity results in expansion of T follicular helper cells and enhanced antitumor immunity</strong></div><div><em>Cancer Immunol. Res.</em> 2014; <strong>2</strong>:207-216</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.A.Alvarez+AriasH.J.KimP.ZhouT.A.HolderriedX.WangG.DranoffH.CantorDisruption+of+CD8%2B+Treg+activity+results+in+expansion+of+T+follicular+helper+cells+and+enhanced+antitumor+immunityCancer+Immunol.+Res.22014207216" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib163" class="citations"><div id="optJrMrYB9kpE" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-optJrMrYB9kpE" title="View in article">4.</a></div><div>Andreatta, M. ∙ Nielsen, M.</div><div><strong>Gapped sequence alignment using artificial neural networks: application to the MHC class I system</strong></div><div><em>Bioinformatics.</em> 2016; <strong>32</strong>:511-517</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.AndreattaM.NielsenGapped+sequence+alignment+using+artificial+neural+networks%3A+application+to+the+MHC+class+I+systemBioinformatics32201651151710.1093%2Fbioinformatics%2Fbtv639" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib4" class="citations"><div id="sref4" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref4" title="View in article">5.</a></div><div>Battegay, M. ∙ Moskophidis, D. ∙ Rahemtulla, A. ...</div><div><strong>Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice</strong></div><div><em>J.&nbsp;Virol.</em> 1994; <strong>68</strong>:4700-4704</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.BattegayD.MoskophidisA.RahemtullaH.HengartnerT.W.MakR.M.ZinkernagelEnhanced+establishment+of+a+virus+carrier+state+in+adult+CD4%2B+T-cell-deficient+miceJ.%C2%A0Virol.68199447004704" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib5" class="citations"><div id="sref5" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref5-1" title="View in article">6.</a></div><div>Bindea, G. ∙ Mlecnik, B. ∙ Tosolini, M. ...</div><div><strong>Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer</strong></div><div><em>Immunity.</em> 2013; <strong>39</strong>:782-795</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.BindeaB.MlecnikM.TosoliniA.KirilovskyM.WaldnerA.C.ObenaufH.AngellT.FredriksenL.LafontaineA.BergerSpatiotemporal+dynamics+of+intratumoral+immune+cells+reveal+the+immune+landscape+in+human+cancerImmunity392013782795" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib6" class="citations"><div id="sref6" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref6" title="View in article">7.</a></div><div>Bocharnikov, A.V. ∙ Keegan, J. ∙ Wacleche, V.S. ..., Accelerating Medicines Partnership (AMP) RA/SLE Network</div><div><strong>PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21</strong></div><div><em>JCI Insight.</em> 2019; <strong>4</strong>:130062</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.V.BocharnikovJ.KeeganV.S.WaclecheY.CaoC.Y.FonsekaG.WangE.S.MuiseK.X.ZhangA.AraziG.KerasAccelerating+Medicines+Partnership+%28AMP%29+RA%2FSLE+NetworkPD-1hiCXCR5-+T+peripheral+helper+cells+promote+B+cell+responses+in+lupus+via+MAF+and+IL-21JCI+Insight42019130062" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib7" class="citations"><div id="sref7" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref7-1" title="View in article">8.</a></div><div>Borst, J. ∙ Ahrends, T. ∙ Bąbała, N. ...</div><div><strong>CD4<sup>+</sup> T&nbsp;cell help in cancer immunology and immunotherapy</strong></div><div><em>Nat. Rev. Immunol.</em> 2018; <strong>18</strong>:635-647</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.BorstT.AhrendsN.B%C4%85ba%C5%82aC.J.M.MeliefW.Kastenm%C3%BCllerCD4%2B+T%C2%A0cell+help+in+cancer+immunology+and+immunotherapyNat.+Rev.+Immunol.182018635647" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib8" class="citations"><div id="sref8" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref8" title="View in article">9.</a></div><div>Bray, F. ∙ Ferlay, J. ∙ Soerjomataram, I. ...</div><div><strong>Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</strong></div><div><em>CA Cancer J. Clin.</em> 2018; <strong>68</strong>:394-424</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=F.BrayJ.FerlayI.SoerjomataramR.L.SiegelL.A.TorreA.JemalGlobal+cancer+statistics+2018%3A+GLOBOCAN+estimates+of+incidence+and+mortality+worldwide+for+36+cancers+in+185+countriesCA+Cancer+J.+Clin.682018394424" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib9" class="citations"><div id="sref9" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref9" title="View in article">10.</a></div><div>Brummelman, J. ∙ Mazza, E.M.C. ∙ Alvisi, G. ...</div><div><strong>High-dimensional single cell analysis identifies stem-like cytotoxic CD8<sup>+</sup> T&nbsp;cells infiltrating human tumors</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2018; <strong>215</strong>:2520-2535</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.BrummelmanE.M.C.MazzaG.AlvisiF.S.ColomboA.GrilliJ.MikulakD.MavilioM.AlloisioF.FerrariE.LopciHigh-dimensional+single+cell+analysis+identifies+stem-like+cytotoxic+CD8%2B+T%C2%A0cells+infiltrating+human+tumorsJ.%C2%A0Exp.+Med.215201825202535" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib10" class="citations"><div id="sref10" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref10" title="View in article">11.</a></div><div>Bruno, T.C. ∙ Ebner, P.J. ∙ Moore, B.L. ...</div><div><strong>Antigen-Presenting Intratumoral B Cells Affect CD4<sup>+</sup> TIL Phenotypes in Non-Small Cell Lung Cancer Patients</strong></div><div><em>Cancer Immunol. Res.</em> 2017; <strong>5</strong>:898-907</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=T.C.BrunoP.J.EbnerB.L.MooreO.G.SquallsK.A.WaughE.B.EruslanovS.SinghalJ.D.MitchellW.A.FranklinD.T.MerrickAntigen-Presenting+Intratumoral+B+Cells+Affect+CD4%2B+TIL+Phenotypes+in+Non-Small+Cell+Lung+Cancer+PatientsCancer+Immunol.+Res.52017898907" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib11" class="citations"><div id="sref11" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref11" title="View in article">12.</a></div><div>Burnett, D.L. ∙ Langley, D.B. ∙ Schofield, P. ...</div><div><strong>Germinal center antibody mutation trajectories are determined by rapid self/foreign discrimination</strong></div><div><em>Science.</em> 2018; <strong>360</strong>:223-226</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.L.BurnettD.B.LangleyP.SchofieldJ.R.HermesT.D.ChanJ.JacksonK.BourneJ.H.ReedK.PattersonB.T.PorebskiGerminal+center+antibody+mutation+trajectories+are+determined+by+rapid+self%2Fforeign+discriminationScience3602018223226" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib12" class="citations"><div id="sref12" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref12-1" title="View in article">13.</a></div><div>Cabrita, R. ∙ Lauss, M. ∙ Sanna, A. ...</div><div><strong>Tertiary lymphoid structures improve immunotherapy and survival in melanoma</strong></div><div><em>Nature.</em> 2020; <strong>577</strong>:561-565</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.CabritaM.LaussA.SannaM.DoniaM.Skaarup+LarsenS.MitraI.JohanssonB.PhungK.HarbstJ.Vallon-ChristerssonTertiary+lymphoid+structures+improve+immunotherapy+and+survival+in+melanomaNature5772020561565" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib13" class="citations"><div id="sref13" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref13-1" title="View in article">14.</a></div><div>Chen, Y. ∙ Zander, R.A. ∙ Wu, X. ...</div><div><strong>BATF regulates progenitor to cytolytic effector CD8<sup>+</sup> T&nbsp;cell transition during chronic viral infection</strong></div><div><em>Nat. Immunol.</em> 2021; <strong>22</strong>:996-1007</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Y.ChenR.A.ZanderX.WuD.M.SchauderM.Y.KasmaniJ.ShenS.ZhengR.BurnsE.J.TaparowskyW.CuiBATF+regulates+progenitor+to+cytolytic+effector+CD8%2B+T%C2%A0cell+transition+during+chronic+viral+infectionNat.+Immunol.2220219961007" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib14" class="citations"><div id="sref14" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref14" title="View in article">15.</a></div><div>Choi, Y.S. ∙ Kageyama, R. ∙ Eto, D. ...</div><div><strong>ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6</strong></div><div><em>Immunity.</em> 2011; <strong>34</strong>:932-946</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Y.S.ChoiR.KageyamaD.EtoT.C.EscobarR.J.JohnstonL.MonticelliC.LaoS.CrottyICOS+receptor+instructs+T+follicular+helper+cell+versus+effector+cell+differentiation+via+induction+of+the+transcriptional+repressor+Bcl6Immunity342011932946" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib15" class="citations"><div id="sref15" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref15" title="View in article">16.</a></div><div>Choi, Y.S. ∙ Yang, J.A. ∙ Crotty, S.</div><div><strong>Dynamic regulation of Bcl6 in follicular helper CD4&nbsp;T (Tfh) cells</strong></div><div><em>Curr. Opin. Immunol.</em> 2013; <strong>25</strong>:366-372</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Y.S.ChoiJ.A.YangS.CrottyDynamic+regulation+of+Bcl6+in+follicular+helper+CD4%C2%A0T+%28Tfh%29+cellsCurr.+Opin.+Immunol.252013366372" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib16" class="citations"><div id="sref16" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref16" title="View in article">17.</a></div><div>Chtanova, T. ∙ Tangye, S.G. ∙ Newton, R. ...</div><div><strong>T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells</strong></div><div><em>J.&nbsp;Immunol.</em> 2004; <strong>173</strong>:68-78</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=T.ChtanovaS.G.TangyeR.NewtonN.FrankM.R.HodgeM.S.RolphC.R.MackayT+follicular+helper+cells+express+a+distinctive+transcriptional+profile%2C+reflecting+their+role+as+non-Th1%2FTh2+effector+cells+that+provide+help+for+B+cellsJ.%C2%A0Immunol.17320046878" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib17" class="citations"><div id="sref17" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref17-1" title="View in article">18.</a></div><div>Cillo, A.R. ∙ Kürten, C.H.L. ∙ Tabib, T. ...</div><div><strong>Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer</strong></div><div><em>Immunity.</em> 2020; <strong>52</strong>:183-199.e9</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.R.CilloC.H.L.K%C3%BCrtenT.TabibZ.QiS.OnkarT.WangA.LiuU.DuvvuriS.KimR.J.SooseImmune+Landscape+of+Viral-+and+Carcinogen-Driven+Head+and+Neck+CancerImmunity522020183199.e9" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib18" class="citations"><div id="sref18" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref18-1" title="View in article">19.</a></div><div>Connolly, K.A. ∙ Kuchroo, M. ∙ Venkat, A. ...</div><div><strong>A reservoir of stem-like CD8<sup>+</sup> T&nbsp;cells in the tumor-draining lymph node preserves the ongoing antitumor immune response</strong></div><div><em>Sci. Immunol.</em> 2021; <strong>6</strong>:eabg7836</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=K.A.ConnollyM.KuchrooA.VenkatA.KhatunJ.WangI.WilliamN.I.HornickB.L.FitzgeraldM.DamoM.Y.KasmaniA+reservoir+of+stem-like+CD8%2B+T%C2%A0cells+in+the+tumor-draining+lymph+node+preserves+the+ongoing+antitumor+immune+responseSci.+Immunol.62021eabg7836" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib19" class="citations"><div id="sref19" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref19" title="View in article">20.</a></div><div>Coquet, J.M. ∙ Kyparissoudis, K. ∙ Pellicci, D.G. ...</div><div><strong>IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production</strong></div><div><em>J.&nbsp;Immunol.</em> 2007; <strong>178</strong>:2827-2834</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.M.CoquetK.KyparissoudisD.G.PellicciG.BesraS.P.BerzinsM.J.SmythD.I.GodfreyIL-21+is+produced+by+NKT+cells+and+modulates+NKT+cell+activation+and+cytokine+productionJ.%C2%A0Immunol.178200728272834" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib20" class="citations"><div id="sref20" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref20-1" title="View in article">21.</a></div><div>Crotty, S.</div><div><strong>Follicular helper CD4 T&nbsp;cells (TFH)</strong></div><div><em>Annu. Rev. Immunol.</em> 2011; <strong>29</strong>:621-663</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.CrottyFollicular+helper+CD4+T%C2%A0cells+%28TFH%29Annu.+Rev.+Immunol.292011621663" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib21" class="citations"><div id="sref21" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref21-1" title="View in article">22.</a></div><div>Crotty, S.</div><div><strong>T Follicular Helper Cell Biology: A Decade of Discovery and Diseases</strong></div><div><em>Immunity.</em> 2019; <strong>50</strong>:1132-1148</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.CrottyT+Follicular+Helper+Cell+Biology%3A+A+Decade+of+Discovery+and+DiseasesImmunity50201911321148" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib22" class="citations"><div id="sref22" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref22" title="View in article">23.</a></div><div>Cyster, J.G. ∙ Allen, C.D.C.</div><div><strong>B Cell Responses: Cell Interaction Dynamics and Decisions</strong></div><div><em>Cell.</em> 2019; <strong>177</strong>:524-540</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.G.CysterC.D.C.AllenB+Cell+Responses%3A+Cell+Interaction+Dynamics+and+DecisionsCell1772019524540" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib23" class="citations"><div id="sref23" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref23-1" title="View in article">24.</a></div><div>Damo, M. ∙ Fitzgerald, B. ∙ Lu, Y. ...</div><div><strong>Inducible de novo expression of neoantigens in tumor cells and mice</strong></div><div><em>Nat. Biotechnol.</em> 2021; <strong>39</strong>:64-73</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.DamoB.FitzgeraldY.LuM.NaderI.WilliamJ.F.CheungK.A.ConnollyG.G.FosterE.Akama-GarrenD.Y.LeeInducible+de+novo+expression+of+neoantigens+in+tumor+cells+and+miceNat.+Biotechnol.3920216473" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib24" class="citations"><div id="sref24" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref24" title="View in article">25.</a></div><div>Deng, S. ∙ Sun, Z. ∙ Qiao, J. ...</div><div><strong>Targeting tumors with IL-21 reshapes the tumor microenvironment by proliferating PD-1intTim-3-CD8+ T&nbsp;cells</strong></div><div><em>JCI Insight.</em> 2020; <strong>5</strong>:132000</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.DengZ.SunJ.QiaoY.LiangL.LiuC.DongA.ShenY.WangH.TangY.X.FuH.PengTargeting+tumors+with+IL-21+reshapes+the+tumor+microenvironment+by+proliferating+PD-1intTim-3-CD8%2B+T%C2%A0cellsJCI+Insight52020132000" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib25" class="citations"><div id="sref25" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref25" title="View in article">26.</a></div><div>Dieu-Nosjean, M.C. ∙ Antoine, M. ∙ Danel, C. ...</div><div><strong>Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures</strong></div><div><em>J.&nbsp;Clin. Oncol.</em> 2008; <strong>26</strong>:4410-4417</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.C.Dieu-NosjeanM.AntoineC.DanelD.HeudesM.WislezV.PoulotN.RabbeL.LauransE.TartourL.de+ChaisemartinLong-term+survival+for+patients+with+non-small-cell+lung+cancer+with+intratumoral+lymphoid+structuresJ.%C2%A0Clin.+Oncol.26200844104417" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib26" class="citations"><div id="sref26" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref26" title="View in article">27.</a></div><div>DuPage, M. ∙ Dooley, A.L. ∙ Jacks, T.</div><div><strong>Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase</strong></div><div><em>Nat. Protoc.</em> 2009; <strong>4</strong>:1064-1072</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.DuPageA.L.DooleyT.JacksConditional+mouse+lung+cancer+models+using+adenoviral+or+lentiviral+delivery+of+Cre+recombinaseNat.+Protoc.4200910641072" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib27" class="citations"><div id="sref27" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref27-1" title="View in article">28.</a></div><div>DuPage, M. ∙ Cheung, A.F. ∙ Mazumdar, C. ...</div><div><strong>Endogenous T&nbsp;cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression</strong></div><div><em>Cancer Cell.</em> 2011; <strong>19</strong>:72-85</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.DuPageA.F.CheungC.MazumdarM.M.WinslowR.BronsonL.M.SchmidtD.CrowleyJ.ChenT.JacksEndogenous+T%C2%A0cell+responses+to+antigens+expressed+in+lung+adenocarcinomas+delay+malignant+tumor+progressionCancer+Cell1920117285" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib28" class="citations"><div id="sref28" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref28" title="View in article">29.</a></div><div>Elgueta, R. ∙ Benson, M.J. ∙ de Vries, V.C. ...</div><div><strong>Molecular mechanism and function of CD40/CD40L engagement in the immune system</strong></div><div><em>Immunol. Rev.</em> 2009; <strong>229</strong>:152-172</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.ElguetaM.J.BensonV.C.de+VriesA.WasiukY.GuoR.J.NoelleMolecular+mechanism+and+function+of+CD40%2FCD40L+engagement+in+the+immune+systemImmunol.+Rev.2292009152172" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib29" class="citations"><div id="sref29" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref29-1" title="View in article">30.</a></div><div>Elsaesser, H. ∙ Sauer, K. ∙ Brooks, D.G.</div><div><strong>IL-21 is required to control chronic viral infection</strong></div><div><em>Science.</em> 2009; <strong>324</strong>:1569-1572</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=H.ElsaesserK.SauerD.G.BrooksIL-21+is+required+to+control+chronic+viral+infectionScience324200915691572" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib30" class="citations"><div id="sref30" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref30" title="View in article">31.</a></div><div>Engelhard, V.H. ∙ Rodriguez, A.B. ∙ Mauldin, I.S. ...</div><div><strong>Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity</strong></div><div><em>J.&nbsp;Immunol.</em> 2018; <strong>200</strong>:432-442</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=V.H.EngelhardA.B.RodriguezI.S.MauldinA.N.WoodsJ.D.PeskeC.L.SlingluffJr.Immune+Cell+Infiltration+and+Tertiary+Lymphoid+Structures+as+Determinants+of+Antitumor+ImmunityJ.%C2%A0Immunol.2002018432442" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib31" class="citations"><div id="sref31" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref31" title="View in article">32.</a></div><div>Ettinger, D.S. ∙ Wood, D.E. ∙ Aggarwal, C. ..., OCN</div><div><strong>NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020</strong></div><div><em>J.&nbsp;Natl. Compr. Canc. Netw.</em> 2019; <strong>17</strong>:1464-1472</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.S.EttingerD.E.WoodC.AggarwalD.L.AisnerW.AkerleyJ.R.BaumanA.BharatD.S.BrunoJ.Y.ChangL.R.ChirieacOCNNCCN+Guidelines+Insights%3A+Non-Small+Cell+Lung+Cancer%2C+Version+1.2020J.%C2%A0Natl.+Compr.+Canc.+Netw.17201914641472" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib32" class="citations"><div id="sref32" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref32" title="View in article">33.</a></div><div>Ferris, S.T. ∙ Durai, V. ∙ Wu, R. ...</div><div><strong>cDC1 prime and are licensed by CD4<sup>+</sup> T&nbsp;cells to induce anti-tumour immunity</strong></div><div><em>Nature.</em> 2020; <strong>584</strong>:624-629</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.T.FerrisV.DuraiR.WuD.J.TheisenJ.P.WardM.D.BernJ.T.Davidson4thP.BagadiaT.LiuC.G.Brise%C3%B1ocDC1+prime+and+are+licensed+by+CD4%2B+T%C2%A0cells+to+induce+anti-tumour+immunityNature5842020624629" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib33" class="citations"><div id="sref33" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref33-1" title="View in article">34.</a></div><div>Fitzgerald, B. ∙ Connolly, K.A. ∙ Cui, C. ...</div><div><strong>A mouse model for the study of anti-tumor T&nbsp;cell responses in Kras-driven lung adenocarcinoma</strong></div><div><em>Cell Rep Methods.</em> 2021; <strong>1</strong>:100080</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=B.FitzgeraldK.A.ConnollyC.CuiE.FagerbergD.L.MariuzzaN.I.HornickG.G.FosterI.WilliamJ.F.CheungN.S.JoshiA+mouse+model+for+the+study+of+anti-tumor+T%C2%A0cell+responses+in+Kras-driven+lung+adenocarcinomaCell+Rep+Methods12021100080" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib34" class="citations"><div id="sref34" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref34" title="View in article">35.</a></div><div>Forde, P.M. ∙ Chaft, J.E. ∙ Smith, K.N. ...</div><div><strong>Neoadjuvant PD-1 Blockade in Resectable Lung Cancer</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2018; <strong>378</strong>:1976-1986</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=P.M.FordeJ.E.ChaftK.N.SmithV.AnagnostouT.R.CottrellM.D.HellmannM.ZahurakS.C.YangD.R.JonesS.BroderickNeoadjuvant+PD-1+Blockade+in+Resectable+Lung+CancerN.%C2%A0Engl.+J.+Med.378201819761986" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib35" class="citations"><div id="sref35" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref35" title="View in article">36.</a></div><div>Fridman, W.H. ∙ Zitvogel, L. ∙ Sautès-Fridman, C. ...</div><div><strong>The immune contexture in cancer prognosis and treatment</strong></div><div><em>Nat. Rev. Clin. Oncol.</em> 2017; <strong>14</strong>:717-734</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=W.H.FridmanL.ZitvogelC.Saut%C3%A8s-FridmanG.KroemerThe+immune+contexture+in+cancer+prognosis+and+treatmentNat.+Rev.+Clin.+Oncol.142017717734" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib36" class="citations"><div id="sref36" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref36-1" title="View in article">37.</a></div><div>Fröhlich, A. ∙ Kisielow, J. ∙ Schmitz, I. ...</div><div><strong>IL-21R on T&nbsp;cells is critical for sustained functionality and control of chronic viral infection</strong></div><div><em>Science.</em> 2009; <strong>324</strong>:1576-1580</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.Fr%C3%B6hlichJ.KisielowI.SchmitzS.FreigangA.T.ShamshievJ.WeberB.J.MarslandA.OxeniusM.KopfIL-21R+on+T%C2%A0cells+is+critical+for+sustained+functionality+and+control+of+chronic+viral+infectionScience324200915761580" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib37" class="citations"><div id="sref37" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref37" title="View in article">38.</a></div><div>Galon, J. ∙ Angell, H.K. ∙ Bedognetti, D. ...</div><div><strong>The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures</strong></div><div><em>Immunity.</em> 2013; <strong>39</strong>:11-26</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.GalonH.K.AngellD.BedognettiF.M.MarincolaThe+continuum+of+cancer+immunosurveillance%3A+prognostic%2C+predictive%2C+and+mechanistic+signaturesImmunity3920131126" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib38" class="citations"><div id="sref38" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref38" title="View in article">39.</a></div><div>Gandhi, L. ∙ Rodríguez-Abreu, D. ∙ Gadgeel, S. ..., KEYNOTE-189 Investigators</div><div><strong>Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2018; <strong>378</strong>:2078-2092</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=L.GandhiD.Rodr%C3%ADguez-AbreuS.GadgeelE.EstebanE.FelipF.De+AngelisM.DomineP.ClinganM.J.HochmairS.F.PowellKEYNOTE-189+InvestigatorsPembrolizumab+plus+Chemotherapy+in+Metastatic+Non-Small-Cell+Lung+CancerN.%C2%A0Engl.+J.+Med.378201820782092" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib39" class="citations"><div id="sref39" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref39" title="View in article">40.</a></div><div>Garaud, S. ∙ Buisseret, L. ∙ Solinas, C. ...</div><div><strong>Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer</strong></div><div><em>JCI Insight.</em> 2019; <strong>5</strong>:129641</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.GaraudL.BuisseretC.SolinasC.Gu-TrantienA.de+WindG.Van+den+EyndenC.NaveauxJ.N.LodewyckxA.BoissonH.DuvillierTumor+infiltrating+B-cells+signal+functional+humoral+immune+responses+in+breast+cancerJCI+Insight52019129641" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib40" class="citations"><div id="sref40" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref40-1" title="View in article">41.</a></div><div>Germain, C. ∙ Gnjatic, S. ∙ Tamzalit, F. ...</div><div><strong>Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer</strong></div><div><em>Am. J. Respir. Crit. Care Med.</em> 2014; <strong>189</strong>:832-844</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.GermainS.GnjaticF.TamzalitS.KnockaertR.RemarkJ.GocA.LepelleyE.BechtS.KatsahianG.BizouardPresence+of+B+cells+in+tertiary+lymphoid+structures+is+associated+with+a+protective+immunity+in+patients+with+lung+cancerAm.+J.+Respir.+Crit.+Care+Med.1892014832844" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib41" class="citations"><div id="sref41" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref41" title="View in article">42.</a></div><div>Gettinger, S.N. ∙ Choi, J. ∙ Mani, N. ...</div><div><strong>A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers</strong></div><div><em>Nat. Commun.</em> 2018; <strong>9</strong>:3196</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.N.GettingerJ.ChoiN.ManiM.F.SanmamedI.DatarR.SowellV.Y.DuE.KaftanS.GoldbergW.DongA+dormant+TIL+phenotype+defines+non-small+cell+lung+carcinomas+sensitive+to+immune+checkpoint+blockersNat.+Commun.920183196" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib42" class="citations"><div id="sref42" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref42-1" title="View in article">43.</a></div><div>Goc, J. ∙ Germain, C. ∙ Vo-Bourgais, T.K. ...</div><div><strong>Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T&nbsp;cells</strong></div><div><em>Cancer Res.</em> 2014; <strong>74</strong>:705-715</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.GocC.GermainT.K.Vo-BourgaisA.LupoC.KleinS.KnockaertL.de+ChaisemartinH.OuakrimE.BechtM.AlifanoDendritic+cells+in+tumor-associated+tertiary+lymphoid+structures+signal+a+Th1+cytotoxic+immune+contexture+and+license+the+positive+prognostic+value+of+infiltrating+CD8%2B+T%C2%A0cellsCancer+Res.742014705715" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib43" class="citations"><div id="sref43" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref43" title="View in article">44.</a></div><div>Goodnow, C.C. ∙ Crosbie, J. ∙ Adelstein, S. ...</div><div><strong>Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice</strong></div><div><em>Nature.</em> 1988; <strong>334</strong>:676-682</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.C.GoodnowJ.CrosbieS.AdelsteinT.B.LavoieS.J.Smith-GillR.A.BrinkH.Pritchard-BriscoeJ.S.WotherspoonR.H.LoblayK.RaphaelAltered+immunoglobulin+expression+and+functional+silencing+of+self-reactive+B+lymphocytes+in+transgenic+miceNature3341988676682" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib44" class="citations"><div id="sref44" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref44" title="View in article">45.</a></div><div>Griss, J. ∙ Bauer, W. ∙ Wagner, C. ...</div><div><strong>B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma</strong></div><div><em>Nat. Commun.</em> 2019; <strong>10</strong>:4186</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.GrissW.BauerC.WagnerM.SimonM.ChenK.Grabmeier-PfistershammerM.Maurer-GranofszkyF.RokaT.PenzC.BockB+cells+sustain+inflammation+and+predict+response+to+immune+checkpoint+blockade+in+human+melanomaNat.+Commun.1020194186" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib45" class="citations"><div id="sref45" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref45-1" title="View in article">46.</a></div><div>Gu-Trantien, C. ∙ Loi, S. ∙ Garaud, S. ...</div><div><strong>CD4<sup>+</sup> follicular helper T&nbsp;cell infiltration predicts breast cancer survival</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2013; <strong>123</strong>:2873-2892</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.Gu-TrantienS.LoiS.GaraudC.EqueterM.LibinA.de+WindM.RavoetH.Le+BuanecC.SibilleG.Manfouo-FoutsopCD4%2B+follicular+helper+T%C2%A0cell+infiltration+predicts+breast+cancer+survivalJ.%C2%A0Clin.+Invest.123201328732892" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib46" class="citations"><div id="sref46" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref46-1" title="View in article">47.</a></div><div>Gu-Trantien, C. ∙ Migliori, E. ∙ Buisseret, L. ...</div><div><strong>CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer</strong></div><div><em>JCI Insight.</em> 2017; <strong>2</strong>:91487</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.Gu-TrantienE.MiglioriL.BuisseretA.de+WindS.Broh%C3%A9eS.GaraudG.No%C3%ABlV.L.Dang+ChiJ.N.LodewyckxC.NaveauxCXCL13-producing+TFH+cells+link+immune+suppression+and+adaptive+memory+in+human+breast+cancerJCI+Insight2201791487" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib47" class="citations"><div id="sref47" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref47-1" title="View in article">48.</a></div><div>Guo, X. ∙ Zhang, Y. ∙ Zheng, L. ...</div><div><strong>Global characterization of T&nbsp;cells in non-small-cell lung cancer by single-cell sequencing</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:978-985</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=X.GuoY.ZhangL.ZhengC.ZhengJ.SongQ.ZhangB.KangZ.LiuL.JinR.XingGlobal+characterization+of+T%C2%A0cells+in+non-small-cell+lung+cancer+by+single-cell+sequencingNat.+Med.242018978985" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib48" class="citations"><div id="sref48" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref48" title="View in article">49.</a></div><div>Hale, J.S. ∙ Youngblood, B. ∙ Latner, D.R. ...</div><div><strong>Distinct memory CD4+ T&nbsp;cells with commitment to T follicular helper- and T helper 1-cell lineages are generated after acute viral infection</strong></div><div><em>Immunity.</em> 2013; <strong>38</strong>:805-817</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.S.HaleB.YoungbloodD.R.LatnerA.U.MohammedL.YeR.S.AkondyT.WuS.S.IyerR.AhmedDistinct+memory+CD4%2B+T%C2%A0cells+with+commitment+to+T+follicular+helper-+and+T+helper+1-cell+lineages+are+generated+after+acute+viral+infectionImmunity382013805817" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib49" class="citations"><div id="sref49" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref49" title="View in article">50.</a></div><div>Hanna, N.H. ∙ Schneider, B.J. ∙ Temin, S. ...</div><div><strong>Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update</strong></div><div><em>J.&nbsp;Clin. Oncol.</em> 2020; <strong>38</strong>:1608-1632</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.H.HannaB.J.SchneiderS.TeminS.BakerJr.J.BrahmerP.M.EllisL.E.GasparR.Y.HaddadP.J.HeskethD.JainTherapy+for+Stage+IV+Non-Small-Cell+Lung+Cancer+Without+Driver+Alterations%3A+ASCO+and+OH+%28CCO%29+Joint+Guideline+UpdateJ.%C2%A0Clin.+Oncol.38202016081632" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib50" class="citations"><div id="sref50" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref50" title="View in article">51.</a></div><div>He, R. ∙ Hou, S. ∙ Liu, C. ...</div><div><strong>Follicular CXCR5- expressing CD8(+) T&nbsp;cells curtail chronic viral infection</strong></div><div><em>Nature.</em> 2016; <strong>537</strong>:412-428</div></div><div class="external-links"><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.007&amp;key=2-s2.0-84988410229" target="_blank" aria-label="Open Scopus in new tab">Scopus (344)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.HeS.HouC.LiuA.ZhangQ.BaiM.HanY.YangG.WeiT.ShenX.YangFollicular+CXCR5-+expressing+CD8%28%2B%29+T%C2%A0cells+curtail+chronic+viral+infectionNature5372016412428" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib51" class="citations"><div id="sref51" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref51-1" title="View in article">52.</a></div><div>Helmink, B.A. ∙ Reddy, S.M. ∙ Gao, J. ...</div><div><strong>B cells and tertiary lymphoid structures promote immunotherapy response</strong></div><div><em>Nature.</em> 2020; <strong>577</strong>:549-555</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=B.A.HelminkS.M.ReddyJ.GaoS.ZhangR.BasarR.ThakurK.YizhakM.Sade-FeldmanJ.BlandoG.HanB+cells+and+tertiary+lymphoid+structures+promote+immunotherapy+responseNature5772020549555" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib52" class="citations"><div id="sref52" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref52" title="View in article">53.</a></div><div>Hennequin, A. ∙ Derangère, V. ∙ Boidot, R. ...</div><div><strong>Tumor infiltration by Tbet+ effector T&nbsp;cells and CD20+ B cells is associated with survival in gastric cancer patients</strong></div><div><em>OncoImmunology.</em> 2015; <strong>5</strong>:e1054598</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.HennequinV.Derang%C3%A8reR.BoidotL.ApetohJ.VincentD.OrryJ.FraisseS.CauseretF.MartinL.ArnouldTumor+infiltration+by+Tbet%2B+effector+T%C2%A0cells+and+CD20%2B+B+cells+is+associated+with+survival+in+gastric+cancer+patientsOncoImmunology52015e1054598" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib53" class="citations"><div id="sref53" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref53" title="View in article">54.</a></div><div>Herbst, R.S. ∙ Giaccone, G. ∙ de Marinis, F. ...</div><div><strong>Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2020; <strong>383</strong>:1328-1339</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.S.HerbstG.GiacconeF.de+MarinisN.ReinmuthA.VergnenegreC.H.BarriosM.MoriseE.FelipZ.AndricS.GeaterAtezolizumab+for+First-Line+Treatment+of+PD-L1-Selected+Patients+with+NSCLCN.%C2%A0Engl.+J.+Med.383202013281339" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib54" class="citations"><div id="sref54" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref54" title="View in article">55.</a></div><div>Hollern, D.P. ∙ Xu, N. ∙ Thennavan, A. ...</div><div><strong>B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer</strong></div><div><em>Cell.</em> 2019; <strong>179</strong>:1191-1206.e21</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.P.HollernN.XuA.ThennavanC.GlodowskiS.Garcia-RecioK.R.MottX.HeJ.P.GarayK.Carey-EwendD.MarronB+Cells+and+T+Follicular+Helper+Cells+Mediate+Response+to+Checkpoint+Inhibitors+in+High+Mutation+Burden+Mouse+Models+of+Breast+CancerCell179201911911206.e21" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib55" class="citations"><div id="sref55" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref55" title="View in article">56.</a></div><div>Hollister, K. ∙ Kusam, S. ∙ Wu, H. ...</div><div><strong>Insights into the role of Bcl6 in follicular Th cells using a new conditional mutant mouse model</strong></div><div><em>J.&nbsp;Immunol.</em> 2013; <strong>191</strong>:3705-3711</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=K.HollisterS.KusamH.WuN.CleggA.MondalD.V.SawantA.L.DentInsights+into+the+role+of+Bcl6+in+follicular+Th+cells+using+a+new+conditional+mutant+mouse+modelJ.%C2%A0Immunol.191201337053711" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib56" class="citations"><div id="sref56" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref56" title="View in article">57.</a></div><div>Huang, A.C. ∙ Postow, M.A. ∙ Orlowski, R.J. ...</div><div><strong>T-cell invigoration to tumour burden ratio associated with anti-PD-1 response</strong></div><div><em>Nature.</em> 2017; <strong>545</strong>:60-65</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.C.HuangM.A.PostowR.J.OrlowskiR.MickB.BengschS.ManneW.XuS.HarmonJ.R.GilesB.WenzT-cell+invigoration+to+tumour+burden+ratio+associated+with+anti-PD-1+responseNature54520176065" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib57" class="citations"><div id="sref57" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref57" title="View in article">58.</a></div><div>Im, S.J. ∙ Hashimoto, M. ∙ Gerner, M.Y. ...</div><div><strong>Defining CD8+ T&nbsp;cells that provide the proliferative burst after PD-1 therapy</strong></div><div><em>Nature.</em> 2016; <strong>537</strong>:417-421</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.J.ImM.HashimotoM.Y.GernerJ.LeeH.T.KissickM.C.BurgerQ.ShanJ.S.HaleJ.LeeT.H.NastiDefining+CD8%2B+T%C2%A0cells+that+provide+the+proliferative+burst+after+PD-1+therapyNature5372016417421" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib58" class="citations"><div id="sref58" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref58" title="View in article">59.</a></div><div>Im, S.J. ∙ Konieczny, B.T. ∙ Hudson, W.H. ...</div><div><strong>PD-1+ stemlike CD8 T&nbsp;cells are resident in lymphoid tissues during persistent LCMV infection</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2020; <strong>117</strong>:4292-4299</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.J.ImB.T.KoniecznyW.H.HudsonD.MasopustR.AhmedPD-1%2B+stemlike+CD8+T%C2%A0cells+are+resident+in+lymphoid+tissues+during+persistent+LCMV+infectionProc.+Natl.+Acad.+Sci.+USA117202042924299" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib59" class="citations"><div id="sref59" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref59" title="View in article">60.</a></div><div>Ise, W. ∙ Fujii, K. ∙ Shiroguchi, K. ...</div><div><strong>T Follicular Helper Cell-Germinal Center B Cell Interaction Strength Regulates Entry into Plasma Cell or Recycling Germinal Center Cell Fate</strong></div><div><em>Immunity.</em> 2018; <strong>48</strong>:702-715.e4</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=W.IseK.FujiiK.ShiroguchiA.ItoK.KometaniK.TakedaE.KawakamiK.YamashitaK.SuzukiT.OkadaT.KurosakiT+Follicular+Helper+Cell-Germinal+Center+B+Cell+Interaction+Strength+Regulates+Entry+into+Plasma+Cell+or+Recycling+Germinal+Center+Cell+FateImmunity482018702715.e4" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib60" class="citations"><div id="sref60" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref60-1" title="View in article">61.</a></div><div>Jiang, X. ∙ Muthusamy, V. ∙ Fedorova, O. ...</div><div><strong>Intratumoral delivery of RIG-I agonist SLR14 induces robust antitumor responses</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2019; <strong>216</strong>:2854-2868</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=X.JiangV.MuthusamyO.FedorovaY.KongD.J.KimM.BosenbergA.M.PyleA.IwasakiIntratumoral+delivery+of+RIG-I+agonist+SLR14+induces+robust+antitumor+responsesJ.%C2%A0Exp.+Med.216201928542868" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib61" class="citations"><div id="sref61" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref61" title="View in article">62.</a></div><div>Johnston, R.J. ∙ Poholek, A.C. ∙ DiToro, D. ...</div><div><strong>Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation</strong></div><div><em>Science.</em> 2009; <strong>325</strong>:1006-1010</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.J.JohnstonA.C.PoholekD.DiToroI.YusufD.EtoB.BarnettA.L.DentJ.CraftS.CrottyBcl6+and+Blimp-1+are+reciprocal+and+antagonistic+regulators+of+T+follicular+helper+cell+differentiationScience325200910061010" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib62" class="citations"><div id="sref62" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref62-1" title="View in article">63.</a></div><div>Joshi, N.S. ∙ Akama-Garren, E.H. ∙ Lu, Y. ...</div><div><strong>Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses</strong></div><div><em>Immunity.</em> 2015; <strong>43</strong>:579-590</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.S.JoshiE.H.Akama-GarrenY.LuD.Y.LeeG.P.ChangA.LiM.DuPageT.TammelaN.R.KerperA.F.FaragoRegulatory+T+Cells+in+Tumor-Associated+Tertiary+Lymphoid+Structures+Suppress+Anti-tumor+T+Cell+ResponsesImmunity432015579590" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib63" class="citations"><div id="sref63" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref63" title="View in article">64.</a></div><div>Kerfoot, S.M. ∙ Yaari, G. ∙ Patel, J.R. ...</div><div><strong>Germinal center B cell and T follicular helper cell development initiates in the interfollicular zone</strong></div><div><em>Immunity.</em> 2011; <strong>34</strong>:947-960</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.M.KerfootG.YaariJ.R.PatelK.L.JohnsonD.G.GonzalezS.H.KleinsteinA.M.HabermanGerminal+center+B+cell+and+T+follicular+helper+cell+development+initiates+in+the+interfollicular+zoneImmunity342011947960" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib64" class="citations"><div id="sref64" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref64" title="View in article">65.</a></div><div>Keskin, D.B. ∙ Anandappa, A.J. ∙ Sun, J. ...</div><div><strong>Neoantigen vaccine generates intratumoral T&nbsp;cell responses in phase Ib glioblastoma trial</strong></div><div><em>Nature.</em> 2019; <strong>565</strong>:234-239</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.B.KeskinA.J.AnandappaJ.SunI.TiroshN.D.MathewsonS.LiG.OliveiraA.Giobbie-HurderK.FeltE.GjiniNeoantigen+vaccine+generates+intratumoral+T%C2%A0cell+responses+in+phase+Ib+glioblastoma+trialNature5652019234239" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib65" class="citations"><div id="sref65" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref65-1" title="View in article">66.</a></div><div>Kim, N. ∙ Kim, H.K. ∙ Lee, K. ...</div><div><strong>Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma</strong></div><div><em>Nat. Commun.</em> 2020; <strong>11</strong>:2285</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.KimH.K.KimK.LeeY.HongJ.H.ChoJ.W.ChoiJ.I.LeeY.L.SuhB.M.KuH.H.EumSingle-cell+RNA+sequencing+demonstrates+the+molecular+and+cellular+reprogramming+of+metastatic+lung+adenocarcinomaNat.+Commun.1120202285" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib66" class="citations"><div id="sref66" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref66" title="View in article">67.</a></div><div>Kolenbrander, A. ∙ Grewe, B. ∙ Nemazee, D. ...</div><div><strong>Generation of T follicular helper cells in&nbsp;vitro: requirement for B-cell receptor cross-linking and cognate B- and T-cell interaction</strong></div><div><em>Immunology.</em> 2018; <strong>153</strong>:214-224</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.KolenbranderB.GreweD.NemazeeK.%C3%9CberlaV.TemchuraGeneration+of+T+follicular+helper+cells+in%C2%A0vitro%3A+requirement+for+B-cell+receptor+cross-linking+and+cognate+B-+and+T-cell+interactionImmunology1532018214224" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib67" class="citations"><div id="sref67" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref67" title="View in article">68.</a></div><div>Korn, T. ∙ Bettelli, E. ∙ Gao, W. ...</div><div><strong>IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells</strong></div><div><em>Nature.</em> 2007; <strong>448</strong>:484-487</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=T.KornE.BettelliW.GaoA.AwasthiA.J%C3%A4gerT.B.StromM.OukkaV.K.KuchrooIL-21+initiates+an+alternative+pathway+to+induce+proinflammatory+T%28H%2917+cellsNature4482007484487" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib68" class="citations"><div id="sref68" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref68" title="View in article">69.</a></div><div>Kreiter, S. ∙ Vormehr, M. ∙ van de Roemer, N. ...</div><div><strong>Mutant MHC class II epitopes drive therapeutic immune responses to cancer</strong></div><div><em>Nature.</em> 2015; <strong>520</strong>:692-696</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.KreiterM.VormehrN.van+de+RoemerM.DikenM.L%C3%B6werJ.DiekmannS.BoegelB.Schr%C3%B6rsF.VascottoJ.C.CastleMutant+MHC+class+II+epitopes+drive+therapeutic+immune+responses+to+cancerNature5202015692696" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib69" class="citations"><div id="sref69" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref69" title="View in article">70.</a></div><div>Kroeger, D.R. ∙ Milne, K. ∙ Nelson, B.H.</div><div><strong>Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer</strong></div><div><em>Clin. Cancer Res.</em> 2016; <strong>22</strong>:3005-3015</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.R.KroegerK.MilneB.H.NelsonTumor-Infiltrating+Plasma+Cells+Are+Associated+with+Tertiary+Lymphoid+Structures%2C+Cytolytic+T-Cell+Responses%2C+and+Superior+Prognosis+in+Ovarian+CancerClin.+Cancer+Res.22201630053015" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib70" class="citations"><div id="sref70" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref70" title="View in article">71.</a></div><div>Lapointe, R. ∙ Bellemare-Pelletier, A. ∙ Housseau, F. ...</div><div><strong>CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T&nbsp;cells</strong></div><div><em>Cancer Res.</em> 2003; <strong>63</strong>:2836-2843</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.LapointeA.Bellemare-PelletierF.HousseauJ.ThibodeauP.HwuCD40-stimulated+B+lymphocytes+pulsed+with+tumor+antigens+are+effective+antigen-presenting+cells+that+can+generate+specific+T%C2%A0cellsCancer+Res.63200328362843" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib71" class="citations"><div id="sref71" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref71" title="View in article">72.</a></div><div>Lee-Chang, C. ∙ Miska, J. ∙ Hou, D. ...</div><div><strong>Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2021; <strong>218</strong>:e20200913</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.Lee-ChangJ.MiskaD.HouA.RashidiP.ZhangR.A.BurgaI.Jusu%C3%A9-TorresT.XiaoV.A.ArrietaD.Y.ZhangActivation+of+4-1BBL%2B+B+cells+with+CD40+agonism+and+IFN%CE%B3+elicits+potent+immunity+against+glioblastomaJ.%C2%A0Exp.+Med.2182021e20200913" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib72" class="citations"><div id="sref72" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref72" title="View in article">73.</a></div><div>Leong, Y.A. ∙ Chen, Y. ∙ Ong, H.S. ...</div><div><strong>CXCR5(+) follicular cytotoxic T&nbsp;cells control viral infection in B cell follicles</strong></div><div><em>Nat. Immunol.</em> 2016; <strong>17</strong>:1187-1196</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Y.A.LeongY.ChenH.S.OngD.WuK.ManC.DeleageM.MinnichB.J.MeckiffY.WeiZ.HouCXCR5%28%2B%29+follicular+cytotoxic+T%C2%A0cells+control+viral+infection+in+B+cell+folliclesNat.+Immunol.17201611871196" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib73" class="citations"><div id="sref73" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref73" title="View in article">74.</a></div><div>Li, Y.J. ∙ Zhang, F. ∙ Qi, Y. ...</div><div><strong>Association of circulating follicular helper T&nbsp;cells with disease course of NMO spectrum disorders</strong></div><div><em>J.&nbsp;Neuroimmunol.</em> 2015; <strong>278</strong>:239-246</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Y.J.LiF.ZhangY.QiG.Q.ChangY.FuL.SuY.ShenN.SunA.BorazanciC.YangAssociation+of+circulating+follicular+helper+T%C2%A0cells+with+disease+course+of+NMO+spectrum+disordersJ.%C2%A0Neuroimmunol.2782015239246" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib74" class="citations"><div id="sref74" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref74" title="View in article">75.</a></div><div>Li, H. ∙ van der Leun, A.M. ∙ Yofe, I. ...</div><div><strong>Dysfunctional CD8&nbsp;T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma</strong></div><div><em>Cell.</em> 2019; <strong>176</strong>:775-789.e18</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=H.LiA.M.van+der+LeunI.YofeY.LublingD.Gelbard-SolodkinA.C.J.van+AkkooiM.van+den+BraberE.A.RozemanJ.B.A.G.HaanenC.U.BlankDysfunctional+CD8%C2%A0T+Cells+Form+a+Proliferative%2C+Dynamically+Regulated+Compartment+within+Human+MelanomaCell1762019775789.e18" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib75" class="citations"><div id="sref75" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref75-1" title="View in article">76.</a></div><div>Li, Y. ∙ Cong, Y. ∙ Jia, M. ...</div><div><strong>Targeting IL-21 to tumor-reactive T&nbsp;cells enhances memory T&nbsp;cell responses and anti-PD-1 antibody therapy</strong></div><div><em>Nat. Commun.</em> 2021; <strong>12</strong>:951</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Y.LiY.CongM.JiaQ.HeH.ZhongY.ZhaoH.LiM.YanJ.YouJ.LiuTargeting+IL-21+to+tumor-reactive+T%C2%A0cells+enhances+memory+T%C2%A0cell+responses+and+anti-PD-1+antibody+therapyNat.+Commun.122021951" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib76" class="citations"><div id="sref76" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref76" title="View in article">77.</a></div><div>Linnemann, C. ∙ van Buuren, M.M. ∙ Bies, L. ...</div><div><strong>High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T&nbsp;cells in human melanoma</strong></div><div><em>Nat. Med.</em> 2015; <strong>21</strong>:81-85</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.LinnemannM.M.van+BuurenL.BiesE.M.VerdegaalR.SchotteJ.J.CalisS.BehjatiA.VeldsH.HilkmannD.E.AtmiouiHigh-throughput+epitope+discovery+reveals+frequent+recognition+of+neo-antigens+by+CD4%2B+T%C2%A0cells+in+human+melanomaNat.+Med.2120158185" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib77" class="citations"><div id="sref77" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref77" title="View in article">78.</a></div><div>Linterman, M.A. ∙ Beaton, L. ∙ Yu, D. ...</div><div><strong>IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2010; <strong>207</strong>:353-363</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.A.LintermanL.BeatonD.YuR.R.RamiscalM.SrivastavaJ.J.HoganN.K.VermaM.J.SmythR.J.RigbyC.G.VinuesaIL-21+acts+directly+on+B+cells+to+regulate+Bcl-6+expression+and+germinal+center+responsesJ.%C2%A0Exp.+Med.2072010353363" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib78" class="citations"><div id="sref78" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref78" title="View in article">79.</a></div><div>Liu, D. ∙ Xu, H. ∙ Shih, C. ...</div><div><strong>T-B-cell entanglement and ICOSL-driven feed-forward regulation of germinal centre reaction</strong></div><div><em>Nature.</em> 2015; <strong>517</strong>:214-218</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.LiuH.XuC.ShihZ.WanX.MaW.MaD.LuoH.QiT-B-cell+entanglement+and+ICOSL-driven+feed-forward+regulation+of+germinal+centre+reactionNature5172015214218" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib79" class="citations"><div id="sref79" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref79" title="View in article">80.</a></div><div>Liu, M. ∙ Kuo, F. ∙ Capistrano, K.J. ...</div><div><strong>TGF-β suppresses type 2 immunity to cancer</strong></div><div><em>Nature.</em> 2020; <strong>587</strong>:115-120</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.LiuF.KuoK.J.CapistranoD.KangB.G.NixonW.ShiC.ChouM.H.DoE.G.StamatiadesS.GaoTGF-%CE%B2+suppresses+type+2+immunity+to+cancerNature5872020115120" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib80" class="citations"><div id="sref80" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref80" title="View in article">81.</a></div><div>Lizotte, P.H. ∙ Ivanova, E.V. ∙ Awad, M.M. ...</div><div><strong>Multiparametric profiling of non-small-cell lung cancers reveals distinct immunophenotypes</strong></div><div><em>JCI Insight.</em> 2016; <strong>1</strong>:e89014</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=P.H.LizotteE.V.IvanovaM.M.AwadR.E.JonesL.KeoghH.LiuR.DriesC.AlmonteG.S.Herter-SprieA.SantosMultiparametric+profiling+of+non-small-cell+lung+cancers+reveals+distinct+immunophenotypesJCI+Insight12016e89014" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib81" class="citations"><div id="sref81" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref81-1" title="View in article">82.</a></div><div>Lu, Y. ∙ Zhao, Q. ∙ Liao, J.Y. ...</div><div><strong>Complement Signals Determine Opposite Effects of B Cells in Chemotherapy-Induced Immunity</strong></div><div><em>Cell.</em> 2020; <strong>180</strong>:1081-1097.e24</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Y.LuQ.ZhaoJ.Y.LiaoE.SongQ.XiaJ.PanY.LiJ.LiB.ZhouY.YeComplement+Signals+Determine+Opposite+Effects+of+B+Cells+in+Chemotherapy-Induced+ImmunityCell180202010811097.e24" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib82" class="citations"><div id="sref82" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref82" title="View in article">83.</a></div><div>Magen, A. ∙ Nie, J. ∙ Ciucci, T. ...</div><div><strong>Single-Cell Profiling Defines Transcriptomic Signatures Specific to Tumor-Reactive versus Virus-Responsive CD4<sup>+</sup> T Cells</strong></div><div><em>Cell Rep.</em> 2019; <strong>29</strong>:3019-3032.e6</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.MagenJ.NieT.CiucciS.TamoutounourY.ZhaoM.MehtaB.TranD.B.McGavernS.HannenhalliR.BosselutSingle-Cell+Profiling+Defines+Transcriptomic+Signatures+Specific+to+Tumor-Reactive+versus+Virus-Responsive+CD4%2B+T+CellsCell+Rep.29201930193032.e6" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib83" class="citations"><div id="sref83" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref83" title="View in article">84.</a></div><div>Manzo, A. ∙ Vitolo, B. ∙ Humby, F. ...</div><div><strong>Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint</strong></div><div><em>Arthritis Rheum.</em> 2008; <strong>58</strong>:3377-3387</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.ManzoB.VitoloF.HumbyR.CaporaliD.JarrossayF.Dell%E2%80%99accioL.CiardelliM.UguccioniC.MontecuccoC.PitzalisMature+antigen-experienced+T+helper+cells+synthesize+and+secrete+the+B+cell+chemoattractant+CXCL13+in+the+inflammatory+environment+of+the+rheumatoid+jointArthritis+Rheum.58200833773387" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib84" class="citations"><div id="sref84" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref84" title="View in article">85.</a></div><div>Marshall, H.D. ∙ Chandele, A. ∙ Jung, Y.W. ...</div><div><strong>Differential expression of Ly6C and T-bet distinguish effector and memory Th1 CD4(+) cell properties during viral infection</strong></div><div><em>Immunity.</em> 2011; <strong>35</strong>:633-646</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=H.D.MarshallA.ChandeleY.W.JungH.MengA.C.PoholekI.A.ParishR.RutishauserW.CuiS.H.KleinsteinJ.CraftS.M.KaechDifferential+expression+of+Ly6C+and+T-bet+distinguish+effector+and+memory+Th1+CD4%28%2B%29+cell+properties+during+viral+infectionImmunity352011633646" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib85" class="citations"><div id="sref85" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref85" title="View in article">86.</a></div><div>Martin-Orozco, N. ∙ Muranski, P. ∙ Chung, Y. ...</div><div><strong>T helper 17 cells promote cytotoxic T&nbsp;cell activation in tumor immunity</strong></div><div><em>Immunity.</em> 2009; <strong>31</strong>:787-798</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.Martin-OrozcoP.MuranskiY.ChungX.O.YangT.YamazakiS.LuP.HwuN.P.RestifoW.W.OverwijkC.DongT+helper+17+cells+promote+cytotoxic+T%C2%A0cell+activation+in+tumor+immunityImmunity312009787798" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib86" class="citations"><div id="sref86" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref86" title="View in article">87.</a></div><div>Matloubian, M. ∙ Concepcion, R.J. ∙ Ahmed, R.</div><div><strong>CD4+ T&nbsp;cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection</strong></div><div><em>J.&nbsp;Virol.</em> 1994; <strong>68</strong>:8056-8063</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.MatloubianR.J.ConcepcionR.AhmedCD4%2B+T%C2%A0cells+are+required+to+sustain+CD8%2B+cytotoxic+T-cell+responses+during+chronic+viral+infectionJ.%C2%A0Virol.68199480568063" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib87" class="citations"><div id="sref87" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref87-1" title="View in article">88.</a></div><div>McFadden, D.G. ∙ Politi, K. ∙ Bhutkar, A. ...</div><div><strong>Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinoma</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2016; <strong>113</strong>:E6409-E6417</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.G.McFaddenK.PolitiA.BhutkarF.K.ChenX.SongM.PirunP.M.SantiagoC.Kim-KiselakJ.T.PlattE.LeeMutational+landscape+of+EGFR-%2C+MYC-%2C+and+Kras-driven+genetically+engineered+mouse+models+of+lung+adenocarcinomaProc.+Natl.+Acad.+Sci.+USA1132016E6409E6417" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib88" class="citations"><div id="sref88" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref88" title="View in article">89.</a></div><div>Mesin, L. ∙ Ersching, J. ∙ Victora, G.D.</div><div><strong>Germinal Center B Cell Dynamics</strong></div><div><em>Immunity.</em> 2016; <strong>45</strong>:471-482</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=L.MesinJ.ErschingG.D.VictoraGerminal+Center+B+Cell+DynamicsImmunity452016471482" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib89" class="citations"><div id="sref89" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref89" title="View in article">90.</a></div><div>Milich, D.R. ∙ McLachlan, A. ∙ Thornton, G.B. ...</div><div><strong>Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T&nbsp;cell site</strong></div><div><em>Nature.</em> 1987; <strong>329</strong>:547-549</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.R.MilichA.McLachlanG.B.ThorntonJ.L.HughesAntibody+production+to+the+nucleocapsid+and+envelope+of+the+hepatitis+B+virus+primed+by+a+single+synthetic+T%C2%A0cell+siteNature3291987547549" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib90" class="citations"><div id="sref90" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref90" title="View in article">91.</a></div><div>Milpied, P. ∙ Cervera-Marzal, I. ∙ Mollichella, M.L. ...</div><div><strong>Human germinal center transcriptional programs are de-synchronized in B cell lymphoma</strong></div><div><em>Nat. Immunol.</em> 2018; <strong>19</strong>:1013-1024</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=P.MilpiedI.Cervera-MarzalM.L.MollichellaB.TessonG.BrisouA.Traverse-GlehenG.SallesL.SpinelliB.NadelHuman+germinal+center+transcriptional+programs+are+de-synchronized+in+B+cell+lymphomaNat.+Immunol.19201810131024" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib91" class="citations"><div id="sref91" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref91" title="View in article">92.</a></div><div>Mitchison, N.A.</div><div><strong>The carrier effect in the secondary response to hapten-protein conjugates. I. Measurement of the effect with transferred cells and objections to the local environment hypothesis</strong></div><div><em>Eur. J. Immunol.</em> 1971; <strong>1</strong>:10-17</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.A.MitchisonThe+carrier+effect+in+the+secondary+response+to+hapten-protein+conjugates.+I.+Measurement+of+the+effect+with+transferred+cells+and+objections+to+the+local+environment+hypothesisEur.+J.+Immunol.119711017" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib92" class="citations"><div id="sref92" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref92" title="View in article">93.</a></div><div>Mitchison, N.A.</div><div><strong>The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation</strong></div><div><em>Eur. J. Immunol.</em> 1971; <strong>1</strong>:18-27</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.A.MitchisonThe+carrier+effect+in+the+secondary+response+to+hapten-protein+conjugates.+II.+Cellular+cooperationEur.+J.+Immunol.119711827" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib93" class="citations"><div id="sref93" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref93" title="View in article">94.</a></div><div>Morita, R. ∙ Schmitt, N. ∙ Bentebibel, S.E. ...</div><div><strong>Human blood CXCR5(+)CD4(+) T&nbsp;cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion</strong></div><div><em>Immunity.</em> 2011; <strong>34</strong>:108-121</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.MoritaN.SchmittS.E.BentebibelR.RanganathanL.BourderyG.ZurawskiE.FoucatM.DullaersS.OhN.SabzghabaeiHuman+blood+CXCR5%28%2B%29CD4%28%2B%29+T%C2%A0cells+are+counterparts+of+T+follicular+cells+and+contain+specific+subsets+that+differentially+support+antibody+secretionImmunity342011108121" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib94" class="citations"><div id="sref94" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref94" title="View in article">95.</a></div><div>Nakayamada, S. ∙ Kanno, Y. ∙ Takahashi, H. ...</div><div><strong>Early Th1 cell differentiation is marked by a Tfh cell-like transition</strong></div><div><em>Immunity.</em> 2011; <strong>35</strong>:919-931</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.NakayamadaY.KannoH.TakahashiD.JankovicK.T.LuT.A.JohnsonH.W.SunG.VahediO.HakimR.HandonEarly+Th1+cell+differentiation+is+marked+by+a+Tfh+cell-like+transitionImmunity352011919931" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib95" class="citations"><div id="sref95" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref95-1" title="View in article">96.</a></div><div>Newman, A.M. ∙ Liu, C.L. ∙ Green, M.R. ...</div><div><strong>Robust enumeration of cell subsets from tissue expression profiles</strong></div><div><em>Nat. Methods.</em> 2015; <strong>12</strong>:453-457</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.M.NewmanC.L.LiuM.R.GreenA.J.GentlesW.FengY.XuC.D.HoangM.DiehnA.A.AlizadehRobust+enumeration+of+cell+subsets+from+tissue+expression+profilesNat.+Methods122015453457" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib96" class="citations"><div id="sref96" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref96-1" title="View in article">97.</a></div><div>Noël, G. ∙ Fontsa, M.L. ∙ Garaud, S. ...</div><div><strong>Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2021; <strong>131</strong>:e139905</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.No%C3%ABlM.L.FontsaS.GaraudP.De+SilvaA.de+WindG.G.Van+den+EyndenR.SalgadoA.BoissonH.LocyN.ThomasFunctional+Th1-oriented+T+follicular+helper+cells+that+infiltrate+human+breast+cancer+promote+effective+adaptive+immunityJ.%C2%A0Clin.+Invest.1312021e139905" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib97" class="citations"><div id="sref97" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref97" title="View in article">98.</a></div><div>Nurieva, R. ∙ Yang, X.O. ∙ Martinez, G. ...</div><div><strong>Essential autocrine regulation by IL-21 in the generation of inflammatory T&nbsp;cells</strong></div><div><em>Nature.</em> 2007; <strong>448</strong>:480-483</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.NurievaX.O.YangG.MartinezY.ZhangA.D.PanopoulosL.MaK.SchlunsQ.TianS.S.WatowichA.M.JettenC.DongEssential+autocrine+regulation+by+IL-21+in+the+generation+of+inflammatory+T%C2%A0cellsNature4482007480483" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib98" class="citations"><div id="sref98" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref98-1" title="View in article">99.</a></div><div>Nurieva, R.I. ∙ Chung, Y. ∙ Hwang, D. ...</div><div><strong>Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages</strong></div><div><em>Immunity.</em> 2008; <strong>29</strong>:138-149</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.I.NurievaY.ChungD.HwangX.O.YangH.S.KangL.MaY.H.WangS.S.WatowichA.M.JettenQ.TianC.DongGeneration+of+T+follicular+helper+cells+is+mediated+by+interleukin-21+but+independent+of+T+helper+1%2C+2%2C+or+17+cell+lineagesImmunity292008138149" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib99" class="citations"><div id="sref99" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref99" title="View in article">100.</a></div><div>Nurieva, R.I. ∙ Chung, Y. ∙ Martinez, G.J. ...</div><div><strong>Bcl6 mediates the development of T follicular helper cells</strong></div><div><em>Science.</em> 2009; <strong>325</strong>:1001-1005</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.I.NurievaY.ChungG.J.MartinezX.O.YangS.TanakaT.D.MatskevitchY.H.WangC.DongBcl6+mediates+the+development+of+T+follicular+helper+cellsScience325200910011005" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib100" class="citations"><div id="sref100" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref100" title="View in article">101.</a></div><div>O’Shea, J.J. ∙ Paul, W.E.</div><div><strong>Mechanisms underlying lineage commitment and plasticity of helper CD4+ T&nbsp;cells</strong></div><div><em>Science.</em> 2010; <strong>327</strong>:1098-1102</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.J.O%E2%80%99SheaW.E.PaulMechanisms+underlying+lineage+commitment+and+plasticity+of+helper+CD4%2B+T%C2%A0cellsScience327201010981102" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib101" class="citations"><div id="sref101" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref101" title="View in article">102.</a></div><div>Oh, D.Y. ∙ Kwek, S.S. ∙ Raju, S.S. ...</div><div><strong>Intratumoral CD4(+) T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer</strong></div><div><em>Cell.</em> 2020; <strong>181</strong>:1612-1625</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.Y.OhS.S.KwekS.S.RajuT.LiE.McCarthyE.ChowD.AranA.IlanoC.S.PaiC.RancanIntratumoral+CD4%28%2B%29+T+Cells+Mediate+Anti-tumor+Cytotoxicity+in+Human+Bladder+CancerCell181202016121625" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib102" class="citations"><div id="sref102" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref102" title="View in article">103.</a></div><div>Ott, P.A. ∙ Hu, Z. ∙ Keskin, D.B. ...</div><div><strong>An immunogenic personal neoantigen vaccine for patients with melanoma</strong></div><div><em>Nature.</em> 2017; <strong>547</strong>:217-221</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=P.A.OttZ.HuD.B.KeskinS.A.ShuklaJ.SunD.J.BozymW.ZhangA.LuomaA.Giobbie-HurderL.PeterAn+immunogenic+personal+neoantigen+vaccine+for+patients+with+melanomaNature5472017217221" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib103" class="citations"><div id="sref103" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref103" title="View in article">104.</a></div><div>Ott, P.A. ∙ Hu-Lieskovan, S. ∙ Chmielowski, B. ...</div><div><strong>A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer</strong></div><div><em>Cell.</em> 2020; <strong>183</strong>:347-362.e24</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=P.A.OttS.Hu-LieskovanB.ChmielowskiR.GovindanA.NaingN.BhardwajK.MargolinM.M.AwadM.D.HellmannJ.J.LinA+Phase+Ib+Trial+of+Personalized+Neoantigen+Therapy+Plus+Anti-PD-1+in+Patients+with+Advanced+Melanoma%2C+Non-small+Cell+Lung+Cancer%2C+or+Bladder+CancerCell1832020347362.e24" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib104" class="citations"><div id="sref104" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref104" title="View in article">105.</a></div><div>Paus, D. ∙ Phan, T.G. ∙ Chan, T.D. ...</div><div><strong>Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2006; <strong>203</strong>:1081-1091</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.PausT.G.PhanT.D.ChanS.GardamA.BastenR.BrinkAntigen+recognition+strength+regulates+the+choice+between+extrafollicular+plasma+cell+and+germinal+center+B+cell+differentiationJ.%C2%A0Exp.+Med.203200610811091" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib105" class="citations"><div id="sref105" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref105-1" title="View in article">106.</a></div><div>Petitprez, F. ∙ de Reyniès, A. ∙ Keung, E.Z. ...</div><div><strong>B cells are associated with survival and immunotherapy response in sarcoma</strong></div><div><em>Nature.</em> 2020; <strong>577</strong>:556-560</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=F.PetitprezA.de+Reyni%C3%A8sE.Z.KeungT.W.ChenC.M.SunJ.CalderaroY.M.JengL.P.HsiaoL.LacroixA.Bougo%C3%BCinB+cells+are+associated+with+survival+and+immunotherapy+response+in+sarcomaNature5772020556560" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib106" class="citations"><div id="sref106" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref106" title="View in article">107.</a></div><div>Pfirschke, C. ∙ Engblom, C. ∙ Rickelt, S. ...</div><div><strong>Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy</strong></div><div><em>Immunity.</em> 2016; <strong>44</strong>:343-354</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.PfirschkeC.EngblomS.RickeltV.Cortez-RetamozoC.GarrisF.PucciT.YamazakiV.Poirier-ColameA.NewtonY.RedouaneImmunogenic+Chemotherapy+Sensitizes+Tumors+to+Checkpoint+Blockade+TherapyImmunity442016343354" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib107" class="citations"><div id="sref107" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref107" title="View in article">108.</a></div><div>Phan, T.G. ∙ Amesbury, M. ∙ Gardam, S. ...</div><div><strong>B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2003; <strong>197</strong>:845-860</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=T.G.PhanM.AmesburyS.GardamJ.CrosbieJ.HasboldP.D.HodgkinA.BastenR.BrinkB+cell+receptor-independent+stimuli+trigger+immunoglobulin+%28Ig%29+class+switch+recombination+and+production+of+IgG+autoantibodies+by+anergic+self-reactive+B+cellsJ.%C2%A0Exp.+Med.1972003845860" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib108" class="citations"><div id="sref108" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref108" title="View in article">109.</a></div><div>Pitzalis, C. ∙ Jones, G.W. ∙ Bombardieri, M. ...</div><div><strong>Ectopic lymphoid-like structures in infection, cancer and autoimmunity</strong></div><div><em>Nat. Rev. Immunol.</em> 2014; <strong>14</strong>:447-462</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.PitzalisG.W.JonesM.BombardieriS.A.JonesEctopic+lymphoid-like+structures+in+infection%2C+cancer+and+autoimmunityNat.+Rev.+Immunol.142014447462" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib109" class="citations"><div id="sref109" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref109" title="View in article">110.</a></div><div>Poholek, A.C. ∙ Hansen, K. ∙ Hernandez, S.G. ...</div><div><strong>In&nbsp;vivo regulation of Bcl6 and T follicular helper cell development</strong></div><div><em>J.&nbsp;Immunol.</em> 2010; <strong>185</strong>:313-326</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.C.PoholekK.HansenS.G.HernandezD.EtoA.ChandeleJ.S.WeinsteinX.DongJ.M.OdegardS.M.KaechA.L.DentIn%C2%A0vivo+regulation+of+Bcl6+and+T+follicular+helper+cell+developmentJ.%C2%A0Immunol.1852010313326" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib110" class="citations"><div id="sref110" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref110-1" title="View in article">111.</a></div><div>Rakaee, M. ∙ Kilvaer, T.K. ∙ Jamaly, S. ...</div><div><strong>Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer</strong></div><div><em>Br. J. Cancer.</em> 2021; <strong>124</strong>:1680-1689</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.RakaeeT.K.KilvaerS.JamalyT.BergE.E.PaulsenM.BerglundE.RichardsenS.AndersenS.Al-SaadM.PoehlTertiary+lymphoid+structure+score%3A+a+promising+approach+to+refine+the+TNM+staging+in+resected+non-small+cell+lung+cancerBr.+J.+Cancer124202116801689" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib111" class="citations"><div id="sref111" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref111" title="View in article">112.</a></div><div>Rao, D.A. ∙ Gurish, M.F. ∙ Marshall, J.L. ...</div><div><strong>Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis</strong></div><div><em>Nature.</em> 2017; <strong>542</strong>:110-114</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.A.RaoM.F.GurishJ.L.MarshallK.SlowikowskiC.Y.FonsekaY.LiuL.T.DonlinL.A.HendersonK.WeiF.MizoguchiPathologically+expanded+peripheral+T+helper+cell+subset+drives+B+cells+in+rheumatoid+arthritisNature5422017110114" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib112" class="citations"><div id="sref112" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref112" title="View in article">113.</a></div><div>Reck, M. ∙ Rodríguez-Abreu, D. ∙ Robinson, A.G. ..., KEYNOTE-024 Investigators</div><div><strong>Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2016; <strong>375</strong>:1823-1833</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.ReckD.Rodr%C3%ADguez-AbreuA.G.RobinsonR.HuiT.Cs%C5%91sziA.F%C3%BCl%C3%B6pM.GottfriedN.PeledA.TafreshiS.CuffeKEYNOTE-024+InvestigatorsPembrolizumab+versus+Chemotherapy+for+PD-L1-Positive+Non-Small-Cell+Lung+CancerN.%C2%A0Engl.+J.+Med.375201618231833" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib113" class="citations"><div id="sref113" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref113-1" title="View in article">114.</a></div><div>Ren, H.M. ∙ Kolawole, E.M. ∙ Ren, M. ...</div><div><strong>IL-21 from high-affinity CD4 T&nbsp;cells drives differentiation of brain-resident CD8 T&nbsp;cells during persistent viral infection</strong></div><div><em>Sci. Immunol.</em> 2020; <strong>5</strong>:eabb5590</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=H.M.RenE.M.KolawoleM.RenG.JinC.S.Netherby-WinslowQ.WadeShwetankZ.S.M.RahmanB.D.EvavoldA.E.LukacherIL-21+from+high-affinity+CD4+T%C2%A0cells+drives+differentiation+of+brain-resident+CD8+T%C2%A0cells+during+persistent+viral+infectionSci.+Immunol.52020eabb5590" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib114" class="citations"><div id="sref114" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref114" title="View in article">115.</a></div><div>Renshaw, B.R. ∙ Fanslow, 3rd, W.C. ∙ Armitage, R.J. ...</div><div><strong>Humoral immune responses in CD40 ligand-deficient mice</strong></div><div><em>J.&nbsp;Exp. Med.</em> 1994; <strong>180</strong>:1889-1900</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=B.R.RenshawW.C.Fanslow3rdR.J.ArmitageK.A.CampbellD.LiggittB.WrightB.L.DavisonC.R.MaliszewskiHumoral+immune+responses+in+CD40+ligand-deficient+miceJ.%C2%A0Exp.+Med.180199418891900" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib115" class="citations"><div id="sref115" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref115" title="View in article">116.</a></div><div>Roberti, M.P. ∙ Yonekura, S. ∙ Duong, C.P.M. ...</div><div><strong>Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer</strong></div><div><em>Nat. Med.</em> 2020; <strong>26</strong>:919-931</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.P.RobertiS.YonekuraC.P.M.DuongM.PicardG.FerrereM.Tidjani+AlouC.RauberV.IebbaC.H.K.LehmannL.AmonChemotherapy-induced+ileal+crypt+apoptosis+and+the+ileal+microbiome+shape+immunosurveillance+and+prognosis+of+proximal+colon+cancerNat.+Med.262020919931" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib116" class="citations"><div id="sref116" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref116" title="View in article">117.</a></div><div>Ruddle, N.H.</div><div><strong>Lymphatic vessels and tertiary lymphoid organs</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2014; <strong>124</strong>:953-959</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.H.RuddleLymphatic+vessels+and+tertiary+lymphoid+organsJ.%C2%A0Clin.+Invest.1242014953959" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib117" class="citations"><div id="sref117" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref117-1" title="View in article">118.</a></div><div>Ruffin, A.T. ∙ Cillo, A.R. ∙ Tabib, T. ...</div><div><strong>B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma</strong></div><div><em>Nat. Commun.</em> 2021; <strong>12</strong>:3349</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.T.RuffinA.R.CilloT.TabibA.LiuS.OnkarS.R.KunningC.LampenfeldH.I.AtiyaI.AbecassisC.H.L.K%C3%BCrtenB+cell+signatures+and+tertiary+lymphoid+structures+contribute+to+outcome+in+head+and+neck+squamous+cell+carcinomaNat.+Commun.1220213349" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib118" class="citations"><div id="sref118" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref118" title="View in article">119.</a></div><div>Russell, S.M. ∙ Liew, F.Y.</div><div><strong>T cells primed by influenza virion internal components can cooperate in the antibody response to haemagglutinin</strong></div><div><em>Nature.</em> 1979; <strong>280</strong>:147-148</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.M.RussellF.Y.LiewT+cells+primed+by+influenza+virion+internal+components+can+cooperate+in+the+antibody+response+to+haemagglutininNature2801979147148" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib119" class="citations"><div id="sref119" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref119" title="View in article">120.</a></div><div>Satpathy, A.T. ∙ Granja, J.M. ∙ Yost, K.E. ...</div><div><strong>Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral T&nbsp;cell exhaustion</strong></div><div><em>Nat. Biotechnol.</em> 2019; <strong>37</strong>:925-936</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.T.SatpathyJ.M.GranjaK.E.YostY.QiF.MeschiG.P.McDermottB.N.OlsenM.R.MumbachS.E.PierceM.R.CorcesMassively+parallel+single-cell+chromatin+landscapes+of+human+immune+cell+development+and+intratumoral+T%C2%A0cell+exhaustionNat.+Biotechnol.372019925936" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib120" class="citations"><div id="sref120" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref120-1" title="View in article">121.</a></div><div>Sautès-Fridman, C. ∙ Lawand, M. ∙ Giraldo, N.A. ...</div><div><strong>Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention</strong></div><div><em>Front. Immunol.</em> 2016; <strong>7</strong>:407</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.Saut%C3%A8s-FridmanM.LawandN.A.GiraldoH.KaplonC.GermainW.H.FridmanM.C.Dieu-NosjeanTertiary+Lymphoid+Structures+in+Cancers%3A+Prognostic+Value%2C+Regulation%2C+and+Manipulation+for+Therapeutic+InterventionFront.+Immunol.72016407" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib121" class="citations"><div id="sref121" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref121-1" title="View in article">122.</a></div><div>Sautès-Fridman, C. ∙ Petitprez, F. ∙ Calderaro, J. ...</div><div><strong>Tertiary lymphoid structures in the era of cancer immunotherapy</strong></div><div><em>Nat. Rev. Cancer.</em> 2019; <strong>19</strong>:307-325</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.Saut%C3%A8s-FridmanF.PetitprezJ.CalderaroW.H.FridmanTertiary+lymphoid+structures+in+the+era+of+cancer+immunotherapyNat.+Rev.+Cancer192019307325" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib122" class="citations"><div id="sref122" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref122" title="View in article">123.</a></div><div>Schabath, M.B. ∙ Cote, M.L.</div><div><strong>Cancer Progress and Priorities: Lung Cancer</strong></div><div><em>Cancer Epidemiol. Biomarkers Prev.</em> 2019; <strong>28</strong>:1563-1579</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.B.SchabathM.L.CoteCancer+Progress+and+Priorities%3A+Lung+CancerCancer+Epidemiol.+Biomarkers+Prev.28201915631579" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib123" class="citations"><div id="sref123" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref123" title="View in article">124.</a></div><div>Schenkel, J.M. ∙ Herbst, R.H. ∙ Canner, D. ...</div><div><strong>Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1<sup>+</sup> CD8<sup>+</sup> T&nbsp;cells in tumor-draining lymph nodes</strong></div><div><em>Immunity.</em> 2021; <strong>54</strong>:2338-2353.e6</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.M.SchenkelR.H.HerbstD.CannerA.LiM.HillmanS.L.ShanahanG.GibbonsO.C.SmithJ.Y.KimP.WestcottConventional+type+I+dendritic+cells+maintain+a+reservoir+of+proliferative+tumor-antigen+specific+TCF-1%2B+CD8%2B+T%C2%A0cells+in+tumor-draining+lymph+nodesImmunity54202123382353.e6" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib124" class="citations"><div id="sref124" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref124" title="View in article">125.</a></div><div>Schumacher, T.N. ∙ Hacohen, N.</div><div><strong>Neoantigens encoded in the cancer genome</strong></div><div><em>Curr. Opin. Immunol.</em> 2016; <strong>41</strong>:98-103</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=T.N.SchumacherN.HacohenNeoantigens+encoded+in+the+cancer+genomeCurr.+Opin.+Immunol.41201698103" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib125" class="citations"><div id="sref125" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref125" title="View in article">126.</a></div><div>Schumacher, T.N. ∙ Scheper, W. ∙ Kvistborg, P.</div><div><strong>Cancer Neoantigens</strong></div><div><em>Annu. Rev. Immunol.</em> 2019; <strong>37</strong>:173-200</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=T.N.SchumacherW.ScheperP.KvistborgCancer+NeoantigensAnnu.+Rev.+Immunol.372019173200" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib126" class="citations"><div id="sref126" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref126" title="View in article">127.</a></div><div>Sette, A. ∙ Moutaftsi, M. ∙ Moyron-Quiroz, J. ...</div><div><strong>Selective CD4+ T&nbsp;cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities</strong></div><div><em>Immunity.</em> 2008; <strong>28</strong>:847-858</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.SetteM.MoutaftsiJ.Moyron-QuirozM.M.McCauslandD.H.DaviesR.J.JohnstonB.PetersM.Rafii-El-Idrissi+BenhniaJ.HoffmannH.P.SuSelective+CD4%2B+T%C2%A0cell+help+for+antibody+responses+to+a+large+viral+pathogen%3A+deterministic+linkage+of+specificitiesImmunity282008847858" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib127" class="citations"><div id="sref127" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref127" title="View in article">128.</a></div><div>Sharonov, G.V. ∙ Serebrovskaya, E.O. ∙ Yuzhakova, D.V. ...</div><div><strong>B cells, plasma cells and antibody repertoires in the tumour microenvironment</strong></div><div><em>Nat. Rev. Immunol.</em> 2020; <strong>20</strong>:294-307</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.V.SharonovE.O.SerebrovskayaD.V.YuzhakovaO.V.BritanovaD.M.ChudakovB+cells%2C+plasma+cells+and+antibody+repertoires+in+the+tumour+microenvironmentNat.+Rev.+Immunol.202020294307" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib128" class="citations"><div id="sref128" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref128" title="View in article">129.</a></div><div>Shulman, Z. ∙ Gitlin, A.D. ∙ Weinstein, J.S. ...</div><div><strong>Dynamic signaling by T follicular helper cells during germinal center B cell selection</strong></div><div><em>Science.</em> 2014; <strong>345</strong>:1058-1062</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Z.ShulmanA.D.GitlinJ.S.WeinsteinB.LainezE.EspluguesR.A.FlavellJ.E.CraftM.C.NussenzweigDynamic+signaling+by+T+follicular+helper+cells+during+germinal+center+B+cell+selectionScience345201410581062" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib129" class="citations"><div id="sref129" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref129" title="View in article">130.</a></div><div>Siliņa, K. ∙ Soltermann, A. ∙ Attar, F.M. ...</div><div><strong>Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma</strong></div><div><em>Cancer Res.</em> 2018; <strong>78</strong>:1308-1320</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=K.Sili%C5%86aA.SoltermannF.M.AttarR.CasanovaZ.M.UckeleyH.ThutM.WandresS.IsajevsP.ChengA.Curioni-FontecedroGerminal+Centers+Determine+the+Prognostic+Relevance+of+Tertiary+Lymphoid+Structures+and+Are+Impaired+by+Corticosteroids+in+Lung+Squamous+Cell+CarcinomaCancer+Res.78201813081320" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib130" class="citations"><div id="sref130" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref130" title="View in article">131.</a></div><div>Singh, H. ∙ Figliola, M.J. ∙ Dawson, M.J. ...</div><div><strong>Reprogramming CD19-specific T&nbsp;cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies</strong></div><div><em>Cancer Res.</em> 2011; <strong>71</strong>:3516-3527</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=H.SinghM.J.FigliolaM.J.DawsonH.HulsS.OlivaresK.SwitzerT.MiS.MaitiP.KebriaeiD.A.LeeReprogramming+CD19-specific+T%C2%A0cells+with+IL-21+signaling+can+improve+adoptive+immunotherapy+of+B-lineage+malignanciesCancer+Res.71201135163527" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib131" class="citations"><div id="sref131" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref131-1" title="View in article">132.</a></div><div>Snell, L.M. ∙ MacLeod, B.L. ∙ Law, J.C. ...</div><div><strong>CD8<sup>+</sup> T Cell Priming in Established Chronic Viral Infection Preferentially Directs Differentiation of Memory-like Cells for Sustained Immunity</strong></div><div><em>Immunity.</em> 2018; <strong>49</strong>:678-694.e5</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=L.M.SnellB.L.MacLeodJ.C.LawI.OsokineH.J.ElsaesserK.HezavehR.J.DicksonM.A.GavinC.J.GuidosT.L.McGahaD.G.BrooksCD8%2B+T+Cell+Priming+in+Established+Chronic+Viral+Infection+Preferentially+Directs+Differentiation+of+Memory-like+Cells+for+Sustained+ImmunityImmunity492018678694.e5" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib132" class="citations"><div id="sref132" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref132" title="View in article">133.</a></div><div>Søndergaard, H. ∙ Skak, K.</div><div><strong>IL-21: roles in immunopathology and cancer therapy</strong></div><div><em>Tissue Antigens.</em> 2009; <strong>74</strong>:467-479</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=H.S%C3%B8ndergaardK.SkakIL-21%3A+roles+in+immunopathology+and+cancer+therapyTissue+Antigens742009467479" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib133" class="citations"><div id="sref133" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref133" title="View in article">134.</a></div><div>Štach, M. ∙ Musil, J. ∙ Cetkovsky, P. ...</div><div><strong>Interleukin 21 Enhances Survival and Expansion of CAR T Cells Via Inhibition of Their Terminal Differentiation during Interaction with Tumor Target Cells</strong></div><div><em>Blood.</em> 2018; <strong>132</strong>:4545</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.%C5%A0tachJ.MusilP.CetkovskyP.OtahalInterleukin+21+Enhances+Survival+and+Expansion+of+CAR+T+Cells+Via+Inhibition+of+Their+Terminal+Differentiation+during+Interaction+with+Tumor+Target+CellsBlood13220184545" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib134" class="citations"><div id="sref134" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref134" title="View in article">135.</a></div><div>Suto, A. ∙ Kashiwakuma, D. ∙ Kagami, S. ...</div><div><strong>Development and characterization of IL-21-producing CD4+ T&nbsp;cells</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2008; <strong>205</strong>:1369-1379</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.SutoD.KashiwakumaS.KagamiK.HiroseN.WatanabeK.YokoteY.SaitoT.NakayamaM.J.GrusbyI.IwamotoH.NakajimaDevelopment+and+characterization+of+IL-21-producing+CD4%2B+T%C2%A0cellsJ.%C2%A0Exp.+Med.205200813691379" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib135" class="citations"><div id="sref135" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref135-1" title="View in article">136.</a></div><div>Tang, Z. ∙ Kang, B. ∙ Li, C. ...</div><div><strong>GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis</strong></div><div><em>Nucleic Acids Res.</em> 2019; <strong>47</strong>:W556-W560</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Z.TangB.KangC.LiT.ChenZ.ZhangGEPIA2%3A+an+enhanced+web+server+for+large-scale+expression+profiling+and+interactive+analysisNucleic+Acids+Res.47W12019W556W560" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib136" class="citations"><div id="sref136" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref136" title="View in article">137.</a></div><div>Thommen, D.S. ∙ Koelzer, V.H. ∙ Herzig, P. ...</div><div><strong>A transcriptionally and functionally distinct PD-1<sup>+</sup> CD8<sup>+</sup> T&nbsp;cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:994-1004</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.S.ThommenV.H.KoelzerP.HerzigA.RollerM.TrefnyS.DimeloeA.KiialainenJ.HanhartC.SchillC.HessA+transcriptionally+and+functionally+distinct+PD-1%2B+CD8%2B+T%C2%A0cell+pool+with+predictive+potential+in+non-small-cell+lung+cancer+treated+with+PD-1+blockadeNat.+Med.2420189941004" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib137" class="citations"><div id="sref137" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref137" title="View in article">138.</a></div><div>Topalian, S.L. ∙ Hodi, F.S. ∙ Brahmer, J.R. ...</div><div><strong>Safety, activity, and immune correlates of anti-PD-1 antibody in cancer</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2012; <strong>366</strong>:2443-2454</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.L.TopalianF.S.HodiJ.R.BrahmerS.N.GettingerD.C.SmithD.F.McDermottJ.D.PowderlyR.D.CarvajalJ.A.SosmanM.B.AtkinsSafety%2C+activity%2C+and+immune+correlates+of+anti-PD-1+antibody+in+cancerN.%C2%A0Engl.+J.+Med.366201224432454" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib138" class="citations"><div id="sref138" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref138" title="View in article">139.</a></div><div>Tran, E. ∙ Turcotte, S. ∙ Gros, A. ...</div><div><strong>Cancer immunotherapy based on mutation-specific CD4+ T&nbsp;cells in a patient with epithelial cancer</strong></div><div><em>Science.</em> 2014; <strong>344</strong>:641-645</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=E.TranS.TurcotteA.GrosP.F.RobbinsY.C.LuM.E.DudleyJ.R.WunderlichR.P.SomervilleK.HoganC.S.HinrichsCancer+immunotherapy+based+on+mutation-specific+CD4%2B+T%C2%A0cells+in+a+patient+with+epithelial+cancerScience3442014641645" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib139" class="citations"><div id="sref139" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref139" title="View in article">140.</a></div><div>Truxova, I. ∙ Kasikova, L. ∙ Hensler, M. ...</div><div><strong>Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients</strong></div><div><em>J.&nbsp;Immunother. Cancer.</em> 2018; <strong>6</strong>:139</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=I.TruxovaL.KasikovaM.HenslerP.SkapaJ.LacoL.PecenL.BelicovaI.PraznovecM.J.HalaskaT.BrtnickyMature+dendritic+cells+correlate+with+favorable+immune+infiltrate+and+improved+prognosis+in+ovarian+carcinoma+patientsJ.%C2%A0Immunother.+Cancer62018139" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib140" class="citations"><div id="sref140" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref140" title="View in article">141.</a></div><div>van de Pavert, S.A. ∙ Mebius, R.E.</div><div><strong>New insights into the development of lymphoid tissues</strong></div><div><em>Nat. Rev. Immunol.</em> 2010; <strong>10</strong>:664-674</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.A.van+de+PavertR.E.MebiusNew+insights+into+the+development+of+lymphoid+tissuesNat.+Rev.+Immunol.102010664674" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib141" class="citations"><div id="sref141" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref141" title="View in article">142.</a></div><div>van der Leun, A.M. ∙ Thommen, D.S. ∙ Schumacher, T.N.</div><div><strong>CD8<sup>+</sup> T&nbsp;cell states in human cancer: insights from single-cell analysis</strong></div><div><em>Nat. Rev. Cancer.</em> 2020; <strong>20</strong>:218-232</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.M.van+der+LeunD.S.ThommenT.N.SchumacherCD8%2B+T%C2%A0cell+states+in+human+cancer%3A+insights+from+single-cell+analysisNat.+Rev.+Cancer202020218232" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib142" class="citations"><div id="sref142" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref142" title="View in article">143.</a></div><div>Vanhersecke, L. ∙ Brunet, M. ∙ Guégan, J.-P. ...</div><div><strong>Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression</strong></div><div><em>Nat. Cancer.</em> 2021; <strong>2</strong>:794-802</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=L.VanherseckeM.BrunetJ.-P.Gu%C3%A9ganC.ReyA.BougouinS.CousinS.Le+MoulecB.BesseY.LoriotM.LarroquetteMature+tertiary+lymphoid+structures+predict+immune+checkpoint+inhibitor+efficacy+in+solid+tumors+independently+of+PD-L1+expressionNat.+Cancer22021794802" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib143" class="citations"><div id="sref143" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref143" title="View in article">144.</a></div><div>Vella, L.A. ∙ Buggert, M. ∙ Manne, S. ...</div><div><strong>T follicular helper cells in human efferent lymph retain lymphoid characteristics</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2019; <strong>129</strong>:3185-3200</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=L.A.VellaM.BuggertS.ManneR.S.HeratiI.SayinL.Kuri-CervantesI.Bukh+BrodyK.C.O%E2%80%99BoyleH.KaprielianJ.R.GilesT+follicular+helper+cells+in+human+efferent+lymph+retain+lymphoid+characteristicsJ.%C2%A0Clin.+Invest.129201931853200" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib144" class="citations"><div id="sref144" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref144" title="View in article">145.</a></div><div>Voabil, P. ∙ de Bruijn, M. ∙ Roelofsen, L.M. ...</div><div><strong>An ex&nbsp;vivo tumor fragment platform to dissect response to PD-1 blockade in cancer</strong></div><div><em>Nat. Med.</em> 2021; <strong>27</strong>:1250-1261</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=P.VoabilM.de+BruijnL.M.RoelofsenS.H.HendriksS.BrokampM.van+den+BraberA.BroeksJ.SandersP.HerzigA.ZippeliusAn+ex%C2%A0vivo+tumor+fragment+platform+to+dissect+response+to+PD-1+blockade+in+cancerNat.+Med.27202112501261" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib145" class="citations"><div id="sref145" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref145" title="View in article">146.</a></div><div>Wang, Y. ∙ Jiang, H. ∙ Luo, H. ...</div><div><strong>An IL-4/21 Inverted Cytokine Receptor Improving CAR-T Cell Potency in Immunosuppressive Solid-Tumor Microenvironment</strong></div><div><em>Front. Immunol.</em> 2019; <strong>10</strong>:1691</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Y.WangH.JiangH.LuoY.SunB.ShiR.SunZ.LiAn+IL-4%2F21+Inverted+Cytokine+Receptor+Improving+CAR-T+Cell+Potency+in+Immunosuppressive+Solid-Tumor+MicroenvironmentFront.+Immunol.1020191691" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib146" class="citations"><div id="sref146" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref146" title="View in article">147.</a></div><div>Wei, L. ∙ Laurence, A. ∙ Elias, K.M. ...</div><div><strong>IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2007; <strong>282</strong>:34605-34610</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=L.WeiA.LaurenceK.M.EliasJ.J.O%E2%80%99SheaIL-21+is+produced+by+Th17+cells+and+drives+IL-17+production+in+a+STAT3-dependent+mannerJ.%C2%A0Biol.+Chem.28220073460534610" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib147" class="citations"><div id="sref147" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref147-1" title="View in article">148.</a></div><div>Weinstein, J.S. ∙ Herman, E.I. ∙ Lainez, B. ...</div><div><strong>TFH cells progressively differentiate to regulate the germinal center response</strong></div><div><em>Nat. Immunol.</em> 2016; <strong>17</strong>:1197-1205</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.S.WeinsteinE.I.HermanB.LainezP.Licona-Lim%C3%B3nE.EspluguesR.FlavellJ.CraftTFH+cells+progressively+differentiate+to+regulate+the+germinal+center+responseNat.+Immunol.17201611971205" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib148" class="citations"><div id="sref148" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref148-1" title="View in article">149.</a></div><div>Weinstein, J.S. ∙ Laidlaw, B.J. ∙ Lu, Y. ...</div><div><strong>STAT4 and T-bet control follicular helper T&nbsp;cell development in viral infections</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2018; <strong>215</strong>:337-355</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.S.WeinsteinB.J.LaidlawY.LuJ.K.WangV.P.SchulzN.LiE.I.HermanS.M.KaechP.G.GallagherJ.CraftSTAT4+and+T-bet+control+follicular+helper+T%C2%A0cell+development+in+viral+infectionsJ.%C2%A0Exp.+Med.2152018337355" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib149" class="citations"><div id="sref149" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref149" title="View in article">150.</a></div><div>Wells, D.K. ∙ van Buuren, M.M. ∙ Dang, K.K. ..., Tumor Neoantigen Selection Alliance</div><div><strong>Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction</strong></div><div><em>Cell.</em> 2020; <strong>183</strong>:818-834.e13</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.K.WellsM.M.van+BuurenK.K.DangV.M.Hubbard-LuceyK.C.F.SheehanK.M.CampbellA.LambJ.P.WardJ.SidneyA.B.BlazquezTumor+Neoantigen+Selection+AllianceKey+Parameters+of+Tumor+Epitope+Immunogenicity+Revealed+Through+a+Consortium+Approach+Improve+Neoantigen+PredictionCell1832020818834.e13" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib150" class="citations"><div id="sref150" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref150-1" title="View in article">151.</a></div><div>Wieland, A. ∙ Patel, M.R. ∙ Cardenas, M.A. ...</div><div><strong>Defining HPV-specific B cell responses in patients with head and neck cancer</strong></div><div><em>Nature.</em> 2021; <strong>597</strong>:274-278</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.WielandM.R.PatelM.A.CardenasC.S.EberhardtW.H.HudsonR.C.ObengC.C.GriffithX.WangZ.G.ChenH.T.KissickDefining+HPV-specific+B+cell+responses+in+patients+with+head+and+neck+cancerNature5972021274278" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib151" class="citations"><div id="sref151" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref151-1" title="View in article">152.</a></div><div>Xin, G. ∙ Schauder, D.M. ∙ Lainez, B. ...</div><div><strong>A Critical Role of IL-21-Induced BATF in Sustaining CD8-T-Cell-Mediated Chronic Viral Control</strong></div><div><em>Cell Rep.</em> 2015; <strong>13</strong>:1118-1124</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.XinD.M.SchauderB.LainezJ.S.WeinsteinZ.DaiY.ChenE.EspluguesR.WenD.WangI.A.ParishA+Critical+Role+of+IL-21-Induced+BATF+in+Sustaining+CD8-T-Cell-Mediated+Chronic+Viral+ControlCell+Rep.13201511181124" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib152" class="citations"><div id="sref152" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref152" title="View in article">153.</a></div><div>Yadav, M. ∙ Jhunjhunwala, S. ∙ Phung, Q.T. ...</div><div><strong>Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing</strong></div><div><em>Nature.</em> 2014; <strong>515</strong>:572-576</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.YadavS.JhunjhunwalaQ.T.PhungP.LupardusJ.TanguayS.BumbacaC.FranciT.K.CheungJ.FritscheT.WeinschenkPredicting+immunogenic+tumour+mutations+by+combining+mass+spectrometry+and+exome+sequencingNature5152014572576" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib153" class="citations"><div id="sref153" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref153" title="View in article">154.</a></div><div>Yamanouchi, S. ∙ Kuwahara, K. ∙ Sakata, A. ...</div><div><strong>A T&nbsp;cell activation antigen, Ly6C, induced on CD4+ Th1 cells mediates an inhibitory signal for secretion of IL-2 and proliferation in peripheral immune responses</strong></div><div><em>Eur. J. Immunol.</em> 1998; <strong>28</strong>:696-707</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.YamanouchiK.KuwaharaA.SakataT.EzakiS.MatsuokaJ.MiyazakiS.HiroseT.TamuraH.NariuchiN.SakaguchiA+T%C2%A0cell+activation+antigen%2C+Ly6C%2C+induced+on+CD4%2B+Th1+cells+mediates+an+inhibitory+signal+for+secretion+of+IL-2+and+proliferation+in+peripheral+immune+responsesEur.+J.+Immunol.281998696707" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib154" class="citations"><div id="sref154" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref154-1" title="View in article">155.</a></div><div>Yi, J.S. ∙ Du, M. ∙ Zajac, A.J.</div><div><strong>A vital role for interleukin-21 in the control of a chronic viral infection</strong></div><div><em>Science.</em> 2009; <strong>324</strong>:1572-1576</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.S.YiM.DuA.J.ZajacA+vital+role+for+interleukin-21+in+the+control+of+a+chronic+viral+infectionScience324200915721576" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib155" class="citations"><div id="sref155" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref155" title="View in article">156.</a></div><div>Yu, D. ∙ Rao, S. ∙ Tsai, L.M. ...</div><div><strong>The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment</strong></div><div><em>Immunity.</em> 2009; <strong>31</strong>:457-468</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.YuS.RaoL.M.TsaiS.K.LeeY.HeE.L.SutcliffeM.SrivastavaM.LintermanL.ZhengN.SimpsonThe+transcriptional+repressor+Bcl-6+directs+T+follicular+helper+cell+lineage+commitmentImmunity312009457468" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib156" class="citations"><div id="sref156" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref156" title="View in article">157.</a></div><div>Zajac, A.J. ∙ Blattman, J.N. ∙ Murali-Krishna, K. ...</div><div><strong>Viral immune evasion due to persistence of activated T&nbsp;cells without effector function</strong></div><div><em>J.&nbsp;Exp. Med.</em> 1998; <strong>188</strong>:2205-2213</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.J.ZajacJ.N.BlattmanK.Murali-KrishnaD.J.SourdiveM.SureshJ.D.AltmanR.AhmedViral+immune+evasion+due+to+persistence+of+activated+T%C2%A0cells+without+effector+functionJ.%C2%A0Exp.+Med.188199822052213" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib157" class="citations"><div id="sref157" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref157" title="View in article">158.</a></div><div>Zander, R.A. ∙ Vijay, R. ∙ Pack, A.D. ...</div><div><strong>Th1-like Plasmodium-Specific Memory CD4<sup>+</sup> T Cells Support Humoral Immunity</strong></div><div><em>Cell Rep.</em> 2018; <strong>23</strong>:1230-1237</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.A.ZanderR.VijayA.D.PackJ.J.GuthmillerA.C.GrahamS.E.LindnerA.M.VaughanS.H.I.KappeN.S.ButlerTh1-like+Plasmodium-Specific+Memory+CD4%2B+T+Cells+Support+Humoral+ImmunityCell+Rep.23201812301237" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib158" class="citations"><div id="sref158" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref158-1" title="View in article">159.</a></div><div>Zander, R. ∙ Schauder, D. ∙ Xin, G. ...</div><div><strong>CD4<sup>+</sup> T Cell Help Is Required for the Formation of a Cytolytic CD8<sup>+</sup> T Cell Subset that Protects against Chronic Infection and Cancer</strong></div><div><em>Immunity.</em> 2019; <strong>51</strong>:1028-1042.e4</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.ZanderD.SchauderG.XinC.NguyenX.WuA.ZajacW.CuiCD4%2B+T+Cell+Help+Is+Required+for+the+Formation+of+a+Cytolytic+CD8%2B+T+Cell+Subset+that+Protects+against+Chronic+Infection+and+CancerImmunity51201910281042.e4" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib159" class="citations"><div id="sref159" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref159" title="View in article">160.</a></div><div>Zhang, B. ∙ Liu, E. ∙ Gertie, J.A. ...</div><div><strong>Divergent T follicular helper cell requirement for IgA and IgE production to peanut during allergic sensitization</strong></div><div><em>Sci. Immunol.</em> 2020; <strong>5</strong>:eaay2754</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=B.ZhangE.LiuJ.A.GertieJ.JosephL.XuE.Y.PinkerD.A.WaizmanJ.CatanzaroK.H.HamzaK.LahlDivergent+T+follicular+helper+cell+requirement+for+IgA+and+IgE+production+to+peanut+during+allergic+sensitizationSci.+Immunol.52020eaay2754" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib160" class="citations"><div id="sref160" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref160" title="View in article">161.</a></div><div>Zhang, Y. ∙ Chen, H. ∙ Mo, H. ...</div><div><strong>Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer</strong></div><div><em>Cancer Cell.</em> 2021;</div><div>Published online October 5, 2021</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Y.ZhangH.ChenH.MoX.HuR.GaoY.ZhaoB.LiuL.NiuX.SunX.YuSingle-cell+analyses+reveal+key+immune+cell+subsets+associated+with+response+to+PD-L1+blockade+in+triple-negative+breast+cancerCancer+Cell202110.1016%2Fj.ccell.2021.09.010Published+online+October+5%2C+2021" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib161" class="citations"><div id="sref161" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref161-1" title="View in article">162.</a></div><div>Zhou, T. ∙ Damsky, W. ∙ Weizman, O.E. ...</div><div><strong>IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy</strong></div><div><em>Nature.</em> 2020; <strong>583</strong>:609-614</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=T.ZhouW.DamskyO.E.WeizmanM.K.McGearyK.P.HartmannC.E.RosenS.FischerR.JacksonR.A.FlavellJ.WangIL-18BP+is+a+secreted+immune+checkpoint+and+barrier+to+IL-18+immunotherapyNature5832020609614" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib162" class="citations"><div id="sref162" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref162" title="View in article">163.</a></div><div>Zotos, D. ∙ Coquet, J.M. ∙ Zhang, Y. ...</div><div><strong>IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2010; <strong>207</strong>:365-378</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.ZotosJ.M.CoquetY.ZhangA.LightK.D%E2%80%99CostaA.KalliesL.M.CorcoranD.I.GodfreyK.M.ToellnerM.J.SmythIL-21+regulates+germinal+center+B+cell+differentiation+and+proliferation+through+a+B+cell-intrinsic+mechanismJ.%C2%A0Exp.+Med.2072010365378" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div></div></div></section></div></section><div class="core-linked-content">
    

        


    

            

            

            <div data-widget-id="8633d695-b258-4908-b86f-e2c268ec3c6b" data-widget-name="UX3HTMLWidget"><script type="text/javascript">
if($('.content-navigation__body__title').length){
$('.content-navigation__body__title').each(function(){
var html=this.innerHTML;
var div = document.createElement("div");
div.innerHTML = html;
var text = div.textContent || div.innerText || "";
this.innerHTML=text;
});
}
</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="393effff-5b44-4681-a9b4-4f029b3540b7" data-widget-name="UX3HTMLWidget"><style>
.linkback-ad .pb-ad {
    display: block;
   height: auto;
    margin-left: 0px;
    margin-right: auto;
}
</style></div>

            

        

    

        

</div></div></div><div class="core-collateral-aside"><section id="core-collateral-figures"><h2>Figures (13)<button class="js--openFigureViewer"><span>Figure Viewer</span></button></h2><div class="core-collateral-aside-wrapper"><div class="grid"><a class="figure__open__ctrl" href="#fig1" aria-label="Go to Figure&amp;nbsp;1"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.007/asset/6b64ef04-6763-4ac0-a8a6-24413285ba87/main.assets/gr1.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs1" aria-label="Go to Figure&amp;nbsp;S1"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.007/asset/84354a04-8ab0-4fa5-b9a7-4096a3ac2db3/main.assets/figs1.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig2" aria-label="Go to Figure&amp;nbsp;2"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.007/asset/ac44ffbb-425b-4502-a610-ad1fdee34644/main.assets/gr2.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs2" aria-label="Go to Figure&amp;nbsp;S2"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.007/asset/9d9b3d4b-f5c8-4e9f-b1a9-ff8d6f27da6c/main.assets/figs2.jpg" aria-hidden="true"></a></div><div id="collapsible-figures" data-expandable="item"><div class="content grid" style="display:none;" role="region" id="collapsible-figures_content"><a class="figure__open__ctrl" href="#figs3" aria-label="Go to Figure&amp;nbsp;S3"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.007/asset/2cebeb6e-8198-461f-8392-0212cba5f1ed/main.assets/figs3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs4" aria-label="Go to Figure&amp;nbsp;S4"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.007/asset/d3cd22f3-be58-48c5-aee2-3ec69ea5ed88/main.assets/figs4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig3" aria-label="Go to Figure&amp;nbsp;3"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.007/asset/b84018e4-3fcf-4f34-86b3-b938b75db490/main.assets/gr3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs5" aria-label="Go to Figure&amp;nbsp;S5"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.007/asset/a095b0a0-50ed-4b37-ae52-294435bb9bff/main.assets/figs5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig4" aria-label="Go to Figure&amp;nbsp;4"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.007/asset/7a537c23-f45e-452e-80b0-a014a22c6c08/main.assets/gr4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs6" aria-label="Go to Figure&amp;nbsp;S6"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.007/asset/92a8a0f7-5080-49e4-8f71-fae83fafa0f8/main.assets/figs6.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig5" aria-label="Go to Figure&amp;nbsp;5"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.007/asset/ff8b9428-9d27-4b20-b642-60c367d20692/main.assets/gr5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig6" aria-label="Go to Figure&amp;nbsp;6"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.007/asset/e6b0aa8e-c5b4-400e-a7b0-3e712f00d11b/main.assets/gr6.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs7" aria-label="Go to Figure&amp;nbsp;S7"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.007/asset/49a6a637-4c59-47a0-9b7b-0c9e87e27e62/main.assets/figs7.jpg" aria-hidden="true"></a></div><button class="trigger" aria-controls="collapsible-figures_content" aria-expanded="false" tabindex="0" role="button"><span class="expand">Show all figures</span><span class="collapse">Hide figures</span><i class="icon-section_arrow_d" aria-hidden="true"></i></button></div></div></section>
    

        


    

            

            

            <section id="core-collateral-metrics" class="publication-list__axel-section"><h2>Article metrics</h2><div><ul class="publication-list rlist publication-list--list plum-x--lazy-load publication-list--axel" data-plum-x-url="/pb/widgets/ux3/publicationList/plumx?widgetId=66dd7e11-7768-4006-93d8-a72b60e2a264&amp;pbContext=%3Bproduct%3Aproduct%3Aelsevier%5C%3Aproduct%5C%3Acell%3Bwebsite%3Awebsite%3Acell-site%3Bctype%3Astring%3AJournal+Content%3Bjournal%3Ajournal%3Acell%3BpageGroup%3Astring%3AArticle+View%3Bpage%3Astring%3AShow+Full+Text%3BrequestedJournal%3Ajournal%3Acell%3Bissue%3Aissue%3Apii%5C%3AS0092867420X00262%3Bwgroup%3Astring%3ADefault+Website+Group%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3Apii%5C%3AS0092867421013222" data-pb-mode-enabled="false"><li aria-label="loading articles" role="alert" class="js--loading plum-x--spinner hidden"></li></ul></div></section>

            

        
<section id="core-collateral-supplementary"><h2>Supplemental information (3)</h2><div class="core-collateral-aside-wrapper"><div class="core-supplementary-material"><div class="core-link"><button class="downloadAllSupplementary"><span>Download all</span></button></div></div><div class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2021.11.007/attachment/8960940c-499e-4ec1-add7-81c969942a9b/mmc1.xlsx" download="mmc1.xlsx"><span id="mmc1-link">Spreadsheet (36.28 KB)</span></a><div class="core-description">Table S1. Differentially expressed genes in T/NK cell clusters and B cell clusters (GEO: GSE131907), related to Figure&nbsp;1</div></div></div><div class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2021.11.007/attachment/71526570-6a11-43c0-bf6c-60d4aefb3fbf/mmc2.pdf" download="mmc2.pdf"><span id="mmc2-link">PDF (41.15 KB)</span></a><div class="core-description">Table S2. DNA and amino acid sequences of HELLO construct, related to Figure&nbsp;2 and STAR Methods</div></div></div><div class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2021.11.007/attachment/653652e4-0638-456e-adf3-3499e0e3998a/mmc3.pdf" download="mmc3.pdf"><span id="mmc3-link">PDF (35.65 KB)</span></a><div class="core-description">Table S3. Prediction of CD8 T&nbsp;cell epitopes in HELLO neoantigen, related to Figure&nbsp;2 and STAR Methods</div></div></div></div></section>
    

        


    

            

            

            <section id="core-collateral-relatedArticles" class="axel-related-articles"><h2 id="relatedArticles" class="top axel-related-articles__title" data-title="Related articles">Related Articles</h2><div data-pb-widget-type="ux3-relatedArticles" data-widget-id="8d3844d1-450e-497c-ab75-a63fc41750ac" data-widget-name="AtyponTempUX3RelatedArticlesWidget" data-article-pii="S0092867421013222" class="ux3DeferredOnScrollWidget axel-related-articles__body ux3DeferredLoaded" data-show-more="true">We haven't found any related articles.</div></section>

            

        
</div></div><aside data-core-aside="right-rail"><div class="inner-wrapper">

    

        


    

            

            

            <div data-widget-id="dca7470d-9085-4d21-a6f4-a66397718146" data-widget-name="UX3HTMLWidget"><input type="hidden" id="gptPage" value="cell-videos"></div>

            

        











        <div data-widget-def="literatumAd" data-widget-id="481d10c2-bbe0-470e-a5ba-207a81ecc8dc" class="adplaceholders" style="right: 0px; position: static;">
        
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd alignCenter  widget-verticalAd" id="481d10c2-bbe0-470e-a5ba-207a81ecc8dc">
                
                
                    
                

                <div class="wrapped " id="Marketplace-Recs">
                    
                    <div class="widget-body body body-verticalAd "><div class="verticalAdContainer">
    <div class="verticalAdLabelContainer">
        <div class="verticalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adVert.gif" alt="Advertisement">
        </div>
    </div>
    <div class="verticalAd">
        





        <div class="pb-ad">
            <script src="//cdn.pbgrd.com/core-cell.js" async=""></script>
<div id="pbgrd-skyr-c"><div id="pbgrd-skyr" style="width: inherit; position: relative; background: transparent;"></div></div>
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        

        </div>
    

</div></aside><div class="core-authors-details" style="display:none"><section class="core-authors"></section></div></article><div data-extent="article-wrapper"><div class="core-container"></div></div><script id="axel-publication-metadata" type="application/json">{"doi":"10.1016/j.cell.2021.11.007","data-is-retraction":false,"data-is-retired":false}
</script><script type="text/javascript" data-ot-ignore="data-ot-ignore" defer="defer" src="https://static.addtoany.com/menu/page.js" class="optanon-category-C0004 ot-vscat-C0004"></script><template id="figure_nav_template"><a href="#" class="open-in-viewer btn btn-dark figure-pop-btn"><i aria-hidden="true" class="icon-export_citation"></i><span>Open in viewer</span></a></template><div id="figure-viewer" role="dialog" aria-modal="true" aria-label="Figure Viewer" class="showCaption showThumbstrip figure-viewer"><nav class="nav-bar figure-viewer__top"><a href="#" title="Close Figure Viewer" role="button" class="figure-viewer__close"><i aria-hidden="true" class="icon-tools_close"></i></a><div class="figure-viewer__title">Neoantigen-driven B cell and CD4&nbsp;T follicular helper cell collaboration promotes anti-tumor CD8 T&nbsp;cell responses</div></nav><div class="frames"><ul class="frames__list"><li><div class="thumbnail__image"><img id="gr1" src="/cms/10.1016/j.cell.2021.11.007/asset/6b64ef04-6763-4ac0-a8a6-24413285ba87/main.assets/gr1.jpg" height="808" width="750" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/bad149f1-339d-4a06-bd02-227f3645af24/main.assets/gr1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs1" src="/cms/10.1016/j.cell.2021.11.007/asset/84354a04-8ab0-4fa5-b9a7-4096a3ac2db3/main.assets/figs1.jpg" height="429" width="753" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/cd8369e7-5756-44ee-b7e5-b56fd76e43a8/main.assets/figs1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr2" src="/cms/10.1016/j.cell.2021.11.007/asset/ac44ffbb-425b-4502-a610-ad1fdee34644/main.assets/gr2.jpg" height="804" width="661" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/9d5209a0-fea8-4983-8016-6bcde576814f/main.assets/gr2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs2" src="/cms/10.1016/j.cell.2021.11.007/asset/9d9b3d4b-f5c8-4e9f-b1a9-ff8d6f27da6c/main.assets/figs2.jpg" height="269" width="499" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/e7014dc2-c928-4f92-a801-4e3003eb3c89/main.assets/figs2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs3" src="/cms/10.1016/j.cell.2021.11.007/asset/2cebeb6e-8198-461f-8392-0212cba5f1ed/main.assets/figs3.jpg" height="450" width="753" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/5f9da058-b02c-44dc-8ac8-12f41e8d79f1/main.assets/figs3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs4" src="/cms/10.1016/j.cell.2021.11.007/asset/d3cd22f3-be58-48c5-aee2-3ec69ea5ed88/main.assets/figs4.jpg" height="364" width="506" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/724eec53-72fc-4a80-a386-e68d951e10f2/main.assets/figs4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr3" src="/cms/10.1016/j.cell.2021.11.007/asset/b84018e4-3fcf-4f34-86b3-b938b75db490/main.assets/gr3.jpg" height="596" width="657" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/8186bc6e-3ac2-4f5c-a41a-d8658999c118/main.assets/gr3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs5" src="/cms/10.1016/j.cell.2021.11.007/asset/a095b0a0-50ed-4b37-ae52-294435bb9bff/main.assets/figs5.jpg" height="398" width="753" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/0381234a-be29-46f7-b2e4-415b58b897ef/main.assets/figs5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr4" src="/cms/10.1016/j.cell.2021.11.007/asset/7a537c23-f45e-452e-80b0-a014a22c6c08/main.assets/gr4.jpg" height="553" width="507" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/d258f2b9-79f6-4dc7-a1f7-4b2a261188f3/main.assets/gr4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs6" src="/cms/10.1016/j.cell.2021.11.007/asset/92a8a0f7-5080-49e4-8f71-fae83fafa0f8/main.assets/figs6.jpg" height="467" width="753" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/3b8dd9c4-17cc-4025-9aaa-9db2154f50b9/main.assets/figs6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr5" src="/cms/10.1016/j.cell.2021.11.007/asset/ff8b9428-9d27-4b20-b642-60c367d20692/main.assets/gr5.jpg" height="718" width="753" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/86eec7af-fa14-479d-853a-2e8bcca6a0c6/main.assets/gr5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr6" src="/cms/10.1016/j.cell.2021.11.007/asset/e6b0aa8e-c5b4-400e-a7b0-3e712f00d11b/main.assets/gr6.jpg" height="716" width="753" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/4cec0ded-a475-4dcc-85f5-592120898cd1/main.assets/gr6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs7" src="/cms/10.1016/j.cell.2021.11.007/asset/49a6a637-4c59-47a0-9b7b-0c9e87e27e62/main.assets/figs7.jpg" height="193" width="753" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/2c5b72de-0539-4a63-be65-fdf60026d00f/main.assets/figs7_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li></ul><a href="#" title="Previous Frame" class="frameButton previousFrameButton frames__prev"><!--span Previous Frame--><i class="icon-arrow_l"></i></a><a href="#" title="Next Frame" class="frameButton nextFrameButton frames__next"><!--span Next Frame--><i class="icon-arrow_r"></i></a></div><div class="caption"><div class="figure-viewer__caption-body"></div></div><div class="toolbar figure-viewer__toolbar"><span class="figure-viewer__counter"></span><a href="#" class="button toggle-caption-button figure-viewer__caption__ctrl"><i aria-hidden="true" class="icon icon-info"></i><span class="label">Hide Caption</span></a><a href="#" class="button download-options-button"><i aria-hidden="true" class="icon icon-gizmo-folder-in download-size-icon"></i><span class="label">Download</span></a><a href="#figures" class="button see-figures figure-viewer__see-figure__ctrl"><i aria-hidden="true" class="icon icon-gizmo-image_figure viewer-size-icon"></i><span class="label">See figure in Article</span></a></div><div class="thumbstrip"><a href="#" class="toggleButton thumbstrip__ctrl"><span>Toggle Thumbstrip</span></a><a href="#" title="Previous Thumbnails" class="thumbstripButton previousThumbstripButton thumbstrip__prev"><i aria-hidden="true" class="icon-arrow_l"></i></a><a href="#" title="Next Thumbnails" class="thumbstripButton nextThumbstripButton thumbstrip__next"><i aria-hidden="true" class="icon-arrow_r"></i></a><div class="thumbstrip__wrapper"><ul class="rlist figure-viewer__thumbslist"><li><div class="thumbnail__label">Figure&nbsp;1</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr1" src="/cms/10.1016/j.cell.2021.11.007/asset/6b64ef04-6763-4ac0-a8a6-24413285ba87/main.assets/gr1.jpg" height="808" width="750" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/bad149f1-339d-4a06-bd02-227f3645af24/main.assets/gr1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S1</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs1" src="/cms/10.1016/j.cell.2021.11.007/asset/84354a04-8ab0-4fa5-b9a7-4096a3ac2db3/main.assets/figs1.jpg" height="429" width="753" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/cd8369e7-5756-44ee-b7e5-b56fd76e43a8/main.assets/figs1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;2</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr2" src="/cms/10.1016/j.cell.2021.11.007/asset/ac44ffbb-425b-4502-a610-ad1fdee34644/main.assets/gr2.jpg" height="804" width="661" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/9d5209a0-fea8-4983-8016-6bcde576814f/main.assets/gr2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S2</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs2" src="/cms/10.1016/j.cell.2021.11.007/asset/9d9b3d4b-f5c8-4e9f-b1a9-ff8d6f27da6c/main.assets/figs2.jpg" height="269" width="499" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/e7014dc2-c928-4f92-a801-4e3003eb3c89/main.assets/figs2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S3</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs3" src="/cms/10.1016/j.cell.2021.11.007/asset/2cebeb6e-8198-461f-8392-0212cba5f1ed/main.assets/figs3.jpg" height="450" width="753" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/5f9da058-b02c-44dc-8ac8-12f41e8d79f1/main.assets/figs3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S4</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs4" src="/cms/10.1016/j.cell.2021.11.007/asset/d3cd22f3-be58-48c5-aee2-3ec69ea5ed88/main.assets/figs4.jpg" height="364" width="506" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/724eec53-72fc-4a80-a386-e68d951e10f2/main.assets/figs4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;3</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr3" src="/cms/10.1016/j.cell.2021.11.007/asset/b84018e4-3fcf-4f34-86b3-b938b75db490/main.assets/gr3.jpg" height="596" width="657" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/8186bc6e-3ac2-4f5c-a41a-d8658999c118/main.assets/gr3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S5</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs5" src="/cms/10.1016/j.cell.2021.11.007/asset/a095b0a0-50ed-4b37-ae52-294435bb9bff/main.assets/figs5.jpg" height="398" width="753" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/0381234a-be29-46f7-b2e4-415b58b897ef/main.assets/figs5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;4</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr4" src="/cms/10.1016/j.cell.2021.11.007/asset/7a537c23-f45e-452e-80b0-a014a22c6c08/main.assets/gr4.jpg" height="553" width="507" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/d258f2b9-79f6-4dc7-a1f7-4b2a261188f3/main.assets/gr4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S6</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs6" src="/cms/10.1016/j.cell.2021.11.007/asset/92a8a0f7-5080-49e4-8f71-fae83fafa0f8/main.assets/figs6.jpg" height="467" width="753" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/3b8dd9c4-17cc-4025-9aaa-9db2154f50b9/main.assets/figs6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;5</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr5" src="/cms/10.1016/j.cell.2021.11.007/asset/ff8b9428-9d27-4b20-b642-60c367d20692/main.assets/gr5.jpg" height="718" width="753" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/86eec7af-fa14-479d-853a-2e8bcca6a0c6/main.assets/gr5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;6</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr6" src="/cms/10.1016/j.cell.2021.11.007/asset/e6b0aa8e-c5b4-400e-a7b0-3e712f00d11b/main.assets/gr6.jpg" height="716" width="753" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/4cec0ded-a475-4dcc-85f5-592120898cd1/main.assets/gr6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S7</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs7" src="/cms/10.1016/j.cell.2021.11.007/asset/49a6a637-4c59-47a0-9b7b-0c9e87e27e62/main.assets/figs7.jpg" height="193" width="753" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.007/asset/2c5b72de-0539-4a63-be65-fdf60026d00f/main.assets/figs7_lrg.jpg" loading="lazy" tabindex="0"></div></div></li></ul></div></div><div class="download figure-viewer__download"><div class="pointer"></div><ul class="rlist downlad__wrapper"><li class="hidden-xs hidden-sm"><a href="/action/downloadFigures?pii=e00489&amp;id=" class="downloadAllButton"><i class="icon icon-gizmo-ppt figure-viewer__download__viewer-size-icon figure-viewer__download__viewer-size-icon--ppt"></i><span class="figure-viewer__download__text"> Download .PPT</span></a></li></ul></div></div><template id="toCitationLink" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span>Go to</span></a></div></template><template id="toCitationButton" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><button class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span>Go to</span></button></div></template><template id="toCitationAccordion" data-collapse-citation="Hide Citations" data-expand-citation="Show Citations" data-collapse-footnote="Hide Footnotes" data-expand-footnote="Show Footnotes"><div class="to-citation__wrapper"><button aria-controls="aria-controls" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="data-expand-title" data-collapsed-title="data-collapsed-title" class="accordion__toggle__title"></span></button><div role="menu" aria-label="links" class="to-citation__accordion no-separator"><ul></ul></div></div></template><template id="toCitationAccordionItem"><li><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span></span></a></li></template><template id="citations_truncate_template"><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--inverse"><span>Show all references</span></button></div></template><template id="collateral_texts_template" data-do="Digital Object" data-figures="Figures" data-metrics="Article Metrics" data-related="Related articles" data-supplementary="Supplemental information"></template><template id="collapsible_authors_template"><button aria-expanded="false" data-expandable="all" data-label-expand="Expand All" data-label-collapse="Collapse All" class="collateral-contributors-control"><span>Expand All</span></button></template>
<template id="collapsible_tables_collapse_template"><div class="collapsible-figure-btn__wrapper expanded"><button aria-expanded="true" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-up"></i><span class="text-uppercase">Collapse</span></button></div></template>
<template id="collapsible_tables_expand_template"><div class="collapsible-figure-btn__wrapper collapsed"><button aria-expanded="false" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-down"></i><span class="text-uppercase">Expand Table</span></button></div></template><template id="authorsAffiliationsLink"><a href="#tab-contributors" class="to-authors-affiliations">Authors Info &amp; Affiliations</a></template></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none  widget-  widget-compact-all" id="756cf18d-e910-4468-936c-0225ae7c669f">
                
                
                    
                

                <div class="wrapped " id="ad for nucleus-single-molecule-technologies">
                    
                    <div class="widget-body body body-  body-compact-all"><div class="pb-ad">
            <script type="text/javascript">
URL_var = 'https://www.cell.com/cell/fulltext/S0092-8674(21)01322-2';

if(URL_var.indexOf("S0165-6147(17)30205-5") > -1
|| URL_var.indexOf("S0167-7799(18)30204-X") > -1 
|| URL_var.indexOf("S0092-8674(18)31649-0") > -1 
|| URL_var.indexOf("S0092-8674(19)30404-0") > -1 
|| URL_var.indexOf("S1097-2765(18)30756-1") > -1 
|| URL_var.indexOf("S0092-8674(18)31452-1") > -1 
|| URL_var.indexOf("S1097-2765(19)30175-3") > -1 
|| URL_var.indexOf("S0092-8674(18)30852-3") > -1 
|| URL_var.indexOf("S0006-3495(18)30295-9") > -1 
|| URL_var.indexOf("S1097-2765(19)30063-2") > -1 
|| URL_var.indexOf("S0006-3495(17)33208-3") > -1 
|| URL_var.indexOf("S2211-1247(18)31639-5") > -1 
|| URL_var.indexOf("S1097-2765(18)30978-X") > -1 
)
    {
document.write('<input type="hidden" id="gpttc" value="nucleus-single-molecule-technologies" class="gpt-Target">')
}
</script>
        </div></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none  widget-" id="754b1780-1117-4371-9285-9cd7020963d5">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body- "><div class="pb-ad">
            <script type="text/javascript">
URL_var = 'https://www.cell.com/cell/fulltext/S0092-8674(21)01322-2';

if(URL_var.indexOf("S1535-6108(19)30104-7") > -1
|| URL_var.indexOf("S0092-8674(18)31394-1") > -1
|| URL_var.indexOf("S1074-7613(19)30033-0") > -1
|| URL_var.indexOf("S1535-6108(18)30473-2") > -1
|| URL_var.indexOf("S0092-8674(19)30154-0") > -1
|| URL_var.indexOf("S1550-4131(18)30178-5") > -1
|| URL_var.indexOf("S1535-6108(19)30242-9") > -1
|| URL_var.indexOf("S1074-7613(18)30431-X") > -1
|| URL_var.indexOf("S0092-8674(19)30618-X") > -1
|| URL_var.indexOf("S1535-6108(18)30472-0") > -1
|| URL_var.indexOf("S1535-6108(18)30120-X") > -1
|| URL_var.indexOf("S0092-8674(18)31247-9") > -1
|| URL_var.indexOf("S1074-7613(18)30085-2") > -1
|| URL_var.indexOf("S1074-7613(18)30080-3") > -1
|| URL_var.indexOf("S1471-4906(18)30210-2") > -1
|| URL_var.indexOf("S1550-4131(19)30304-3") > -1
|| URL_var.indexOf("S1934-5909(18)30599-X") > -1
|| URL_var.indexOf("S2405-8033(19)30024-X") > -1
|| URL_var.indexOf("S1535-6108(18)30109-0") > -1
|| URL_var.indexOf("S0962-8924(18)30127-2") > -1
)
    {
document.write('<input type="hidden" id="gpttc" value="nucleus-tumor-immune-microenvironment" class="gpt-Target">')
}
</script>
        </div></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="9c9ff7a1-a035-49f6-a336-600c9419c518" data-widget-name="UX3HTMLWidget"><!-- Start of HubSpot Embed Code --> 

<script type="text/plain" class="optanon-category-4" id="hs-script-loader" async="" defer="" src="//js.hs-scripts.com/519224.js"></script> 

<!-- End of HubSpot Embed Code --></div>

            

        

    

        


    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget sessionValidationWidget none  widget-none  widget-compact-all" id="0257aef7-6074-4898-a989-1c3f693225a2">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none  body-compact-all"><script>
    $.ajax({
        url: "https://www.cell.com/ssoSessionCheck",
        type: "GET",
        dataType: "jsonp",
        success: function (data) {
            if(data.RefreshSession) {
                location.reload();
            }
        },
        error : function (){
            console.warn("can't validate CSAS session.");
        }
    });
</script></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasSsoUrls none  widget-none  widget-compact-all" id="948bc5c4-8b0d-47be-b5ad-6570559802d1">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none  body-compact-all"><!-- clear SSO URLs after all iFrames are rendered or after passing a time out-->
<script>
    setTimeout(clearSsoUrlsFun,10000);
    var iFramesList = document.getElementById("sso-urls-div").getElementsByTagName("iframe");
    var renderedIFramesCount = 0;
    var numberOfIFrames = iFramesList.length;
    var skipRefresh = false;
    for (var i = 0; i < iFramesList.length; i++) {
        var iFrame = iFramesList[i];
        iFrame.addEventListener("load", function() {
            renderedIFramesCount = renderedIFramesCount + 1;
            if (renderedIFramesCount >= numberOfIFrames)
            {
                clearSsoUrlsFun();
            }
        });
    }

    function clearSsoUrlsFun() {
        if (skipRefresh == false && numberOfIFrames > 0)
        {
            skipRefresh = true;
            $.ajax({
                url: "https://www.cell.com/action/clearSsoUrls",
                type: "GET",
                dataType: "jsonp",
                error : errorCallingAjx
            });
        }
    }

    function errorCallingAjx(){
        console.log("can't delete sso urls .")
    }
</script></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="d95b4a46-dc4d-4ca8-83f9-8b6724c649ec" class="ux3 ">
        
    

        


    

            

            

            <div data-widget-id="d95b4a46-dc4d-4ca8-83f9-8b6724c649ec" data-widget-name="ux3-layout-widget" class="fonts-loaded"><div class="footer clearfix">
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header widget-horizontalAd" id="a07ee92b-3942-49f8-9186-a2a08fc3fc56">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement">
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <!-- Beginning Async AdSlot 4 for Ad unit els.cellpress/cell  ### size: [[728,90]] -->
<div class="gpt-ad" data-adsize="cell-leaderboard" data-page="" data-site="cell" data-pos="4"></div>
<!-- End AdSlot 4 -->
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="23703bbc-af46-4f3f-a5bb-dd52891ff0ff" data-widget-name="UX3HTMLWidget"><div class="footer__top">
    <div class="footer__logo centered"><a href="/home" title="Cell Press"><!-- Generator: Adobe Illustrator 25.2.1, SVG Export Plug-In . SVG Version: 6.00 Build 0)  -->
<svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 300 72" style="enable-background:new 0 0 300 72;" xml:space="preserve">
<style type="text/css">
	.st0{fill:#007DBC;}
</style>
<g>
	<path class="st0" d="M39.4,7.5c-2.3-0.3-4.4,1.1-4.9,3.3l-1.8,7.4c-0.4,1.8-1.9,3.1-3.8,3.3l-10.5,1.2C7.1,24-1,34.3,0.7,45.6
		c1.3,9,8.6,15.7,17.2,17c2.3,0.3,4.4-1.1,4.9-3.3l1.8-7.4c0.4-1.8,1.9-3.1,3.8-3.3l10.5-1.2c11.3-1.2,19.4-11.6,17.8-22.9
		C55.3,15.4,48.1,8.8,39.4,7.5z M37.1,34l-6.6,0.8c-1.1,0.1-2,0.9-2.3,2l-1.9,8.1c-0.6,2.4-2.5,4.2-5,4.5c-3.8,0.4-7.1-2.4-7.4-6.2
		c-0.3-3.7,2.6-6.8,6.3-7.2l6.6-0.8c1.1-0.1,2-0.9,2.3-2l1.9-8.1c0.6-2.4,2.5-4.2,5-4.5c3.8-0.4,7.1,2.4,7.4,6.2
		C43.7,30.5,40.8,33.6,37.1,34z"></path>
	<rect x="153.1" y="13.9" class="st0" width="8.2" height="42.3"></rect>
	<path class="st0" d="M90.2,20.4c7.3,0,8.6,4.8,9.4,7.3h8.8c-0.5-6.2-5.6-14.9-18.2-14.9c-10.9,0-19.4,7.5-19.4,22.3
		c0,14.6,8.1,22.2,19.3,22.2c10.6,0,16.6-6.4,18.4-15.6h-8.8c-1.1,5.2-4.5,7.9-9.4,7.9c-7.5,0-10.5-6.8-10.5-14.4
		C79.7,23.3,85.9,20.4,90.2,20.4z"></path>
	<path class="st0" d="M125.2,24c-13.7,0-15,12.1-15,15.8c0,12.9,6.8,17.1,15.6,17.1c5.4,0,11.6-2.5,13.8-10H131
		c-0.7,2.2-3,3.4-5.3,3.4c-6.6,0-7.1-5.3-7.3-7.7h21.5v-1.5C139.9,27,131.3,24,125.2,24z M118.6,37.4c0.5-4.1,2.5-6.6,6.4-6.6
		c2.6,0,5.9,1.5,6.4,6.6H118.6z"></path>
	<rect x="142" y="13.9" class="st0" width="8.2" height="42.3"></rect>
	<path class="st0" d="M174,13.8h-9.8V21h7.2c4.3,0,8.2,0.9,8.2,6.4c0,5.4-3.9,6.4-8.2,6.4h-7.2V41h9.8c10.6,0,14.7-6.7,14.7-13.6
		C188.7,20.5,184.6,13.8,174,13.8z"></path>
	<path class="st0" d="M210.5,24.9c-0.5-0.2-1.2-0.3-1.8-0.3c-4.1,0-8.3,2.7-9.8,6.5h-0.1v-5.7h-8v30.7h8.4V42.3
		c0-5.4,2.1-9.9,8.3-9.9c1,0,2.3,0.1,3,0.3V24.9z"></path>
	<path class="st0" d="M225.6,24.6c-9.3,0-15.7,7-15.7,16.2c0,9.5,6,16.1,15.7,16.1c6.9,0,12-3.1,14.4-10.3h-7.4
		c-0.5,1.9-3.3,4-6.6,4c-4.7,0-7.3-2.4-7.5-7.8h22.1C241.1,33.4,236,24.6,225.6,24.6z M218.4,37.5c0.1-2.4,1.7-6.5,7-6.5
		c4.1,0,5.9,2.3,6.7,6.5H218.4z"></path>
	<path class="st0" d="M260.3,37.7c-4.8-1.1-9.6-1.5-9.6-4.6c0-2.5,2.8-2.9,4.7-2.9c3,0,5.5,0.9,5.8,4.2h8c-0.7-7.5-6.8-9.8-13.5-9.8
		c-6.6,0-13.4,2-13.4,9.9c0,5.4,4.9,7.1,9.7,8.2c6.1,1.3,9.6,2.2,9.6,4.8c0,3-3.1,3.9-5.5,3.9c-3.3,0-6.4-1.5-6.5-5.2h-8
		C242,54.3,248.9,57,256,57c7,0,14-2.6,14-10.7C270.1,40.6,265.2,38.8,260.3,37.7z"></path>
	<path class="st0" d="M289.8,37.7c-4.8-1.1-9.6-1.5-9.6-4.6c0-2.5,2.8-2.9,4.7-2.9c3,0,5.5,0.9,5.8,4.2h8c-0.7-7.5-6.8-9.8-13.5-9.8
		c-6.6,0-13.4,2-13.4,9.9c0,5.4,4.9,7.1,9.7,8.2c6.1,1.3,9.6,2.2,9.6,4.8c0,3-3.1,3.9-5.5,3.9c-3.3,0-6.4-1.5-6.5-5.2h-8
		c0.4,8.1,7.3,10.8,14.4,10.8c7,0,14-2.6,14-10.7C299.6,40.6,294.7,38.8,289.8,37.7z"></path>
	<path class="st0" d="M34.1,57.6c0.3-0.2,0.4-0.6,0.4-1c0-0.5-0.2-0.9-0.5-1.1c-0.3-0.2-0.8-0.3-1.4-0.3h-1.9v5.1h0.8V58h0.8
		l1.3,2.2h0.9l-1.4-2.2C33.6,57.9,33.9,57.8,34.1,57.6z M32.5,57.3h-0.9v-1.5h1c0.1,0,0.3,0,0.4,0c0.1,0,0.3,0,0.4,0.1
		c0.1,0,0.2,0.1,0.3,0.2c0.1,0.1,0.1,0.2,0.1,0.4c0,0.2,0,0.3-0.1,0.4c-0.1,0.1-0.2,0.2-0.3,0.2c-0.1,0.1-0.2,0.1-0.4,0.1
		C32.8,57.3,32.6,57.3,32.5,57.3z"></path>
	<path class="st0" d="M35.6,54.2c-0.4-0.4-0.9-0.7-1.4-0.9c-0.5-0.2-1.1-0.3-1.7-0.3c-0.6,0-1.2,0.1-1.7,0.3c-0.6,0.2-1,0.5-1.4,0.9
		c-0.4,0.4-0.7,0.9-1,1.5c-0.2,0.6-0.4,1.2-0.4,1.9c0,0.7,0.1,1.3,0.3,1.8c0.2,0.6,0.5,1,0.9,1.5c0.4,0.4,0.9,0.7,1.4,1
		c0.6,0.2,1.2,0.4,1.8,0.4c0.6,0,1.2-0.1,1.7-0.3c0.5-0.2,1-0.5,1.4-0.9c0.4-0.4,0.7-0.9,1-1.5c0.2-0.6,0.4-1.2,0.4-1.9
		c0-0.7-0.1-1.3-0.4-1.9C36.4,55.1,36,54.6,35.6,54.2z M35.7,59.1c-0.2,0.5-0.4,0.9-0.8,1.2c-0.3,0.3-0.7,0.6-1.1,0.8
		c-0.4,0.2-0.9,0.3-1.4,0.3c-0.6,0-1-0.1-1.5-0.3c-0.4-0.2-0.8-0.5-1.1-0.8c-0.3-0.3-0.5-0.7-0.7-1.2c-0.2-0.5-0.2-1-0.2-1.5
		c0-0.6,0.1-1.1,0.3-1.5c0.2-0.5,0.4-0.9,0.8-1.2c0.3-0.3,0.7-0.6,1.1-0.8c0.4-0.2,0.9-0.3,1.4-0.3c0.5,0,1,0.1,1.4,0.3
		c0.4,0.2,0.8,0.4,1.1,0.8c0.3,0.3,0.6,0.7,0.8,1.2c0.2,0.5,0.3,1,0.3,1.5C36,58.1,35.9,58.6,35.7,59.1z"></path>
</g>
</svg></a></div>
    <div class="footer__social-links">
        <ul class="rlist rlist--inline centered">
            <li><a href="http://on.fb.me/1tgHakh" title="Facebook" target="_blank"><i aria-hidden="true" class="icon-Icon_Facebook"></i></a></li>

            <li><a href="https://www.instagram.com/cellpress/" title="Instagram" target="_blank"><svg width="18px" height="18px" viewBox="0 0 18 18" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-147.000000, -16.000000)" fill-rule="nonzero" fill="#969696"> <g id="Instagram-Logo" transform="translate(147.000000, 16.000000)"> <path d="M9,1.62580645 C11.4096774,1.62580645 11.7,1.62580645 12.6290323,1.68387097 C13.5,1.71290323 13.9935484,1.85806452 14.3129032,2.00322581 C14.7193548,2.17741935 15.0387097,2.3516129 15.3580645,2.67096774 C15.6774194,2.99032258 15.8806452,3.28064516 16.0258065,3.71612903 C16.1419355,4.03548387 16.2870968,4.5 16.3451613,5.4 C16.3741935,6.35806452 16.4032258,6.61935484 16.4032258,9.02903226 C16.4032258,11.4387097 16.4032258,11.7290323 16.3451613,12.6580645 C16.316129,13.5290323 16.1709677,14.0225806 16.0258065,14.3419355 C15.8516129,14.7483871 15.6774194,15.0677419 15.3580645,15.3870968 C15.0387097,15.7064516 14.7483871,15.9096774 14.3129032,16.0548387 C13.9935484,16.1709677 13.5290323,16.316129 12.6290323,16.3741935 C11.6709677,16.4032258 11.4096774,16.4322581 9,16.4322581 C6.59032258,16.4322581 6.3,16.4322581 5.37096774,16.3741935 C4.5,16.3451613 4.00645161,16.2 3.68709677,16.0548387 C3.28064516,15.8806452 2.96129032,15.7064516 2.64193548,15.3870968 C2.32258065,15.0677419 2.11935484,14.7774194 1.97419355,14.3419355 C1.85806452,14.0225806 1.71290323,13.5580645 1.65483871,12.6580645 C1.62580645,11.7 1.62580645,11.4096774 1.62580645,9 C1.62580645,6.59032258 1.62580645,6.3 1.68387097,5.37096774 C1.71290323,4.5 1.85806452,4.00645161 2.00322581,3.68709677 C2.17741935,3.28064516 2.3516129,2.96129032 2.67096774,2.64193548 C2.99032258,2.32258065 3.28064516,2.11935484 3.71612903,1.97419355 C4.03548387,1.85806452 4.5,1.71290323 5.4,1.65483871 C6.3,1.62580645 6.59032258,1.62580645 9,1.62580645 L9,1.62580645 Z M9,0 C6.56129032,0 6.24193548,0 5.28387097,0.0580645161 C4.32580645,0.116129032 3.65806452,0.261290323 3.10645161,0.464516129 C2.52580645,0.696774194 2.00322581,1.01612903 1.50967742,1.50967742 C1.01612903,2.00322581 0.696774194,2.52580645 0.464516129,3.10645161 C0.232258065,3.68709677 0.0870967742,4.32580645 0.0580645161,5.28387097 C0,6.24193548 0,6.56129032 0,9 C0,11.4387097 0,11.7580645 0.0580645161,12.716129 C0.116129032,13.6741935 0.261290323,14.3419355 0.464516129,14.8935484 C0.696774194,15.4741935 1.01612903,15.9967742 1.50967742,16.4903226 C2.00322581,16.983871 2.52580645,17.3032258 3.10645161,17.5354839 C3.68709677,17.7677419 4.32580645,17.9129032 5.28387097,17.9419355 C6.24193548,18 6.56129032,18 9,18 C11.4387097,18 11.7580645,18 12.716129,17.9419355 C13.6741935,17.883871 14.3419355,17.7387097 14.8935484,17.5354839 C15.4741935,17.3032258 15.9967742,16.983871 16.4903226,16.4903226 C16.983871,15.9967742 17.3032258,15.4741935 17.5354839,14.8935484 C17.7677419,14.3129032 17.9129032,13.6741935 17.9419355,12.716129 C18,11.7580645 18,11.4387097 18,9 C18,6.56129032 18,6.24193548 17.9419355,5.28387097 C17.883871,4.32580645 17.7387097,3.65806452 17.5354839,3.10645161 C17.3032258,2.52580645 16.983871,2.00322581 16.4903226,1.50967742 C15.9967742,1.01612903 15.4741935,0.696774194 14.8935484,0.464516129 C14.3129032,0.232258065 13.6741935,0.0870967742 12.716129,0.0580645161 C11.7580645,0 11.4387097,0 9,0 L9,0 Z"></path> <path d="M9,4.38387097 C6.44516129,4.38387097 4.38387097,6.44516129 4.38387097,9 C4.38387097,11.5548387 6.44516129,13.616129 9,13.616129 C11.5548387,13.616129 13.616129,11.5548387 13.616129,9 C13.616129,6.44516129 11.5548387,4.38387097 9,4.38387097 Z M9,11.9903226 C7.34516129,11.9903226 6.00967742,10.6548387 6.00967742,9 C6.00967742,7.34516129 7.34516129,6.00967742 9,6.00967742 C10.6548387,6.00967742 11.9903226,7.34516129 11.9903226,9 C11.9903226,10.6548387 10.6548387,11.9903226 9,11.9903226 Z"></path> <circle id="Oval" cx="13.7903226" cy="4.20967742" r="1.07419355"></circle> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.linkedin.com/company/cell-press/" title="LinkedIn" target="_blank"><i aria-hidden="true" class="icon-linkedin"></i></a></li>
            
                        <li><a href="http://bit.ly/1zq7Q5T" title="Twitter" target="_blank">
                <!--<i aria-hidden="true" class="icon-Icon_Twitter"></i></a>-->
                
                <svg id="xicon" viewBox="0 0 1200 1227" xmlns="http://www.w3.org/2000/svg" aria-hidden="true" role="none"><path fill="#969696" d="M714.163 519.284L1160.89 0H1055.03L667.137 450.887L357.328 0H0L468.492 681.821L0 1226.37H105.866L515.491 750.218L842.672 1226.37H1200L714.137 519.284H714.163ZM569.165 687.828L521.697 619.934L144.011 79.6944H306.615L611.412 515.685L658.88 583.579L1055.08 1150.3H892.476L569.165 687.854V687.828Z"></path></svg> 

                    <style>
                    .footer svg#xicon {
                      height: 16px;
                    }
                    </style>
            </a></li>

            
            <li><a href="/pb-assets/marketing/WeChat/WeChat-1557753222727.jpg" title="WeChat" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-122.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="wechat" transform="translate(122.000000, 17.000000)"> <path d="M12.375,4.5 L12.375,4.5 L12.4875,4.5 L12.4875,4.5 C12.6898579,4.48604473 12.8520408,4.32704187 12.87,4.125 C12.8705905,4.04725572 12.8470025,3.9712499 12.8025,3.9075 C11.94,1.5675 9.4425,0 6.5625,0 C2.9475,0 0,2.52 0,5.625 C0.0313772094,7.34410122 0.895513317,8.94093526 2.3175,9.9075 L1.5675,11.46 C1.49009368,11.6087816 1.52088865,11.7908702 1.64291494,11.9059236 C1.76494122,12.0209769 1.94852501,12.0410168 2.0925,11.955 L4.08,10.8225 C4.61861992,11.0129999 5.17724298,11.1413322 5.745,11.205 C5.86564124,11.2178337 5.98503738,11.1715098 6.06545426,11.0806685 C6.14587113,10.9898272 6.17737153,10.865694 6.15,10.7475 C6.06148727,10.4219419 6.01114891,10.0871918 6,9.75 C6,6.855 8.8575,4.5 12.375,4.5 Z M8.25,3 C8.66421356,3 9,3.33578644 9,3.75 C9,4.16421356 8.66421356,4.5 8.25,4.5 C7.83578644,4.5 7.5,4.16421356 7.5,3.75 C7.5,3.33578644 7.83578644,3 8.25,3 Z M4.5,4.5 C4.08578644,4.5 3.75,4.16421356 3.75,3.75 C3.75,3.33578644 4.08578644,3 4.5,3 C4.91421356,3 5.25,3.33578644 5.25,3.75 C5.25,4.16421356 4.91421356,4.5 4.5,4.5 Z"></path> <path d="M18,9.75 C18,7.2675 15.48,5.25 12.375,5.25 C9.27,5.25 6.75,7.2675 6.75,9.75 C6.75,12.2325 9.27,14.25 12.375,14.25 C12.9568557,14.2502837 13.5364258,14.1772075 14.1,14.0325 L15.96,14.9625 C16.0114248,14.9874074 16.0678613,15.0002339 16.125,15 C16.2497193,14.9993787 16.3659682,14.9367912 16.4351508,14.8330172 C16.5043335,14.7292432 16.5173955,14.5978644 16.47,14.4825 L15.96,13.2075 C17.1784092,12.4716325 17.9450305,11.1723221 18,9.75 L18,9.75 Z M10.5,9 C10.0857864,9 9.75,8.66421356 9.75,8.25 C9.75,7.83578644 10.0857864,7.5 10.5,7.5 C10.9142136,7.5 11.25,7.83578644 11.25,8.25 C11.25,8.66421356 10.9142136,9 10.5,9 Z M14.25,9 C13.8357864,9 13.5,8.66421356 13.5,8.25 C13.5,7.83578644 13.8357864,7.5 14.25,7.5 C14.6642136,7.5 15,7.83578644 15,8.25 C15,8.66421356 14.6642136,9 14.25,9 Z" opacity="0.959999979"></path> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.weibo.com/CellPress" title="Weibo" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-99.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="weibo" transform="translate(99.000000, 14.000000)"> <g transform="translate(0.000000, 3.000000)"> <path d="M13.2402211,7.47054172 C12.9918392,7.39866484 12.821608,7.34902326 12.9514975,7.03290287 C13.232804,6.34602189 13.2622915,5.75359781 12.9571055,5.33095486 C12.3847236,4.5380684 10.8191759,4.58064295 9.02514573,5.30975376 C9.02514573,5.30889193 8.46144724,5.54882627 8.60544724,5.11515185 C8.88150754,4.25435294 8.83953769,3.53386047 8.41043216,3.11759508 C7.43716583,2.17285363 4.84824121,3.15344733 2.62745729,5.3059617 C0.964944724,6.9186238 0,8.62798358 0,10.105855 C0,12.9324952 3.73748744,14.8235294 7.39429146,14.8235294 C12.1877186,14.8235294 15.3768844,11.9501778 15.3768844,9.80576471 C15.3768844,8.50974008 14.2514774,7.77442408 13.2402211,7.47054172 Z M7.40424121,13.5561176 C4.48625126,13.8315595 1.9678794,12.5686293 1.77811055,10.7327524 C1.58870352,8.89773735 3.80098492,7.18579207 6.71861307,6.90948837 C9.63678392,6.63266758 12.1556985,7.89663201 12.3447437,9.73164706 C12.533608,11.5675239 10.3227739,13.2796416 7.40424121,13.5561176 Z M18,5.16875787 C17.9985528,2.31402189 15.5695477,0 12.5728643,0 C12.222995,0 11.9396985,0.270098495 11.9396985,0.603283174 C11.9396985,0.936640219 12.222995,1.20656635 12.5728643,1.20656635 C14.8708945,1.20656635 16.7336683,2.98159781 16.7336683,5.17099863 C16.7336683,5.50435568 17.0173266,5.77428181 17.3668342,5.77428181 C17.7167035,5.77428181 18,5.50435568 18,5.17099863 C18,5.17099863 18,5.1696197 18,5.16875787 Z M15.4841608,5.08016142 C15.1948945,3.73415048 14.0812462,2.67323393 12.6683819,2.39744733 C12.3262915,2.33039672 11.9914372,2.54051163 11.9212462,2.86680164 C11.8506935,3.19309166 12.0712161,3.51179754 12.4133065,3.57919289 C13.3319397,3.75845417 14.0559196,4.44774829 14.2438794,5.32302599 C14.3146131,5.64931601 14.6491055,5.85925855 14.9915578,5.7923803 C15.3338291,5.72498495 15.5541709,5.40627907 15.4841608,5.08016142 Z M5.90761809,8.7069275 C4.7321005,8.9320383 3.93901508,9.87126402 4.1358392,10.8044569 C4.33248241,11.7378222 5.44504523,12.311803 6.62056281,12.0865198 C7.79571859,11.861409 8.58916583,10.922528 8.3921608,9.98899042 C8.19569849,9.0559699 7.08277387,8.48181669 5.90761809,8.7069275 Z"></path> </g> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.youtube.com/user/cellvideoabstracts" title="YouTube" target="_blank"><svg width="18px" height="13px" viewBox="0 0 18 13" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-76.000000, -19.000000)" fill-rule="nonzero" fill="#969696"> <g id="youtube" transform="translate(76.000000, 14.000000)"> <path d="M17.2984219,6.41974219 C16.6486641,5.64735937 15.4490625,5.33232422 13.1580703,5.33232422 L4.84175391,5.33232422 C2.49834375,5.33232422 1.27838672,5.66771484 0.631089844,6.49001953 C0,7.29172266 0,8.47304297 0,10.1080547 L0,13.2243047 C0,16.3917773 0.748792969,18 4.84175391,18 L13.1581055,18 C15.1448555,18 16.2457383,17.7219844 16.9579688,17.040375 C17.688375,16.3413984 18,15.2001211 18,13.2243047 L18,10.1080547 C18,8.38381641 17.951168,7.19553516 17.2984219,6.41974219 Z M11.5560703,12.0963867 L7.77965625,14.0700586 C7.69524609,14.1141797 7.60289062,14.136082 7.51071094,14.136082 C7.40629687,14.136082 7.30212891,14.1079922 7.20987891,14.0521289 C7.03613672,13.9468711 6.93007031,13.7585391 6.93007031,13.5554414 L6.93007031,9.62075391 C6.93007031,9.41800781 7.03585547,9.22985156 7.20924609,9.12452344 C7.38267187,9.01919531 7.59839062,9.01198828 7.77832031,9.10546875 L11.5547344,11.0664141 C11.7468633,11.1661523 11.8675195,11.3645039 11.8678008,11.5809258 C11.8680469,11.7975586 11.747918,11.9961914 11.5560703,12.0963867 Z"></path> </g> </g> </g></svg></a></li>
            
        </ul>
    </div>
</div>

<style>

.ux3 .footer__logo svg {
    max-width: 160px !important;
}

.ux3 .footer__social-links a svg {
    max-width: 26px;
    height: 1.15rem;
    width: auto;
}

.ux3 .footer__social-links a:hover svg path {
    fill: #353535;
}

</style></div>

            

        

    

        


    

            

            
                <div class="footer__bottom text-onDark">
            

            <div data-widget-id="06227714-c621-4651-9879-b0ce5176cccc" data-widget-name="ux3-layout-widget"><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="07e1d276-b4dd-4870-b858-ed74e70d64ef" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="group">
		<h2 class="group__title">Life &amp; medical sciences journals</h2>
		<ul class="rlist clearfix sided">
		<li>
			<a alt="Cell" href="/cell/home">Cell</a>
		</li>
		<li>
			<a alt="Cancer Cell" href="/cancer-cell/home">Cancer Cell</a>
		</li>
		<li>
			<a alt="Cell Chemical Biology" href="/cell-chemical-biology">Cell Chemical Biology</a>
		</li>
		<li>
			<a alt="Cell Genomics" href="/cell-genomics/home">Cell Genomics</a>
		</li>
		<li>
			<a alt="Cell Host and Microbe" href="/cell-host-microbe/home">Cell Host &amp; Microbe</a>
		</li>
		<li>
			<a alt="Cell Metabolism" href="/cell-metabolism/home">Cell Metabolism</a>
		</li>
		<li>
			<a alt="Cell Reports" href="/cell-reports/home">Cell Reports</a>
		</li>
		<li>
			<a alt="Cell Reports Medicine" href="/cell-reports-medicine/home">Cell Reports Medicine</a>
		</li>
		<li>
			<a alt="Cell Stem Cell" href="/cell-stem-cell/home">Cell Stem Cell</a>
		</li>
		<li>
			<a alt="Cell Systems" href="/cell-systems/home">Cell Systems</a>
		</li>
		<li>
			<a alt="Current Biology" href="/current-biology/home">Current Biology</a>
		</li>
		<li>
			<a alt="Developmental Cell" href="/developmental-cell/home">Developmental Cell</a>
		</li>
		<li>
			<a alt="Immunity" href="/immunity/home">Immunity</a>
		</li>
		<li>
			<a alt="Med" href="/med/home">Med</a>
		</li>
		<li>
			<a alt="Molecular Cell" href="/molecular-cell/home">Molecular Cell</a>
		</li>
		<li>
			<a alt="Neuron" href="/neuron/home">Neuron</a>
		</li>
		<li>
			<a alt="Structure" href="/structure/home">Structure</a>
		</li>
		<li>
			<a alt="American Journal of Human Genetics" href="/ajhg/home">American Journal of Human Genetics (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Biophysical Journal" href="/biophysj/home">Biophysical Journal (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Biophysical Reports" href="/biophysreports/home">Biophysical Reports (<i>partner</i>)</a>
		</li>	
		<li>
			<a alt="HGG Advances" href="/hgg-advances/home">Human Genetics and Genomics Advances (<i>partner</i>)</a></li>
		<li>
			<a alt="Molecular Plant" href="/molecular-plant/home">Molecular Plant (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy" href="/molecular-therapy-family/molecular-therapy/home">Molecular Therapy (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Methods and Clinical Development" href="/molecular-therapy-family/methods/home">Molecular Therapy Methods &amp; Clinical Development (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Nucleic Acids" href="/molecular-therapy-family/nucleic-acids/home">Molecular Therapy Nucleic Acids (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Oncology" href="/molecular-therapy-family/oncology/home">Molecular Therapy Oncology (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Plant Communications" href="/plant-communications/home">Plant Communications (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Stem Cell Reports" href="/stem-cell-reports/home">Stem Cell Reports (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Trends in Biochemical Sciences" href="/trends/biochemical-sciences/home">Trends in Biochemical Sciences</a>
		</li>
		<li>
		</li><li>
			<a alt="Trends in Cancer" href="/trends/cancer/home">Trends in Cancer</a>
		</li>
		<li>
			<a alt="Trends in Cell Biology" href="/trends/cell-biology/home">Trends in Cell Biology</a>
		</li>
		<li>
			<a alt="Trends in Ecology and Evolution" href="/trends/ecology-evolution/home">Trends in Ecology &amp; Evolution</a>
		</li>
		<li>
			<a alt="Trends in Endocrinology and Metabolism" href="/trends/endocrinology-metabolism/home">Trends in Endocrinology &amp; Metabolism</a>
		</li>
		<li>
			<a alt="Trends in Genetics" href="/trends/genetics/home">Trends in Genetics</a>
		</li>
		<li>
			<a alt="Trends in Immunology" href="/trends/immunology/home">Trends in Immunology</a>
		</li>
		<li>
			<a alt="Trends in Microbiology" href="/trends/microbiology/home">Trends in Microbiology</a>
		</li>
		<li>
			<a alt="Trends in Molecular Medicine" href="/trends/molecular-medicine/home">Trends in Molecular Medicine</a>
		</li>
		<li>
			<a alt="Trends in Neurosciences" href="/trends/neurosciences/home">Trends in Neurosciences</a>
		</li>
		<li>
			<a alt="Trends in Parasitology" href="/trends/parasitology/home">Trends in Parasitology</a>
		</li>
		<li>
			<a alt="Trends in Pharmacological Sciences" href="/trends/pharmacological-sciences/home">Trends in Pharmacological Sciences</a>
		</li>
		<li>
			<a alt="Trends in Plant Science" href="/trends/plant-science/home">Trends in Plant Science</a>
		</li>
		</ul>
	</div>

	<div class="group">
		<h2 class="group__title">Physical sciences &amp; engineering journals</h2>
		<ul class="rlist clearfix sided">
		  <li><a alt="Cell Biomaterials" href="/cell-biomaterials/home">Cell Biomaterials</a></li>
		  <li>
			<a alt="Cell Reports Physical Science" href="/cell-reports-physical-science/home">Cell Reports Physical Science</a>
		</li>
		<li>
			<a alt="Chem" href="/chem/home">Chem</a>
		</li>
		<li>
			<a alt="Chem Catalysis" href="/chem-catalysis/home">Chem Catalysis</a>
		</li>
		<li>
			<a alt="Device" href="/device/home">Device</a>
		</li>
		<li>
			<a alt="Joule" href="/joule/home">Joule</a>
		</li>
		<li>
			<a alt="Matter" href="/matter/home">Matter</a>
		</li>	
		<li><a alt="Matter" href="/newton/home">Newton</a></li>
		<li>
			<a alt="Trends in Chemistry" href="/trends/chemistry/home">Trends in Chemistry</a>
		</li>			
		</ul>
	</div>

<div class="group">
	<h2 class="group__title">Multidisciplinary journals</h2>
	<ul class="rlist clearfix sided">
	  		<li>
			<a alt="Cell Reports Methods" href="/cell-reports-methods/home">Cell Reports Methods</a>
		</li>
		<li>
			<a alt="Cell Reports Sustainability" href="/cell-reports-sustainability/home">Cell Reports Sustainability</a>
		</li>
		<li>
			<a alt="Heliyon" href="/heliyon/home">Heliyon</a>
		</li>	
		<li>
			<a alt="iScience" href="/iscience/home">iScience</a>
		</li>
		<li>
			<a alt="One Earth" href="/one-earth/home">One Earth</a>
		</li>
		<li>
			<a alt="Patterns" href="/patterns/home">Patterns</a>
		</li>
		<li>
			<a alt="STAR Protocols" href="/star-protocols/home">STAR Protocols</a>
		</li>
		<li>
			<a alt="Nexus" href="/nexus/home">Nexus (<i>partner</i>)</a>
		</li>			
        <li>
			<a alt="The Innovation" href="/the-innovation/home">The Innovation (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Trends in Biotechnology" href="/trends/biotechnology/home">Trends in Biotechnology</a>
		</li>
		<li>
			<a alt="Trends in Cognitive Sciences" href="/trends/cognitive-sciences/home">Trends in Cognitive Sciences</a>
		</li>
	</ul>
</div>

</div>
</div>

            

        
</div><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="850476de-00cb-4c0d-943c-bf1881da24f9" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="clearfix">
		<div class="group sided">
			<h2 class="group__title">Authors</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Submit article" href="/submit-to-cell-press">Submit article</a>
				</li>
				<li>
					<a alt="Multi-Journal Submission" href="/multi-journal-submission">Multi-Journal Submission</a>
				</li>
				<li>
					<a alt="STAR Methods" href="/star-authors-guide">STAR Methods</a>
				</li>
				<li>
					<a alt="Sneak Peek – Preprints" href="/sneakpeek">Sneak Peek – Preprints</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">Reviewers</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Reviewers" href="/reviewers">Information for reviewers</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">News &amp; events</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Newsroom" href="/newsroom">Newsroom</a>
				</li>
				<li>
					<a alt="Events" href="/events">Events</a>
				</li>
				<li>
					<a alt="Cell Symposia" href="/symposia">Cell Symposia</a>
				</li>
				<li>
					<a alt="Consortia Hub" href="/consortia">Consortia Hub</a>
				</li>
				<li>
					<a alt="Webinars" href="/webinars">Webinars</a>
				</li>
								<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">Multimedia</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Cell Press Podcast" href="/podcast">Cell Press Podcast</a>
				</li>
				<li>
					<a alt="Cell Press Videos" href="/video">Cell Press Videos</a>
				</li>
				<li>
					<a alt="Color and Comics" href="/comics">Coloring and Comics</a>
				</li>
				<li>
					<a alt="Figure360" href="/video-guidelines">Figure360</a>
				</li>
				<li>
					<a alt="Cell Picture Show" href="/pictureshow">Cell Picture Show</a>
				</li>
				<li>
					<a alt="Research Arc" href="/research-arc">Research Arc</a>
				</li>
			</ul>
		</div>

		<div class="group sided">
			<h2 class="group__title">About</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="About Cell Press" href="/about">About Cell Press</a>
				</li>

				<li>
					<a alt="Open access" href="/open-access">Open access</a>
				</li>
				<li>
					<a alt="COVID Hub" href="/covid-19">COVID Hub</a>
				</li>
				<li>
					<a alt="Sustainability" href="/sustainability">Sustainability hub</a>
				</li>
				<li>
					<a alt="Inclusion and diversity" href="/diversity">Inclusion and diversity</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
			<h2 class="group__title">Contact</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Contact us" href="/contact">Contact us</a>
				</li>
				<li>
					<a alt="Help and Support" href="https://service.elsevier.com/app/overview/cell-press/" target="_blank">Help &amp; Support</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
			<h2 class="group__title">Careers</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Cell Press Careers" href="https://relx.wd3.myworkdayjobs.com/en-US/ElsevierJobs" target="_blank">Cell Press Careers</a>
				</li>
			</ul>
		</div>
	</div>
</div></div>

            

        
</div><div class="col-sm-4 col-md-2 clearfix">
    

        


    

            

            

            <div data-widget-id="beafac41-1cfc-440b-9b55-74aba4a5612c" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="group">
		<h2 class="group__title">Access</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="Subscribe" href="/subscribe">Subscribe</a>
			</li>
			<li>
				<a alt="Claim" href="/activate">Claim</a>
			</li>
			<li>
				<a alt="Read It Now" href="/read-it-now">Read-It-Now</a>
			</li>
			<li>
				<a alt="Recommend to Librarian" href="http://info.cell.com/request-access-to-cell-press-content" target="_blank">Recommend to Librarian</a>
			</li>
			<li>
				<a alt="Publication Alerts" href="/action/showPreferences?menuTab=Alerts">Publication Alerts</a>
			</li>
		</ul>
	</div>
	<div class="group">
		<h2 class="group__title">Collections</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="Best of Cell Press" href="/bestof">Best of Cell Press</a>
			</li>
			<li>
				<a alt="Cell Press Reviews" href="/reviews">Cell Press Reviews</a>
			</li>
			<li>
				<a alt="Cell Selections" href="/selections">Cell Press Selections</a>
			</li>
			<li>
				<a alt="Nucleus Collections" href="/nucleus">Nucleus Collections</a>
			</li>
			<li>
				<a alt="SnapShots" href="/snapshots">SnapShot Archive</a>
			</li>
		</ul>
	</div>
	<div class="group">
		<h2 class="group__title">Information</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="For Advertisters" href="/media-kit">For Advertisers</a>
			</li>
			<li>
				<a alt="For Recruiters" target="_blank" href="/pb-assets/Cell/common/CP-RecruitmentKit-US-2018-LowRes-1712070648.pdf">For Recruiters</a>
			</li>
			<li>
				<a alt="For Librarians" target="_blank" href="https://www.elsevier.com/products/sciencedirect/journals/direct-subscription-journals">For Librarians</a>
			</li>
			<li>
				<a alt="Privacy Policy" target="_blank" href="https://www.elsevier.com/legal/privacy-policy">Privacy Policy</a>
			</li>
			<li>
				<a alt="Terms and Conditions" target="_blank" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions">Terms and Conditions</a>
			</li>
			<li>
				<a alt="Accessibility" href="/accessibility">Accessibility</a>
			</li>
		</ul>
	</div>
</div></div>

            

        
</div></div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="779ad11f-7bcd-4a2a-a2cd-8c67b649cbb2" data-widget-name="UX3HTMLWidget"><style>
 
button#cookieBtn {
   text-decoration: none;
   background-color: transparent;
   color: #005789;
   font-weight: bold;
   padding: 0;
   margin: 0;
   font-size: 14px;
}
 
button#cookieBtn:hover {
   text-decoration: underline;
}

</style>
<script>
// HIDE ONETRUST BACKGROUND AFTER USER PRESSES ESCAPE KEY
setTimeout(function(){ 
   $("#onetrust-pc-sdk").on("keydown", function(e) { 
      if (e.keyCode == 27) {  // ESC key
         setTimeout(function(){ 
            $(".onetrust-pc-dark-filter").css("display","none");
         }, 100); 
      }
   });
}, 5000);
</script>

<span class="align-center copy-right">
<hr>
<p align="center"><b>The content on this site is intended for healthcare professionals and researchers across all fields of science.</b></p>
<hr>
<div>
<p>We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the 
      <b><button id="cookieBtn" class="ot-sdk-show-settings" type="button" aria-label="Manage cookie consent preferences">Cookie Settings</button></b> for this site.<br>

All content on this site: Copyright © 2025 Elsevier Inc., its licensors, and contributors. <br>All rights are reserved, including those for text and data mining, AI training, and similar technologies. <br>For all open access content, the relevant licensing terms apply.
</p>
<ul class="rlist--inline">
			<li>
				<a alt="Privacy Policy" target="_blank" href="https://www.elsevier.com/legal/privacy-policy">Privacy Policy</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Terms and Conditions" target="_blank" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions">Terms &amp; Conditions</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Accessibility" href="/accessibility">Accessibility</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Help and Support" target="_blank" href="https://service.elsevier.com/app/overview/cell-press/">Help &amp; Support</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Contact" href="/contact">Contact</a>
			</li>
			</ul>
<p>
<a href="https://www.relx.com"><img src="/pb/assets/raw/Health%20Advance/images/relx-1554393210983.png" alt="RELX" rel="nofollow" target="_new"></a></p>
</div>

</span></div>

            

        

    

        


    

            

            

            <div data-widget-id="c5e179c1-156e-41e3-af7f-5e307efa8acf" data-widget-name="UX3HTMLWidget"><style>#brandingRow{
    background-color:#fff;
    padding:7px 26px 7px 30px;
    color:#007DBC;
    font-size:14px;
    clear:both;
    width:100%
}
#brandingRow a{
    text-decoration:none;
    color:#007DBC
}
#brandingRow a:hover{
    text-decoration:underline
}
#brandingRowRight{
    display:inline;
    float:right;
    width:auto;
    padding:0;
    margin:0
}
svg#cp_logo {
  float: none;
  height: 36px;
  width: 36px;
  margin-left: 0px;
  margin-top: 0px;
}

footer hr {
  display: block;
}

@media screen and (max-width: 600px){
    #brandingRow{
        font-size:12px
    }
}
@media screen and (max-width: 750px){
    #brandingRow{
        padding:7px 18px 7px 16px
    }
    svg#cp_logo{
        margin-right:10px
    }
}
@media screen and (max-width: 800px) {
   a#cpIconLnk {
      display: none;
   }
}

.header__wrapper.clearfix .col-xs-6:first-of-type{
    width:55%
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2){
    width:45%
}
@media screen and (min-width: 800px) and (max-width: 1000px){
    .header__wrapper.clearfix .col-xs-6:first-of-type{
        width:75%
    }
    .header__wrapper.clearfix .col-xs-6:nth-of-type(2){
        width:25%
    }
}

</style>

<script>
var partnerx = false;
var overrideEndorsement = "";
var tmpj = $("input[name='journalCode']").attr("value");
	
if (window.location.pathname == "/molecular-therapy-family/home") {
	tmpj = "ymthe";
}
	
var ribbonx = "";
if (tmpj == "ajhg" || tmpj == "bpj" || tmpj == "molp" || tmpj == "xplc" || tmpj == "stemcr" || tmpj == "ymthe" || tmpj == "xhgg" || tmpj == "omtn" || tmpj == "omto" || tmpj == "omtm" || tmpj == "biophysreports" ||  tmpj == "bpr" || tmpj == "xinn" || tmpj == "omton") {
	partnerx = true;
	ribbonx = "<a href='https://www.cell.com' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press partner journal</a>";
} else if (tmpj != "" && tmpj != "undefined" && tmpj != undefined) {
	ribbonx = "<a href='/' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press journal</a>";
} else {
	ribbonx = "<a href='/' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press resource</a>";
}
	
if (window.location.pathname == "/") {
	ribbonx = "";
}
if (overrideEndorsement != "") {
	ribbonx = overrideEndorsement;
}

$(".header__wrapper.clearfix").prepend("<div id='brandingRow'><a href='/' data-aa-name='science that inspires' data-aa-region='cp global header' title='Visit Cell.com'>Science that inspires</a><p id='brandingRowRight'>" + ribbonx + "</p></div>");
	
// handle scrolling effect on article pages
if ($("article").length > 0) {
	var scrollx;
	$(window).scroll(function() {
		scrollx = $(window).scrollTop();
		if (scrollx > 0) { 
			$("#brandingRow").css("display","none"); 
		} else {
			$("#brandingRow").css("display","block");
		}
	});
}

if (window.location.pathname == "/" || partnerx == false) {
               $("<a href='/home' id='cpIconLnk' data-aa-name='cell press logo' data-aa-region='cp global header' title='Cell Press' target='_blank'><svg id='cp_logo' version='1.1' xmlns='http://www.w3.org/2000/svg' xmlns:xlink='http://www.w3.org/1999/xlink' x='0px' y='0px' viewBox='0 0 100 98.1' style='enable-background:new 0 0 100 98.1;' xml:space='preserve' height='100' width='98.1'><path style='fill:#FFFFFF;' d='M69.09,0.09c-4.01-0.6-7.83,1.94-8.78,5.89l-3.14,13.11c-0.76,3.19-3.44,5.56-6.7,5.93l-18.6,2.13          C11.83,29.31-2.53,47.66,0.37,67.78c2.3,15.96,15.18,27.77,30.54,30.08c4.01,0.6,7.83-1.94,8.78-5.89l3.14-13.11 c0.76-3.19,3.44-5.56,6.69-5.93l18.6-2.13c20.04-2.17,34.41-20.52,31.5-40.65C97.32,14.21,84.45,2.39,69.09,0.09z M65.06,47.2  l-11.75,1.4c-1.98,0.21-3.62,1.65-4.08,3.59l-3.43,14.3c-1.01,4.22-4.5,7.39-8.8,8c-6.66,0.72-12.63-4.2-13.15-10.92                c-0.51-6.5,4.6-12.11,11.08-12.81l11.75-1.39c1.98-0.22,3.62-1.65,4.08-3.59l3.43-14.3c1.01-4.22,4.5-7.39,8.8-8          c6.66-0.72,12.63,4.19,13.15,10.92C76.66,40.89,71.55,46.5,65.06,47.2z'/></svg></a>").insertBefore(".header__wrapper.clearfix .journal-logos:eq(0)");
}


</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="1af759b7-9bb6-4413-ada9-51a8333e8fb8" data-widget-name="UX3HTMLWidget"><style>
    /*This was added temporarily until the PB changelog tab issue got fixed. [LIT-444969 - c#4]*/
    [data-tab-id="changelogTab"] {
        display: none !important;
    }
    
    /*This was added temporarily until the PB changelog tab issue got fixed. [LIT-518839]*/
    @media (min-width: 769px) {
        .ux3 .quick-search .dropBlock [data-db-target-of],
        .quick-search .dropBlock [data-db-target-of] {
            width: 100vw !important;
        }
    }
</style></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

            

            

            <div data-widget-id="d7e0813b-a300-497a-ab37-9c3ddaf03e71" data-widget-name="UX3HTMLWidget"><!--
<div class="session-reminder hidden">
    <div class="session-reminder__overlay">
        <div class="session-reminder__dialog">
            <div class="session-reminder__dialog-inner">
                <div class="dialog-header" role="dialog" aria-labelledby="dialog-title" aria-describedby="dialog-desc">
                    <h2 class="dialog-header-title" id="dialog-title">
                        <span>Session Timeout</span>
                        <div class="dialog-timer">(2:00)</div>
                    </h2>
                    <button class="dialog-close" type="button" aria-label="close dialog">
                        <i class="icon-tools_close" aria-hidden="true"></i>
                    </button>
                </div>
                <div class="dialog-body">
                    <p class="dialog-desc" id="dialog-desc">Your session will expire shortly. If you are still working, click the ‘Keep Me Logged In’ button below. If you do not respond within the next minute, you will be automatically logged out.</p>
                    <p class="dialog-expired sr-only" aria-live="polite"></p>
                </div>
                <div class="dialog-footer">
                    <button class="session-reset" type="button">Keep Me Logged In</button>
                </div>
            </div>
        </div>
    </div>
</div>
<a class="sr-only" href="javascript:void(0)" aria-hidden="true"></a>
--></div>

            

        
        </div>
    </div>


































    



















        
        
            
                <script src="/products/marlin/cell/releasedAssets/js/main.bundle-90475670808d5d3eee41.js"></script>
            
        
        
        

    




<script type="text/javascript">
    var pageData =  {"journal":{"specialty":"Cell Press","issn":"0092-8674","name":"Cell"},"page":{"loadTimestamp":"1749592078991","server":"cell","environment":"prod","businessUnit":"ELS:RAP:JBS","noTracking":"","name":"fulltext:html","section":"Cell","language":"en","type":"CP-CA","productName":"JB"},"visitor":{"departmentName":"|ae:ScienceDirect Guests","accessType":"ae:ANON_GUEST|ae:ANON_GUEST","accountId":"ae:838949|ae:228598","accountName":"ae:Cell Guest Account|ae:ScienceDirect Guests","departmentId":"ae:977212|ae:291352","ipAddress":"189.120.74.179","loginStatus":"anonymous","userId":"ae:246228266|ae:12975512"},"content":[{"accessType":"article:free:openarchive","volumeNumber":"184","issueNumber":"25","viewState":"fulltext","format":"MIME-HTML","id":"pii:S0092867421013222","coverDate":"202112","type":"XOCS-JOURNAL:SCOPE-FULL","title":"Neoantigendriven B cell and CD4xa0T follicular helper cell collaboration promotes antitumor CD8 Txa0cell responses","status":"S300"}]};
</script>

<script type="text/javascript">
    if(typeof pageDataTracker !== "undefined") {
        pageDataTracker.trackPageLoad();
    }
</script>
<script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'94dc11f5fa1d4292',t:'MTc0OTU5MjA3OC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script><iframe height="1" width="1" style="position: absolute; top: 0px; left: 0px; border: none; visibility: hidden;"></iframe><script defer="" src="https://static.cloudflareinsights.com/beacon.min.js/vcd15cbe7772f49c399c6a5babf22c1241717689176015" integrity="sha512-ZpsOmlRQV6y907TI0dKBHq9Md29nnaEIPlkf84rnaERnq6zvWvPUqr2ft8M1aS28oN72PdrCzSjY4U6VaAw1EQ==" data-cf-beacon="{&quot;rayId&quot;:&quot;94dc11f5fa1d4292&quot;,&quot;serverTiming&quot;:{&quot;name&quot;:{&quot;cfExtPri&quot;:true,&quot;cfEdge&quot;:true,&quot;cfOrigin&quot;:true,&quot;cfL4&quot;:true,&quot;cfSpeedBrain&quot;:true,&quot;cfCacheStatus&quot;:true}},&quot;version&quot;:&quot;2025.6.2&quot;,&quot;token&quot;:&quot;57a02315956f4b2e82817b3dfa99b1a2&quot;}" crossorigin="anonymous"></script>


<div id="addtoany" style="position: static;"><div class="a2a_overlay" id="a2a_overlay"></div><div id="a2a_modal" class="a2a_modal a2a_hide" role="dialog" tabindex="-1" aria-label=""><div class="a2a_modal_body a2a_menu a2a_hide" id="a2a_copy_link"><label for="a2a_copy_link_text" id="a2a_copy_link_icon" class="a2a_svg a2a_s_link a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><title>Copy link</title><path fill="#FFF" d="M7.591 21.177c0-.36.126-.665.377-.917l2.804-2.804a1.235 1.235 0 0 1 .913-.378c.377 0 .7.144.97.43-.026.028-.11.11-.255.25-.144.14-.24.236-.29.29a2.82 2.82 0 0 0-.2.256 1.056 1.056 0 0 0-.177.344 1.43 1.43 0 0 0-.046.37c0 .36.126.666.377.918a1.25 1.25 0 0 0 .918.377c.126.001.251-.015.373-.047.125-.037.242-.096.345-.175.09-.06.176-.127.256-.2.1-.094.196-.19.29-.29.14-.142.223-.23.25-.254.297.28.445.607.445.984 0 .36-.126.664-.377.916l-2.778 2.79a1.242 1.242 0 0 1-.917.364c-.36 0-.665-.118-.917-.35l-1.982-1.97a1.223 1.223 0 0 1-.378-.9l-.001-.004Zm9.477-9.504c0-.36.126-.665.377-.917l2.777-2.79a1.235 1.235 0 0 1 .913-.378c.35 0 .656.12.917.364l1.984 1.968c.254.252.38.553.38.903 0 .36-.126.665-.38.917l-2.802 2.804a1.238 1.238 0 0 1-.916.364c-.377 0-.7-.14-.97-.418.026-.027.11-.11.255-.25a7.5 7.5 0 0 0 .29-.29c.072-.08.139-.166.2-.255.08-.103.14-.22.176-.344.032-.12.048-.245.047-.37 0-.36-.126-.662-.377-.914a1.247 1.247 0 0 0-.917-.377c-.136 0-.26.015-.37.046-.114.03-.23.09-.346.175a3.868 3.868 0 0 0-.256.2c-.054.05-.15.148-.29.29-.14.146-.222.23-.25.258-.294-.278-.442-.606-.442-.983v-.003ZM5.003 21.177c0 1.078.382 1.99 1.146 2.736l1.982 1.968c.745.75 1.658 1.12 2.736 1.12 1.087 0 2.004-.38 2.75-1.143l2.777-2.79c.75-.747 1.12-1.66 1.12-2.737 0-1.106-.392-2.046-1.183-2.818l1.186-1.185c.774.79 1.708 1.186 2.805 1.186 1.078 0 1.995-.376 2.75-1.13l2.803-2.81c.751-.754 1.128-1.671 1.128-2.748 0-1.08-.382-1.993-1.146-2.738L23.875 6.12C23.13 5.372 22.218 5 21.139 5c-1.087 0-2.004.382-2.75 1.146l-2.777 2.79c-.75.747-1.12 1.66-1.12 2.737 0 1.105.392 2.045 1.183 2.817l-1.186 1.186c-.774-.79-1.708-1.186-2.805-1.186-1.078 0-1.995.377-2.75 1.132L6.13 18.426c-.754.755-1.13 1.672-1.13 2.75l.003.001Z"></path></svg></label><input id="a2a_copy_link_text" type="text" title="Copy link" readonly=""><div id="a2a_copy_link_copied">✓</div></div><div class="a2a_modal_body a2a_menu a2a_thanks a2a_hide" id="a2a_thanks"><div class="a2a_localize" data-a2a-localize="inner,ThanksForSharing">Thanks for sharing!</div></div></div><div class="a2a_menu a2a_full a2a_localize" id="a2apage_full" role="dialog" tabindex="-1" aria-label="Share" data-a2a-localize="title,Share"><div class="a2a_full_header"><div id="a2apage_find_container" class="a2a_menu_find_container"><label for="a2apage_find" id="a2apage_find_icon" class="a2a_svg a2a_s_find"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" aria-hidden="true"><title>Find any service</title><path fill="#CCC" d="M19.7 18.2l-4.5-4.5c.7-1.1 1.2-2.3 1.2-3.6 0-3.5-2.8-6.3-6.3-6.3s-6.3 2.8-6.3 6.3 2.8 6.3 6.3 6.3c1.4 0 2.6-.4 3.6-1.2l4.5 4.5c.6.6 1.3.7 1.7.2.5-.4.4-1.1-.2-1.7zm-9.6-3.6c-2.5 0-4.5-2.1-4.5-4.5 0-2.5 2.1-4.5 4.5-4.5 2.5 0 4.5 2.1 4.5 4.5s-2 4.5-4.5 4.5z"></path></svg></label><input id="a2apage_find" class="a2a_menu_find a2a_localize" type="text" autocomplete="off" title="Find any service" data-a2a-localize="title,FindAnyServiceToAddTo"></div></div><div class="a2a_full_services" id="a2apage_full_services" role="presentation"></div><div class="a2a_full_footer"><a href="https://www.addtoany.com" title="Share Buttons" rel="noopener" target="_blank"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span>AddToAny</a></div></div><div id="a2apage_dropdown" class="a2a_menu a2a_mini a2a_localize a2a_hide" tabindex="-1" aria-label="Share" data-a2a-localize="label,Share"><div class="a2a_mini_services" id="a2apage_mini_services"></div><div id="a2apage_cols_container" class="a2a_cols_container"><div class="a2a_col1" id="a2apage_col1"></div><div id="a2apage_2_col1" class="a2a_hide"></div><div class="a2a_clear"></div></div><div class="a2apage_wide a2a_wide"><a href="#addtoany" id="a2apage_show_more_less" class="a2a_more a2a_localize" title="Show all" data-a2a-localize="title,ShowAll"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span><span class="a2a_localize" data-a2a-localize="inner,More">More…</span></a></div></div><div style="height: 1px; width: 1px; position: absolute; z-index: 100000; top: 0px; visibility: hidden;"><iframe id="a2a_sm_ifr" title="AddToAny Utility Frame" aria-hidden="true" src="https://static.addtoany.com/menu/sm.25.html#type=core&amp;event=load" style="height: 1px; width: 1px; border: 0px; left: 0px; top: 0px; position: absolute; z-index: 100000; display: none;"></iframe></div></div><div role="status" aria-live="assertive" aria-relevant="additions" class="ui-helper-hidden-accessible"></div><div id="onetrust-consent-sdk" data-nosnippet="true"><div class="onetrust-pc-dark-filter ot-fade-in" style="z-index:2147483645;"></div><div id="onetrust-banner-sdk" class="otFlat bottom ot-wo-title ot-buttons-fw" tabindex="0" role="region" aria-label="Cookie banner"><div role="dialog" aria-modal="true" aria-label="Privacy"><div class="ot-sdk-container"><div class="ot-sdk-row"><div id="onetrust-group-container" class="ot-sdk-eight ot-sdk-columns"><div class="banner_logo"></div><div id="onetrust-policy"><div id="onetrust-policy-text">We use cookies that are necessary to make our site work. We may also use additional cookies to analyze, improve, and personalize our content and your digital experience. For more information, see our<a class="ot-cookie-policy-link" href="https://www.elsevier.com/legal/cookienotice" target="_blank" aria-label=", opens in a new tab" rel="noopener">Cookie Policy</a></div></div></div><div id="onetrust-button-group-parent" class="ot-sdk-three ot-sdk-columns"><div id="onetrust-button-group"><button id="onetrust-pc-btn-handler" class="cookie-setting-link">Cookie Settings</button>  <button id="onetrust-accept-btn-handler">Accept all cookies</button></div></div></div></div><!-- Close Button --><div id="onetrust-close-btn-container"></div><!-- Close Button END--></div></div><div id="onetrust-pc-sdk" class="otPcCenter ot-hide ot-fade-in" lang="en" aria-label="Preference center" role="region"><div role="dialog" aria-modal="true" style="height: 100%;" aria-label="Cookie Preference Center"><!-- Close Button --><div class="ot-pc-header"><!-- Logo Tag --><div class="ot-pc-logo" role="img" aria-label="Company Logo"><img alt="Company Logo" src="https://cdn.cookielaw.org/logos/static/ot_company_logo.png"></div></div><!-- Close Button --><div id="ot-pc-content" class="ot-pc-scrollbar"><div class="ot-optout-signal ot-hide"><div class="ot-optout-icon"><svg xmlns="http://www.w3.org/2000/svg"><path class="ot-floating-button__svg-fill" d="M14.588 0l.445.328c1.807 1.303 3.961 2.533 6.461 3.688 2.015.93 4.576 1.746 7.682 2.446 0 14.178-4.73 24.133-14.19 29.864l-.398.236C4.863 30.87 0 20.837 0 6.462c3.107-.7 5.668-1.516 7.682-2.446 2.709-1.251 5.01-2.59 6.906-4.016zm5.87 13.88a.75.75 0 00-.974.159l-5.475 6.625-3.005-2.997-.077-.067a.75.75 0 00-.983 1.13l4.172 4.16 6.525-7.895.06-.083a.75.75 0 00-.16-.973z" fill="#FFF" fill-rule="evenodd"></path></svg></div><span></span></div><h2 id="ot-pc-title">Cookie Preference Center</h2><div id="ot-pc-desc">We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our <a href="https://www.elsevier.com/legal/cookienotice/_nocache" target="_blank">Cookie Policy</a> and the list of <a href="https://support.google.com/admanager/answer/9012903" target="_blank">Google Ad-Tech Vendors</a>.
<br>
<br>
You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer. See the different category headings below to find out more or change your settings.
<br>
</div><button id="accept-recommended-btn-handler">Allow all</button><section class="ot-sdk-row ot-cat-grp"><h3 id="ot-category-title"> Manage Consent Preferences</h3><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="1"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-1" aria-labelledby="ot-header-id-1 ot-status-id-1"></button><!-- Accordion header --><div class="ot-acc-hdr ot-always-active-group"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-1">Strictly Necessary Cookies</h4><div id="ot-status-id-1" class="ot-always-active">Always active</div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-1">These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
<br><br></p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="1">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="3"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-3" aria-labelledby="ot-header-id-3"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-3">Functional Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-3" id="ot-group-id-3" role="switch" class="category-switch-handler" data-optanongroupid="3" aria-labelledby="ot-header-id-3"> <label class="ot-switch" for="ot-group-id-3"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Functional Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-3">These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="3">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="2"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-2" aria-labelledby="ot-header-id-2"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-2">Performance Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-2" id="ot-group-id-2" role="switch" class="category-switch-handler" data-optanongroupid="2" aria-labelledby="ot-header-id-2"> <label class="ot-switch" for="ot-group-id-2"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Performance Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-2">These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="2">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="4"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-4" aria-labelledby="ot-header-id-4"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-4">Targeting Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-4" id="ot-group-id-4" role="switch" class="category-switch-handler" data-optanongroupid="4" aria-labelledby="ot-header-id-4"> <label class="ot-switch" for="ot-group-id-4"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Targeting Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-4">These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. If you do not allow these cookies, you will experience less targeted advertising.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="4">Cookie Details List‎</button></div></div></div><!-- Groups sections starts --><!-- Group section ends --><!-- Accordion Group section starts --><!-- Accordion Group section ends --></section></div><section id="ot-pc-lst" class="ot-hide ot-hosts-ui ot-pc-scrollbar"><div id="ot-pc-hdr"><div id="ot-lst-title"><button class="ot-link-btn back-btn-handler" aria-label="Back"><svg id="ot-back-arw" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 444.531 444.531" xml:space="preserve"><title>Back Button</title><g><path fill="#656565" d="M213.13,222.409L351.88,83.653c7.05-7.043,10.567-15.657,10.567-25.841c0-10.183-3.518-18.793-10.567-25.835
                    l-21.409-21.416C323.432,3.521,314.817,0,304.637,0s-18.791,3.521-25.841,10.561L92.649,196.425
                    c-7.044,7.043-10.566,15.656-10.566,25.841s3.521,18.791,10.566,25.837l186.146,185.864c7.05,7.043,15.66,10.564,25.841,10.564
                    s18.795-3.521,25.834-10.564l21.409-21.412c7.05-7.039,10.567-15.604,10.567-25.697c0-10.085-3.518-18.746-10.567-25.978
                    L213.13,222.409z"></path></g></svg></button><h3>Cookie List</h3></div><div class="ot-lst-subhdr"><div class="ot-search-cntr"><p role="status" class="ot-scrn-rdr"></p><input id="vendor-search-handler" type="text" name="vendor-search-handler" placeholder="Search…" aria-label="Cookie list search"> <svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 -30 110 110" aria-hidden="true"><title>Search Icon</title><path fill="#2e3644" d="M55.146,51.887L41.588,37.786c3.486-4.144,5.396-9.358,5.396-14.786c0-12.682-10.318-23-23-23s-23,10.318-23,23
            s10.318,23,23,23c4.761,0,9.298-1.436,13.177-4.162l13.661,14.208c0.571,0.593,1.339,0.92,2.162,0.92
            c0.779,0,1.518-0.297,2.079-0.837C56.255,54.982,56.293,53.08,55.146,51.887z M23.984,6c9.374,0,17,7.626,17,17s-7.626,17-17,17
            s-17-7.626-17-17S14.61,6,23.984,6z"></path></svg></div><div class="ot-fltr-cntr"><button id="filter-btn-handler" aria-label="Filter" aria-haspopup="true"><svg role="presentation" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 402.577 402.577" xml:space="preserve"><title>Filter Icon</title><g><path fill="#fff" d="M400.858,11.427c-3.241-7.421-8.85-11.132-16.854-11.136H18.564c-7.993,0-13.61,3.715-16.846,11.136
      c-3.234,7.801-1.903,14.467,3.999,19.985l140.757,140.753v138.755c0,4.955,1.809,9.232,5.424,12.854l73.085,73.083
      c3.429,3.614,7.71,5.428,12.851,5.428c2.282,0,4.66-0.479,7.135-1.43c7.426-3.238,11.14-8.851,11.14-16.845V172.166L396.861,31.413
      C402.765,25.895,404.093,19.231,400.858,11.427z"></path></g></svg></button></div><div id="ot-anchor"></div><section id="ot-fltr-modal"><div id="ot-fltr-cnt"><button id="clear-filters-handler">Clear</button><div class="ot-fltr-scrlcnt ot-pc-scrollbar"><div class="ot-fltr-opts" role="list"><div class="ot-fltr-opt" role="listitem"><div class="ot-chkbox"><input id="chkbox-id" type="checkbox" class="category-filter-handler"> <label for="chkbox-id"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div><div class="ot-fltr-btns"><button id="filter-apply-handler">Apply</button> <button id="filter-cancel-handler">Cancel</button></div></div></div></section></div></div><section id="ot-lst-cnt" class="ot-host-cnt ot-pc-scrollbar"><div id="ot-sel-blk"><div class="ot-sel-all"><div class="ot-sel-all-hdr"><span class="ot-consent-hdr">Consent</span> <span class="ot-li-hdr">Leg.Interest</span></div><div class="ot-sel-all-chkbox"><div class="ot-chkbox" id="ot-selall-hostcntr"><input id="select-all-hosts-groups-handler" type="checkbox"> <label for="select-all-hosts-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-vencntr"><input id="select-all-vendor-groups-handler" type="checkbox"> <label for="select-all-vendor-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-licntr"><input id="select-all-vendor-leg-handler" type="checkbox"> <label for="select-all-vendor-leg-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div></div><div class="ot-sdk-row"><div class="ot-sdk-column"><ul id="ot-host-lst"></ul></div></div></section></section><div class="ot-pc-footer ot-pc-scrollbar"><div class="ot-btn-container"> <button class="save-preference-btn-handler onetrust-close-btn-handler">Confirm my choices</button></div><!-- Footer logo --><div class="ot-pc-footer-logo"><a href="https://www.onetrust.com/products/cookie-consent/" target="_blank" rel="noopener noreferrer" aria-label="Powered by OneTrust Opens in a new Tab"><img alt="Powered by Onetrust" src="https://cdn.cookielaw.org/logos/static/powered_by_logo.svg" title="Powered by OneTrust Opens in a new Tab"></a></div></div><!-- Cookie subgroup container --><!-- Vendor list link --><!-- Cookie lost link --><!-- Toggle HTML element --><!-- Checkbox HTML --><!-- plus minus--><!-- Arrow SVG element --><!-- Accordion basic element --><span class="ot-scrn-rdr" aria-atomic="true" aria-live="polite"></span><!-- Vendor Service container and item template --></div><iframe class="ot-text-resize" sandbox="allow-same-origin" title="onetrust-text-resize" style="position: absolute; top: -50000px; width: 100em;" aria-hidden="true"></iframe></div></div><div id="crossmark-widget" style="display: none;"><div class="crossmark-reset crossmark-overlay"></div><div class="crossmark-reset crossmark-popup"><div class="crossmark-reset crossmark-popup__offset"><div class="crossmark-reset crossmark-popup__inner"><div class="crossmark-reset crossmark-popup__header"><button class="crossmark-reset crossmark-popup__btn-close"><span class="sr-only">__("articleCrossmark.closePopup")</span></button></div><div class="crossmark-reset crossmark-popup__content-wrapper"><iframe class="crossmark-reset crossmark-popup__content" title="Crossmark service - Intentionally blank" aria-hidden="false" tabindex="0" src="https://crossmark.crossref.org/dialog?doi=10.1016%2Fj.cell.2021.11.007&amp;domain=www.cell.com&amp;uri_scheme=https%3A&amp;cm_version=v2.0"></iframe></div></div></div></div></div></body></html>